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 We have successfully applied the Zr→Zn methodology developed in the Wipf group to 
the preparation of functionalized allylic amides and alcohols via the 1,2-addition to imines and 
α-keto esters.  During the preparation of allylic amides, concomitant formation of C-
cyclopropylalkylamides was observed in CH2Cl2.  The combination of the Zr→Zn methodology 
with the Simmons-Smith cyclopropanation reaction has led to the discovery of a novel cascade 
reaction for the preparation of C,C-dicyclopropylmethylamides from simple, readily available 
starting materials.  These functionalized amides have served as precursors in a diversity-oriented 
approach for the preparation of 7-, 8-, and 9-membered azaspirocyclic ring structures based on 
reductive amination, epoxide opening or ring-closing metathesis strategies. 
 Finally, a small library of α,β-cyclopropyl-γ-amino acids was prepared in 6-7 steps from 
readily available starting materials and evaluated for their potential as peptide mimetics. Simple 
amide derivatives were found to adopt stable sheet-like structures in the solid state, whereas the 
structural properties of oligopeptides were not readily assessed using crystallographic 
techniques.  A combination of molecular modeling, circular dichroism and NMR studies was 
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1.1.1 Preparation and Use of Alkenylzirconocenes 
The development of organozirconium compounds as useful reactive intermediates for synthetic 
organic and inorganic chemists was sparked nearly two decades after the synthesis of the first 
zirconocene, Cp2ZrBr2,1 by the preparation of zirconocene hydrides2 in the early 1970’s.  These 
complexes have found broad use in synthetic organic and polymer chemistry.  Shortly after the 
discovery of zirconocene hydrochloride, Schwartz and co-workers pioneered its use for the 
functionalization of alkenes3 and alkynes4 via hydrometalation, and the reagent is now 
commonly known as “Schwartz reagent”.  Hydrozirconation5 is a mild method for the 
preparation of functionalized organometallic compounds from readily available precursors 
(alkenes and alkynes).  Original preparations of Schwartz reagent suffered from contamination 
with inorganic salts or over-reduced zirconocene dihydride;2a,6 an improved protocol was 
introduced by Buchwald and co-workers incorporating a CH2Cl2 washing step to convert the 
dihydride to hydrochloride.7  While traditional organometallic reagents such as organolithiums 
                                                 
1 Wilkinson, G.; Pauson, P. L.; Birmingham, J. M.; Cotton, F. A. J. Am. Chem. Soc. 1953, 75, 1011. 
2 (a) Wailes, P. C.; Weigold, H. J. Organomet. Chem. 1970, 24, 405. (b) Wailes, P. C.; Weigold, H. J. Organomet. 
Chem. 1970, 24, 413. 
3 (a) Wailes, P. C.; Weigold, H. J. Organomet. Chem. 1972, 43, C32. (b) Hart, D. W.; Schwartz, J. J. Am. Chem. 
Soc. 1974, 96, 8115. 
4 (a) Wailes, P. C.; Weigold, H.; Bell, A. P. J. Organomet. Chem. 1971, 27, 373. (b) Hart, D. W.; Blackburn, T. F.; 
Schwartz, J. J. Am. Chem. Soc. 1975, 97, 679. 
5 (a) Schwartz, J.; Labinger, J. A. Angew. Chem., Int. Ed. Engl. 1976, 15, 333. (b) Labinger, J. A. In Comprehensive 
Organic Synthesis; Trost, B. M.; Fleming, I., Eds.; Pergamon Press: Oxford, 1991; Vol. 8, p 667. (c) Wipf, P; Jahn, 
H. Tetrahedron, 1996, 52, 12853. (d) Wipf, P.; Takahashi, H.; Zhuang, N. Pure Appl. Chem. 1998, 70, 1077. 
6 (a) Wailes, P. C.; Weigold, H. Inorg. Synth. 1979, 19, 223. (b) Carr, D. B.; Schwartz, J. J. Am. Chem. Soc. 1979, 
101, 3521. 
7 (a) Buchwald, S. L.; La Maire, S. J.; Nielsen, R. B.; Watson, B. T.; King, S. M. Tetrahedron Lett. 1987, 28, 3895. 
(b) Buchwald, S. L.; La Maire, S. J.; Nielsen, R. B.; Watson, B. T.; King, S. M. Org. Synth. 1993, 71, 77. 
 2
and organomagnesiums suffer from poor functional group compatability, the hydrozirconation of 
alkynes can be carried out in the presence of ethers, bulky esters (ie, TIPS, t-Bu), acyl silanes, 
and alkenes (with ≤ 1 equiv Cp2ZrHCl).  Despite the inherent polarization of the C-Zr bond 
(similar to C-Mg of Grignard reagents), their reactivity is comparatively attenuated due to steric 
shielding of the organometallic bond by the cyclopentadienyl ligands.  However, the 
transmetalation5c,8 of alkyl- and alkenylzirconocenes has been accomplished with a myriad of 
metals, including Al,9 B,10 Cu,11 Hg,12 Ni,13 Pd,14 and Sn,15 thereby allowing for selective 
transformations of the alkenylorganometallic reagent.  For example, upon hydrozirconation of 
alkynes 1, the alkenylzironcocenes16 2 have been employed as intermediates for the 
stereoselective introduction of numerous functional groups.  Trapping with an electrophilic 
source of halogens affords vinyl halides 3;3,4b,17 reaction with isonitriles 4 followed by mild 
hydrolysis (aqueous HOAc) affords enals 5;18 Pd(0) mediated cross-coupling reactions of 
halocarbons 6 with or without added ZnCl2 afford trisubstituted olefins 7;19,20 activation with 
                                                 
8 Lipshutz, B. H.; Pfeiffer, S. S.; Tomioka, T.; Noson, K. In Titanium and Zirconium in Organic Synthesis; Marek, 
I., Ed.; Wiley-VCH: Weinheim, 2002; p 110. 
9 (a) Carr, D. B.; Schwartz, J. J. Am. Chem. Soc. 1977, 99, 638. (b) Van Horn, D. E.; Negishi, E. J. Am. Chem. Soc. 
1978, 100, 2252. (c) Yoshida, T.; Negishi, E. J. Am. Chem. Soc. 1981, 103, 4985. (d) Negishi, E.; Boardman, L. D. 
Tetrahedron Lett. 1982, 23, 3327. (e) Kondakov, D. Y.; Negishi, E. J. Am. Chem. Soc. 1996, 118, 1577. 
10 (a) Marselia, J. A.; Caulton, K. G. J. Am. Chem. Soc. 1982, 104, 2361. (b) Cole, T. E.; Quintanilla, R.; Rodewald, 
S. Organometallics 1991, 10, 3777. (c) Cole, T. E.; Rodewald, S.; Watson, C. L. Tetrahedron Lett. 1992, 33, 5295. 
(d) Cole, T. E.; Quintanilla, R. J. Org. Chem. 1992, 57, 7366. (e) Pereira, S.; Srebnik, M. Organometallics 1995, 14, 
3127. 
11 (a) Yoshifuji, M.; Loots, M. J.; Schwartz, J. Tetrahedron Lett. 1977, 15, 1303. (b) Wipf, P.; Smitrovich, J. H. J. 
Org. Chem. 1991, 56, 6494. (c) Wipf, P.; Smitrovich, J. H.; Moon, C.-W. J. Org. Chem. 1992, 57, 3178. 
12 Budnik, R. A.; Kochi, J. K. J. Organomet. Chem. 1976, 116, C3. 
13 (a) Negishi, E.; Van Horn, D. E. J. Am. Chem. Soc. 1977, 99, 3168. (b) Negishi, E.; Okukado, N.; King, A. O.; 
Van Horn, D. E.; Spiegel, B. I. J. Am. Chem. Soc. 1978, 100, 2254. (c) Negishi, E.; Takahashi, T.; Baba, S.; Van 
Horn, D. E.; Okukado, N. J. Am. Chem. Soc. 1987, 109, 2393. (d) Hauske, J. R.; Dorff, P.; Julian, S.; Martinelli, G.; 
Bussolari, J. Tetrahedron Lett. 1992, 33, 3715. 
14 (a) Okukado, N.; Van Horn, D. E.; Klima, W. E.; Negishi, E. Tetrahedron Lett. 1978, 16, 1027. (b) Temple, J. S.; 
Schwartz, J. J. Am. Chem. Soc. 1980, 102, 7381. (c) Hayasi, Y.; Riediker, M.; Temple, J. S.; Schwartz, J. 
Tetrahedron Lett. 1981, 22, 2629. (d) Barrett, A. G. M.; Pena, M.; Williardson, J. A. J. Org. Chem. 1996, 61, 1082. 
15 (a) Kim, S.; Kim, K. H. Tetrahedron Lett. 1995, 36, 3725. (b) Vedejs, E.; Haight, A. R.; Moss, O. J. Am. Chem. 
Soc. 1992, 114, 6556. 
16 (a) Wipf, P.; Kendall, C. Chem. Eur. J. 2002, 8, 1778. (b) Wipf, P.; Nunes, R. L. Tetrahedron 2004, 60, 1269. 
17 For representative examples in total synthesis, see (a) Ragan, J. A.; Nakatsuka, M.; Smith, D. B.; Uehling, D. E.; 
Schreiber, S. L. J. Org. Chem. 1989, 54, 4267. (b) Ireland, R. E.; Highsmith, T. K.; Gegnas, L. D.; Gleason, J. L. J. 
Org. Chem. 1992, 57, 5071. (c) Smith, A. B.; Chen, S. S.-Y.; Nelson, F. C.; Reichert, J. M.; Salvatore, B. A. J. Am. 
Chem. Soc. 1995, 117, 12013. 
18 (a) Bertolo, C. A.; Schwartz, J. J. Am. Chem. Soc. 1976, 98, 262. (b) Fryzuk, M. D.; Bates, G. S.; Stone, C. 
Tetrahedron Lett. 1986, 27, 1537. (c) Negishi, E.; Swanson, D. R.; Miller, S. R. Tetrahedron Lett. 1988, 29, 1631. 
(d) Wipf, P.; Xu, W. J. Org. Chem. 1996, 61, 6556. 
19 Negishi, E.; Okukado, N.; King, A. O.; Van Horn, D. E.; Spiegel, B. I. J. Am. Chem. Soc. 1978, 100, 2254. 
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Ag(I) salts affords cationic zirconocenes which act as nucleophiles in the addition to aldehydes 8 
affording allylic alcohols 9;21 and acid chlorides 10 react in the presence of catalytic Cu(I) salts 











































Scheme 1.1. Hydrozirconation-trapping of alkenes and alkynes 
 
 One of the most challenging facets of hydrozirconation is the selective hydrometalation 
of unsymmetrical internal alkynes.  Generally, there is preferential hydrozirconation to afford the 
alkenylzirconocene bearing zirconium at the sterically least demanding position, although 
sometimes this preference is only modest.  Recently, Panek and co-workers have developed a 
methodology for the stereoselective preparation of E- or Z-olefins from internal trimethylsilyl-
substituted alkynes (Scheme 1.2).23  Hydrozirconation of alkyne 12 in THF at 50 °C with 2.5 
equiv of Cp2ZrHCl allowed for the thermodynamic equilibration to the least sterically 
encumbered alkenylzirconocene which is trapped with I2 to give vinyl iodide 13 in excellent 
                                                 
20 For Ni-catalyzed coupling of alkenylzirconocenes, see Ni, Y.; Amarasinghe, K. K. D.; Mongomery, J. Org. Lett. 
2002, 4, 1743. 
21 (a) Maeta, H.; Hashimoto, T.; Hasegawa, T.; Suzuki, K. Tetrahedron Lett. 1992, 33, 5965. (b) Wipf, P.; Xu, W. J. 
Org. Chem. 1993, 58, 825. 
22 Wipf, P.; Xu, W. Synlett 1992, 718. 
23 (a) Panek, J. S.; Hu, T. J. Org. Chem. 1997, 62, 4914. (b) Panek, J. S.; Hu, T. J. Org. Chem. 1997, 62, 4912. (c) 
Arefolov, A.; Langille, N. F.; Panek, J. S. Org. Lett. 2001, 3, 3281. (d) Langille, N. F.; Panek, J. S. Org. Lett. 2004, 
6, 3203. 
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yield.  Negishi coupling with ethylzinc iodide afforded the trisubstituted alkene 14.  
Iododesilylation in CH2Cl2 afforded vinyl iodide which was treated under Negishi cross-coupling 
conditions with the in situ prepared functionalized zinc reagent 15 affording 77% of the 
functionalized Z-trisubstituted alkene 16, an advanced intermediate for their proposed synthesis 
of discodermolide.  The most interesting feature of this protocol is that the E-trisubstituted 
isomer can be easily prepared simply by reversing the Negishi coupling steps.  Coupling of 13 
with alkylzinc reagent 15 afforded the intermediate vinylsilane 17 (55%).  Iododesilylation 











































1) I2, CH2Cl2 (70%)
2) Pd(PPh3)4













Scheme 1.2. Synthesis of (E)- and (Z)-trisubstituted olefins via Pd-catalyzed cross-coupling 
reactions 
 Alternatively, alkenylzirconocenes have been prepared by the oxidative addition of 
Cp2ZrBu2 (known as the Negishi reagent24) into vinyl halides;25 and Marek and co-workers have 
                                                 
24 Negishi, E.; Cederbaum, F. E.; Takahashi, T. Tetrahedron Lett. 1986, 27, 2829. 
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extended this methodology to include ethers,26 sulfonates, sulfides sulfoxides and sulfones.27  
Wipf and Kendall have recently taken advantage of this approach for the preparation of 
alkenylzirconocenes for the synthesis of allylic and homoallylic amides.28  Treatment of 2-
bromopropene with the Negishi reagent affords the vinylzirconocene 20.  After transmetalation 
to dimethylzinc, and treatment with CH2I2 followed by imine 21, homoallylic amide 22 is formed 
in 75% yield.  Conversely, if 21 is added directly after Me2Zn, a mixture of allylic and 
























Scheme 1.3. Synthesis of vinylorganometallics by Zr(II) insertion processes 
 
1.1.2 Addition of Organozinc Reagents to Imines and Carbonyl Compounds 
 The addition of alkylzinc reagents to aldehydes29 and imines30 has been widely studied 
and numerous investigations towards the asymmetric preparation of secondary alcohols and 
                                                 
25 (a) Takahashi, T.; Kotora, M.; Fischer, R.; Nishihara, Y.; Nakajima, K. J. Am. Chem. Soc. 1995, 117, 11039. (b) 
Ichikawa, J.; Fujiwara, M.; Nawata, H.; Okauchi, T.; Minami, T. Tetrahedron Lett. 1996, 37, 8799. (c) Fujiwara, M.; 
Ichikawa, J.; Okauchi, T.; Minami, T. Tetrahedron Lett. 1999, 40, 7261. 
26 Liard, A.; Marek, I. J. Org. Chem. 2000, 65, 7218. 
27 (a) Farhat, S.; Marek, I. Angew. Chem., Int. Ed. Engl. 2002, 41, 1410. (b) Farhat, S.; Zouev, I.; Marek, I. 
Tetrahedron 2004, 60, 1329. 
28 Wipf, P.; Kendall, C. Org. Lett. 2001, 3, 2773. 
29 For recent reviews on the catalytic asymmetric organozinc additions to carbonyl compounds, see (a) Noyori, R.; 
Kitamura, M. Angew Chem., Int. Ed. Engl. 1991, 30, 49. (b) Soai, K.; Niwa, S. Chem. Rev. 1992, 92, 833. (c) Pu, L.; 
Yu, H.-B. Chem. Rev. 2001, 101, 757. 
30 For recent reviews on the asymmetric alkylation of imines, see (a) Enders, D.; Reinhold, U. Tetrahedron: 
Asymmetry 1997, 8, 1895. (b) Bloch, R. Chem. Rev. 1998, 98, 1407. (c) Kobayashi, S.; Ishitani, H. Chem. Rev. 1999, 
99, 1069. 
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amines have been reported.  The majority of ligands or catalysts for the dialkylzinc addition to 
aldehydes perform poorly when aliphatic aldehydes are used.  Wipf and Wang have recently 
designed a new ligand scaffold, CHAOx,  for the enantioselective alkylation of aldehydes with 
diethylzinc (Scheme 1.4).31  This ligand, 26, is particularly effective for the alkylation of 
aliphatic aldehydes affording optically enriched secondary alcohols with very good to excellent 
enantioselectivities (ee 83-98%) while decreased selectivity was observed for aromatic or α,β-
unsaturated aldehydes (ee 11-80%).  While numerous ligands for the alkylzinc addition to 
aldehydes have a pronounced non-linear relationship32 between eecatalyst and eeproduct, the CHAOx 
ligand has been found to form a monomeric complex with ethylzinc using molecular modeling.33  
This prediction was verified experimentally when a linear relationship between eecatalyst and 













Scheme 1.4. Catalytic asymmetric addition of diethylzinc to aldehydes with the CHAOx ligand 
26 
 
 There have been numerous reports in recent years detailing the asymmetric addition of 
alkylzinc reagents to imines.34  Analogous to the findings for aldehydes, the addition of alkyl 
                                                 
31 Wipf, P.; Wang, X. Org. Lett. 2002, 4, 1197. 
32 (a) Girard, C.; Kagan, H. B. Angew. Chem., Int. Ed. Engl. 1998, 37, 2923. (b) Fenwick, D. R.; Kagan, H. B. Top. 
Stereochem. 1999, 22, 257. (c) Heller, D.; Drexler, H.-J.; Fischer, C.; Buschmann, H.; Baumann, W.; Heller, B. 
Angew. Chem., Int. Ed. Engl. 2000, 39, 495. (d) Kagan, H. B. Synlett 2001, 888. (e) Kagan, H. B. Adv. Synth. Cat. 
2001, 343, 227. 
33 Wipf, P.; Pierce, J. G.; Wang, X. Tetrahedron: Asymmetry 2003, 14, 3605. 
34 (a) Fujihara, H.; Nagai, K.; Tomioka, K. J. Am. Chem. Soc. 2000, 122, 12055. (b) Jimeno, C.; Reddy, K. S.; Sola, 
L.; Moyano, A.; Pericas, M. A.; Riera, A. Org. Lett. 2000, 2, 3157. (c) Sato, I.; Kodaka, R.; Soai, K. J. Chem. Soc., 
Perkin Trans. 1 2001, 2912. (d) Pinho, P.; Andersson, P. G. Tetrahedron 2001, 57, 1615. (e) Porter, J. R.; Traverse, 
J. F.; Hoveyda, A. H.; Snapper, M. L. J. Am. Chem. Soc. 2001, 123, 984. (f) Porter, J. R.; Traverse, J. F.; Hoveyda, 
A. H.; Snapper, M. L. J. Am. Chem. Soc. 2001, 123, 10409. (g) Wei, C.; Li, C.-J. J. Am. Chem. Soc. 2002, 124, 
5638. (h) Dahmen, S.; Bräse, S. J. Am. Chem. Soc. 2002, 124, 5940. (i) Zhang, H. L.; Zhang, X. M.; Gong, L. Z.; 
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zinc reagents to imines does not occur in the absence of either a ligand to activate the zinc 
reagent or a Lewis acid to activate the imine.  Charette and co-workers have recently described 
their efforts towards the copper-catalyzed asymmetric addition of alkylzinc reagents to N-
diphenylphosphinoyl imines 28.35  In the presence of only 6 mol % Cu(OTf)2 and 3 mol % of the 
bisphosphine monoxide catalyst 29 (coined (R,R)-BozPHOS), dialkylzinc reagents (2-3 equiv) 
can be added to 28 at 0 °C in toluene over 12-36 h, affording the desired secondary 
phosphinamides 30 in excellent yields and enantioselectivities.36  Diphosphine catalysts such as 
Me-DuPHOS can also be used; however in the case of unreactive zinc reagents such as Me2Zn, a 










R22Zn (2 equiv), toluene
R1 R2
NHP(O)Ph2 R1 = Aryl, cyclopropyl
         furyl





Scheme 1.5. Catalytic asymmetric addition of dialkylzinc reagents to N-diphenylphosphinoyl 
imines 
 
 While Knochel and co-workers have made significant strides towards the preparation of 
functionalized organozinc reagents,37 the addition of alkenyl- or alkynylzinc reagents represents 
a step forward for the preparation of highly valuable allylic and propargylic alcohols and 
amines.38,39  The attraction of alkynes as direct precursors for organometallic reagents stems 
                                                 
Mi, A. Q.; Cui, X.; Jiang, Y. Z.; Choi, M. C. K.; Chan, A. S. C. Org. Lett. 2002, 4, 1399. (j) Hermanns, N.; Dahmen, 
S.; Bolm, C.; Bräse, S. Angew. Chem., Int. Ed. Engl. 2002, 41, 3692. 
35 (a) Boezio, A. A.; Charette, A. B. J. Am. Chem. Soc. 2003, 125, 1692. (b) Boezio, A. A.; Pytkowicz, J.; Côté, A.; 
Charette, A. B. J. Am. Chem. Soc. 2003, 125, 14260. (c) Côté, A.; Boezio, A. A.; Charette, A. B. Proc. Natl. Acad. 
Sci. USA 2004, 101, 5405. 
36 Functionalized diorganozinc reagents prepared according to Knochel’s protocol have also been used in this 
reaction, although (CuOTf)2•PhMe is substituted for Cu(OTf)2. 
37 For reviews on the preparation and use of functionalized organozinc reagents, see (a) Knochel, P.; Singer, R. D. 
Chem. Rev. 1993, 93, 2117. (b) Knochel, P.; Millot, N.; Rodriguez, A. L.; Tucker, L. E. Org. React. 2001, 58, 417. 
38 For representative examples of the addition of alkynylides to aldehydes, see (a) Shahi, S. P.; Koide, K. Angew. 
Chem., Int. Ed. Engl. 2004, 43, 2525. 
39 For representative additions of alkynylides to imines, see (a) Enders, D.; Schankat, J. Helv. Chim. Acta 1995, 78, 
970. (b) Harwood, L. M.; Vines, K. J.; Drew, M. G. B. Synlett 1996, 1051. (c) Brasseur, D.; Marek, I.; Normant, J.-
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from their ready availability from commercial sources and bench stability.  Recently, it has been 
demonstrated by Carreira and co-workers that zinc alkynylides can be added to aldehydes and 
imines under mild conditions to afford propargylic alcohols40 and amides41 in excellent yields 
and, in the case of aldehydes, high enantioselectivity (Scheme 1.6).  Treatment of alkyne 31 and 
aldehyde 32 with Et3N in the presence of catalytic Zn(OTf)2 and N-methylephedrine (33) affords 
the optically enriched propargylic alcohols 34.  This methodology has also been used for the 
preparation of propargylic amines via the addition of zinc alkynylides (stoichiometric) to in situ 













R4 PPh21) Zn(OTf)2, Et3N
    TMPDA
2) R3CH=NR4 (35)




Scheme 1.6. Preparation of functionalized propargylic alcohols and amines by Zn(OTf)2 
promoted alkynylation 
 
 Early studies by Oppolzer and Radinov of the asymmetric addition of divinylzinc to 
aldehydes43 in the presence of chiral amino alcohols have led to the implementation of numerous 
protocols for the stereoselective synthesis of allylic alcohols.44  In 1991, Srebnik reported the 
                                                 
F. Tetrahedron 1996, 52, 7235. (d) Sato, Y.; Nishimata, T.; Mori, M. Heterocycles 1997, 44, 443. (e) Cossy, J.; 
Poitevin, C.; Pardo, D. G.; Peglion, J.-L.; Dessinges, A. Synlett 1998, 251. (f) Li, C.-J.; Wei, C. Chem. Commun. 
2002, 268. (g) Koradin, C.; Polborn, K.; Knochel, P. Angew. Chem., Int. Ed. Engl. 2002, 41, 2535. 
40 (a) Frantz, D. E.; Fässler, R.; Carreira, E. M. J. Am. Chem. Soc. 2000, 122, 1806. (b) Anand, N. K.; Carreira, E. 
M. J. Am. Chem. Soc. 2001, 123, 9687. (c) Boyall, D.; Frantz, D. E.; Carreira, E. M. Org. Lett. 2002, 4, 2605. 
41 (a) Frantz, D. E.; Fässler, R.; Carreira, E. M. J. Am. Chem. Soc. 1999, 121, 11245. (b) Fischer, C.; Carreira, E. M. 
Org. Lett. 2001, 3, 4319. (c) Fischer, C.; Carreira, E. M. Org. Lett. 2004, 6, 1497. 
42 For the addition of zinc alkynylides to nitrones, see Fässler, R.; Frantz, D. E.; Oetiker, J.; Carreira, E. M. Angew. 
Chem., Int. Ed. Engl. 2002, 41, 3054. 
43 Oppolzer, W.; Radinov, R. N. Tetrahedron Lett. 1988, 29, 5645. 
44 For a functionally related Ni catalyzed approach to allylic alcohols and amines, see (a) Huang, W.-S.; Chan, J.; 
Jamison, T. F. Org. Lett. 2000, 2, 4221. (b) Patel, S. J.; Jamison, T. F. Angew. Chem., Int. Ed. Engl. 2003, 42, 1364. 
(c) Miller, K. M.; Huang, W.-S.; Jamison, T. F. J. Am. Chem. Soc. 2003, 125, 3442. (d) Molinaro, C.; Jamison, T. F. 
J. Am. Chem. Soc. 2003, 125, 8076. (e) Miller, K. M.; Luanphaisarnnont, T.; Molinaro, C.; Jamison, T. F. J. Am. 
Chem. Soc. 2004, 126, 4130. (f) Patel, S. J.; Jamison, T. F. Angew. Chem., Int. Ed. Engl. 2004, 43, 3941. 
 9
preparation of vinylzinc reagents via transmetalation of alkenylboranes with dialkylzincs, while 
also studying the migratory properties of alkyl and alkenyl ligands on zinc.45  Shortly thereafter, 
Oppolzer and Radinov reported the enantioselective vinylation of aldehydes with vinylzinc 
halides46 in the presence of a chiral amino alcohol.  They have since modified this approach to 
incorporate the in situ generation of vinylzinc reagents via the hydroboration-transmetalation 
pathway of Srebnik in both the inter-47 and intramolecular48 variant of this reaction.  Recently, 
Walsh and co-workers adapted this protocol to the enantioselective synthesis of amino acids and 
allylic amines (Scheme 1.7).49  The allylic alcohols 39 were prepared by hydroboration of 
terminal alkynes 31 with dicyclohexylborane followed by transmetalation to zinc and 
asymmetric addition to benzaldehyde in the presence of Nugent’s ligand, MIB.50  Transposition 
of the olefin using Overman’s trichloracetimidate rearrangement51 afforded the valuable allylic 
amides in good to excellent yields with complete transfer of configuration.  Oxidative cleavage 
of the olefin to the methyl ester using Marshall’s protocol (O3, NaOH, MeOH)52 affords the 





3) 37 (2 mol %)






















Scheme 1.7. B→Zn transmetalation and addition to aldehydes: Enantioselective synthesis of 
amino acids and allylic amines 
                                                 
45 (a) Srebnik, M. Tetrahedron Lett. 1991, 32, 2449. (b) Laloe, E.; Srebnik, M. Tetrahedron Lett. 1994, 35, 5587. 
46 Oppolzer, W.; Radinov, R. N. Tetrahedron Lett. 1991, 32, 5777. 
47 Oppolzer, W.; Radinov, R. N. Helv. Chim. Acta 1992, 75, 170. 
48 (a) Oppolzer, W.; Radinov, R. N.; De Brabander, J. Tetrahedron Lett. 1995, 36, 2607. (b) Oppolzer, W.; Radinov, 
R. N.; El-Sayed, E. J. Org. Chem. 2001, 66, 4766. 
49 Chen, Y. K.; Lurain, A. E.; Walsh, P. J. J. Am. Chem. Soc. 2002, 124, 12225. 
50 Nugent, W. A. J. Chem. Soc., Chem. Commun. 1999, 1369. 
51 (a) Overman, L. E. J. Am. Chem. Soc. 1976, 98, 2901. (b) Overman, L. E. Acc. Chem. Res. 1980, 13, 218. 
52 (a) Marshall, J. A.; Garofalo, A. W.; Sedrani, R. C. Synlett 1992, 643. (b) Marshall, J. A.; Garofalo, A. W. J. Org. 
Chem. 1993, 58, 3675. 
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 Wipf and Xu reported in 1994 that the vinylzinc reagents prepared via the 
hydrozirconation of alkynes 1 and transmetalation to dimethylzinc underwent smooth addition to 
aldehydes affording racemic 42 (Table 1.1).53  Interestingly, whereas alkyl- or alkenylzinc 
reagents require activation to promote their addition to aldehydes,54 the addition of alkenylzinc 
reagents prepared using this protocol proceeds without the requirement of ligand activation.  
Indeed, it was found that the addition of diethylzinc to aldehydes proceeds in the presence of 
catalytic amounts of Cp2ZrCl2 (conversion ca. 50% in 4 h compared to <5% in the absence of 
zirconocene catalyst).55  Accordingly, the presumed byproduct of the Zr→Zn transmetalation 
(Cp2ZrMeCl) is thought to be responsible for the in situ activation of aldehydes.  Subsequently, 
Wipf and Ribe have extended this protocol to include the asymmetric addition of 
alkenylzirconocenes to aldehydes in the presence of dimethylzinc and chiral ligands (Table 
1.1).55  Wipf and Xu originally reported that the Zr→Zn reaction proceeded with 38% ee in the 
presence of the diphenylprolinol ligand 43 (entry 1);53 however, an induction period was later 
discovered, and stirring 43 with the vinylzinc reagent for 1 h56 afforded 42 in 81% ee (entry 1).  
A switch to van Koten’s aminothiol ligand 44 (entry 2, R4 = Me)57 resulted in improved 
enantioselection.  Increasing the steric bulk of the aminothiol (entry 3, 45; R4 = Et) resulted in a 
modest improvement in the enantioselectivity.  The reaction works well with most aromatic 
aldehydes (entries 4-8); however, p-anisaldehyde afforded 42 with only 63% ee.  3-Hexyne 
afforded the highest ee for the vinylation of benzaldehyde (entry 9, 99% ee) while aliphatic 
aldehydes did not perform particularly well under the reaction conditions (entries 10, 11).  A 
strong positive non-linear effect32 was observed for aminothiol ligand 44, indicating the likely 
presence of a dimeric species in solution.58 
  
                                                 
53 (a) Wipf, P.; Xu, W. Tetrahedron Lett. 1994, 35, 5197. (b) Wipf, P.; Xu, W. Org. Synth. 1996, 74, 205. 
54 (a) Oguni, N.; Omi, T.; Yamamoto, Y.; Nakamura, A. Chem. Lett. 1983, 841. (b) Oguni, N.; Omi, T. Tetrahedron 
Lett. 1984, 25, 2823. (c) Kitamura, M.; Suga, S.; Kawai, K.; Noyori, R. J. Am. Chem. Soc. 1986, 108, 6071. 
55 (a) Wipf, P.; Ribe, S. J. Org. Chem. 1998, 63, 6454. (b) Ribe, S. D. Ph.D Dissertation, University of Pittsburgh, 
2003. 
56 This induction period is believed to be required to maximize the solubility of the ligand metal complex.  See ref. 
55b for details. 
57 Knotter, D. M.; van Maanen, H. L.; Grove, D. M.; Spek, A. L.; van Koten, G. Inorg. Chem. 1991, 30, 3309. 
58 Wipf, P.; Jayasuriya, N.; Ribe, S. Chirality 2003, 15, 208. 
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44; R4 = Me








1 C4H9 H Ph 43 92 38 (81a) 
2 C4H9 H Ph 44 76 89 
3 C4H9 H Ph 45 80 95 
4 C4H9 H p-ClC6H4 45 83 97 
5 C4H9 H p-CF3C6H4 45 71 93 
6 C4H9 H p-MeOC6H4 45 75 63 
7 C4H9 H m-MeOC6H4 45 79 99 
8 C(CH3)3 H Ph 45 73 83 
9 C2H5 C2H5 Ph 45 66 99 
10 C4H9 H c-C6H11 45 63 74 
11 C4H9 H PhCH2CH2 45 71 64 
a15 mol % ligand with 1 h induction period 
  
 While there are abundant reports on the asymmetric alkylation of aldehydes, the 
challenge of performing a stereocontrolled addition to ketones has only recently been 
successfully addressed.59  There are two major difficulties in this reaction.  First, ketones are 
inherently less reactive than aldehydes as there are two electron-donating alkyl groups.  Second, 
enantiofacial discrimination is challenging since the difference in size between the two 
substituents is much less apparent with two alkyl groups compared to one alkyl and one 
hydrogen substituent.  α-Keto esters have been used successfully in alkylation reactions and their 
reactivity is often comparable to aldehydes, and facial discrimination can be accomplished by 
taking advantage of the chelating properties of the keto ester.60,61,62  DiMauro and Kozlowski 
                                                 
59 (a) Dosa, P. I.; Fu, G. C. J. Am. Chem. Soc. 1998, 120, 445. (b) Ramon, D. J.; Yus, M. Tetrahedron Lett. 1998, 39, 
1239. (c) Ramon, D. J.; Yus, M. Tetrahedron 1998, 54, 5651. (d) Garcia, C.; LaRochelle, L. K.; Walsh, P. J. J. Am. 
Chem. Soc. 2002, 124, 10970. (e) Li, H.; Garcia, C.; Walsh, P. J. Proc. Nat. Acad. Sci. 2004, 101, 5425. 
60 Kovacs, L. Recl. Trav. Chim. Pays-Bas 1993, 112, 471. 
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have recently accomplished the first catalytic asymmetric ethylation of α-keto esters with 
diethylzinc (Scheme 1.8).63  In the absence of catalyst, very little conversion of keto ester 46 to 
α-hydroxy ester 48 is observed; consequently the allylic alcohol resulting from reduction of the 
ketone was the major product.  After some optimization of the ligand, the titanium complex of 47 















R1 = alkyl, aryl
R2 = alkyl  
Scheme 1.8. Catalytic asymmetric addition of diethyl zinc to α-keto esters 
  
 As part of their continuing work on the asymmetric alkylation of carbonyl compounds 
with in situ derived zinc reagents, Walsh and co-workers have developed protocols for the 
asymmetric addition of vinylzinc reagents to ketones (Scheme 1.9).64  During their initial 
attempts to extend their methodology for the preparation of allylic alcohols to include the 
addition to ketones, they observed the formation of an unexpected product.64a  After careful 
examination and optimization, the symmetric diol 49 was isolated as the major product, 
generally with excellent control of diastereoselectivity.  Combination of the methodology 
developed by Wipf and co-workers55 with the Walsh protocol for the asymmetric alkylation of 
ketones59d,e led to the discovery of an asymmetric vinylation of ketones in the presence of the 
titanium complex of ligand 50.  To achieve a high degree of facial selectivity, one of the groups 
                                                 
61 Whitesell, J. K. Chem. Rev. 1992, 92, 953. 
62 (a) Ito, Y.; Sawamura, M.; Hamashima, H.; Emura, T.; Hayashi, T. Tetrahedron Lett. 1989, 30, 4681. (b) Evans, 
D. A.; Burgey, C. S.; Kozlowski, M. C.; Tregay, S. W. J. Am. Chem. Soc. 1999, 121, 686. (c) Juhl, K.; Gathergood, 
N.; Jorgensen, K. A. J. Chem. Soc., Chem. Commun. 2000, 2211. (d) Evans, D. A.; Janey, J. M. Org. Lett. 2001, 3, 
2125. (e) Ghosh, A. K.; Shirai, M. Tetrahedron Lett. 2001, 42, 6231. (f) Jensen, K. B.; Thorbauge, J.; Hazell, R. G.; 
Jorgensen, K. A. Angew. Chem., Int. Ed. 2001, 40, 160. 
63 (a) DiMauro, E. F.; Kozlowski, M. C. Org. Lett. 2002, 4, 3781. (b) DiMauro, E. F.; Kozlowski, M. C. J. Am. 
Chem. Soc. 2002, 124, 12668. 
64 (a) Garcia, C.; Libra, E. R.; Carroll, P. J.; Walsh, P. J. J. Am. Chem. Soc. 2003, 125, 3210. (b) Li, H.; Walsh, P. J. 
J. Am. Chem. Soc. 2004, 126, 6538. 
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of the ketone must be aromatic; however, good enantioselectivity (79%) was observed for the 







    R4COR5, 50
1) Cy2BH
2) Me2Zn
3) 37 (2 mol %)

















(dr 1:1 to >20:1%)
84-98%
(ee 79-97%)
R1 = alkyl, aryl
R4, R5 = alkyl, aryl
R1 = alkyl, aryl
R4, R5 = alkyl, aryl
 
Scheme 1.9. Hydrometalation-transmetalation to zinc and addition to ketones 
 
 The first extension of the Wipf methodology to the vinylation of ketones was disclosed in 
2001 by Chavez and Jacobsen as part of their total synthesis of the phosphatase inhibitor 
fostriecin (Scheme 1.10).65  Hydrozirconation of 1-octyne and transmetalation to zinc followed 
by reaction with the epoxy ketone 53 afforded the allylic alcohol 54 with excellent control of 
diasteroselectivity (>30:1).  The use of the functionalized alkyne 55 which was required for the 
synthesis resulted in a lower isolated yield of the desired tertiary allylic alcohol; however the 
diastereoselectivity was once again excellent and 56 could be elaborated in 9 subsequent steps to 
the natural product.  
 The Zr→Zn methodology has been successfully applied by a number of research groups 
for their efforts toward the total synthesis of various natural products (Figure 1.1).  Along with 
the application towards the preparation of fostriecin, the hydrozirconation-transmetalation to zinc 
and addition to aldehydes has been used for the preparation of curacin A,18d nisamycin,66 
halichlorine,67 ratjadone,68 leucascandrolide A,69 lobatamide C,70 and laulimalide.71 
                                                 
65 Chavez, D. E.; Jacobsen, E. N. Angew. Chem., Int. Ed. Engl. 2001, 40, 3667. 
66 (a) Wipf, P.; Coish, P. D. G. Tetrahedron Lett. 1997, 38, 5073. (b) Wipf, P.; Coish, P. D. G. J. Org. Chem. 1999, 
64, 5053. 
67 Trauner, D.; Schwarz, J. B.; Danishefsky, S. J. Angew. Chem., Int. Ed. Engl. 1999, 38, 3542. 
68 Williams, D. R.; Ihle, D. C.; Plummer, S. V. Org. Lett. 2001, 3, 1383. 
69 (a) Wipf, P.; Reeves, J. T. Chem. Commun. 2002, 2066. (b) Williams, D. R.; Plummer, S. V.; Patnaik, S. Angew. 






































Scheme 1.10. Zr→Zn transmetalation and addition to an α,β-epoxyketone: Jacobsen’s total 
synthesis of fostriecin 
 
  
                                                 
70 (a) Shen, R.; Lin, C. T.; Porco Jr., J. A. J. Am. Chem. Soc. 2002, 124, 5650. (b) Shen, R.; Lin, C. T.; Bowman, E. 
J.; Bowman, B. J.; Porco Jr., J. A. J. Am. Chem. Soc. 2003, 125, 7889. 











































































Figure 1.1. Applications of the Zr→Zn methodology in total synthesis72 
                                                 
72 The bond formed using the Zr→Zn methodology is labeled in the figure. 
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1.1.3 Simmons-Smith Cyclopropanation Reactions 
Our studies toward the preparation of allylic amines using the Zr→Zn methodology have led to 
the discovery of a novel reaction pathway which affords C-cyclopropylalkylamides in good 
yields and with excellent diastereofacial control.  This reaction presumably occurs via the 
directed Simmons-Smith cyclopropanation of the intermediate allylic amide.73,74  Nearly thirty 
years after the original report of the preparation of IZnCH2I by Emschwiller,75 Simmons and 
Smith reported that this reagent was useful for the stereospecific synthesis of cyclopropanes from 
alkenes,73 and it has become known as the Simmons-Smith reagent.  While a number of metals 
other than zinc have been shown to be effective for the cyclopropanation of olefins,76,77,78 zinc 
reagents are the most broadly utilized.  Of the most prominently used metals, samarium and zinc 
exhibit excellent chemoselectivity for allylic alcohols in the presence of other alkenes while 
aluminum reagents will react with isolated olefins in the presence of allylic alcohols (Table 
1.2).79  The cyclopropanation of geraniol proceeds with excellent control of regioselectivity for 
the allylic alcohol when zinc and samarium reagents are used (entries 1, 3).  Conversely, the 
aluminum based reagent affords almost exclusively cyclopropane at the distal olefin site (entry 
2).  There have been reports that initial deprotonation of allylic alcohols facilitates the directed 
cyclopropanation reaction, however in this case there appears to be little effect on the 
regioselectivity (entries 4-7).80  The Shi reagent, the most reactive cyclopropanating reagent 
prepared to date (CF3CO2ZnCH2I), affords a statistical mixture of products (entry 8).81  If the 
                                                 
73 (a) Simmons, H. E.; Smith, R. D. J. Am. Chem. Soc. 1958, 80, 5323. (b) Smith, H. E.; Simmons, R. D. J. Am. 
Chem. Soc. 1959, 81, 4256. 
74 (a) Simmons, H. E.; Cairns, T. L.; Vladuchick, S. A.; Hoiness, C. M. Org. React. 1973, 20, 1. (b) Charette, A. B.; 
Beauchemin, A. Org. React. 2001, 58, 1. (c) Lebel, H.; Marcoux, J.-F.; Molinaro, C.; Charette, A. B. Chem. Rev. 
2003, 103, 977. 
75 Emschwiller, G. C. R. Hebd. Seance Acad. Sci. 1929, 188, 1555. 
76 For the cyclopropanation of alkenes with metal carbenoids (M-CH2X) from metals other than Al, Sm and Zn, see 
(a) Hoberg, H. Liebigs Ann. Chem. 1962, 656, 1. (b) Miller, D. B. Tetrahedron Lett. 1964, 5, 989. (c) Seyferth, D.; 
Eisert, M. A.; Todd, L. J. J. Am. Chem. Soc. 1964, 86, 121. (d) Furukawa, J.; Kawabata, N.; Fujita, T. Tetrahedron 
1970, 26, 243. (e) Seyferth, D.; Andrews, S. B. J. Organomet. Chem. 1971, 30, 151. (f) Kawabata, N.; Naka, M.; 
Yamashita, S. J. Am. Chem. Soc. 1976, 98, 2676. (f) Maruoka, K.; Fukutani, Y.; Yamamoto, H. J. Org. Chem. 1985, 
50, 4412. 
77 For a recent review on the cyclopropanation of alkenes using transition metal stabilized carbenes (M=CH2), 
prepared by transition metal-mediated decomposition of diazo compounds, see Davies, H. L. M.; Antoulinakis, E. G. 
Org. React. 2001, 57, 1. 
78 Corey, E. J.; Chaykovsky, M. J. J. Am. Chem. Soc. 1965, 87, 1353. 
79 Charette, A. B.; Beauchemin, A. J. Organomet. Chem. 2001, 617-618, 702. 
80 These protocols do, however, reduce the amount of CH2I2 required in the reaction. 
81 This reagent was introduced by Shi and co-workers and is reported to be the best reagent for the cyclopropanation 
of unactivated olefins.  It has also been reported as an efficient reagent for the anti-cyclopropanation of acyclic 
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corresponding benzyl ether of 57 is reacted under any of these conditions, cyclopropanation is 
favored at the olefin proximal to the ether functionality (entries 9-14). 
 










entry R deprotonation carbenoid 58:59:60 
1 H none Et2Zn, CH2I2 74:2:3 
2 H none i-Bu3Al, CH2I2 1:76:4 
3 H none Sm(Hg), ICH2Cl 98:0:0 
4 H Et2Zn EtZnCH2I 80:2:8 
5 H Et2Zn Zn(CH2I)2 88:2:6 
6 H Et2Zn Zn(CH2I)2•DME 70:2:1 
7 H Et2Zn IZnCH2I•Et2O 91:2:3 
8 H Et2Zn CF3CO2ZnCH2I 31:32:19 
9 Bn n/a i-Bu3Al, CH2I2 67:0:0 
10 Bn n/a Sm(Hg), ICH2Cl 75:0:0 
11 Bn n/a EtZnCH2I 92:0:1 
12 Bn n/a Zn(CH2I)2 97:0:1 
13 Bn n/a IZnCH2I•Et2O 92:0:0 
14 Bn n/a CF3CO2ZnCH2I 91:0:6 
 
 The three foremost methods for the preparation of zinc-based cyclopropanating reagents 
are oxidative addition,73 alkyl exchange82 and nucleophilic displacement (Figure 1.2).83  
Oxidative addition (activated Zn metal and CH2X2) is the oldest and most common method for 
the generation of the Simmons-Smith reagent for cyclopropanations involving zinc.  While this is 
                                                 
allylic ethers (ref. 81b).  See (a) Yang, Z.; Lorenz, J. C.; Shi, Y. Tetrahedron Lett. 1998, 39, 8621. (b) Charette, A. 
B.; Lacasse, M.-C. Org. Lett. 2002, 4, 3351. (c) Lorenz, J. C.; Long, J.; Yang, Z.; Xue, S.; Xie, Y.; Shi, Y. J. Org. 
Chem. 2004, 69, 327. 
82 (a) Furukawa, J.; Kawabata, N.; Nishimura, J. Tetrahedron Lett. 1966, 7, 3353. (b) Furukawa, J.; Kawabata, N.; 
Nishimura, J. Tetrahedron 1968, 24, 53. 
83 (a) Wittig, G.; Schwarzenback, K. Angew. Chem. 1959, 71, 652. (b) Wittig, G.; Wingler, F. Chem. Ber. 1964, 97, 
2146. 
 18
the most stable form of the reagent, it is also the least reactive, since the electrophilic character 
of the reagent is retarded due to the necessary use of an ether solvent (THF, Et2O, DME).84  The 
alkyl exchange reaction82,85 is now the method of choice for generating reactive zinc-derived 
cyclopropanating reagents affording the highest degree of diastereoselectivity86 in directed 
Simmons-Smith reactions.87  It has been noted that this exchange process is accelerated by traces 
of oxygen in the solvent,88  and the adventitious oxygen in the solvent is usually sufficient to 
catalyze this process.  The major advantage of this protocol is that the reactions proceed in non-
coordinating solvents (CH2Cl2, Cl(CH2)2Cl), and both reagents (Et2Zn and CH2X2) are 
commercially available and can be used without purification.  The reactivity of these reagents is 
greater than those prepared by oxidative addition; however, their stability is significantly lower.87  
Finally, treatment of ZnI2 with diazomethane to form IZnCH2I or Zn(CH2I)2 was reported by 



















66 6765  
Figure 1.2. Preparation of zinc carbenoids 
                                                 
84 Charette, A. B.; Marcoux, J.-F. Synlett 1995, 1197. 
85 EtZnCH2I is commonly referred to as Furukawa’s reagent.  While the diastereoselectivities observed using this 
reagent are often best, the reagent stability is poor as it readily decomposes to PrZnI.  In these cases, excess CH2I2 is 
usually employed, generating IZnCH2I (Simmons-Smith reagent) from the decomposition product, PrZnI.  
86 Charette, A. B.; Lebel, H. J. Org. Chem. 1995, 60, 2966. 
87 For structural characterization and commentary on the stability of various zinc carbenoids, see (a) Denmark, S. E.; 
Edwards, J. P.; Wilson, S. R. J. Am. Chem. Soc. 1991, 113, 723. (b) Denmark, S. E.; Edwards, J. P.; Wilson, S. R. J. 
Am. Chem. Soc. 1992, 114, 2592. (c) Charette, A. B.; Brochu, C. J. Am. Chem. Soc. 1995, 117, 11367. (d) Charette, 
A. B.; Marcoux, J.-F. J. Am. Chem. Soc. 1996, 118, 4539. (e) Charette, A. B.; Marcoux, J.-F.; Bélanger-Gariépy, F. 
J. Am. Chem. Soc. 1996, 118, 6792. (f) Charette, A. B.; Molinaro, C.; Brochu, C. J. Am. Chem. Soc. 2001, 123, 
12160. (f) Charette, A.; Beauchemin, A.; Francoeur, S.; Bélanger-Gariépy, F.; Enright, G. D. Chem. Commun. 2002, 
466. 
88 (a) Miyano, S.; Hashimoto, H. J. Chem. Soc., Chem. Commun. 1971, 1418. (b) Miyano, S.; Hashimoto, H. Bull. 
Chem. Soc. Jpn. 1973, 46, 892. 
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 The Simmons-Smith cyclopropanation reaction is greatly influenced by adjacent Lewis 
basic functionality (ie, alcohols, ethers, amides, etc.).  The hydroxyl-directed Simmons-Smith 
cyclopropanation reaction was beautifully employed by Oppolzer and co-workers in the 
synthesis of (R)-muscone, highlighting their methodology for the asymmetric formation of allylic 
alcohols (Scheme 1.11).89  Hydroboration of ω-ynal 68 followed by transmetalation to zinc and 
intramolecular vinylation of the aldehyde in the presence of Noyori’s DAIB ligand90 afforded 
allylic alcohol 70 (75%, 92% ee).  The allylic alcohol was subjected to Denmark’s 
cyclopropanation conditions91 affording the desired syn-cyclopropylcarbinol 71 as a single 
diastereomer.92  Oxidation to the known ketone93 followed by reductive opening of the 






















Scheme 1.11. Oppolzer's synthesis of muscone: Hydroxy-directed cyclopropanation of a cyclic 
olefin 
 
 For acyclic systems, the cyclopropanation of chiral allylic alcohols will generally favor 
the syn-diastereomer whereas chiral allylic ethers tend to favor the anti-diastereomer (Table 1.3).  
                                                 
89 Oppolzer, W.; Radinov, R. N. J. Am. Chem. Soc. 1993, 115, 1593. 
90 Noyori, R.; Suga, S.; Kawai, K.; Okada, S.; Kitamura, M. Pure Appl. Chem. 1988, 60, 1597. 
91 Denmark, S. E.; Edwards, J. P. J. Org. Chem. 1991, 56, 6974. 
92 For a review on substrate directed reactions, see Hoveyda, A. H.; Evans, D. A.; Fu, G. C. Chem. Rev. 1993, 93, 
1307. 
93 Nelson, K. A.; Mash, E. A. J. Org. Chem. 1986, 51, 2721. 
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The traditional Simmons-Smith reagent affords a nearly 1:1 mixture of syn- and anti-alcohols 73 
and 74 (entry 1).  Using the Furukawa reagent, this ratio is greatly improved (entry 2) and as the 
size of R1 increases, the selectivity for the syn-product increases, while R2 seems to have little 
effect on the selectivity (data not shown).  Alkyl ethers favor the anti-diastereomer 74, however, 
as the steric bulk of R1 increases, the selectivity switches to favor the syn-isomer 73.  For 
compounds where R3 ≠ H, the syn-diastereomer is always favored for both alcohols and ethers, 
however the choice of reagent is paramount to achieve optimal selectivity.  The exception is 
when the Shi reagent is used for the cyclopropanation of silyl protected allylic alcohols; very 
good anti-selectivity has been observed regardless of the substitution pattern at the olefin. 
 















72 73; syn 74; anti  
entry R1 R2 R3 R4 carbenoid 73:74 
1 Me Me H H Zn/Cu, CH2I2 56:44 
2 Me Me H H Et2Zn, CH2I2 86:14 
3 Ph Me H H Et2Zn, CH2I2 >98:2 
4 i-Pr Ph H H Et2Zn, CH2I2 >98:2 
5 Me Ph H Bn Et2Zn, CH2I2 10:90 
6 Et Ph H Bn Et2Zn, CH2I2 33:67 
7 i-Pr Ph H Bn Et2Zn, CH2I2 95:5 
8 Me Ph H TBS CF3CO2ZnCH2I 2:98 
9 Me H Ph(CH2)3 Bn Et2Zn, CH2I2 15:1 
10 Me H Ph(CH2)2 TIPS CF3CO2ZnCH2I 3:97 
 
 Two limiting transition states for the cyclopropanation of allylic ethers (R = PG) and 
alcohols (R = ZnX; A and B, Figure 1.3) have been proposed by Charette to explain the outcome 
of the directed cyclopropanation reactions.78b,94,95  A bridging metal (LnMX) has been proposed 
to account for the observed acceleration of Simmons-Smith cyclopropanation in the presence of 
                                                 
94 Charette, A. B.; Lebel, H.; Gagnon, A. Tetrahedron 1999, 55, 8845. 
95 For recent transition state calculations of the Simmons-Smith cyclopropanation reaction, see (a) Bernardi, F.; 
Bottoni, A.; Miscione, G. P. J. Am. Chem. Soc. 1997, 119, 12300. (b) Nakamura, E.; Hirai, A.; Nakamura, M. J. Am. 
Chem. Soc. 1998, 120, 5844. (c) Nakamura, M.; Hirai, A.; Nakamura, E. J. Am. Chem. Soc. 2003, 125, 2341. 
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Lewis acids.96,97  For allylic alcohols, the transition state in which A1,3-strain is minimized 
predominates (particularly when R1 ≠ H), affording the syn-diastereomer via transition state B.  
This model also minimizes the interaction of the incoming carbenoid with R4.  The driving force 
for anti-selectivity in the case of allylic ethers is the unfavorable gauche interaction between the 
protective group R and R4.  However, as the steric bulk of R4 increases, the minimization of 


























Figure 1.3. Transition states for the directed cyclopropanation of chiral allylic alcohols and 
ethers 
 
 While there are numerous examples of oxygen-directed cyclopropanation reactions, there 
are only a few examples of nitrogen-directed Simmons-Smith cyclopropanation reactions of 
allylic amines (vide infra) or amides.98  However, an interesting study by Marquez and co-
workers compared the diastereofacial directing power of an amide to a hydroxy group in the 
cyclopropanation of a cyclopentene derivative (Scheme 1.12).98c  The unprotected amide 75 
directs the cyclopropanation syn to the amide functionality (anti to the hydroxy group).  
Conversely, when the amide is doubly protected with an acetate and benzoate as in 77, the 
hydroxy group directs the cyclopropanation syn to the hydroxyl (anti to the amide).  On the basis 
of these results, a secondary amide is a stronger directing group than a hydroxyl functionality.  
                                                 
96 For a review on the bonding in bridged transition metal complexes, see Holton, J.; Lappert, M. F.; Pearce, R.; 
Yarrow, P. I. W. Chem. Rev. 1983, 83, 135. 
97 (a) Wittig, G.; Wingler, F. Chem. Ber. 1964, 97, 2146. (b) Friedrich, E. C.; Lunetta, S. E.; Lewis, E. J. J. Org. 
Chem. 1989, 54, 2388. (c) Charette, A. B.; Juteau, H. J. Am. Chem. Soc. 1994, 116, 2651. (d) Denmark, S. E.; O’ 
Connor, S. P. J. Org. Chem. 1997, 62, 3390. 
98 (a) Avramoff, M. Eur. J. Med. Chem. 1981, 16, 199. (b) Russ, P.; Ezzitouni, A.; Marquez, V. E. Tetrahedron Lett. 
1997, 38, 723. (c) Russ, P.; Ezzitouni, A.; Marquez, V. E. J. Org. Chem. 1997, 62, 4870. (d) Aggarwal, V. K.; Fang, 
G. Y.; Meek, G. Org. Lett. 2003, 5, 4417. 
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Unfortunately, there have not been any studies reported for this competition in an acyclic system 

























Scheme 1.12. Hydroxy vs. amide in the directed Simmons-Smith cyclopropanation 
 
 As part of their studies directed towards the synthesis of the oligocyclopropane-
containing natural product FR-900848,99,100 Barrett and Tustin described their findings of the 
diastereoselective cyclopropanation of dienyl alcohols 79 (Table 1.4).101  The anti-diastereomer 
80 was favored in all cases, although the selectivity increases with the size of R. Barrett 
rationalized the observed selectivity by using a combination of stereoelectronic and steric effects; 
however, A1,3-strain arguments alone can also be used to correctly predict the stereochemical 
outcome of this reaction. 
 




R OH R OH
79 80 81  
entry R yield (%) diastereomeric ratio 
80:81 
1 Me 68 5:1 
2 Ph 80 5:1 
3 i-Pr 72 6:1 
4 C6H11 78 7:1 
5 TBDPSOCH2 72 >95:5 
                                                 
99 For a review on oligocyclopropyl-containing natural products, see Pietruszka, J. Chem. Rev. 2003, 103, 1051. 
100 For Barrett’s total synthesis of FR-900848, see (a) Barrett, A. G. M.; Kasdorf, K. J. Chem. Soc., Chem. Commun. 
1996, 325. (b) Barrett, A. G. M.; Doubleday, W. W.; Kasdorf, K.; Tustin, G. J. J. Org. Chem. 1996, 61, 3280. 
101 Barrett, A. G. M.; Tustin, G. J. J. Chem. Soc., Chem. Commun. 1995, 355. 
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 Methylenecyclopropanes are valuable intermediates in organic synthesis having found 
use in the Ni(0)- or Pd(0)-catalyzed reaction with alkenes and alkynes for the formation of 5-
membered rings.102,103  Lautens and Delanghe have recently applied the Simmons-Smith 
cyclopropanation reaction of allenyl alcohols for the regio- and diastereocontrolled preparation 
of methylenecyclopropanes (Table 1.5).104  While the majority of cyclopropanating reagents 
afforded a poor selectivity for methylenecyclopropanes83 and 84 over spiropentanes 85 and 86, 
excellent selectivities were observed when the allenyl alcohol 82 was pretreated with base prior 
to introduction of the cyclopropanating reagent (entry 6).  Interestingly, similar results were also 
obtained without the requirement for base treatment using Molander’s samarium-mediated 
cyclopropanation conditions (entry 7).105  
 Charette and co-workers have also investigated the formation of spiropentanes;106,107 they 
have successfully extended the application of their asymmetric cyclopropanation reaction96c,108 
of allylic alcohols in the presence of chiral dioxaborolane ligand 88 to the achiral allenyl 
alcohols 87 (Scheme 1.13).  Accordingly, treatment of 87 with the DME complex of Zn(CH2I)2 
(3 equiv) in the presence of 88 (1.2 equiv) afforded the spiropentanes 89 in very good yields and 






                                                 
102 For a review on the preparation of heterocycles from alkylidenecyclopropanes, see Brandi, A.; Cicchi, S.; 
Cordero, F. M.; Goti, A. Chem. Rev. 2003, 103, 1213. 
103 For representative examples, see (a) Noyori, R.; Odagi, T.; Takaya, H. J. Am. Chem. Soc. 1970, 92, 5780. (b) 
Ohta, T.; Takaya, H. In Comprehensive Organic Synthesis; Trost, B. M., Ed.; Pergamon Press: Oxford, 1991; Vol. 5, 
p 1185. (c) Brandi, A.; Cordero, F.; De Sarlo, F.; Goti, A.; Guarna, A. Synlett 1993, 1. (d) Es-Sayed, M.; Heiner, T.; 
de Meijere, A. Synlett 1993, 57. 
104 (a) Lautens, M.; Delanghe, P. H. M. J. Org. Chem. 1993, 58, 5037. (b) Lautens, M.; Delanghe, P. H. M. J. Am. 
Chem. Soc. 1994, 116, 8526. 
105 (a) Molander, G. A.; Etter, J. B. J. Org. Chem. 1987, 52, 3942. (b) Molander, G. A.; Harring, L. S. J. Org. Chem. 
1989, 54, 3525. 
106 For a review on oligospirocyclopropanes, see de Meijere, A.; Kozhushkov, S. I. Chem. Rev. 2000, 100, 93. 
107 Charette, A. B.; Jolicoeur, E.; Bydlinski, G. A. S. Org. Lett. 2001, 3, 3293. 
108 (a) Charette, A. B.; Prescott, S.; Brochu, C. J. Org. Chem. 1995, 60, 1081. (b) Charette, A. B.; Lebel, H.; 
Molinaro, C. J. Am. Chem. Soc. 1998, 120, 11943. 
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1 Zn(Cu) (2) CH2I2 (2) 83:17a 40 
2 Zn(Cu) (5) CH2I2 (3.5) 27:54a 100 
3 Et2Zn (1) ClCH2I (1) 67:3:20:10 69 
4 Et2Zn (2.1) CH2I2 (2.1) 45:55a 92 
5 Et3Al (1.2) CH2I2 (1.2) ND <5 
6 Et2Zn (1) ClCH2I (1) 91:2:4:3b 83 
7 Sm (10) ClCH2I (10) 90:10:0:0 82c 
aRatio of (83:84):(85:86), 83:84 and 85:86 not determined; b82 was deprotonated prior to 


















R1 = alkyl, cycloalkyl
R1 = Ph, 7% (ee 92%)
 
Scheme 1.13. Enantioselective formation of spiropentanes via the Simmons-Smith 
cyclopropanation reaction 
 
 The vast majority of applications of Simmons-Smith reagents in synthesis is in the 
preparation of cyclopropanes; however, the zinc carbenoids have also been found to be useful for 
 25
the homologation of organometallic reagents.109,110  Recently, Marek and co-workers have 
developed a four-component reaction incorporating the zinc carbenoid mediated homologation of 
an alkenyl copper species (Scheme 1.14).111,112  Carbocupration113 of the chiral alkynyl sulfoxide 
90 affords the intermediate vinyl copper species 91 which is treated with Zn(CH2I)2 to afford the 
vinylzinc reagent 92.  The intermediate vinylzinc reagent undergoes a rearrangement to afford 
the reactive allylzinc intermediate which adds to aldehydes or imines with excellent 










































Scheme 1.14. Zinc carbenoid mediated homologation of alkenylcopper reagents: 
Diastereoselective allylation of aldehydes and imines 
 
 Unlike allylic alcohols, allylic amines usually can not be used in the Simmons-Smith 
cyclopropanation due to ammonium ylide formation.115  Over 40 years ago, the reaction of the 
Simmons-Smith reagent with trimethylamine was reported by Wittig and Schwarzenbach to 
                                                 
109 (a) Knochel, P.; Jeong, N.; Rozema, M. J.; Yeh, M. C. P. J. Am. Chem. Soc. 1989, 111, 6476. (b) Knochel, P.; 
Chou, T.-S.; Chen, H. G.; Yeh, M. C. P.; Rozema, M. J. Org. Chem. 1989, 54, 5202. (c) Knochel, P.; Rao, S. A. J. 
Am. Chem. Soc. 1990, 112, 6146. (d) Sidduri, A.; Rozema, M. J.; Knochel, P. J. Org. Chem. 1993, 58, 2694. 
110 For a recent review on the homologation of sp3 zinc carbenoids, see Marek, I. Tetrahedron 2002, 58, 9463. 
111 Sklute, G.; Amsallem, D.; Shabli, A.; Varghese, J. P.; Marek, I. J. Am. Chem. Soc. 2003, 125, 11776. 
112 Abramovitch, A.; Varghese, J. P.; Marek, I. Org. Lett. 2004, 6, 621. 
113 (a) Truce, W. E.; Lusch, M. J. J. J. Org. Chem. 1974, 39, 3174. (b) Truce, W. E.; Lusch, M. J. J. J. Org. Chem. 
1978, 43, 2252. (c) Fiandanese, V.; Marchese, G.; Naso, F. Tetrahedron Lett. 1978, 19, 5131. 
114 The observed diastereoselectivity when R1 = H was considerably lower (4:1). 
115 For an example of a Simmons-Smith cyclopropanation reaction using an allylic amine, see ref. 98d. 
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afford quaternary ammonium salts, presumably via an intermediate ammonium ylide.116  
Recently, Aggarwal and co-workers have taken advantage of this method to initiate the [2,3] 
sigmatropic rearrangement of allylic amines (Scheme 1.15).117  During the course of their 
studies, they found that the ammonium ylides would not undergo the desired rearrangement with 
the Simmons-Smith reagent alone, however, upon treatment with n-BuLi, the zinc ate complex is 
formed affording the product of [2,3] sigmatropic rearrangement.  Accordingly, treatment of 96 
with Zn(CH2I)2 followed by n-BuLi affords predominantly oxacine 97 arising from the [2,3] 
sigmatropic rearrangement with a small amount of the [1,2] product 98.  Alkylation occurs on 
the same face as the substituent at the 2-positions of the oxazolidine, affording a diastereomeric 
mixture of ammonium ylides 99 and 100.  [2,3]-Sigmatropic rearrangements have been found 
experimentally to be faster than the competing [1,2] or Stevens rearrangement, accounting for 
the formation of 97 from 99.  However, the competing [2,3] rearrangement of 100 would afford 
an oxacine-containing a highly strained (E)- olefin, and only the Stevens product 98 is observed. 
 
N
































Scheme 1.15. Sigmatropic rearrangements of ammonium ylides generated from tertiary amines 
and Zn carbenoids 
 
 
                                                 
116 Wittig, G.; Schwarzenbach, K. Liebigs Ann. Chem. 1961, 650, 1. 
117 Aggarwal, V. K.; Fang, G.; Charmant, J. P. H.; Meek, G. Org. Lett. 2003, 5, 1757. 
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1.1.4 Reactions of Strained Bicycloalkanes 
 During the course of our studies on the reactivity of imines with in situ generated 
alkenylzinc reagents, a cascade process was discovered which involved the intermediacy of a 
bicyclo[1.1.0]butane.118  As early as 1905, there were reports on the preparation of 
bicyclo[1.1.0]butanes, however, these protocols were subsequently found to be irreproducible.119  
The results were also questioned due to the use of highly acidic conditions, and bicyclobutanes 
are now known to undergo ring-opening at pH < 4.  The first verified synthesis of a 
bicyclobutane was achieved by Wiberg and co-workers in 1959, and there are now numerous 
reports on their preparation.118a  These strained bicycloalkanes are interesting intermediates 
whose physical properties and reactivity patterns have been studied extensively (Figure 1.4).  In 
contrast to bicyclo[2.1.0]pentane, the strain energy of bicyclo[1.1.0]butane (66 kcal/mol) is not 
the sum of its parts; it is considerably more than twice that observed for cyclopropane (27 
kcal/mol) whereas the strain energy of bicyclopentane (51 kcal/mol) is approximately the sum of 
strain in cyclopropane and cyclobutane (26 kcal/mol) .  The puckered nature (θ ~ 126 °) of 
bicyclobutane differentiates the exo- and endo-hydrogens in the 1H NMR.  The exo hydrogens 
(Ha) for unsymmetrical bicyclobutanes are often observed as an AB quartet, coupled through a 
W arrangement.  Conversely, the endo-hydrogens often appear as singlets.  For simple 
bicyclobutanes, these hydrogens can be interconverted by inversion although the calculated 







J ~ 10 Hz
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Figure 1.4. Some physical properties of bicyclo[1.1.0]butanes 
                                                 
118 (a) Wiberg, K. B.; Ciula, R. P. J. Am. Chem. Soc. 1959, 81, 5261. (b) Wiberg, K. B.; Lampman, G. M. 
Tetrahedron Lett. 1963, 4, 2173. (c) Wiberg, K. B.; Lampman, G. M.; Ciula, R. P.; Connor, D. S.; Schertler, P.; 
Lavanish, J. Tetrahedron 1965, 21, 2749. 
119 These early studies also did not benefit from modern spectroscopic analytical tools.  Cf. Perkin, W. H.; Simonsen, 
J. L. Proc. Chem. Soc. 1905, 21, 256. 
120 Nguyen, K. A.; Gordon, M. S.; Boatz, J. A. J. Am. Chem. Soc. 1994, 116, 9241. 
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 The reactivity of bicyclobutanes revolves primarily around the central bond which has 
been suggested to have 96% p character.121  Accordingly, many of the reactions of alkenes are 
also possible for bicyclobutanes and the central bond undergoes polymerization reactions,122 
addition of halogens and alcohols,118c and will react with benzyne intermediates123 and 
radicals.124  Perhaps the most intriguing facet of bicyclobutane reactivity is their reaction with 
transition metals.125  The majority of these metals afford allyl carbene metal complexes,126 often 
followed by a 1,2-hydrogen shift to afford conjugated dienes.127  Noyori and co-workers have 
developed the Ni(0)-catalyzed reaction of bicyclobutanes with electron deficient alkenes.128  For 
example, reaction of bicyclobutane in methyl acrylate in the presence of 5 mol % Ni(COD)2 
afforded a 65:35 mixture of cyclopropanes 103 and 104 in 92% yield via the proposed 

















Scheme 1.16. Ni(0) mediated carbene formation from bicyclo[1.1.0]butanes 
 
                                                 
121 Newton, M. D.; Schulman, J. M. J. Am. Chem. Soc. 1972, 94, 767. 
122 (a) Hall Jr., H. K.; Smith, C. D.; Blanchard Jr., E. P.; Cherkofsky, S. C.; Sieja, J. B. J. Am. Chem. Soc. 1971, 93, 
121. (b) Chen, X.-P.; Padias, A. B.; Hall Jr., H. K. Macromolecules 2001, 34, 3514. (c) Chen, X.-P.; Padias, A. B.; 
Hall Jr., H. K. Macromolecules 2002, 35, 3328. 
123 Pomeranz, M.; Wilke, R. N.; Gruber, G. W.; Roy, U. J. Am. Chem. Soc. 1972, 94, 2752. 
124 Hall, J. K.; Blanchard, E. P.; Cherkofsky, S. C.; Sieja, J. B.; Sheppard, W. A. J. Am. Chem. Soc. 1971, 93, 110. 
125 Bishop III, K. C., Chem. Rev. 1976, 76, 461. 
126 Dauben, W. G.; Kielbania, A. J., Jr. J. Am. Chem. Soc. 1972, 94, 767. 
127 For representative reactions, see (a) Paquette, L. A. Acc. Chem. Res. 1971, 4, 280. (b) Gassman, P. G.; Atkins, T. 
J. J. Am. Chem. Soc. 1971, 93, 1042. (c) Gassman, P. G.; Meyer, G. R.; Williams, F. J. J. Am. Chem. Soc. 1972, 94, 
7741. (d) Moriarty, R. M.; Chen, K.-N.; Flippen, J. L. J. Am. Chem. Soc. 1973, 95, 6489. 
128 (a) Noyori, R.; Suzuki, T.; Kumagai, Y.; Takaya, H. J. Am. Chem. Soc. 1971, 93, 5894. (b) Noyori, R. 
Tetrahedron Lett. 1973, 14, 1691. (c) Noyori, R.; Kawauchi, H.; Takaya, H. Tetrahedron Lett. 1974, 15, 1749. (d) 
Takaya, H.; Suzuki, T.; Kumagai, Y.; Hosoya, M.; Kawauchi, H.; Noyori, R. J. Org. Chem. 1981, 46, 2854. 
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 Of particular interest in the context of the Simmons-Smith cyclopropanation is the 
reaction of bicyclobutanes with carbenes which affords 1,4-dienes 107 via a double σ-bond 
insertion pathway (Scheme 1.17).118c,129,130  Since the vast majority of reactions ofbicyclobutanes 
occur at the central bond, it was anticipated that the reaction with a carbene would afford the 
corresponding bicyclo[1.1.1]pentane 106.  However, only traces of this compound were 
observed.  Wiberg and Doering initially proposed a mechanism involving diradical 
intermediates, however, recent experiments and calculations support a concerted cycloaddition 
process.131  Using semi-empirical MNDO calculations, the attack of methylenecarbene was 
found to cleave the central and side bonds simultaneously.  In fact, the authors could not locate 
an energetic minimum corresponding to intermediates along the radical pathway.  However, 
three transition states for the attack of singlet carbene on bicyclobutane were found.  One 
pathway involved attack at the central bond and would lead to 106, while the remaining 
transition states involved endo-attack of the carbene along the calculated trajectory for the 






















Scheme 1.17. Reaction of bicyclo[1.1.0]butanes with carbenes 
                                                 
129 (a) von Doering, W.; Coburn Jr., J. F. Tetrahedron Lett. 1965, 6, 991. (b) Applequist, D. E.; Wheeler, J. W. 
Tetrahedron Lett. 1977, 18, 3411. 
130 For examples of single σ-bond insertion processes, see (a) Rybtchinski, B.; Milstein, D. Angew. Chem., Int. Ed. 
Engl. 1999, 38, 871. (b) Murakami, M.; Itahashi, T.; Ito, Y. J. Am. Chem. Soc. 2002, 124, 13976. 
131 Jackson, J. E.; Mock, G. B.; Tetef, M. L.; Zheng, G.-X.; Jones, Jr., M. Tetrahedron 1985, 41, 1453. 
132 (a) Lehn, J. M.; Wipff, G. J. Chem. Soc., Chem. Commun. 1973, 747. (b) Hoz, S. Tetrahedron 1984, 40, 5213. 
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1.2 Synthesis of Functionalized Allylic Amines and Alcohols 
 
1.2.1 Dimethylzinc-Mediated Addition of Alkenylzirconocenes to Aldimines133 
 Prompted by the results of Drs. Wenjing Xu and Seth Ribe in the Wipf group, we sought 
to develop a method for the stereoselective preparation of allylic amides134,135 in one-pot, using a 
single solvent.  Since CH2Cl2 and THF are excellent solvents for the hydrozirconation of 
alkynes, these solvents were chosen as a starting point to study the alkenylzirconocene addition 
to imine 21 (Scheme 1.18).136  Unfortunately, the reaction in THF did not reproducibly afford the 
desired allylic amine 110, and in CH2Cl2 the concomitant formation of C-cyclopropylalkylamide 
111 as a major byproduct was observed (vide infra).  Fortunately, a modification of the 
conditions of Xu and Ribe afforded good to excellent yields of the desired allylic amide.  
Accordingly, after hydrozirconation in CH2Cl2, the solvent was removed, and the residue was 



















Scheme 1.18. Dimethylzinc-mediated addition of alkenylzirconocenes to imine 21 
 
 To further probe the scope of this reaction aldehydes, 112-117 were condensed with 
phosphinamide 118 in the presence of Et3N and TiCl4 to give the functionalized aldimines 119-
                                                 
133 Wipf, P; Kendall, C.; Stephenson, C. R. J. J. Am. Chem. Soc. 2003, 125, 761. 
134 For the addition of alkenylzinc reagents to nitrones, see Pandya, S. U.; Garçon, C.; Chavant, P. Y.; Py, S.; Vallée, 
Y. Chem. Commun. 2001, 1806. 
135 For a Zr→Rh transmetalation approach to allylic amides, see Kakuuchi, A.; Taguchi, T.; Hanzawa, Y. 
Tetrahedron Lett. 2003, 44, 923. 
136 Jennings, W. B.; Lovely, C. J. Tetrahedron 1991, 47, 5561. 
137 1,2-Dichloroethane was also found to be an efficient solvent for allylic amine formation. 
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124 in poor to moderate yields (Scheme 1.19).136  Despite the low yields obtained for these 


















p-Cl, 117  
Scheme 1.19. Preparation of N-diphenylphosphinoyl aldimines 
 
 The addition of in situ generated alkenylzinc reagents to the N-diphenylphosphinoyl 
imines (119-124, Scheme 1.19) was undertaken in toluene.  Hydrozirconation of alkynes 108, 
125 or 127 in CH2Cl2 followed by a solvent switch to toluene, transmetalation to zinc and 
addition to imine afforded the desired allylic amides in 52-82% yield (Table 1.6).  Methyl esters 
(entries 1 and 2) and silyl ethers were tolerated under the reaction conditions as well as terminal 
trimethylsilyl substituted alkynes (entry 2).  Electron donating groups in the ortho- and meta-
position of the imine afforded the desired allylic amides in good yields, although the para-
substituted imine (not shown) did not perform well in this reaction, affording <30% of the 
desired allylic amide.  Interestingly, the nitro-substituted imines (entries 5 and 6) did not cause 










Table 1.6. Zr→Zn mediated coupling of alkynes and N-diphenylphosphinoylimines 






















































O2N 123  
C4H9
NHP(O)Ph2
O2N 132  
73 
7 108 NP(O)Ph2
Cl 124  
C4H9
NHP(O)Ph2
Cl 133  
77 




1.2.2 Dimethylzinc-Mediated Addition of Alkenylzirconocenes to α-Keto and α-Imino 
Esters138 
We were motivated by the initial results of Xu53 and Ribe55 to probe the reactivity of alkenylzinc 
reagents derived from the hydrozirconation of alkynes with ketones.  It became quickly apparent 
that these vinylzinc reagents could not be successfully employed in the direct addition to 
unactivated ketones.139  We turned our attention to the more reactive α-keto esters and 
envisioned the possibility to use alkenylzirconocene reagents without transmetalation for the 
preparation of allylic alcohols (Scheme 1.20).  In the absence of added Lewis acid, no conversion 
to the desired allylic alcohol 135 was observed.  Several Lewis acids were screened as potential 
activators for the addition of the alkenylzirconocene derived from 108 to keto ester 134, and 
several additives were capable to promote the desired reaction.  However, with the exception of 
ZnCl2,140 conversion was low and the reaction could not be pushed to completion even with 
stoichiometric quantities of Lewis acid.  The optimal results were obtained using conditions 














Sc(OTf)3; 135:134 = 7:1
ZnCl2; 135 only, 81%
Me2Zn; 135 only, 93%  
Scheme 1.20. Activation of α-keto ester 134 with Lewis acids for the 1,2-addition of 
alkenylzirconocenes 
 
 The tertiary α-hydroxy carboxylates are substructures found in both natural products and 
pharmaceuticals.141 The dimethylzinc-mediated addition of alkenylzirconocenes to α-keto esters 
proceeds smoothly in 1-2 h in 75-96% yield at r.t. providing access to important 1,2-
                                                 
138 Wipf, P.; Stephenson, C. R. J. Org. Lett. 2003, 5, 2449. 
139 Our alkenylzinc reagents failed to react with acetophenone at r.t. and upon warming afforded multiple products.  
The only successful ketone addition of an alkenylzinc reagent derived from an alkenylzirconocene in the absence of 
external Lewis acid was reported by Chavez and Jacobsen (ref. 65). 
140 Zheng, B.; Srebnik, M. J. Org. Chem. 1995, 60, 3278. 
141 (a) Comins, D. L.; Hong, H.; Saha, J. K.; Jianhua, G. J. Org. Chem. 1994, 59, 5120. (b) Senanayake, C. H.; Fang, 
Q. K.; Grover, P.; Bakale, R. P.; Vandenbossche, C. P.; Wald, S. A. Tetrahedron Lett. 1999, 40, 819. 
 34
dioxygenated building blocks (Table 1.7).142  Ester functionalities were tolerated in both 
substrate and alkyne component, while internal alkynes (entry 2), silyl ethers (entry 3), Lewis 
basic benzyl ethers (entry 5) and enynes (entry 6) all successfully afforded allylic alcohols via 
1,2-addition to phenyl- (entries 1-6) and methyl-substituted keto esters (entries 7 and 8).  As an 
extension of the methodology developed for the 1,2-addition of alkenylzirconocenes to N-
diphenylphosphinoyl imines, α-imino ester 148 was prepared (vide infra) and subjected to the 
vinylation conditions affording allylic amides 149 and 150 in 92% and 93% yield, respectively 
(entries 9 and 10). 
 We had hoped to be able to devlop this methodology as a catalytic asymmetric reaction.  
To this end, the conditions developed by Wipf and Ribe were employed to effect the asymmetric 
addition of the alkenylzirconocene derived from 108 to α-keto ester 134 (Figure 1.5).  
Unfortunately, the isolated allylic alcohol 135 was racemic in the presence of ligands 45, 151 
and 152.31,55  Similarly, the known Ti Lewis acids 153143 and 154,144 and bis(oxazoline) derived 
Lewis acids 155 and 156145 afforded the desired allylic alcohol; however 135 was isolated as a 
racemic mixture.  Previous studies by Wipf and Ribe have shown that the catalyzed process was 
only two-fold faster than the background reaction for the vinylzinc addition to aldehydes.55  We 
have qualitatively observed that α-keto esters react marginally faster than aldehydes under the 
Zr→Zn reaction conditions and it is possible that the background reaction simply out-competes 






                                                 
142 (a) Akiyams, T.; Nishimoto, H.; Ishikawa, K.; Ozaki, S. Chem. Lett. 1992, 447. (b) Fuji, K.; Tanaka, K.; Ahn, 
M.; Mizuchi, M. Chem. Pharm. Bull. 1994, 42, 957. (c) Huang, D.-L.; Draper, R. W.; Lih, D. Tetrahedron Lett. 
1994, 35, 661. (d) Tamai, Y.; Nakano, T.; Miyano, S. J. Chem. Soc., Perkin Trans. 1 1994, 439 and references cited 
therein. 
143 Rozema, M. J.; AchyuthaRao, S.; Knochel, P. J. Org. Chem. 1992, 57, 1956. 
144 Seebach, D.; Beck, A.K.; Heckel, A. Angew. Chem., Int. Ed. Engl. 2001, 40, 92. 
145 For recent reviews on the use of chiral bis(oxazoline) ligands, see (a) Ghosh, A. K.; Mathivanan, P.; Cappiello, J. 
Tetrahedron: Asymmetry 1998, 9, 1-45. (b) Johnson, J. S.; Evans, D. A. Acc. Chem. Res. 2000, 33, 325-335. 
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Table 1.7. Addition of alkenylzinc reagents to α-keto- and α-imino esters 
entry alkyne keto- or imino ester allylic alcohol or amide yield (%)a 














































































































155 (M = Zn)
156 (M = Cu)
152
 
Figure 1.5. Ligands and chiral Lewis acids used in attempted asymmetric vinylzinc addition to 
α-keto ester 134 
 Fortunately, the chelating properties of α-keto esters have been exploited for the 
diastereoselective addition of organometallic reagents to α-keto esters60,146 and amides.147  
Accordingly, treatment of 158 with α,α-dichloromethylmethyl ether at 50 °C afforded 159148 in 
70% yield149 and the menthyl and 8-phenylmenthyl150 keto esters 162 and 163 were prepared by 
condensation of the alcohols 160 and 161 with 159 in the presence of pyridine and DMAP at      
0 °C in excellent yield.  While the dimethylzinc-mediated addition of the alkenylzirconocene 
derived from 108 to the menthyl-derived keto ester 162 afforded the desired allylic alcohol with 
modest diastereofacial control (dr 3.3:1), the 8-phenylmenthyl derivative 163 afforded 165 as a 
single diastereomer.151 
 The stereochemical outcome of the addition process was verified by the preparation of 
the known diol 167152 from allylic alcohol 165.  Reduction (LiAlH4, Et2O) of 165 afforded diol 
166 (87%, ee >99%) and recovered auxiliary 161 (92%).  The minor enantiomer of 166 was not 
observed by HPLC analysis (Chiralcel OD).153  Hydrogenation (H2, Rh/Al2O3) afforded 167 in 
 
                                                 
146 (a) Whitesell, J. K.; Bhattacharya, A.; Henke, K. J. Chem. Soc., Chem. Commun. 1982, 988. (b) Basavaiah, D.; 
Bharathi, T. K. Tetrahedron Lett. 1991, 32, 3417. 
147 Kiegel, K.; Jurczak, J. Tetrahedron Lett. 1999, 40, 1009. 
148 Ottenheijim, H. C. J.; de Man, J. H. M. Synthesis 1975, 163. 
149 Acid chloride 159 readily decomposes when stored at room temperature affording mixtures of 159 and benzoyl 
chloride.  It was stored under N2 at -20 °C and the purity was checked by 1H NMR immediately prior to use. 
150 Corey, E. J.; Ensley, H. E. J. Am. Chem. Soc. 1975, 97, 6908. 
151 The diastereoselectivity was determined by analysis of the crude mixture by 500 MHz 1H NMR. 
152 Vanhessche, K. P. M.; Sharpless, K. B. J. Org. Chem. 1996, 61, 7978. 




























    -78 oC to -20 oC






164, R = H; 47%; dr = 3.3:1
165, R = Ph; 77%; dr > 95:5
158
 
Scheme 1.21. Diastereoselective addition of alkenylzinc reagents to chiral α-keto esters 162 and 
163 
 
97% yield.  Comparison to the literature value for the optical rotation of 167 indicated that our 
diol was prepared in >89% ee.  However, we were unable to detect the minor enantiomer by 





















[α]D +2.15 (c 1.1, EtOH); ee >99% (HPLC)
lit. [α]D + 0.9 (c 1.6, EtOH); ee = 37% (HPLC)
 
Scheme 1.22. Verification of the absolute configuration of 165 
 
 With the stereochemical correlation via the sign of the optical rotation of 167, the 
addition was confirmed to occur onto the si-face of the keto ester 163 affording the allylic 
alcohol 165 in the (R)-configuration.  Ab initio energy minimization (HF-6-31G*) predicted that 
the chelated conformation 168 shown in Figure 1.6 is at least 1.7 kcal/mol lower in energy than 
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any alternative conformer.154  Included in this analysis were all mono coordinated structures 
where the keto ester adopts a dipole minimizing conformation of the carbonyl groups.  The 
calculation and our observed results are also in accord with Whitesell’s π-stacking model for 









Figure 1.6. Stereoview of the lowest energy Me2Zn chelated α-keto ester 168 
 
 As shown in Table 1.7, alkenylzinc reagents can also be added to imino ester 148, 
prepared in 40% yield by condensation of keto ester 134 with diphenylphosphinamide 118 in the 
presence of Et3N and TiCl4 (Scheme 1.23).155  The chiral imino ester 169 was similarly prepared 
in 69% yield and was found to have increased stability compared to 148.  Hydrozirconation of 
108 followed by transmetalation to dimethylzinc and addition to 169 afforded a disappointing 
5:1 mixture of diastereomers by 600 MHz 1H NMR analysis.156  We envisioned that 
precomplexation of 169 with an external Lewis acid would increase the bias for the reaction 
occurring via a chelated structure similar to the keto ester in Figure 1.6.  After a quick evaluation 
of Lewis acids,157 precomplexing 169 with 1 equiv of TiCl(O-i-Pr)3 and treatment with the 
                                                 
154 The geometry was optimized by Prof. Peter Wipf using the Spartan program.  
155 The lower yield for the preparation of 148 can be attributed to facile hydrolysis during purification compared 
with 8-phenylmenthyl derivative 169. 
156 Lowering the reaction temperature to -40 °C did not improve the diastereoselection and the reaction did not 
proceed at -78 °C, possibly due to the formation of precipitates. 
157 ZnCl2, 81%, dr 3.0:1; Sn(OTf)2, trace; MgBr2, 35%, dr 1:1; Zn(OTf)2, 65%, dr 5.5:1. 
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vinylzinc reagent derived from alkynes 108 and 125 at -40 °C afforded allylic amides 170 (70%; 
dr = 7.8:1) and 171 (84%; dr = 7.4:1) respectively in good yields and improved 
diastereoselectivity. 
134; R = Me




(118) 148; R = Me; 40%






    -78 oC to -40 oC
e) TiCl(O-i-Pr)3, 169






108; R = C4H9
125; R = (CH2)2OTBDPS
170; R = C4H9; 70%
    dr = 7.8:1
171; R = (CH2)2OTBDPS; 84%
    dr = 7.4:1
 
Scheme 1.23. Diastereoselective addition of alkenylzinc reagents to chiral α-imino ester 169 in 
the presence of TiCl(O-i-Pr)3 
 
 The si-face stereoselectivity of the addition of the vinylzinc reagents was confirmed by 
the synthesis of amino ester (-)-173 (Scheme 1.24).  Saponification of (2R)-170 (KO-t-Bu, H2O, 
THF) followed by methylation (TMSCHN2, MeOH) afforded ester (+)-149.  Hydrogenation 
using Adams’ catalyst (H2, PtO2, MeOH) afforded the saturated amino ester 172 and 
dephosphinoylation (HCl, MeOH) followed by Cbz protection (Cbz-Cl, NaHCO3, EtOAc/H2O) 
afforded the desired amino acid derivative (-)-173.  We were able to independently prepare (+)-
173 from Cbz-D-Phg-OMe via oxazolidinone 174158 using Seebach’s methodology for the self-
regeneration of stereocenters.159  Deprotonation of 174 with NaHMDS at -78 °C and treatment 
with freshly prepared hexyl triflate160 in THF and HMPA afforded 175 as a single 
diastereomer.161  Opening of the oxazolidinone (NaOMe, MeOH) afforded the protected amino 
ester, (+)-173.  Comparison of the sign of the optical rotations permitted the assignment of the 
major diastereomer of the vinylzinc addition to imine 169 as the (2R)-stereoisomer, confirming 
that this addition occurs onto the si-face of 169 via a chelated transition state. 
                                                 
158 O’Donnell, M. J.; Fang, Z.; Ma, X.; Huffman, J. C. Heterocycles 1997, 46, 617. 
159 Seebach, D.; Sting, A. R.; Hoffman, M. Angew. Chem., Int. Ed. Engl. 1996, 35, 2708. 
160 Fife, W. K.; Ranganathan, P.; Zeldin, M. J. Org. Chem. 1990, 55, 5610. 
161 The diastereoselectivity was assayed by analysis of the crude 1H NMR at 80 °C in DMSO-d6. 
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1) KOt-Bu, H2O
    THF, 70 oC
2) TMSCHN2














[α]D -32.4 (c 0.5, CHCl3)






































Scheme 1.24. Confirmation of the configuration of vinylzinc adduct (2R)-170 
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1.3 Zirconium-Mediated Cascade Reactions of Aldimines 
An interesting side reaction was observed during the addition of 174 to N-
diphenylphosphinoylimine 30 when the reaction was attempted in CH2Cl2.  While the expected 
allylic amide 110 was formed during this process, concomitant formation of C-
cyclopropylalkylamide 111 was also observed (Scheme 1.18).162 
 
1.3.1 Synthesis of C-Cyclopropylmethylamides by Tandem Alkenylzirconocene Aldimine 
Addition-Simmons Smith Cyclopropanation133,163 
 
 The originally developed conditions for the formation of 111 required the use of excess 
Cp2ZrHCl, Me2Zn and alkyne; however, allylic amide always remained.  The addition of CH2I2 
(5 equiv) after consumption of 21 completed the cyclopropanation reaction, affording 76% of 
111.  Accordingly, a variety of C-cyclopropylalkylamides were prepared using this protocol with 
diphenylphosphinoylimines derived from substituted benzaldehydes (Table 1.8).  Terminal 
alkynes (entries 1, 3-7) and unsymmetrical internal alkynes (entry 2) perform well in this 
reaction.  Electron withdrawing (entries 3-5) and donating (entry 6) substituents were 
accommodated in the reaction affording the desired amino cyclopropanes.  Interestingly, the 
ortho-methoxy substituted imine 120 afforded a mixture of C-cyclopropylalkylamide 184 and 
allylic amide 129 despite attempts to force the reaction to completion.164  This three-component 
condensation can also be scaled up to afford preparatively useful quantities of C-
cyclopropylalkylamides.  For example, 177 was prepared in 75% yield (3.1 mmol of 21) and 
55% (11.5 mmol of 21), while the reaction with internal alkyne 178 afforded 61% of C-
cyclopropylalkylamide 179 (5.9 mmol of 21). 
  
                                                 
162 The cyclopropane product was first observed by Dr. Christopher Kendall.  Traces of this product are also 
observed in reactions carried out in toluene or Cl(CH2)2Cl due to residual CH2Cl2 from the hydrozirconation 
process. 
163 Wipf, P.; Kendall, C.; Stephenson, C. R. J. J. Am. Chem. Soc. 2003, 125, 761. 
164 Prolonged reaction times at reflux in CH2Cl2 or an additional portion of CH2I2 (5 equiv) did not significantly 
affect this transformation. 
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1) Cp2ZrHCl (3 equiv)
    CH2Cl2
2) Me2Zn (3 equiv)
3) 28, reflux
4) CH2I2 (5 equiv)
    reflux(3 equiv)  
entry alkyne imine C-cyclopropylalkylamide yield (%)a



















3 108 119 
C4H9
NHP(O)Ph2
MeO2C 180  
69 






5 108 124 
C4H9
NHP(O)Ph2
Cl 182  
65 













aYield of isolated, analytically pure product based on imine; b3.5 g of imine; c1.8 g of imine;  
dA mixture of allylic- and C-cyclopropylalkylamide was isolated (184:129 = 1:1.7) 
 
 
 The observed anti-diastereoselectivity165 can be explained using a model akin to those 
proposed for the Simmons-Smith cyclopropanation of allylic ethers (Figure 1.7).  For R ≠ H, the 
A1,3-strain-minimized166 transition state A predominates for the cyclopropanation of allylic 
                                                 
165 The diastereoselectivity was confirmed by X-ray crystallographic analysis of the benzamide derivative of 111 
prepared by Dr. Chris Kendall.  See (a) ref. 163. (b) Kendall, C. Ph.D Dissertation, University of Pittsburgh, 2004. 
166 Hoffman, R. W. Chem. Rev. 1989, 89, 1841. 
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amides, leading to the syn-diastereomer 185 (vide infra).  However, for R = H, the repulsive 
interactions of the bulky nitrogen protective group with the olefin control the facial attack, and 





































Minimize interaction with diphenyl-
phosphinoyl substituent on nitrogen
leads to anti-diastereomer








Figure 1.7. Proposed transition states leading to syn- or anti-C-cyclopropylalkylamides 
 
 As an extension of this new methodology for the stereoselective preparation of C-
cyclopropylalkylamides, we wanted to examine if vinylcyclopropanes could be easily prepared 
under these conditions.  Vinylcyclopropanes could prove to be valuable starting materials for the 
preparation of amino acids (See Chapter 2) or for application in higher order cycloaddition 
chemistry, providing rapid access to building blocks previously available only via multi-step 
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synthesis.167  In order to examine this possibility, we chose to prepare enyne 143.  Water-
accelerated carboalumination of 55 followed by iodination afforded the vinyl iodide 187 in 85% 
yield (Scheme 1.25).168  Sonagashira coupling169 with 188 (Pd(PPh3)4, CuI, i-Pr2NH) and 
desilylation (TBAF, THF/MeOH) afforded 143 in excellent yield (80%, 3 steps).  Under the 
standard reaction conditions developed for C-cyclopropylalkylamide formation (3 equiv 189, 
Cp2ZrHCl and Me2Zn), bicyclopropane 190 was isolated as a single diastereomer in 70% yield.  
Unfortunately, we were unable to determine the relative configuration of this sample since 
crystals suitable for x-ray diffraction analysis could not be grown for 190 or simple amide 
deriviatives.  In hopes of overcoming this problem, 195 was prepared in an analogous fashion 
beginning with the carboalumination of 3-butyn-1-ol.170  TBDPS-protection (TBDPS-Cl, Imid) 
and Sonagashira coupling with 188 (Pd(PPh3)4, CuI, i-Pr2NH) followed by C-desilylation 
(K2CO3, MeOH) afforded 195.  Under otherwise identical conditions, the second 
cyclopropanation was more sluggish for this enyne.  However, the reaction could be driven to 
completion with the use of excess CH2I2 (3 x 5 equiv) to afford the desired bicylopropane 196 in 
53% yield.  Desilylation (TBAF, AcOH) afforded alcohol 197 which was crystallized from Et2O 
by slow evaporation to afford crystals suitable for diffraction studies.  The reaction proceeded to 
afford the anti-anti-diastereomer of bicyclopropane 196 (Figure 1.8).   
 While the anti-relationship between the amide and the proximal cyclopropane was 
expected based on our model for the cyclopropanation of simple allylic amides (Figure 1.7), a 
rational explanation for the syn-stereoselectivity for the cyclopropanation of the distal olefin was 
not immediately obvious.171  However, given the elongated N-Zn and C-Zn bonds (ca. 2 Å),172 
intramolecular delivery of the carbenoid remains feasible despite the trans-cyclopropane present 
in the 8-membered ring.  Assuming that the compound must fold into a conformation such that 
                                                 
167 (a) Wender, P. A.; Rieck, H.; Fuji, M. J. Am. Chem. Soc. 1998, 120, 10976. (b) Trost, B.M.; Toste, F.D.; Shen, 
H. J. Am. Chem. Soc. 2000, 122, 3534. 
168 (a) Wipf, P.; Lim, S. Angew. Chem., Int. Ed. Engl. 1993, 32, 1068. (b) Ribe, S.; Wipf, P. J. Chem. Soc., Chem. 
Commun. 2001, 299. 
169 Sonagashira, K. In Metal-Catalyzed Cross-Coupling Reactions; Diederich, F., Stang, P. J., Eds.: Wiley-VCH: 
New York, 1998; p 203. 
170 Negishi, E.; Takahashi, T. Synthesis 1988, 1. 
171 Intermolecular cyclopropanation was ruled out based upon control experiments in which alkenes which were 
added to the reaction did not undergo cyclopropanation. 
172 For C-Zn and N-Zn bond lengths taken from x-ray structures of zinc carbenoids see (a) C-Zn; Charette, A. B.; 
Marcoux, J.-F.; Molinaro, C.; Beauchemin, A.; Brochu, C.; Isabel, E. J. Am. Chem. Soc. 2000, 122, 4508.  (b)  N-
Zn; Denmark, S. E.; O’Connor, S. P.; Wilson, S. R. Angew. Chem., Int. Ed. Engl. 1998, 37, 1149. (c) See also ref. 
87. 
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the reaction occurs with the proximal cyclopropane outside of the 8-membered ring, then two 
limiting transition states must be considered (Figure 1.9).  In transition state A, the 
vinylcyclopropane is extended in the s-trans conformation (minimizing A1,3-strain) and the 
eight-membered ring folds into a chair conformation, delivering the carbenoid to the re-face of 






















2) Me2Zn, -78 to 0 oC





















2) Me2Zn, -78 to 0 oC
3) 21, CH2Cl2, reflux
4) CH2I2 (3 x 5 equiv)


























Scheme 1.25. Synthesis of bicyclopropanes from aldimines and enynes using the Zr→Zn 
methodology for C-cyclopropylalkylamide formation 
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diastereomer must be formed by delivery to the si-face of the olefin.  Accordingly, the 
vinylcyclopropane must adopt an s-cis-conformation (transition state B), forcing unfavorable 
non-bonded interactions between the methyl group of the olefin and the pseudo axial hydrogen 
of the cyclopropane.  The observed diastereoselectivity is in excellent accord with the results of 
Barrett and co-workers for the cyclopropanation of dienyl alcohols and ethers.101 
 The methodology developed herein has been successfully applied to the preparation of 
novel cyclopropane-containing amino acids and to initiate β-turns173 or stabilize extended 









Figure 1.8. Stereoview of the x-ray crystal structure of 197 generated using Chem3D175 
 
                                                 
173 Wipf, P.; Xiao, J. Org. Lett. 2005, 7, 103. 
174 See Chapter 2 for details. 
































Figure 1.9. Proposed transition state for the diastereoselective formation of bicyclopropanes 
from enynes and aldimines 
 
1.3.2 Synthesis of C,C-Dicyclopropylmethylamides by Double C,C-σ-Bond Insertions into 
Bicyclobutanes176 
During the course of our studies towards the preparation of cyclopropyl amino acids using our 
Zr→Zn methodology, we found that propargyl ethers such as 141 did not afford C-
cyclopropylalkylamides.  Fortunately, we were able to use Zn(CH2I)2 in place of CH2I2 for these 
less reactive substrates (vide infra).  The application of this protocol during the dimethylzinc-
mediated addition of the alkenylzirconocene derived from 108 to alkynyl imine 201163 afforded 
C,C-dicyclopropylmethylamide 202 in 60% yield as a single diastereomer (Scheme 1.26).177  In 
the course of this remarkable cascade process, ten new C,C-bonds were formed, while two C,C-
bonds were broken, including the alkyne triple bond of the imine. 
  One of the disadvantages of our methodology for the preparation of C-
cyclopropylalkylamides163 is that a three-fold excess of the alkenylzinc reagent (alkyne, 
Cp2ZrHCl and Me2Zn) is required.178  We briefly examined conditions to optimize the formation 
of 202, while attempting to decrease the amount of zirconium, zinc and alkyne (Table 1.9). 
                                                 
176 Wipf, P.; Stephenson, C. R. J.; Okumura, K. J. Am. Chem. Soc. 2003, 125, 14694. 
177 The structure of a related C,C-dicyclopropylmethylamide was fully assigned using 2D-NMR techniques. 
178 The lifetime of the vinylzinc reagent prepared under these conditions is significantly shorter in CH2Cl2 than 
toluene.  Wipf, P.; Kendall, C., Unpublished results.  For a related study on the stability of vinylzinc reagents 
prepared from B→Zn transmetalation, see ref. 64a. 
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Switching solvents from CH2Cl2 (entry 1) to toluene or chlorobenzene (entries 2 and 3) permitted 
the use of only 1.5 equiv of the vinylzinc reagent as the reaction proceeded smoothly to afford 
the intermediate allylic amide.  However, these solvents appear to be incompatible with the 
conditions for the second step of the reaction resulting in lower isolated yields of 202.  A 
similarly non-polar solvent, dichloroethane, also was useful for the addition to N-
diphenylphosphinoyl imines (vide supra) and is generally regarded as an ideal solvent for the 
Simmons-Smith cyclopropanation reaction.91  Accordingly, the multi-component condensation in 
dichloroethane with 4 equiv of Zn(CH2I)2 afforded 60% (entry 4) of 202.  Lowering the reaction 
temperature to 0 °C improved the yield slightly to 68% (entry 5).  While the improvements 
achieved in the reaction yield were modest at best, the overall transformation is superior as we 





    -78 oC to 0 oC
3) 201, reflux
4) Zn(CH2I)2
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Scheme 1.26. Multi-component synthesis of C,C-dicyclopropylmethylamide 202 from imine 
201, alkyne 108 and Zn(CH2I)2 
  
 A selection of N-diphenylphosphinoylalkynylimines was prepared according to a 
modification of a literature procedure (Table 1.10).136  A variety of electron-rich (entries 2-4), 
electron-poor (entry 5) and heterocyclic (entry 6) imines were prepared.  In all cases, the isolated 
yield was low to modest although the reactions could easily be scaled up to afford gram 
quantities of imine.  In the case of entry 6, the imine readily decomposed during purification and 
was used in the subsequent reaction without extensive purification. 
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Table 1.9. Optimization of the formation of 202 from alkyne 108 and imine 201 










1 3 3 3 3 CH2Cl2 r.t. 60 
2 1.5 1.5 1.5 4 toluene r.t. <50 
3 1.5 1.5 1.5 4 C6H5Cl 0 46 
4 1.5 1.5 1.5 4 Cl(CH2)2Cl r.t. 60 
5 1.5 1.5 1.5 4 Cl(CH2)2Cl 0 68 
aYield of isolated, analytically pure product based on imine. 
  
Table 1.10. Preparation of alkynyl imines from aryl-substituted propynals 











































aYield of isolated, analytically pure product based on aldehyde;180 bImine was used  
without further purification 
  
 
                                                 
179 The aldehydes were prepared from the corresponding teminal acetylene (n-BuLi, THF, then DMF) and were used 
without extensive purification. 
180 We did not rigourously attempt to optimize the yield of imine formation. 
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 The functionalized imines were subjected to the optimized reaction conditions for C,C-
dicylopropylmethylamide formation (Table 1.11).  While the parent imine 201 afforded 202 in 
good yield, electron-donating (entries 2-4), electron-withdrawing (entry 5) and hetrocyclic 
imines (entry 6) were well tolerated, affording the corresponding C,C-dicyclopropylmethyl-
amides in 47-58% yield.  The variation in the alkyne portion follows the general reactivity 
principles of alkenylzirconocenes and it was not surprising that alkynes bearing silyl ethers 
(entry 7), silyl and ortho esters181 (entries 8 and 9) as well as sulfonamides and carbamates 
afforded the C,C-dicyclopropylmethylamides in 43-55% yield.  For the preparation of 219 on >1 
mmol scale, Zn(CH2I)2•DME complex182 was substituted for Zn(CH2I)2 without noticeable 
attenuation in reactivity despite the presence of the deactivating DME ligand.  While the overall 
yield in this transformation is moderate, the yield per C,C-bond forming event (6) is excellent 
(87-94%).183 
 As part of our studies to better understand the reaction of propargyl amides with zinc 
carbenoids, model propargylic amides 226 and 228 were prepared.  N-Protection of propargyl 
amine followed by Sonagashira coupling169 afforded the unsubstituted propargyl phosphinamide 
226.  Treatment of a solution of 226 in CH2Cl2 or Cl(CH2)2Cl with Zn(CH2I)2 did not result in 
any conversion to 227.  However, stirring 226 with Me2Zn followed by treatment with Zn(CH2I)2 
afforded 61% of C-cyclopropylalkylamide 227.  This result was intriguing since allylic amides 
are cyclopropanated without pre-treatment with an alkylzinc reagent.133  Similarly, allylic amide 
228 was prepared using the Zr→Zn methodology and subjected to the rearrangement conditions 
affording 202 in 72% yield.  This important extension of the methodology allows for an increase 
in the diversity of structures available as the reaction cascade no longer must be initiated by an 
imine alkenylation event. 
 
                                                 
181 (a) Wipf, P.; Xu, W. J. Org. Chem. 1993, 58, 5880. (b) Wipf, P.; Xu, W.; Kim, H.; Takahashi, H. Tetrahedron 
1997, 53, 16575. 
182 The reaction of Et2Zn with CH2I2 is very exothermic and explosions have been observed in the Charette lab.  
They have suggested the use of the DME complex as a safe alternative to Zn(CH2I)2 for reactions requiring >1 mmol 
of zinc carbenoid.  For details, see ref. 108b.  
183 The formation of a cyclopropane during this process has been counted as one bond forming event. 
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Table 1.11. Synthesis of C,C-dicyclopropylmethylamides via the Zr→Zn initiated multi-
component condensation reaction 
entry alkyne imine C,C-dicyclopropylmethylamide yield (%)a 






2 108 205 
NHP(O)Ph2
C4H9
MeO 214  
50 











5 108 211 
NHP(O)Ph2
C4H9
Cl 217  
58 
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2) PhI, Pd(PPh3)4





























61% 72%108  
Scheme 1.27. Synthesis of C,C-dicyclopropylalkylamides from propargyl phosphinamides 
 
 Examing further the scope of the reaction to include internal alkynes precipitated a 
fortuitous result; the reaction of 136 with 211 under our standard rection conditions afforded 
bicyclobutane 229 as the major product and the expected C,C-dicylopropylmethylamide was not 
observed (Scheme 1.28).184  Decreasing the amount of zinc carbenoid (4 to 2.5 equiv) resulted in 
cleaner conversion to the bicyclo[1.1.0]butane product 229.  In fact, both electron-withdrawing 
(p-ClC6H4) and -donating (m-MeOC6H4) aryl-substituted bicyclo[1.1.0]butanes could be easily 
prepared using this protocol.  Initially, we had difficulty generating the alkenylzinc reagent of the 
unsymmetrical, internal alkyne 231 due to an unselective hydrometalation event.  Using the 
protocol developed by Panek,23 231 was hydrozirconated in THF at 50 °C; yet the addition to 
201 was extrememly sluggish at 0 °C or even r.t.185  Fortunately, the use of microwave 
irradiation (90 °C for 30 min) resolved this problem and treatment of the intermediate allylic 
amide with 10 equiv of Zn(CH2I)2 at -20 °C afforded the desired bicyclo[1.1.0]butane in 55% 
yield.186 
                                                 
184 Traces of alkene containing products were removed by treatment of the crude reaction mixture with OsO4/NMO. 
185 The reaction did not reach completion even after 24 h at r.t. 
186 The more hindered cyclohexyl substituent seems to greatly affect the reactivity of the olefin under the 
cyclopropanation conditions and excess reagent was used.  However, at elevated temperatures, the excess reagent 




    -30 oC to 0 oC
3) 207, or 211, 0 oC
4) Zn(CH2I)2 (2.5 equiv)





229, 53%; Ar = (m-MeO)C6H4
230, 51%; Ar = (p-Cl)C6H4
C2H5 136
C2H5
1) Cp2ZrHCl, THF, 50 oC
2) Me2Zn, Cl(CH2)2Cl
    -30 oC to 0 oC
3) 201, µW, 90 oC, 30 min. 
4) Zn(CH2I)2 (10 equiv)









Scheme 1.28. Synthesis of bicyclo[1.1.0]butanes from alkynyl imines and internal alkynes 
 
 Before postulating a mechanism to account for the formation of C,C-dicyclopropylalkyl-
amides in this cascade process, isotopic labeling was performed in the reaction of 108 with 201.  
Hydrozirconation of 108 in CD2Cl2 (3 equiv alkyne, Cp2ZrHCl), transmetalation to zinc (3 equiv 
Me2Zn) and addition to the 201 (CD2Cl2, reflux) followed by treatment with Zn(CD2I)2 afforded 



















Scheme 1.29. Isotopic labelling studies: Synthesis of deuterated C,C-dicylopropylalkylamide 
233 
 
 On the basis of the evidence that we have gathered thus far, the mechanism for the 
formation of C,C-dicyclopropylmethylamides outlined in Figure 1.10 is proposed.  The Zr→Zn 
methodology affords the metalated allylic amide 236.  Alkyl group exchange upon treatment 
with Zn(CH2I)2 followed by a nitrogen-directed Simmons-Smith cyclopropanation gives the 
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amino cyclopropane 238.  With excess zinc carbenoid, the alkyne is now cyclopropanated twice 
to afford the bicyclobutane 242 via the proposed cyclopropene intermediate 241.  As we have 
already demonstrated, the bicyclo[1.1.0]butane intermediate can be isolated when internal 
alkynes are used in this reaction cascade.  These reactive intermediates have been shown to 
undergo double σ-bond insertion reactions with carbenes to afford the skipped diene 244.118,131  
The net result of this insertion is the scission of the C1-C3 and C1-C4 bonds and the formation of 
a 1,1-disubstituted olefin between C1 and C5.  Finally, Simmons-Smith cyclopropanation of the 














































































Figure 1.10. Proposed mechanism for the formation of dicyclopropylmethylamides 
                                                 
187 Upon prolonged exposure, and particularly in the case of electron rich aromatics, the styrenyl olefin may also 
react with the carbenoid. 
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1.3.3 Synthesis of Functionalized Azaspirocycles from C,C-Dicyclopropylmethylamides188 
 While the C,C-dicyclopropylmethylamide scaffold is interesting in itself for further 
biological evaluation, the flexible nature of these compounds raises issues with metabolism and 
bioavailability.189  In order to address this issue, we targeted 5-, 6-, and 7-membered nitrogen-
containing heterocycles to expand the structural diversity of these new building blocks.190  N-
Alkylation of 248 on nitrogen followed by ring closing metathesis191,192,193 was presumed to 
afford the desired azepines 250 (Table 1.12).194  Upon deprotonation of 248 with NaH, no 
alkylation with allyl iodide was observed at r.t., and on warming to 70 °C, conversion to the N-
allylated product 249 was slow.  Treatment of the anion with HMPA followed by allyl iodide 
and heating at 70 °C resulted in clean conversion to the desired alkylated intermediates 249 in 
good to excellent yields in 1-2 h.  Following a literature protocol for the preparation of azepines 
using ring closing metathesis in refluxing Cl(CH2)2Cl (bp 83 °C),194d 249 was rapidly consumed, 
however, alkene isomerization to the enamide prior to cyclization was competitive with ring-
closing to azepine 250 (enamide:azepine ~1:1).194c,195 A simple change in solvent to CH2Cl2 (bp 
40 °C) minimized the isomerization pathway196 leading to the desired azepines in 63-84% yield.   
 
                                                 
188 Wipf, P.; Stephenson, C. R. J.; Walczak, M. A. A. Org. Lett. 2004, 6, 3009. 
189 Veber, D. F.; Johnson, S. R.; Cheng, H.-Y.; Smith, B. R.; Ward, K. W.; Kopple, K. D. J. Med. Chem. 2002, 45, 
2615. 
190 For short reviews on diversity-oriented synthesis, see (a) Spring, D. R. Org. Biomol. Chem. 2003, 1, 3867. (b) 
Burke, M. D.; Schreiber, S. L. Angew. Chem., Int. Ed. Engl. 2004, 43, 46. 
191 For some recent reviews on ring closing metathesis, see (a) Schuster, M.; Blechert, S. Angew. Chem., Int. Ed. 
Engl. 1997, 36, 2036. (b) Grubbs, R. H.; Chang, S. Tetrahedron 1998, 54, 4413. (c) Furstner, A. Angew. Chem., Int. 
Ed. Engl. 2000, 39, 3012. 
192 For a recent review on the formation of nitrogen-containing heterocycles by ring closing metathesis, see Deiters, 
A.; Martin, S. F. Chem. Rev. 2004, 104, 2199. 
193 For discussion of the mechanism of Ru-based ring-closing metathesis reactions, see (a) Sanford, M. S.; Ulman, 
M.; Grubbs, R. H. J. Am. Chem. Soc. 2001, 123, 749. (b) Sanford, M. S.; Love, J. A.; Grubbs, R. H. J. Am. Chem. 
Soc. 2001, 123, 6543. 
194 For the preparation of azepines by ring closing metathesis, see (a) Fu, G. C.; Grubbs, R. H. J. Am. Chem. Soc. 
1992, 114, 7324. (b) Furstner, A.; Guth, O.; Duffels, A.; Seidel, G.; Liebl, M.; Gabor, B.; Mynott, R. Chem. Eur. J. 
2001, 7, 4811. (c) Wipf, P.; Rector, S.; Takahashi, H. J. Am. Chem. Soc. 2002, 124, 14848. (d) Hoffmann, T.; 
Waibel, R.; Gmeiner, P. J. Org. Chem. 2003, 68, 62. 
195 For examples of olefin isomerization with metathesis catalysts, see (a) Sutton, A. E.; Seigal, B. A.; Finnegan, D. 
F.; Snapper, M. L. J. Am. Chem. Soc. 2002, 124, 13390. (b) Lehman, S. E., Jr.; Schwendeman, J. E.; O’Donnell, P. 
M.; Wagener, K. B. Inorg. Chim. Acta 2003, 345, 190. (c) Hong, S. H.; Day, M. W.; Grubbs, R. H. J. Am. Chem. 
Soc. 2004, 126, 7414. 
196 Approximately 10-15% of enamide was usually observed under these conditions. 
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Metathesis catalyst  
 
entry amide N-allylation product yield 
(%)a 







































































Table 1.12. Cont’d 
entry amide N-allylation product yield 
(%)a 






























aYield of isolated, analytically pure product based on phosphinamide; bYield of isolated, analytically pure product 
based on allyl phosphinamide 
  
Functionalization was tolerated both in the arene portion as well as the cyclopropane-containing 
side chain.  Isomerization of the styrenyl olefin in 249 or 250 was never observed under these 
reaction conditions.197 
 The functionality present in the C,C-dicyclopropylmethylamide scaffold also affords the 
opportunity to prepare pyrrolidines by a reductive amination pathway (Scheme 1.30).  Oxidative 
cleavage of the 1,1-disubstituted olefin in 202 and 215 using the protocol developed by Johnson 
and Lemieux afforded the aryl ketones 266 and 267 in good yields.198  Unfortunately, direct 
reductive amination under Lewis acidic conditions (Ph3SiH/BF3•OEt2,199 TiCl4/Et3SiH) failed to 
afford the desired pyrrolidine.200  We have previously taken advantage of the acid lability of the 
diphenylphosphinoyl group for derivatization and found that a simple three-step, one-pot 
protocol involving N-deprotection (HCl, MeOH) followed by reductive amination (NaBH3CN, 
MeOH) and acylation (AcCl, DIPEA) could be used to generate the pyrrolidines 268 and 269.  
                                                 
197 Prolonged storage of these unsaturated azepines at r.t. leads to presumed isomerization to an enamide product, 
although this by-product has not been rigorously characterized. 
198 (a) Pappo, R.; Allen, D. S.; Lemieux, R. U.; Johnson, W. S. J. Org. Chem. 1956, 21, 478. (b) Wipf, P.; Kim, Y.; 
Goldstein, D. M. J. Am. Chem. Soc. 1995, 117, 11106. 
199 Rudolph, A. C.; Machauer, R.; Martin, S. F. Tetrahedron Lett. 2004, 45, 4895. 
200 The Lewis acidic conditions appear to promote the N-dephosphinoylation and the desired pyrrolidines could not 
be isolated in acceptable yields. 
 58
While the observed diastereoselection for pyrrolidine formation was poor (<2:1), the 



















202: Ar = Ph
215: Ar = (m-MeO)C6H4
266; Ar = Ph, 77%
267; Ar = (m-MeO)C6H4, 56 %
268; Ar = Ph, 70% (268a:268b = 1.8:1)
269; Ar = (m-MeO)C6H4, 68% (269a:269b = 1.7:1)  
Scheme 1.30. Reductive amination approach for the synthesis of azaspiroheptanes 
 
 Finally, we believed that the corresponding piperidine scaffold could be accessed using 
the intramolecular aminolysis of epoxide 270 (Scheme 1.31).202  Not surprisingly, the 
epoxidation of 202 with m-CPBA was not influenced by the remote stereocenters affording a 1:1 
mixture of diastereomeric epoxides 270a and 270b.  The mixture was subjected to the conditions 
developed for the N-alkylation of phosphinamides 248 with allyl iodide.  To our surprise, a 
stereodivergent pathway was revealed and two cyclization products, piperidine 271 and 
pyrrolidine 272 were isolated, each as single diastereomers.  We surmised that the diastereomeric 
epoxides each afforded a single heterocyclic product.  We were intrigued by the possibility of a 
stereospecific cyclization event and to test our conjecture, 270a and 270b were separated by 
column chromatography and individually reacted under our cyclization conditions.  To our 
delight, 270a afforded only piperidine 271 while 270b afforded only pyrrolidine 272.  The 
relative stereochemistry of 272 was confirmed by the presence of a NOESY cross peak between 
the methine hydrogen and the hydroxymethylene group.  The relative stereochemistry of 270a 
and 270b was inferred on the basis of an assumed inversion of stereochemistry for the 
conversion of 270b to 272. 
                                                 
201 Similar results were observed by Martin and co-workers under these reductive amination conditions.  They were 
able to improve the diastereoselectivity using the combination of Ph3SiH/BF3•OEt2.For details, see ref. 199. 
202 (a) LaLonde, R. T.; Muhammad, N.; Wong, C. F.; Sturiale, E. R. J. Org. Chem. 1980, 45, 3664. (b) Nuhrich, A.; 
Moulines, J. Tetrahedron 1991, 47, 3075. (c) Breternitz, H.-J.; Schaumann, E. J. Chem. Soc., Perkin Trans. 1 1999, 































































Scheme 1.31. Stereospecific formation of azaspiroheptanes and azaspirooctanes by 
intramolecular epoxide aminolysis 
 
 At this stage, we can only speculate about the nature of this selective cyclization; 
however, it has been demonstrated that the cyclopropyl side chain plays an important role in this 
cyclization (Figure 1.11).  When the cyclopropyl side chain is replaced with either R2 = H or Me 
(R1 = Ph),203 only the 6-endo cyclization products are observed.  The regioselectivity of epoxide 
opening is reversed when R1,R2 = H, and only the 5-exo product is formed.203  With these control 
experiments in mind, it is reasonable to conclude that in the absence of a bulky substituent at R2, 
the 6-endo mode of cyclization is favored for 1,1-disubstituted epoxides.  However, as the size of 
R2 increases, the preference for R2 to remain pseudo-equatorial forces the reaction to the 5-exo 
cyclization pathway for 273b.  For epoxide 273a, the interaction of the diphenylphosphinoyl 
                                                 
203 These experiments were performed by Mr. Maciej Walczak.  When R2=Me, both diastereomers of the epoxide 
afford the 6-endo cyclization product. 
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group and R1 must disfavor the conformer that would lead to the product of 5-exo opening, 274.  
Rotation of R2 away from the nitrogen protecting group to conformer B favors the 6-endo 
opening (in a boat-like transition state), leading to piperidine 275.  When R2 is small, this 
preference must outweigh the A-value of the methyl group, forcing it axial in one diastereomer.  
Conversely, when R2 is large, the ring flip to put R2 axial is disfavored and the 5-exo pathway 













































Figure 1.11. Predictive model for the stereospecificity of epoxide aminolysis 
1.4 Microwave-Assisted Reactions of Alkenylzirconocenes204 
 The addition of alkenylzinc reagents to imines is a valuable protocol for the preparation 
of allylic- and C-cyclopropylalkylamides.  The foremost disadvantage, in terms of library 
preparation, is the investment of time required from hydrozironcation until reaction completion 
(ca. 8-24 h).  In the case of alkyne 231, the addition to imine 201 was extremely slow 
(incomplete after 24 h) under our standard reaction conditions (Scheme 1.28).  Using microwave 
irradiation, the addition of the vinylzinc reagent proceeded in only 30 min at 90 °C.  Since the 
hydrozirconation of alkynes is prohibitively slow in toluene, this improved protocol still required 
a solvent switch from THF to toluene.  Interestingly, the hydrozirconation was also found to be 
                                                 
204 Wipf, P.; Janjic, J.; Stephenson, C. R. J. Org. Biomol. Chem. 2004, 2, 443. 
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significantly accelerated by microwave irradiation; the hydrozirconation of 108 in toluene is 
complete within 5 min at 60 °C.205  Upon transmetalation to zinc, the addition of the vinylzinc 
reagent to 21 was complete after 5 min at 100 °C (Table 1.13).  A simplified work-up protocol 
was also used for the rapid preparation of allylic amides (entries 1 and 2) employing a MeOH 
quench at 0 °C and filtration through a pad of SiO2 prior to chromatography.206  The 
unsymmetrical internal alkynes 231 and 279 were hydrozirconated in toluene under optimized 
conditions at 60 °C followed by addition to 21 and 119 at 100 °C in only 5 min (entries 3 and 4).  
This protocol has also been applied to the synthesis of C-cyclopropylalkylamides (entries 5-7), 
however the hydrozirconation of alkynes 281, 108, 125 was carried out in CH2Cl2 at r.t.  
Transmetalation to dimethylzinc at -78 °C, followed by addition to 21 or 119 in CH2Cl2 at 100 
°C affords a mixture of allylic- and C-cyclopropylalkylamide.  After cooling to 0 °C, CH2I2 is 
added and the reactions were further heated in the microwave for 20 min to complete the 
conversion of allylic amides to cyclopropanes 282, 111 and 176 in good yields and excellent 
diastereoselectivity.207 
  In order to expand the diversity of compounds available using the microwave 
technology, the C-cyclopropylalkylamide 282 was N-deprotected in acidic methanol and the 
intermediate hydrochloride salt 283 was coupled with an acid chloride, a sulfonyl chloride and a 
chloroformate to afford the amide 284, sulfonamide 285 and carbamate 286 in excellent yields 
over two steps (Scheme 1.32).208 
                                                 
205 Heating the hydrozirconation reaction also seems to accelerate a decomposition pathway, often leading to a 
purple coloration of the reaction.  This color fades on cooling or addition of Me2Zn and imine. 
206 This modification greatly simplifies the work-up protocol, avoiding emulsions often associated with the aqueous 
quench of the organometallic reaction. 
207 The minor diastereomer was not observed in the 1H NMR of the crude reaction mixture. 
208 The microwave protocols developed herein and analogous protocols developed for allylic amide derivatization by 
Jelena Janjic and Dr. Christopher Kendall have been adapted by the UPCMLD for the preparation of a library of 
allylic- and C-cyclopropylalkylamides.  Cf. Wipf, P.; Coleman, C. M.; Janjic, J.; Iyer, P. S.; Fodor, M. D.; Shafer, Y. 
A.; Stephenson, C. R. J.; Kendall, C.; Day, B. W. J. Comb. Chem. 2005, In Press. 
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Table 1.13. Microwave-accelerated synthesis of allylic- and C-cyclopropylalkylamides 
entry alkyne imine product yield (%)a 










































aYield of isolated, analytically pure product based on imine; bAlkynes 231 and 279 were 




















































 In summary, a number of efficient protocols have been developed for the preparation of a 
diverse assortment of products which would have been previously available only using multi-
step protocols (Figure 1.12).  The preparation of simple allylic amines and alcohols has been 
described using a straightforward, one-pot protocol.  This method has been extended to the 
synthesis of C-cyclopropylalkylamides, hinging only upon the choice of solvent for the reaction.  
Furthermore, the use of functionalized imines has led to the discovery of a novel cascade 
reaction for the preparation of C,C-dicyclopropylmethylamides from simple, readily available 
starting materials.  Highlights of this cascade are the formation of ten new carbon-carbon bonds, 
the scission of an sp-sp bond and the diastereocontrolled construction of three new stereocenters.  
Products of these reactions have been used in a diversity-oriented approach for the preparation of 
7-, 8-, and 9-membered azaspirocyclic ring structures based on reductive amination, epoxide 
opening or ring-closing metathesis strategies. 
 From the simple allylic amines and alcohols 288, 289, and 289 to more complex 
heterocyclic scaffolds, such as azaspirocycles 294-297, the practical protocols for the preparation 
of these building blocks should prove useful for the preparation of libraries for the discovery and 
evaluation of novel lead structures for biological evaluation.  The highlight of the reactions 
described in Chapter 1 is the remarkable cooperativity of zirconium and zinc and it is expected 

































































Figure 1.12. Summary of oxygen- and nitrogen-containing products that have been prepared 
using the Zr→Zn transmetalation addition pathway 
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1.6 Experimental Part 
General.  All moisture-sensitive reactions were performed under an atmosphere of N2 and 
glassware was flame dried under vacuum or dried in an oven at 140 °C for 2 h prior to use.  
DME and Et2O and THF were dried by distillation over Na/Benzophenone and Et3N, i-Pr2NH 
and Cl(CH2)2Cl were dried by distillation over CaH2.  Toluene and CH2Cl2 were purified by 
filtration through activated alumina.  CD2Cl2 was used from a freshly opened ampule without 
purification.  Me3Al (neat), Me2Zn (2.0 M in toluene), Et2Zn (neat), and CH2I2 were purchased 
from the Aldrich Chemical Company.  Unless otherwise stated, solvents or reagents were used as 
received.  Cp2ZrHCl,209 118,210 imines 21,210 119,210 123,210 124,210 alkynes 125,211 127,212 
141,213 178,214 223,215 231,216 279217 and allylic amide 228215 were prepared according to 
literature procedures.  Zn(CH2I)2 was prepared by dropwise addition of CH2I2 (0.20 mL, 2.4 
mmol) to a freshly prepared solution of Et2Zn (0.15 g, 1.2 mmol) in Cl(CH2)2Cl (1.0 mL) at        
–20 °C and stirring for 10 min.  Zn(CH2I)2•DME was prepared by dropwise addition of CH2I2 
(0.59 mL, 7.3 mmol) to a freshly prepared solution of Et2Zn (0.45 g, 3.6 mmol) and DME (0.39 
mL, 3.6 mmol) in Cl(CH2)2Cl (3.0 mL) at –30 °C and and used after stirring for 10 min. 
 Analytical thin layer chromatography (TLC) was performed on pre-coated silica gel 60 F-
254 plates (particle size 0.040-0.055 mm, 230-400 mesh) and visualization was accomplished 
with a 254 nm UV light and/or by staining with Vaughn's reagent (4.8 g of (NH4)6Mo7O24•4H2O 
and 0.20 g of Ce(SO4)2 in 100 mL of 3.5 N H2SO4 solution) or KMnO4 (1.5 g of KMnO4 and 1.5 
g of K2CO3 in 100 mL of a 0.1% aqueous NaOH solution).   
 Unless stated otherwise, NMR spectra were recorded at 300 MHz/76 MHz (1H NMR/13C 
NMR) using a Bruker AVANCE 300 MHz spectrometer at 21 °C in CDCl3.  High field 500 
MHz/126 MHz (1H NMR/13C NMR) and 600 MHz/151 MHz (1H NMR/13C NMR) were 
recorded on Bruker AVANCE 500 MHz and 600 MHz spectrometers respectively.  Chemical 
                                                 
209 Buchwald, S. L.; LaMaire, S. J.; Nielsen, R. B. Org. Synth. 1993, 71, 77 
210 Jennings, W. B.; Lovely, C. J. Tetrahedron 1991, 47, 5561. 
211 Wipf, P.; Xu, W. Org. Synth. 1996, 74, 205. 
212 Alexakis, A.; Marek, I.; Mangeney, P.; Normant, J. F. Tetrahedron 1991, 47, 1677. 
213 Ishikawa, T.; Mizuta, T.; Hagiwara, K.; Aikawa, T.; Kudo, T.; Saito, S. J. Org. Chem. 2003, 68, 3702. 
214 Na, Y.; Ko, S.; Hwang, L. K.; Chang, S. Tetrahedron Lett. 2003, 44, 4475. 
215 Wipf, P.; Kendall, C.; Stephenson, C. R. J. J. Am. Chem. Soc. 2003, 125, 761. 
216 McComsey, D. F.; Reitz, A. B.; Maryanoff, C. A.; Maryanoff, B. E. Synth. Commun. 1986, 16, 1535. 
217 Pasto, D. J.; Shults, R. H.; McGrath, J. A.; Waterhouse, A. J. Org. Chem. 1978, 43, 1382. 
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shifts (δ) are reported as follows:  chemical shift, multiplicity (s=singlet, d=doublet, t=triplet, 
q=quartet, m=multiplet, b=broad), coupling constants, and integration.  For all phosphorous 
containing compounds, data for 13C spectra are tabulated by observed peak.  IR spectra were 
obtained on a Nicolet AVATAR 360 FT-IR E.S.P. spectrometer.  Mass spectra were obtained on 
a Micromass Autospec double focusing instrument.  Optical rotations were measured on a 
Perkin-Elmer 241 polarimeter.  Microwave experiments were run on a CEM Discover instrument 




N-(2-Methoxybenzylidene)-P,P-diphenylphosphinamide (120).  According to a literature 
procedure,210 118 (1.0 g, 4.6 mmol), o-anisaldehyde (0.63 g, 4.6 mmol), TiCl4 (0.30 mL, 2.8 
mmol), and Et3N (1.9 mL, 14 mmol) in CH2Cl2 (24 mL) afforded 120 (0.82 g, 53%) as a 
colorless solid:  mp 142.0-144.0 °C (hexanes/EtOAc); IR (KBr) 3052, 3018, 2966, 2942, 2840, 
1681, 1608, 1597, 1576, 1487, 1468, 1638, 1365, 1302, 1290, 1249, 1204, 1179, 1162, 1122   
cm-1; 1H NMR δ 9.81 (d, J = 32.6 Hz, 1 H), 8.24 (dd, J = 7.8, 1.7 Hz, 1 H), 7.99-7.92 (m, 4 H), 
7.56-7.42 (m, 7 H), 7.05 (t, J = 7.4 Hz, 1 H), 6.96 (d, J = 8.4 Hz, 1 H), 3.89 (s, 3 H); 13C NMR δ 
170.15, 170.06, 161.32, 132.05, 131.83, 131.79, 131.75, 131.71, 128.65, 128.48, 128.33, 120.76, 
111.61, 55.68; MS (EI) m/z (intensity) 335 (M+, 16), 304 (36), 216 (34), 202 (100), 155 (21), 134 





N-(3-Methoxy-benzylidene)-P,P-diphenylphosphinamide (121).  According to a literature 
procedure,210 118 (1.0 g, 4.6 mmol), m-anisaldehyde (0.63 g, 4.6 mmol), TiCl4 (0.30 mL, 2.8 
mmol), and Et3N (1.9 mL, 14 mmol) in CH2Cl2 (24 mL) afforded 121 (0.45 g, 29%) as a 
colorless solid:  mp 89.5-92.0 °C (hexanes/EtOAc); IR (KBr) 3080, 3057, 2946, 2845, 1685, 
1615, 1579, 1491, 1436, 1275, 1204, 1156, 1128, 1109 cm-1; 1H NMR δ 9.29 (d, J = 31.9 Hz, 1 
H), 7.98-7.91 (m, 4 H), 7.59-7.40 (m, 9 H), 7.16-7.15 (m, 1 H), 3.90 (s, 3 H); 13C NMR δ 173.59, 
173.49, 160.04, 137.37, 137.04, 133.89, 132.21, 131.67, 131.54, 131.42, 129.86, 128.44, 128.28, 
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123.35, 119.85, 113.78, 55.31; MS (EI) m/z (intensity) 335 (M+, 11), 216 (100), 199 (81), 140 





N-(3-Nitro-benzylidene)-P,P-diphenylphosphinamide (122).  According to a literature 
procedure,210 118 (1.0 g, 4.6 mmol), m-nitrobenzaldehyde (0.70 g, 4.6 mmol), TiCl4 (0.30 mL, 
2.8 mmol), and Et3N (1.9 mL, 14 mmol) in CH2Cl2 (24 mL) afforded 122 (0.36 g, 22%) as a 
light yellow solid:  IR (KBr) 3074, 1652, 1623, 1574, 1529, 1438, 1350, 1211, 1185, 1125, 1109 
cm-1; 1H NMR δ 9.41 (d, J = 31.0 Hz, 1 H), 8.90 (s, 1 H), 8.46-8.43 (m, 1 H), 8.27 (d, J = 7.7 Hz, 
1 H), 8.00-7.93 (m, 4 H), 7.73 (t, J = 7.8 Hz, 1 H), 7.58-7.47 (m, 6 H); 13C NMR δ 171.30, 
171.20, 137.57, 137.23, 136.37, 133.08, 132.40, 132.37, 132.08, 131.94, 131.84, 131.72, 131.39, 
130.39, 128.95, 128.78, 128.63, 127.79, 123.95; MS (EI) m/z (intensity) 350 (M+, 10), 201 (100), 
77 (17); HRMS (EI) m/z calculated for C19H15N2O3P 350.0820, found 350.0809. 
OTBDPS
NHP(O)Ph2
MeO2C 126  
Methyl 4-[1-(diphenylphosphinoyl)amino-5-(tert-butyldiphenylsilanyloxy)pent-2-enyl]-
benzoate (126).  General Protocol A.  To a suspension of Cp2ZrHCl (0.11g, 0.41 mmol) in dry 
CH2Cl2 (1.0 mL) was added a solution of 125 (0.13 g, 0.41 mmol) in CH2Cl2 (1.0 mL).  The 
reaction mixture was stirred for 5 min and all volatile material was removed in vacuo.  The 
residue was dissolved in dry toluene (2.0 mL), cooled to -78 °C, treated with Me2Zn (0.21 mL, 
0.41 mmol, 2.0 M in toluene), warmed to 0 °C and treated with 119 (0.10 g, 0.28 mmol).  The 
reaction mixture was warmed to r.t., stirred for 1.5 h, quenched with sat. NH4Cl, diluted with 
EtOAc and filtered through Celite.  The mixture was extracted with EtOAc (3x) and the 
combined organic layers were washed with brine, dried (MgSO4) and concentrated.  The residue 
was purified by chromatography on deactivated SiO2 (1:4, hexanes/EtOAc containing 1% v/v 
Et3N) to give 126 (0.15 g, 82%) as a colorless foam:  IR (neat) 3175, 3171, 2953, 2931, 2857, 
1722, 1438, 1281, 1189, 1111 cm-1; 1H NMR δ 7.97-7.90 (m, 4 H), 7.83-7.75 (m, 2 H), 7.64-7.60 
(m, 4 H), 7.51-7.33 (m, 14 H), 5.77-5.69 (m, 1 H), 5.56-5.46 (m 1 H), 4.88-4.80 (m, 1 H), 3.92 
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(s, 3 H), 3.63 (t, J = 6.5 Hz, 2 H), 3.28 (dd, J = 9.8, 6.2 Hz, 1 H), 2.27 (q, J = 6.6 Hz, 2 H), 1.00 
(s, 9 H); 13C NMR δ 167.01, 147.93, 147.87, 135.66, 133.91, 133.42, 133.30, 133.23, 132.43, 
132.34, 132.30, 132.21, 132.11, 132.08, 132.05, 132.01, 131.71, 131.51, 129.97, 129.76, 129.71, 
129.15, 128.68, 128.64, 128.51, 128.47, 127.77, 127.26, 63.35, 56.63, 52.23, 35.67, 26.95, 
19.32; MS (EI) m/z (intensity) 616 ([M-C4H9]+, 3), 467 (3), 437 (5), 379 (8), 309 (86), 199 (100), 
183 (36), 135 (31), 111 (61), 83 (77), 69 (86); HRMS (EI) m/z calculated for C37H35NO4SiP   







(128).  According to the General Protocol A, Cp2ZrHCl (0.15 g, 0.58 mmol), 127 (0.12 g, 0.58 
mmol), Me2Zn (0.29 mL, 0.58 mmol, 2.0 M in toluene) and 119 (0.14 g, 0.38 mmol) (14 h 
reaction time) afforded 128 (0.12 g, 52%) as a light yellow solid:  mp 136.0-138.0 °C 
(hexanes/EtOAc); IR (KBr) 3114, 2953, 2927, 2857, 1722, 1609, 1437, 1278, 1193, 1107 cm-1; 
1H NMR δ 7.96-7.83 (m, 6 H), 7.49-7.38 (m, 8 H), 6.86 (d, J = 11.2 Hz, 1 H), 6.47-6.38          
(m, 1 H), 5.87-5.78 (m, 1 H), 4.99 (t, J = 10.9 Hz, 1 H), 3.88 (s, 3 H), 3.28 (dd, J = 10.2, 6.3 Hz, 
1 H), 2.22-2.16 (m, 2 H), 1.49-1.42 (m 2 H), 1.40-1.24 (bm, 6 H), 0.93-0.89 (m, 3 H), 0.07       
(s, 9 H); 13C NMR δ 167.11, 148.58, 148.54, 142.13, 140.40, 140.35, 138.65, 133.79, 132.92, 
132.79, 132.15, 132.10, 132.02, 131.17, 129.97, 129.16, 128.75, 128.59, 128.45, 128.23, 59.90, 
52.24, 33.05, 31.89, 29.20, 29.07, 22.85, 14.30, 0.44; MS (EI) m/z (intensity) 573 (M+, 2), 558 
(11), 364 (6), 323 (19), 274 (10), 201 (14), 181 (27), 73 (100); HRMS (EI) m/z calculated for 




N-[1-(2-Methoxyphenyl)-hept-2-enyl]-P,P-diphenylphosphinamide (129).  According to the 
General Protocol A, Cp2ZrHCl (0.12 g, 0.45 mmol), 108 (51 µL, 0.48 mmol), Me2Zn (0.22 mL, 
0.45 mmol, 2.0 M in toluene) and 120 (0.10 g, 0.30 mmol) (1 h reaction time) afforded 129   
(0.10 g, 80%) as a colorless solid:  mp 126.0-127.5 °C (hexanes/EtOAc); IR (KBr) 3433, 3174, 
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2918, 1597, 1492, 1436, 1241, 1184 cm-1; 1H NMR δ 7.92-7.76 (m, 4 H), 7.49-7.33 (m, 6 H), 
7.27-7.21 (m, 1 H), 7.06 (dd, J = 7.5, 1.7 Hz, 1 H), 6.92-6.84 (m, 2 H), 5.77 (ddt, J = 15.3, 6.3, 
1.3 Hz, 1 H), 5.42 (dtd, J = 15.1, 6.7, 1.4 Hz, 1 H), 4.86 (dt, J = 9.9, 5.9 Hz, 1 H), 4.10 (dd, J = 
10.5, 8.0 Hz, 1 H), 3.74 (s, 3 H), 1.97-1.93 (m, 2 H), 1.29-1.25 (m, 4 H), 0.88-0.83 (m, 3 H); 13C 
NMR δ 156.85, 134.35, 133.64, 132.64, 132.54, 132.35, 132.16, 131.92, 131.75, 131.71, 131.64, 
131.61, 131.25, 131.18, 128.52, 128.44, 128.40, 128.35, 128.22, 120.93, 111.25, 55.37, 54.80, 
31.93, 31.40, 22.30, 14.07; MS (EI) m/z (intensity) 419 (M+, 10), 362 (19), 336 (8), 218 (100), 






N-[1-(3-Methoxy-phenyl)-hept-2-enyl]-P,P-diphenylphosphinamide (130).  According to the 
General Protocol A, Cp2ZrHCl (0.12 g, 0.45 mmol), 108 (51 µL, 0.45 mmol), Me2Zn (0.22 mL, 
0.45 mmol, 2.0 M in toluene) and 121 (0.10 g, 0.30 mmol) (4 h reaction time) afforded 130 (83 
mg, 66%) as a colorless solid:  mp 74.0-77.2 °C (hexanes/EtOAc); IR (KBr) 3189, 3056, 2953, 
2930, 2869, 1599, 1489, 1463, 1437, 1257, 1184, 1122, 1109 cm-1; 1H NMR δ 7.98-7.84 (m, 4 
H), 7.56-7.39 (m, 6 H), 7.31-7.21 (m, 1 H), 6.99-6.90 (m, 2 H), 6.82 (dd, J = 8.2, 2.4 Hz, 1 H), 
5.68 (dd, J = 15.3, 6.0 Hz, 1 H), 5.61-5.51 (m, 1 H), 4.85-4.77 (m, 1 H), 3.82 (s, 3 H), 3.33 (dd, J 
= 9.2, 6.4 Hz, 1 H), 2.05-1.99 (m, 2 H), 1.34-1.28 (m, 4 H), 0.94-0.89 (m, 3 H); 13C NMR δ 
159.83, 144.97, 144.89, 133.93, 133.58, 132.74, 132.53, 132.49, 132.45, 132.40, 132.32, 132.22, 
132.00, 131.95, 131.91, 131.87, 131.73, 131.67, 119.46, 112.92, 112.73, 57.11, 55.39, 32.01, 
31.35, 22.45, 14.13; MS (EI) m/z (intensity) 419 (M+, 10), 362 (5), 336 (5), 218 (100), 201 (47), 





N-[1-(3-Nitrophenyl)hept-2-enyl]-P,P-diphenylphosphinamide (131).  According to the 
General Protocol A, Cp2ZrHCl (0.11 g, 0.43 mmol), 108 (49 µL, 0.43 mmol), Me2Zn (0.21 mL, 
0.43 mmol, 2.0 M in toluene) and 122 (0.10 g, 0.28 mmol) (1.5 h reaction time) afforded 131  
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(93 mg, 75%) as a light yellow solid:  mp 120.0-121.5 °C (hexanes/EtOAc); IR (KBr) 3177, 
3060, 2955, 2931, 2858, 1526, 1453, 1436, 1350, 1182, 1141, 1124 cm-1; 1H NMR δ 8.15-8.13 
(m, 1 H), 8.04-8.01 (m, 1 H), 7.93-7.86 (m 2 H), 7.79-7.68 (m 3 H), 7.53-7.39 (m, 5 H), 7.35-
7.29 (m, 2 H), 5.65 (dd, J = 15.3, 6.4 Hz, 1 H), 5.53 (dt, J = 15.5, 6.3 Hz, 1 H), 4.88 (ddd, J = 
9.7, 9.7, 6.4 Hz, 1 H), 3.69 (dd, J = 9.3, 6.9 Hz, 1 H), 2.04-1.97 (m, 2 H), 1.36-1.20 (m, 4 H), 
0.89-0.84 (m, 3 H); 13C NMR δ 148.30, 145.42, 145.36, 133.97, 133.84, 133.27, 133.18, 132.44, 
132.31, 132.15, 132.03, 131.57, 131.47, 130.66, 130.58, 129.50, 128.72, 128.61, 128.55, 128.44, 
122.26, 122.11, 56.40, 31.97, 31.20, 22.35, 14.02; MS (EI) m/z (intensity) 434 (M+, 21), 417 
(65), 377 (12), 233 (28), 218 (23), 201 (100), 77 (21); HRMS (EI) m/z calculated for 
C25H27N2O3P 434.1759, found 434.1766. 
C4H9
NHP(O)Ph2
O2N 132  
N-[1-(4-Nitrophenyl)hept-2-enyl]-P,P-diphenylphosphinamide (132).  According to the 
General Protocol A, Cp2ZrHCl (0.11 g, 0.43 mmol), 108 (49 µL, 0.43 mmol), Me2Zn (0.21 mL, 
0.43 mmol, 2.0 M in toluene) and 123 (0.10 g, 0.28 mmol) (1 h reaction time) afforded 132 (90 
mg, 73%) as a light yellow solid:  mp 138.5-141.0 °C (hexanes/EtOAc); IR (KBr) 3153, 2958, 
2928, 2970, 1606, 1595, 1519, 1438, 1345, 1182, 1123, 1111 cm-1; 1H NMR δ 8.14 (d, J = 8.6 
Hz, 2 H), 7.95-7.88 (m, 2 H), 7.82-7.76 (m, 2 H), 7.56-7.44 (m, 6 H), 7.40-7.34 (m, 2 H), 5.64 
(dd, J = 15.4, 6.1 Hz, 1 H), 5.57-4.48 (m, 1 H), 4.90 (dt, J = 9.8, 6.4 Hz, 1 H), 3.39 (dd, J = 9.4, 
6.5 Hz, 1 H), 2.05-1.99 (m, 2 H), 1.36-1.22 (m, 4 H), 0.91-0.86 (m, 3 H); 13C NMR δ 150.57, 
150.52, 147.10, 134.13, 133.25, 133.08, 132.50, 132.37, 132.26, 132.22, 132.17, 132.13, 132.05, 
131.54, 130.46, 128.77, 128.70, 128.60, 128.53, 128.18, 123.81, 56.57, 32.01, 31.22, 22.38, 
14.06; MS (EI) m/z (intensity) 434 (M+, 17), 377 (12), 233 (100), 201 (97), 155 (10), 77 (28); 





N-[1-(4-Chlorophenyl)hept-2-enyl]-P,P-diphenylphosphinamide (133).  According to the 
General Protocol A, Cp2ZrHCl (0.11 g, 0.44 mmol), 108 (51 µL, 0.44 mmol),  Me2Zn (0.22 mL, 
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0.441 mmol, 2.0 M in toluene) and 124 (0.10 g, 0.294 mmol) (2 h reaction time) afforded 133 
(96 mg, 77%) as a light yellow solid:  mp 147.4-149.2 °C (hexanes/EtOAc); IR (KBr) 3117, 
3053, 2953, 2924, 2869, 1491, 1456, 1437, 1194, 1181, 1171, 1121, 1109 cm-1; 1H NMR δ 7.96-
7.90 (m, 2 H), 7.85-7.78 (m, 2 H), 7.55-7.36 (m, 6 H), 7.37-7.24 (m, 4 H), 5.64 (dd, J = 15.3, 6.0 
Hz, 1 H), 5.55-4.46 (m, 1 H), 4.79 (dt, J = 9.7, 6.2 Hz, 1 H), 3.24 (dd, J = 9.4, 6.1 Hz, 1 H), 2.04-
1.97 (m, 2 H), 1.32-1.28 (m, 4 H), 0.91-0.87 (m, 3 H); 13C NMR δ 141.75, 141.69, 133.59, 
133.47, 133.10, 133.03, 132.51, 132.38, 132.32, 132.19, 132.06, 132.02, 131.00, 131.96, 131.88, 
131.77, 131.44, 131.38, 128.72, 128.66, 128.50, 128.48, 56.42, 31.99, 31.32, 22.41, 14.10; MS 
(EI) m/z (intensity) 423 (M+, 8), 222 (87), 201 (100), 125 (26), 115 (19), 77 (64); HRMS (EI) m/z 





(E)-2-Hydroxy-2-phenyloct-3-enoic acid methyl ester (135).  General Protocol B.  To a 
suspension of Cp2ZrHCl (0.24 g, 0.91 mmol) in dry CH2Cl2 (4.0 mL) was added 108 (0.10 mL, 
0.91 mmol) and the reaction mixture was stirred for 10 min at r.t.  The solvent was removed in 
vacuo, and the residue was dissolved in dry toluene (4.0 mL), cooled to -78 °C, treated with 
Me2Zn (0.46 mL, 0.91 mmol, 2.0 M in toluene) and warmed to 0 °C.  After addition of 134 (87 
µL, 0.61 mmol) the reaction warmed to r.t. and stirred for 2 h, quenched with sat. NH4Cl, diluted 
with EtOAc, and filtered through Celite. The layers were separated and the aqueous layer was 
extracted with EtOAc (2x).  The combined organic layers were washed with brine, dried 
(MgSO4) and concentrated.  The residue was purified by chromatography on SiO2 (19:1, 
hexanes/EtOAc) to give 135 (0.14 g, 93%) as a colorless oil:  IR (neat) 3511, 3028, 3956, 2928, 
2872, 2857, 1732, 1494, 1449, 1436, 1254, 1152 cm-1; 1H NMR δ 7.53-7.50 (m, 2 H), 7.39-7.30 
(m, 3 H), 6.01-5.99 (m, 2 H), 3.80 (s, 3 H), 2.17-2.10 (m, 2 H), 1.44-1.30 (m, 4 H), 0.91 (t, J = 
7.0 Hz, 3 H); 13C NMR δ 175.26, 141.85, 132.61, 129.71, 128.39, 128.09, 126.34, 78.32, 53.53, 
32.04, 31.31, 22.42, 14.08; MS (EI) m/z (intensity) 248 (M+, 1), 189 (100), 133 (72), 105 (55), 










(E)-3-Ethyl-2-hydroxy-2-phenylhex-3-enoic acid methyl ester (137).  According to the 
General Protocol B, Cp2ZrHCl (0.24 g, 0.91 mmol), 136 (0.10 mL, 0.91 mmol), Me2Zn (0.46 
mL, 0.91 mmol, 2.0 M in toluene) and 134 (87 µL, 0.61 mmol) afforded 137 (0.11 g, 76%) as a 
colorless oil:  IR (neat) 3503, 2965, 2935, 2874, 1728, 1493, 1449, 1436, 1375, 1249, 1170 cm-1; 
1H NMR δ 7.56-7.53 (m, 2 H), 7.35-7.30 (m, 3 H), 5.26 (t, J = 7.2 Hz, 1 H), 3.82 (s, 3 H), 3.72 
(bs, 1 H), 2.19-2.07 (m, 4 H), 0.99 (t, J = 7.5 Hz, 6 H); 13C NMR δ 175.50, 141.36, 140.42, 
131.78, 128.03, 127.78, 127.53, 83.59, 53.28, 22.03, 21.49, 15.04, 14.19; MS (EI) m/z (intensity) 







(E)-6-(tert-Butyldiphenylsilanyloxy)-2-hydroxy-2-phenylhex-3-enoic acid methyl ester  
(138).  According to the General Protocol B, Cp2ZrHCl (0.24 g, 0.91 mmol), 125 (0.28 g, 0.91 
mmol), Me2Zn (0.46 mL, 0.91 mmol, 2.0 M in toluene) and 134 (87 µL, 0.61 mmol) afforded 
138 (0.24 g, 83%) as a colorless oil:  IR (neat) 3510, 3070, 2954, 2931, 2857, 1734, 1489, 1472, 
1447, 1428, 1256, 1149, 1112 cm-1; 1H NMR δ 7.69-7.66 (m, 4H), 7.54-7.51 (m, 2 H), 7.44-7.30 
(m, 9 H), 6.13-5.99 (m, 2 H), 3.83-3.73 (m, 2 H), 3.78 (s, 3 H), 2.42, 2.38 (AB, J = 6.1 Hz, 2 H), 
1.05 (s, 9 H); 13C NMR δ 175.10, 141.65, 135.74, 133.94, 131.70, 129.76, 129.16, 128.48, 
128.11, 127.81, 126.35, 78.32, 63.33, 53.54, 35.73, 26.98, 19.35; MS (EI) m/z (intensity) 456 
([M-H2O]+, 2), 399 (10), 355 (12), 199 (100), 169 (43), 135 (25), 105 (23), 91 (16); HRMS (EI) 
m/z calculated for C29H32O3Si (M-H2O) 456.2121, found 456.2132. 
CO2TIPS
139  
O-Triisopropylsilyl pent-4-ynoate (139).  To a cooled (0 °C) solution of 4-pentynoic acid (1.1 
g, 12 mmol) in dry CH2Cl2 (25 mL) was added imidazole (0.78 g, 12 mmol) and TIPS-Cl (2.2 g, 
12 mmol) and the reaction was stirred for 2 h, diluted with CH2Cl2 and filtered through Celite.  
The solution was washed with H2O, 10% HCl and brine, dried (MgSO4) and concentrated.  The 
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residue was purified by Kugelrohr distillation (90-120 °C @ ~1 mm Hg) to afford 139 (2.8 g, 
94%) as a colorless oil:  IR (neat) 3314, 2946, 2869, 1720, 1466, 1371, 1268, 1192 cm-1; 1H 
NMR δ 2.63-2.58 (m, 2 H), 2.53-2.48 (m, 2 H), 1.97 (t, J = 2.6 Hz, 1 H), 1.37-1.24 (m, 3 H), 
1.09 (d, J = 7.2 Hz, 18 H); 13C NMR δ 171.62, 82.67, 68.88, 34.84, 17.68, 14.63, 11.82; MS (EI) 
m/z (intensity) 254 (M+, 0.1), 135 (25), 83 (100); HRMS (EI) m/z calculated for C11H19O2Si (M-






(E)-2-Hydroxy-2-phenylhept-3-enedioic acid 7-triisopropylsilyl ester 1-methyl ester  (140). 
According to the General Protocol B, Cp2ZrHCl (0.24 g, 0.91 mmol), 139 (0.23 g, 0.91 mmol), 
Me2Zn (0.46 mL, 0.91 mmol, 2.0 M in toluene) and 134 (87 µL, 0.61 mmol) afforded 140 (0.21 
g, 82%) as a colorless oil:  IR (neat) 3507, 2947, 2868, 1720, 1465, 1449, 1436, 1369, 1256, 
1187, 1140 cm-1; 1H NMR δ 7.52-7.49 (m, 2 H), 7.38-7.30 (m, 3 H), 6.12-5.97 (m, 2 H), 3.84-
3.78 (m, 1 H), 3.80 (s, 3 H), 2.53-2.46 (m, 4 H), 1.37-1.22 (m, 3 H), 1.07 (d, J = 7.1 Hz, 18 H); 
13C NMR δ 174.93, 172.77, 141.85, 131.28, 130.42, 128.44, 128.06, 126.28, 78.33, 53.35, 35.41, 
27.81, 17.92, 12.17; MS (EI) m/z (intensity) 402 ([M-H2O]+, 4), 359 (10), 345 (13), 283 (10), 







(E)-5-Benzyloxy-2-hydroxy-2-phenylpent-3-enoic acid methyl ester (142). According to the 
General Protocol B, Cp2ZrHCl (0.52 g, 2.0 mmol), 141 (0.29 g, 2.0 mmol), Me2Zn (1.0 mL, 2.0 
mmol, 2.0 M in toluene) and 134 (0.19 mL, 1.3 mmol) afforded 142 (0.38 g, 90%) as a colorless 
oil:  IR (neat) 3500, 3062, 3030, 2952, 2853, 1733, 1495, 1450, 1436, 1362, 1252 cm-1; 1H NMR 
δ 7.55-7.51 (m, 2 H), 7.38-7.34 (m, 8 H), 6.34 (dt, J = 15.4, 1.5 Hz, 1 H), 6.16 (dt, J = 15.4, 5.2 
Hz, 1 H), 4.53 (s, 2 H), 4.13 (dd, J = 5.2, 1.5 Hz, 2 H), 3.91 (bs, 1 H), 3.81 (s, 3 H); 13C NMR 
δ 174.64, 141.34, 138.19, 131.97, 128.48, 128.15, 128.08, 127.86, 127.74, 126.12, 78.10, 72.41, 
69.76, 53.55; MS (EI) m/z (intensity) 253 ([M-CO2Me]+, 18), 105 (13), 91 (100); HRMS (EI) 







(E,E)-2-Hydroxy-6-methyl-2-phenyldodeca-3,5-dienoic acid methyl ester (144).  According 
to the General Protocol B, Cp2ZrHCl (0.24 g, 0.91 mmol), 143218 (0.14 g, 0.91 mmol), Me2Zn 
(0.46 mL, 0.91 mmol, 2.0 M in toluene) and 134 (87 µL, 0.61 mmol) afforded 144 (0.17 g, 88%) 
as a colorless oil:  IR (neat) 3504, 2955, 2928, 2856, 1732, 1652, 1493, 1449, 1436, 1384, 1250, 
1198, 1139  cm-1; 1H NMR δ 7.54-7.51 (m, 2 H), 7.36-7.30 (m, 3 H), 6.81 (dd, J = 15.0, 11.1 Hz, 
1 H), 6.10 (d, J = 15.1 Hz, 1 H), 5.94 (d, J = 11.1 Hz, 1 H), 3.89 (bs, 1 H), 3.81 (s, 3 H), 2.06 (t, 
J = 7.2 Hz, 2 H), 1.77 (s, 3 H), 1.45-1.38 (m, 2 H), 1.34-1.29 (m, 6 H), 0.91-0.87 (m, 3 H); 13C 
NMR δ 175.13, 141.88, 141.72, 129.84, 128.50, 128.12, 127.33, 126.28, 123.50, 78.49, 53.58, 
40.14, 31.93, 29.19, 27.93, 22.76, 16.89, 14.26; MS (EI) m/z (intensity) 316 (M+, 5), 257 (76), 




 (E)-2-Hydroxy-2-methyloct-3-enoic acid ethyl ester (146).  According to the General Protocol 
B, Cp2ZrHCl (0.24 g, 0.91 mmol), 108 (0.10 mL, 0.91 mmol), Me2Zn (0.46 mL, 0.91 mmol, 2.0 
M in toluene) and 145 (67 µL, 0.61 mmol) afforded 146 (0.11 g, 93%) as a colorless oil:  IR 
(neat) 3518, 2959, 2930, 2873, 1730, 1449, 1372, 1256, 1203, 1140, 1107 cm-1; 1H NMR δ 5.81 
(dt, J = 15.4, 6.8 Hz, 1 H), 5.56 (dt, J = 15.4, 1.3 Hz, 1 H), 4.21 (q, J = 7.1 Hz, 2 H), 3.32 (s, 1 
H), 2.02 (q, J = 6.7 Hz, 2 H), 1.45 (s, 3 H), 1.39-1.25 (m, 7 H), 0.89 (t, J = 6.9 Hz, 3 H); 13C 
NMR δ 176.14, 131.64, 131.03, 74.30, 62.10, 31.84, 31.30, 26.06, 22.27, 14.26, 14.02; MS (EI) 
m/z (intensity) 200 (M+, 0.2), 180 (1), 127 (100), 111 (8); HRMS (EI) m/z calculated for 





(E)-6-(tert-Butyldiphenylsilanyloxy)-2-hydroxy-2-methylhex-3-enoic acid ethyl ester  (147).  
According to the General Protocol B, Cp2ZrHCl (0.24 g, 0.91 mmol), 125 (0.28 g, 0.91 mmol), 
Me2Zn (0.46 mL, 0.91 mmol, 2.0 M in toluene) and 145 (67 µL, 0.61 mmol) afforded 147 (0.20 
                                                 
218 See pages 90-91 for the preparation of 143. 
 76
g, 75%) as a colorless oil:  IR (neat) 3520, 3071, 3048, 2932, 2858, 1730, 1473, 1428, 1259, 
1206, 1188, 1112 cm-1; 1H NMR δ 7.69-7.65 (m, 4 H), 7.43-7.36 (m, 6 H), 5.88 (dt, J = 15.5, 6.9 
Hz, 1 H), 5.67 (dt, J = 15.5, 1.2 Hz, 1 H), 4.28-4.13 (m, 2 H), 3.70 (t, J = 6.5 Hz, 2 H), 3.24 (s, 1 
H), 2.31 (qd, J = 6.7, 1.2 Hz, 2 H), 1.47 (s, 3 H), 1.28 (t, J = 7.1 Hz, 3 H), 1.05 (s, 9 H); 13C 
NMR δ 175.97, 135.72, 133.98, 133.58, 129.74, 127.78, 127.46, 74.34, 63.40, 62.17, 35.59, 
26.91, 26.13, 19.35, 14.26; MS (EI) m/z (intensity) 408 ([M-H2O]+, 0.4), 369 (9), 339 (11) 293 
(7), 229 (18), 199 (100), 135 (23); HRMS (EI) m/z calculated for C25H32O3Si (M-H2O) 




(P,P-Diphenylphosphinoylimino)phenylacetic acid methyl ester (148).  To a cooled (0 °C) 
solution of 134 (0.65 mL, 4.6 mmol), 118 (1.7 g, 8.0 mmol) and Et3N (3.2 mL, 23 mmol) in dry 
CH2Cl2 (20 mL) was dropwise added a solution of TiCl4 (0.50 mL, 4.6 mmol) in dry CH2Cl2 (5.0 
mL).  The reaction mixture was warmed to r.t., stirred for 24 h, diluted with ether (0.10 L), 
filtered through a pad of Celite/Florisil (1:1) and concentrated.  The crude residue was purified 
by chromatography on SiO2 (3:7, hexanes/EtOAc) followed by precipitation from a minimal 
amount of CH2Cl2 with dry hexanes to give 148 (0.66 g, 40%) as a colorless solid: mp 118.5-
120.5 °C (hexanes/CH2Cl2); IR (KBr) 3058, 2963, 1746, 1737, 1649, 1619, 1591, 1575, 1450, 
1437, 1430, 1303, 1199, 1123, 1105; 1H NMR δ 7.99-7.91 (m, 6 H), 7.63-7.43 (m, 9 H), 4.06 (s, 
3 H); 13C NMR δ 170.32, 170.20, 166.20, 165.99, 133.81, 133.78, 131.87, 131.83, 131.72, 
131.59, 129.00, 128.87, 128.55, 128.38, 53.37; MS (EI) m/z (intensity) 363 (M+, 0.2), 304 (27), 




2-(P,P-Diphenylphosphinoylamino)-2-phenyloct-3-enoic acid methyl ester (149)  General 
Protocol C.  To a suspension of Cp2ZrHCl (0.11 g, 0.41 mmol) in dry CH2Cl2 (2.0 mL) was 
added 108 (47 µL, 0.41 mmol) and the reaction mixture was stirred for 10 min at r.t.  The solvent 
was removed in vacuo, and the residue was dissolved in dry toluene (2.0 mL), cooled to -78 °C, 
treated with Me2Zn (0.21 mL, 0.41 mmol, 2.0 M in toluene) and warmed to 0 °C.  After addition 
of 148 (0.10 g, 0.28 mmol) the reaction mixture was stirred for 1 h, quenched with sat. NH4Cl, 
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diluted with EtOAc, and filtered through Celite. The aqueous layer was extracted with EtOAc 
(2x).  The combined organic layers were washed with brine, dried (MgSO4) and concentrated.  
The residue was purified by chromatography on deactivated SiO2 (3:7, hexanes/EtOAc 
containing 1% v/v Et3N) to give 149 (0.11 g, 92%) as a colorless oil:  IR (neat) 3376, 3058, 
2955, 2928, 2858, 1734, 1438, 1391, 1242, 1207, 1122, 1050 cm-1; 1H NMR δ 7.85-7.75 (m, 4 
H), 7.46-7.33 (m, 8 H), 7.24-7.17 (m, 3 H), 5.96 (dt, J = 15.6, 1.5 Hz, 1 H), 5.53 (dt, J = 15.6, 
6.6 Hz, 1 H), 4.41 (d, J = 6.1 Hz, 1 H), 3.79 (s, 3 H), 1.85-1.76 (m, 2 H), 1.29-1.05 (m, 4 H), 
0.82 (t, J = 6.8 Hz, 3 H); 13C NMR δ 174.25, 174.18, 139.79, 136.44, 135.54, 135.04, 133.86, 
133.32, 131.92, 131.80, 131.50, 131.37, 131.08, 129.07, 128.34, 128.17, 128.10, 127.93, 127.88, 
127.76, 127.58, 68.25, 53.01, 31.69, 30.37, 22.14, 13.73; MS (EI) m/z (intensity) 447 (M+, 2), 





acid methyl ester (150).  According to the General Protocol C, Cp2ZrHCl (0.11 g, 0.41 mmol), 
125 (0.13 g, 0.41 mmol), Me2Zn (0.21 mL, 0.41 mmol, 2.0 M in toluene) and 148 (0.10 g, 0.28 
mmol) afforded 150 (0.17 g, 93%) as a colorless oil:  IR (neat) 3372, 3056, 2953, 2931, 2857, 
1735, 1472, 1437, 1389, 1242, 1208, 1110 cm-1; 1H NMR δ 7.82-7.74 (m, 4 H), 7.63-7.59 (m, 4 
H), 7.45-7.19 (m, 17 H), 6.08 (dt, J = 15.7, 1.3 Hz, 1 H), 5.62 (dt, J = 15.6, 6.8 Hz, 1 H), 4.42 (d, 
J = 5.9 Hz, 1 H), 3.77 (s, 3 H), 3.52-3.40 (m, 2 H), 2.20-1.97 (m, 2 H), 1.00 (s, 9 H); 13C NMR 
δ 174.23, 174.16, 139.39, 139.32, 135.46, 135.29, 134.88, 133.83, 133.78, 133.60, 133.14, 
132.88, 131.91, 131.79, 131.47, 131.35, 131.13, 131.04, 129.48, 128.36, 128.19, 128.13, 127.93, 
127.67, 127.54, 68.24, 62.76, 53.14, 35.43, 26.71, 19.08; MS (EI) m/z (intensity) 673 (M+, 1), 
616 (68), 536 (9), 399 (9), 358 (21), 201 (100), 135 (52); HRMS (EI) m/z calculated for 










(2R,3E)-2-Hydroxy-2-phenyloct-3-enoic acid (-)-8-phenylmenthyl ester (165).  To a 
suspension of Cp2ZrHCl (80 mg, 0.31 mmol) in dry CH2Cl2 (2.0 mL) was added 108 (36 µL, 
0.31 mmol).  The reaction stirred for 10 min. at r.t., solvent was removed in vacuo, and the 
residue was dissolved in dry toluene (2.0 mL), cooled to -78 °C, treated with Me2Zn (0.16 mL, 
0.31 mmol, 2.0 M in toluene) and warmed to -20 °C.  After addition of 163 (75 mg, 0.21 mmol), 
the reaction mixture was stirred for 12 h, quenched with sat. NH4Cl, diluted with EtOAc, and 
filtered through Celite.  The aqueous layer was extracted with EtOAc (2x) and the combined 
organic layers were washed with brine, dried (MgSO4) and concentrated.  The residue was 
purified by chromatography on SiO2 (19:1, hexanes/EtOAc) to give the allylic alcohol 165 (71 
mg, 77%) as a colorless oil:  [α]D -56.1, (c 0.92, EtOH); IR (neat) 3499, 3058, 2956, 2925, 2870, 
1719, 1448, 1246, 1151 cm-1; 1H NMR δ 7.65-7.62 (m, 2 H), 7.46-7.27 (m, 8 H), 6.19-6.03 (m, 2 
H), 4.98 (td, J = 10.7, 4.3 Hz, 1 H), 3.15 (bs, 1 H), 2.37-2.30 (m, 2 H), 2.16-2.01 (m, 2 H), 1.75-
1.47 (m, 8 H), 1.23 (s, 3 H), 1.18-1.06 (m, 8 H), 1.04 (d, J = 12.9 Hz, 3 H); 13C NMR (MeOD) δ 
173.19, 151.05, 141.45, 132.49, 130.23, 128.30, 127.97, 126.65, 125.69, 125.51, 78.27, 77.81, 
50.35, 41.33, 39.96, 34.60, 32.08, 31.48, 31.44, 27.29, 27.18, 25.90, 22.39, 21.88, 14.13; MS 
(EI) m/z (intensity) 448 (M+, 0.4), 216 (53), 189 (50), 143 (45), 119 (100), 105 (62), 91 (67); 





(2R,3E)-2-Phenyloct-3-ene-1,2-diol (166).  The crude residue from the preparation of 165 (0.33 
mmol scale) was dissolved in dry Et2O (1.5 mL), cooled to -78 °C, treated with LiAlH4 (0.72 
mL, 0.72 mmol, 1.0 M in Et2O), warmed to room temperature and stirred for 2 h.  The reaction 
was cooled to 0 °C, quenched with sat. NH4Cl, diluted with EtOAc, and filtered through Celite.  
The aqueous layer was extracted with EtOAc (2x) and the combined organic layers were washed 
with brine, dried (MgSO4) and concentrated.  The residue was purified by chromatography on 
SiO2 (3:1, hexanes/EtOAc) to give the auxilliary 161 (42 mg, 92%) and the desired product 166 
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(42 mg, 87%, >99% ee by HPLC analysis (Chiralcel OD, 97.5:2.5 hexanes/i-PrOH) Rt (+)-166 
19.1 min, (-)-166 20.5 min219) as a colorless solid:  mp 49.0-51.5 °C (hexanes/EtOAc); [α]D 
+16.9, (c 0.65, EtOH); IR (neat) 3373, 1956, 2926, 2856, 1448, 1378, 1265, 1067 cm-1; 1H NMR 
(CD3OD) δ 7.46 (d, J = 7.5 Hz, 2 H), 7.30 (t, J = 7.2 Hz, 2 H), 7.20 (t, J = 7.4 Hz, 1 H), 5.82 (d, 
J = 16.0 Hz, 1 H), 5.69 (dt, J = 15.6, 6.4 Hz, 1 H), 3.70 (s, 2 H), 2.12-2.05 (m, 2 H), 1.42-1.27 
(m, 4 H), 0.89 (t, J = 6.9 Hz, 3 H); 13C NMR (CD3OD) δ 145.64, 134.66, 132.03, 128.84, 127.74, 
127.25, 77.92, 70.64, 33.31, 32.62, 23.26, 14.28; MS (EI) m/z (intensity) 220 (M+, 0.8), 202 (33), 
189 (67), 173 (92), 155 (45), 145 (75), 129 (48), 133 (85), 129 (50), 105 (87), 91 (100); HRMS 





(R)-2-Phenyloctane-1,2-diol (167).220  To a solution of 166 (77 mg, 0.18 mmol) in EtOAc (3.0 
mL) was added Rh/Al2O3 (36 mg, 5 wt % Rh on Al2O3) and the reaction vessel was evacuated, 
purged with H2 (1 atm) and stirred for 1 h.  The mixture was filtered through a plug of Celite and 
concentrated, and the residue was purified by chromatography on SiO2 (3:1, Hexanes/EtOAc) to 
give 167 (75 mg, 97%, >99% ee by HPLC analysis (Chiralcel OD, 97.5:2.5 hexanes/i-PrOH) Rt 
(+)-167 18.3 min, (-)-167 20.1 min221) as a colorless solid:  mp 35.5-37.0 °C (hexanes/EtOAc); 
[α]D +2.15, (c 1.1, EtOH); 1H NMR δ 7.43-7.35 (m, 4 H), 7.30-7.24 (m, 1 H), 3.83 (dd, J = 11.0, 
2.7 Hz, 1 H), 3.71-3.65 (m, 1 H), 2.66 (s, 1 H), 1.85-1.76 (m, 3 H), 1.34-1.21 (m, 7 H), 1.10-0.99 







 (P,P-Diphenylphosphinoylimino)phenylacetic acid (-)-8-phenylmenthyl ester (169).  To a 
cooled (0 °C) solution of 163 (0.85 g, 2.3 mmol), 118 (1.3 g, 5.8 mmol) and Et3N (0.97 mL, 7.0 
mmol) in dry CH2Cl2 (15 mL) was added dropwise a solution of TiCl4 (0.26 mL, 2.3 mmol) in 
dry CH2Cl2 (5.0 mL).  The reaction mixture was warmed to r.t., stirred for 36 h, diluted with 
                                                 
219 The peak for the minor enantiomer was inferred from the HPLC trace of (+/-)-166. 
220 Vanhessche, K. P. M.; Sharpless, K. B. J. Org. Chem. 1996, 61, 7978. 
221 The peak for the minor enantiomer was inferred from the HPLC trace of (+/-)-167. 
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ether (0.10 L), filtered through a pad of Celite/Florisil (1:1) and concentrated.  The crude residue 
was purified by chromatography on SiO2 (7:3, hexanes/EtOAc) to give 169 (0.91 g, 69%) as a 
colorless foam:  [α]D -19.7 (c 0.44, CHCl3); IR (KBr) 3057, 2958, 2924, 2869, 1731, 1631, 1594, 
1577, 1483, 1449, 1293, 1216, 1180, 1124, 1108; 1H NMR (600 MHz) δ 8.06 (dd, J = 11.9, 6.9 
Hz, 2 H), 7.90 (d, J = 7.9 Hz, 2 H), 7.85 (dd, J = 12.2, 7.1 Hz, 2 H), 7.57 (t, J = 7.3 Hz, 1 H), 
7.51-7.43 (m, 8 H), 7.08-7.07 (m, 2 H), 6.89-6.88 (m, 3 H), 5.04 (td, J = 10.7, 4.0 Hz, 1 H), 2.71 
(dq, J = 12.2, 2.4 Hz, 1 H), 1.96 (ddd, J = 12.2, 10.7, 3.2 Hz, 1 H), 1.60-1.54 (m, 2 H), 1.42 (dq, 
J = 13.6, 3.2 Hz, 1 H), 1.27 (s, 3 H), 1.20 (q, J = 12.1 Hz, 1 H), 1.17 (s, 3 H), 1.07 (dq, J = 12.9, 
3.1 Hz, 1 H), 0.96 (d, J = 6.3 Hz, 3 H), 0.84 (dq, J = 12.4, 3.2 Hz, 1 H); 13C NMR δ 169.87, 
169.76, 164.27, 164.06, 151.30, 134.16, 134.05, 133.87, 133.76, 133.24, 132.38, 132.16, 132.04, 
131.97, 131.68, 131.65, 131.46, 131.33, 129.07, 128.49, 128.36, 128.19, 127.52, 125.21, 124.67, 
79.47, 50.84, 40.59, 39.94, 34.61, 31.54, 27.38, 27.12, 24.95, 21.82; MS (EI) m/z (intensity) 563 
(M+, 0.8), 445 (1), 350 (8), 304 (13), 201 (100), 119 (33), 103 (15), 91 (18); HRMS (EI) m/z 













(2R)-2-(P,P-Diphenylphosphinoylamino)-2-phenyloct-3-enoic acid (-)-8-phenylmenthyl 
ester ((2R)-170) and (2S)-2-(P,P-Diphenylphosphinoylamino)-2-phenyloct-3-enoic acid (-)-
8-phenylmenthyl ester ((2S)-170).  General Protocol D.  To a suspension of Cp2ZrHCl (0.23 g, 
0.89 mmol) in dry CH2Cl2 (4.0 mL) was added 108 (0.10 mL, 0.89 mmol) and the reaction 
mixture was stirred for 10 min. at r.t.  The solvent was removed in vacuo, and the residue was 
dissolved in dry toluene (2.0 mL), cooled to -78 °C, and treated with Me2Zn (0.44 mL, 0.89 
mmol, 2.0 M in toluene).  Upon warming to -40 °C, the solution was transferred via cannula to a 
pre-cooled (-40 °C) solution of 169 (0.25 g, 0.44 mmol) and ClTi(O-iPr)3 (0.44 mL, 0.44 mmol, 
1.0 M in CH2Cl2) in dry toluene (1.0 mL).  The organometallic-containing flask was washed with 
dry toluene (2 x 0.50 mL) and these washing were transferred to the imine flask via cannula. The 
reaction mixture was stirred for 24 h, quenched with sat. NH4Cl, diluted with EtOAc, and filtered 
through Celite.  The aqueous layer was extracted with EtOAc (2x) and the combined organic 
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layers were washed with brine, dried (MgSO4) and concentrated.  The residue was purified by 
chromatography on deactivated SiO2 (3:2, hexanes/EtOAc containing 1% v/v Et3N) to give (2R)-
170 and (2S)-170 (0.20 g, 70%, dr 7.8:1) as a colorless foam.  The diastereomers were separated 
by chromatography on deactivated SiO2 (17:3, hexanes/EtOAc containing 1% v/v Et3N):  (2R)-
170 (major isomer):  [α]D -14.2 (c 0.89, CHCl3); IR (neat) 3410, 3054, 2961, 2929, 1720, 1635, 
1439, 1265, 1208, 1123 cm-1; 1H NMR δ 7.85-7.77 (m, 2 H), 7.73-7.66 (m, 2 H), 7.46-7.36 (m, 6 
H), 7.30-7.27 (m, 2 H), 7.18-7.07 (m, 8 H), 5.98-5.81 (m, 2 H), 4.85 (dt, J = 10.6, 4.2 Hz, 1 H), 
4.49 (d, J = 7.5 Hz, 1 H), 2.08-1.94 (m, 3 H), 1.80-1.71 (m, 1 H), 1.47-1.40 (m, 2 H), 1.33-1.25 
(m, 4 H), 1.22-1.14 (m, 1 H), 1.08 (s, 3 H), 0.99-0.85 (m, 5 H), 0.84 (d, J = 6.3 Hz, 3 H), 0.81 (s, 
3 H), 0.75-0.63 (m, 1 H); 13C NMR δ 172.50, 172.39, 150.02, 139.15, 139.12, 135.97, 135.43, 
135.17, 133.72, 133.45, 131.83, 131.76, 131.70, 131.63, 131.18, 130.94, 129.23, 129.19, 128.31, 
128.16, 128.00, 127.82, 127.66, 125.54, 125.21, 78.23, 68.15, 50.41, 41.08, 40.05, 34.26, 31.84, 
31.26, 30.68, 30.21, 27.42, 22.79, 22.19, 21.60, 13.82; MS (EI) m/z (intensity) 647 (M+, 1), 432 
(2), 415 (2), 388 (100), 201 (69), 119 (39), 105 (35); HRMS (EI) m/z calculated for C42H50NO3P 
647.3528, found 647.3526. 
(2S)-170 (minor isomer): [α]D -15.5 (c 0.89, CHCl3); IR (neat) 3373, 2955, 2924, 2854, 1722, 
1439, 1212, 1122 cm-1; 1H NMR (600 MHz) δ 7.83-7.80 (m, 4 H), 7.50-7.48 (m, 3 H), 7.44-7.41 
(m, 3 H), 7.37-7.36 (m, 2 H), 7.28-7.25 (m, 2 H), 7.23-7.22 (m, 1 H), 7.05-7.04 (m, 2 H), 6.99-
6.97 (m, 3 H), 5.82 (dt, J = 15.5, 1.5 Hz, 1 H), 5.47 (dt, J = 15.5, 6.6 Hz, 1 H), 4.91 (dt, J = 10.6, 
4.1 Hz, 1 H), 4.02 (d, J = 6.6 Hz, 1 H), 2.12-2.09 (m, 1 H), 1.95-1.90 (m, 1 H), 1.75-1.66 (m, 2 
H), 1.55-1.53 (m, 2 H), 1.49-1.43 (m, 1 H), 1.39-1.37 (m, 1 H), 1.16-1.11 (m, 2 H), 1.15 (s, 3 H), 
1.11 (s, 3 H), 1.04-0.98 (m, 4 H), 0.89 (d, J = 6.5 Hz, 3 H), 0.79 (t, J = 7.3 Hz, 3 H); 13C NMR δ 
172.53, 172.46, 150.46, 139.63, 139.57, 137.26, 135.96, 135.42, 134.27, 133.68, 132.02, 131.90, 
131.75, 131.62, 131.26, 131.08, 130.80, 128.98, 128.94, 128.36, 128.18, 128.00, 127.90, 127.80, 
127.68, 125.39, 125.05, 78.09, 68.24, 50.36, 41.20, 40.04, 34.50, 31.70, 34.42, 30.27, 28.94, 
27.34, 24.78, 22.29, 21.71, 13.83; MS (EI) m/z (intensity) 647 (M+, 0.7), 433 (3), 388 (100), 201 
















enoic acid (-)-8-phenylmenthyl ester ((2R)-171) and (2S)-2-(P,P-Diphenylphosphinoyl-
amino)-6-(tert-butyldiphenylsilanyloxy)-2-phenylhex-3-enoic acid (-)-8-phenylmenthyl ester 
((2S)-171).  According to the General Protocol D, Cp2ZrHCl (0.27 g, 1.1 mmol), 125 (0.33 g, 1.1 
mmol), Me2Zn (0.53 mL, 1.1 mmol, 2.0 M in toluene), ClTi(O-iPr)3 (0.53 mL, 0.53 mmol, 1.0 M 
in CH2Cl2) and 169 (0.30 g, 0.53 mmol) afforded (2R)-171 and (2S)-171 (0.39 g, 84%, dr 7.4:1) 
as a colorless foam:  (2R)-171 (major isomer):  [α]D -11.7 (c 0.94, CHCl3); IR (neat) 3364, 3057, 
2928, 2858, 1722, 1493, 1440, 1212, 1110 cm-1; 1H NMR δ 7.80-7.71 (m, 4 H), 7.69-7.64 (m, 4 
H), 7.46-7.24 (m, 15 H), 7.18-7.06 (m, 7 H), 6.04 (d, J = 15.7 Hz, 1 H), 5.87 (dt, J = 15.6, 6.6 
Hz, 1 H), 4.84 (dt, J = 10.5, 4.1 Hz, 1 H), 4.40 (d, J = 7.1 Hz, 1 H), 3.64-3.53 (m, 2 H), 2.33-2.15 
(m, 2 H), 2.06-1.99 (m, 1 H), 1.81-1.72 (m, 1 H), 1.47-1.39 (m, 2 H), 1.21-1.13 (m, 1 H), 1.07 (s, 
3 H), 1.05 (s, 9 H), 0.99-0.84 (m, 2 H), 0.81-0.80 (m, 6 H), 0.75-0.62 (m, 1 H); 13C NMR δ 
172.47, 172.38, 150.18, 138.74, 138.71, 135.52, 135.25, 135.18, 133.86, 133.54, 133.46, 132.19, 
131.84, 131.81, 131.72, 131.69, 131.26, 131.04, 129.56, 128.47, 128.20, 128.11, 128.03, 127.94, 
127.88, 127.81, 127.74, 127.63, 125.58, 125.24, 78.35, 68.22, 63.21, 50.34, 40.98, 40.06, 35.71, 
34.27, 31.33, 30.09, 27.46, 26.86, 22.95, 21.65, 19.17; MS (ESI) m/z (intensity) 897 ([M+Na]+, 
65), 874 ([M+H]+, 100); HRMS (ESI) m/z calculated for C56H64NO4NaSiP (M+Na) 896.4240, 
found 896.4240. 
(2S)-171 (minor isomer): [α]D -8.1 (c 0.53, CHCl3); IR (neat) 3322, 3056, 2957, 2926, 2855, 
1723, 1591, 1440, 1388, 1213, 1110 cm-1; 1H NMR δ 7.83-7.74 (m, 4 H), 7.59-7.56 (m, 4 H), 
7.51-7.48 (m, 2 H), 7.42-7.20 (m, 15 H), 7.03-6.92 (m, 5 H), 5.89 (d, J = 15.7 Hz, 1 H), 5.50 (dt, 
J = 15.6, 6.7 Hz, 1 H), 4.90 (dt, J = 10.7, 4.2 Hz, 1 H), 3.98 (d, J = 5.9 Hz, 1 H), 3.42-3.28 (m, 2 
H), 2.12-2.01 (m, 2 H), 1.96-1.84 (m, 2 H), 1.56-1.52 (m, 2 H), 1.41-1.36 (m, 1 H), 1.11 (s, 3 H), 
1.06 (s, 3 H), 1.06-1.03 (m, 1 H), 0.98 (s, 9 H), 0.88 (d, J = 6.4 Hz, 3 H), 0.89-0.84 (m, 1 H), 
0.84-0.72 (m, 1 H); 13C NMR δ 172.41, 172.34, 150.52, 139.31, 139.24, 135.77. 135.52. 135.34. 
134.07. 133.98. 133.57. 132.03. 131.91. 131.70. 131.57. 131.29. 131.10. 130.97. 130.93. 129.48. 
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128.35, 128.19, 128.02, 127.89, 127.87, 127.82, 127.57, 125.39, 125.02, 78.14, 68.22, 62.82, 
50.30, 41.18, 40.00, 35.42, 34.53, 31.45, 28.75, 27.34, 26.83, 24.91, 21.74, 19.13; MS (ESI) m/z 
(intensity) 874 ([M+H]+, 50), 371 (25); HRMS (ESI) m/z calculated for C56H65NO4SiP (M+H) 




(+)-(2R)-2-(P,P-Diphenylphosphinoylamino)-2-phenyloct-3-enoic acid methyl ester ((+)-
149).  To a solution of KOt-Bu (0.14 g, 1.2 mmol) in dry THF (2.0 mL) was added H2O (6.0 µL, 
0.33 mmol). The suspension was stirred for 10 min, treated with a solution of (2R)-170 (0.10 g, 
0.15 mmol) in dry THF (1.0 mL) and heated at 70 °C for 5 h.  The reaction mixture was cooled 
to r.t., quenched with 10% HCl and extracted with EtOAc (3x).  The combined organic layers 
were washed with brine, dried (MgSO4) and concentrated.  A solution of the residue in MeOH 
(1.5 mL) was treated with TMSCHN2 (0.30 mL, 0.60 mmol, 2.0 M in hexanes), stirred for 15 
min, quenched at 0 °C with 10% HCl, and extracted with EtOAc (3x). The combined organic 
layers were washed with brine, dried (MgSO4) and concentrated.  The crude residue was purified 
by chromatography on SiO2 (1:1, hexanes/EtOAc) to give (+)-149 (58 mg, 84%) as a colorless 




(+)-(2R)-2-(P,P-Diphenylphosphinoylamino)-2-phenyloctanoic acid methyl ester (172).  A 
mixture of (+)-149 (0.12 g, 0.28 mmol) and PtO2 (6.0 mg, 26 µmol) in MeOH (3.0 mL) was 
evacuated, flushed with H2 (1 atm), and stirred for 1.5 h.  The reaction mixture was filtered 
through Celite, concentrated and purified by chromatography on SiO2 (1:1, hexanes/EtOAc) to 
give 172 (0.12 g, quant.) as a colorless oil:  [α]D +2.15 (c 0.93, CHCl3); IR (neat) 3369, 3058, 
2954, 2928, 2856, 1732, 1438, 1392, 1245, 1208, 1147, 1122, 1109, 1073 cm-1; 1H NMR δ 7.82-
7.75 (m, 2 H), 7.56-7.39 (m, 5 H), 7.31-7.27 (m, 1 H), 7.23-7.15 (m, 4 H), 7.10-7.07 (m, 3 H), 
4.69 (d, J = 8.1 Hz, 1 H), 3.69 (s, 3 H), 2.59 (dt, J = 12.9, 4.2 Hz, 1 H), 2.23 (dt, J = 12.3, 4.2 Hz, 
1 H), 1.75-1.65 (m, 1 H), 1.33-1.17 (m, 6 H), 1.05-0.90 (m, 1 H), 0.87 (t, J = 6.7 Hz, 3 H); 13C 
NMR δ 175.12, 174.98, 140.80, 140.76, 135.43, 133.75, 132.07, 131.95, 131.57, 131.54, 131.31, 
131.18, 130.78, 130.75, 128.43, 128.26, 127.97, 127.80, 127.62, 127.50, 126.51, 66.92, 52.89, 
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36.40, 31.58, 29.19, 24.32, 22.54, 13.96; MS (EI) m/z (intensity) 449 (M+, 6), 391 (43), 390 
(100), 364 (32), 202 (22), 201 (67), 77 (21); HRMS (EI) m/z calculated for C27H32NO3P 




(-)-(2R)-2-Benzyloxycarbonylamino-2-phenyloctanoic acid methyl ester ((-)-173).  To a 
solution of (+)-172 (0.12 g, 0.28 mmol) in MeOH (1.5 mL) was added a solution of HCl (1.5 
mL, 1.0 M in MeOH). The reaction mixture was stirred for 12 h, concentrated and dissolved in 
EtOAc (2.0 mL) and H2O (2.0 mL), cooled to 0 °C, treated with NaHCO3 (0.12 g, 1.4 mmol) and 
Cbz-Cl (48 µL, 0.33 mmol) and stirred for 1.5 h.  The solution was diluted with H2O and EtOAc 
and the aqueous layer was extracted with EtOAc (2x). The combined organic layers were washed 
with brine, dried (MgSO4) and concentrated.  The crude residue was purified by chromatography 
on SiO2 (19:1, hexanes/EtOAc) to give (-)-173 (78 mg, 73%, 96.5% ee by HPLC (Chiralcel OD, 
99.5:0.5, hexanes/i-PrOH) Rt (-)-173 17.1 min, (+)-173 19.4 min)) as a colorless solid:  mp 66.0-
68.5 °C (hexanes/EtOAc); [α]D -32.4 (c 0.51, CHCl3); IR (neat) 3420, 3063, 3032, 2955, 2928, 
2858, 1726, 1495, 1453, 1319, 1253, 1087, 1069, 1036 cm-1; 1H NMR δ 7.53-7.27 (m, 10 H), 
6.46 (bs, 1 H), 5.08, 5.00 (AB, J = 11.9 Hz, 2 H), 3.68 (s, 3 H), 2.77 (bm, 1 H), 2.49-2.41 (m, 1 
H), 1.37-1.29 (m, 7 H), 1.08-1.01 (m, 1 H), 0.91 (t, J = 6.3 Hz, 3 H); 13C NMR δ 173.2, 153.7, 
140.2, 136.5, 128.4, 127.9, 127.7, 125.9, 66.4, 65.3, 53.2, 33.0, 31.6, 29.1, 24.1, 22.5, 14.0; MS 
(EI) m/z (intensity) 384 ([M+H]+, 0.5), 383 (M+, 2), 325 (38), 324 (87), 281 (42), 280 (100), 254 










(2R,4R)-benzyl 4-hexyl-5-oxo-2,4-diphenyloxazolidine-3-carboxylate (175).  To a solution of 
174222 (0.20 g, 0.54 mmol) and HMPA (93 µL, 0.54 mmol) in dry THF (8.0 mL) at -78 °C was 
added NaHMDS (0.32 mL, 0.64 mmol, 2.0 M in THF). The reaction mixture was stirred for 20 
                                                 
222 O’Donnell, M. J.; Fang, Z.; Ma, X.; Huffman, J. C. Heterocycles 1997, 46, 617. 
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min and freshly prepared hexyl triflate223 (0.38 g, 1.6 mmol) was added as a solution in THF (2.0 
mL). After 3 h, the solution was quenched with sat. NH4Cl and extracted with EtOAc (3x).  The 
combined organic layers were washed with brine, dried (MgSO4) and concentrated.  The crude 
residue was purified by chromatography on SiO2 (19:1, hexanes/EtOAc) to give 175 (0.18 g, 
73%) as a colorless oil:  [α]D +29.4 (c 1.1, CHCl3); IR (neat) 3064, 3036, 2928, 2857, 1796, 
1716, 1495, 1451, 1401, 1345, 1234, 1174, 1138, 1113, 1028 cm-1; 1H NMR (DMSO-d6, 80 °C) 
δ 7.51-7.47 (m, 2 H), 7.39-7.34 (m, 8 H), 7.29-7.27 (m, 3 H), 7.17-7.12 (m, 2 H), 6.90 (s, 1 H), 
5.13, 5.07 (AB, J = 12.4 Hz, 2 H), 2.70-2.65 (m, 1 H), 2.36-2.27 (m, 1 H), 1.26-1.24 (m, 8 H), 
0.87 (t, J = 7.2 Hz, 3 H); 13C NMR (DMSO-d6, 80 °C) δ 171.9, 151.7, 137.9, 136.1, 135.1, 
129.2, 127.8, 127.7, 127.6, 127.4, 126.6, 125.6, 88.5, 67.6, 66.7, 36.4, 30.3, 27.6, 23.3, 21.3, 
13.1; MS (EI) m/z (intensity) 457 (M+, 1), 372 (23), 328 (16), 278 (5), 193 (5), 91 (100); HRMS 




(+)-(2S)-2-Benzyloxycarbonylamino-2-phenyloctanoic acid methyl ester ((+)-173).  To a 
solution of 175 (90 mg, 0.20 mmol) in MeOH (2.0 mL) was added NaOMe (32 mg, 0.59 mmol). 
The reaction mixture was stirred for 2.5 h, quenched with sat. NH4Cl and extracted with EtOAc 
(3x).  The combined organic layers were washed with brine, dried (MgSO4) and concentrated.  
The crude residue was purified by chromatography on SiO2 (19:1, hexanes/EtOAc) to give (+)-
173 (62 mg, 82%, >99% ee by HPLC (Chiralcel OD, 99.5:0.5, hexanes/i-PrOH) Rt (-)-173 17.1 






P,P-diphenylphosphinamide (177).  General Protocol E.  To a suspension of Cp2ZrHCl (9.0 g, 
35 mmol) in dry CH2Cl2 (60 mL) was added at 0 °C a solution of 125 (11 g, 35 mmol) in dry 
CH2Cl2 (20 mL).  The reaction mixture was warmed to r.t., stirred for 10 min, cooled to -78 °C, 
                                                 
223 Fife, W. K.; Ranganathan, P.; Zeldin, M. J. Org. Chem. 1990, 55, 5610. 
224 The peak for the minor enantiomer was inferred from the HPLC trace for (-)-173. 
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treated with Me2Zn (18 mL, 35 mmol, 2.0 M in toluene) and warmed to 0 °C.  After addition of 
19 (3.5 g, 12 mmol), the reaction was heated at reflux for 10 h, cooled to r.t., treated with CH2I2 
(4.7 mL, 58 mmol), heated at reflux for 4 h and quenched at 0 °C with sat. NH4Cl.  The mixture 
was filtered through Celite, extracted with EtOAc (3x) and the combined organic layers were 
washed with brine, dried (MgSO4) and concentrated.  The residue was purified by 
chromatography on deactivated SiO2 (1:1, hexanes/EtOAc containing 1% v/v Et3N) to afford 177 
(4.0 g, 55%) as a colorless foam:  IR (neat) 3188, 3057, 2930, 2857, 1438, 1428, 1189, 1111   
cm-1; 1H NMR δ 7.95-7.87 (m, 2 H), 7.81-7.66 (m, 6 H), 7.49-7.37 (m, 10 H), 7.34-7.26 (m, 7 
H), 3.87-3.70 (m, 3 H), 3.43 (dd, J = 8.7, 5.7 Hz, 1 H), 1.59 (dq, J = 13.5, 6.8 Hz, 1 H), 1.39 (dq, 
J = 13.7, 6.8 Hz, 1 H), 1.08 (s, 9 H), 1.08-1.01 (m, 1 H), 0.87-0.76 (m, 1 H), 0.44 (dt, J = 8.6, 4.9 
Hz, 1 H), 0.30 (dt, J = 8.4, 5.1 Hz, 1 H); 13C NMR δ 143.25, 143.18, 135.51, 135.48, 133.95, 
132.28, 132.25, 131.89, 131.77, 131.66, 131.53, 129.45, 128.42, 128.20, 128.06, 127.53, 126.95, 
126.71, 63.99, 58.61, 36.43, 26.85, 26.57, 26.50, 19.08, 15.53, 10.22; MS (ESI) m/z (intensity) 
652 ([M+Na]+, 100), 630 ([M+H]+, 10); HRMS (ESI) m/z calculated for C40H44NO2PSiNa 






methyl)-P,P-diphenylphosphinamide (179).  To a suspension of Cp2ZrHCl (4.6 g, 18 mmol) in 
dry CH2Cl2 (30 mL) was added at 0 °C a solution of 178 (5.7 g, 18 mmol) in dry CH2Cl2 (10 
mL).  The reaction mixture was warmed to r.t. and stirred for 10 min, cooled to -78 °C, treated 
with Me2Zn (8.8 mL, 18 mmol, 2.0 M in toluene) and warmed to 0 °C.  After addition of 21 (1.8 
g, 5.9 mmol), the mixture was heated at reflux for 10 h, cooled to r.t., treated with CH2I2 (2.4 
mL, 30 mmol), heated at reflux for 4 h and quenched at 0 °C with sat. NH4Cl.  The solution was 
filtered through Celite, extracted with EtOAc (3x), and the combined organic layers were washed 
with brine, dried (MgSO4) and concentrated.  The residue was purified by chromatography on 
deactivated SiO2 (1:1, hexanes/EtOAc containing 1% v/v Et3N) to afford 179 (2.3 g, 61%) as a 
colorless foam:  IR (neat) 3208, 3055, 2930, 2857, 1437, 1185, 1110 cm-1; 1H NMR δ 7.93-7.86 
(m, 2 H), 7.82-7.72 (m, 6 H), 7.55-7.41 (m, 10 H), 7.38-7.26 (m, 7 H), 3.89-3.70 (m, 3 H), 3.35 
(dd, J = 9.9, 7.0 Hz, 1 H), 1.86-1.75 (m, 1 H), 1.57-1.45 (m, 1 H), 1.12 (s, 9 H), 1.02 (s, 3 H), 
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0.92 (dd, J = 9.0, 5.0 Hz, 1 H), 0.86-0.76 (m, 1 H), 0.06 (t, J = 5.0 Hz, 1 H); 13C NMR δ 142.23, 
142.17, 135.54, 134.12, 134.03, 133.00, 132.97, 132.51, 132.40, 131.90, 131.77, 131.72, 131.69, 
131.62, 131.59, 131.25, 129.49, 128.46, 128.29, 128.25, 128.08, 128.04, 127.56, 127.18, 126.86, 
64.25, 62.18, 32.26, 26.86, 24.55, 24.48, 19.13, 19.08, 17.25, 15.07; MS (ESI) m/z (intensity) 
666 ([M+Na]+, 100), 644 ([M+H]+, 33), 428 (29); HRMS (ESI) m/z calculated for 






benzoate (180).  According to the General Protocol E, Cp2ZrHCl (0.21 g, 0.83 mmol), 108 (95 
µL, 0.83 mmol), Me2Zn (0.41 mL, 0.83 mmol, 2.0 M in toluene) and 119 (0.10 g, 0.28 mmol) in 
dry CH2Cl2 (2.0 mL) followed by CH2I2 (0.11 mL, 1.4 mmol) afforded 180 (88 mg, 69%) as a 
colorless solid:  mp 141.0-143.0 °C (hexanes/EtOAc); IR (KBr) 3172, 2954, 2921, 1720, 1437, 
1275, 1181, 1107 cm-1; 1H NMR δ 7.98-7.88 (m, 4 H), 7.76-7.69 (m, 2 H), 7.56-7.69 (m, 4 H), 
7.34-7.28 (m, 4 H), 3.93 (s, 3 H), 3.83 (q, J = 8.8 Hz, 1 H), 3.46 (dd, J = 8.4, 5.7 Hz, 1 H), 1.4-
1.2 (m, 5 H), 1.17-1.09 (m, 1 H), 1.04-0.95 (m, 1 H), 0.91-0.86 (m, 3 H), 0.80-0.76 (m, 1 H), 
0.42 (dt, J = 8.5, 4.8 Hz, 1 H), 0.28 (dt, J = 8.3, 5.0 Hz, 1 H); 13C NMR δ 167.14, 148.81, 
148.75, 134.15, 133.12, 132.60, 132.47, 132.17, 132.12, 132.08, 132.04, 131.97, 131.93, 131.39, 
129.85, 129.03, 128.8, 128.61, 128.55, 128.38, 127.01, 58.78, 52.28, 33.46, 31.96, 27.11, 27.04, 
22.75, 19.20, 14.33, 10.98; MS (EI) m/z (intensity) 461 (M+, 13), 364 (100), 256 (37), 218 (17), 







oxyethyl)cyclopropyl)methyl)benzoate (181).  According to the General Protocol E, Cp2ZrHCl 
(0.21 g, 0.83 mmol), 125 (0.26 g, 0.83 mmol), Me2Zn (0.41 mL, 0.83 mmol, 2.0 M in toluene) 
and 119 (0.10 g, 0.28 mmol) in dry CH2Cl2 (2.0 mL) followed by CH2I2 (0.11 mL, 1.4 mmol) 
afforded 181 (0.16 g, 84%) as a colorless foam:  IR (neat) 3179, 2930, 2858, 1721, 1435, 1280, 
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1187, 1109 cm-1; 1H NMR δ 7.94 (d, J = 8.3 Hz, 2 H), 7.87-7.80 (m, 2 H), 7.71-7.67 (m, 1 H), 
7.65-7.59 (m, 5 H), 7.44-7.32 (m, 11 H), 7.29-7.23 (m, 4 H), 3.92 (s, 3 H), 3.84-3.68 (m, 3 H), 
3.43 (dd, J = 8.6, 5.3 Hz, 1 H), 1.51-138 (m, 2 H), 1.02 (s, 9 H), 1.02-0.94 (m, 1 H), 0.84-0.78 
(m, 1 H), 0.42 (dt, J = 8.6, 5.0 Hz, 1 H), 0.28 (dt, J = 8.3, 5.2 Hz, 1 H); 13C NMR δ 167.13, 
148.84, 148.78, 135.80, 135.77, 134.17, 134.09, 134.01, 133.11, 132.62, 132.49, 132.32, 132.16, 
132.10, 132.07, 132.04, 131.97, 131.94, 131.39, 129.88, 129.82, 129.04, 128.78, 128.62, 128.56, 
128.39, 127.88, 127.84, 127.00, 64.30, 58.66, 52.30, 36.67, 27.16, 26.92, 26.85, 19.39, 15.96, 
10.70; MS (EI) m/z (intensity) 687 (M+, 0.6), 664 (2), 630 (100), 364 (14), 201 (34), 77 (15); 






diphenylphosphinamide (182).  According to the General Protocol E, Cp2ZrHCl (0.33 g, 0.88 
mmol), 108 (0.10 mL, 0.88 mmol), Me2Zn (0.44 mL, 0.88 mmol, 2.0 M in toluene) and 124 
(0.10 g, 0.29 mmol) in dry CH2Cl2 (2.0 mL) followed by CH2I2 (0.12 mL, 1.5 mmol) afforded 
182 (84 mg, 65%) as a colorless solid:  mp 147.7-149.5 °C (hexanes/EtOAc); IR (KBr) 3434, 
3179, 2920, 1490, 1460, 1436, 1184 cm-1; 1H NMR δ 7.96-7.89 (m, 2 H), 7.78-7.71 (m, 2 H), 
7.57-7.43 (m, 4 H), 7.38-7.19 (m, 6 H), 3.81-3.72 (q, J = 8.5 Hz, 1 H), 3.34 (dd, J = 8.3, 5.6 Hz, 
1 H), 1.4-1.25 (m, 5 H), 1.15-1.08 (m, 1 H), 1.02-0.95 (m, 1 H), 0.92-0.87 (m, 3 H), 0.79, 0.71 
(m, 1 H), 0.39 (dt, J = 8.5, 4.8 Hz, 1 H), 0.28 (dt, J = 8.3, 5.1 Hz, 1 H); 13C NMR δ 142.09, 
142.03, 134.09, 133.24, 132.72, 132.44, 132.31, 132.09, 132.96, 131.90, 131.78, 131.75, 131.52, 
128.62, 128.43, 128.38, 128.26, 58.39, 33.36, 31.86, 26.90, 26.82, 22.65, 19.09, 14.24, 10.86; 
MS (EI) m/z (intensity) 437 (M+, 4), 340 (54), 256 (17), 201 (100), 77 (21); HRMS (EI) m/z 






diphenylphosphinamide (183).  According to the General Protocol E, Cp2ZrHCl (0.35 g, 1.3 
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mmol), 108 (0.15 mL, 1.3 mmol), Me2Zn (0.67 mL, 1.3 mmol, 2.0 M in toluene) and 121 (0.15 
g, 0.45 mmol) in dry CH2Cl2 (3.0 mL) followed by CH2I2 (0.18 mL, 2.2 mmol) afforded 183 (99 
mg, 51%) as a colorless solid:  mp 114.5-117.0 °C (hexanes/EtOAc); IR (KBr) 3433, 3164, 
2922, 1599, 1461, 1435, 1184 cm-1; 1H NMR δ 7.91 (ddd, J = 11.9, 7.9, 1.4, 2 H), 7.78-7.71 (m, 
2 H), 7.51-7.40 (m, 4 H), 7.35-7.27 (m, 2 H), 7.21 (t, J = 7.9 Hz, 1 H), 6.86 (d, J = 7.7 Hz, 1 H), 
6.79-6.75 (m, 2 H), 3.78 (s, 3 H), 3.78-3.69 (m, 1 H), 3.30 (dd, J = 8.6, 5.9 Hz, 1 H), 1.35-1.25 
(m, 5 H), 1.07-0.94 (m, 2 H), 0.89-0.84 (m, 3 H), 0.78-0.72 (m, 1 H), 0.40 (dt, J = 9.4, 4.8 Hz, 1 
H), 0.24 (dt, J = 10.9, 5.9 Hz, 1 H); 13C NMR δ 159.62, 145.32, 145.24, 134.50, 133.38, 132.80, 
132.64, 132.51, 132.16, 132.04, 131.94, 131.90, 131.78, 131.75, 131.66, 129.47, 128.67, 128.50, 
128.47, 128.30, 59.10, 55.35, 31.91, 26.97, 26.91, 22.74, 19.10, 14.28, 10.96; MS (EI) m/z 
(intensity) 433 (M+, 5), 390 (3), 376 (5), 349 (27), 336 (69), 256 (20), 232 (28), 201 (72), 86 







diphenylphosphinamide (184).  According to the General Protocol E, Cp2ZrHCl (0.35 g, 1.3 
mmol), 108 (0.15 mL, 1.3 mmol), Me2Zn (0.67 mL, 1.3 mmol, 2.0 M in toluene) and 120 (0.15 
g, 0.45 mmol) in dry CH2Cl2 (3.0 mL) followed by addition of CH2I2 (0.18 mL, 2.2 mmol) 
afforded 184 (63 mg, 32%) and 129 (0.11 g, 55%) as colorless solids.  184:  mp 155.2-156.0 °C 
(hexanes/EtOAc); IR (KBr) 3204, 2949, 2923, 1600, 1492, 1436, 1242, 1184 cm-1; 1H NMR δ 
7.90-7.83 (m, 2 H), 7.75-7.68 (m, 2 H), 7.50-7.39 (m, 4 H), 7.33-7.27 (m, 2 H), 7.25-7.19 (m, 1 
H), 6.99 (dd, J = 7.3, 1.5 Hz, 1 H), 6.89-6.83 (m, 2 H), 4.05-3.98 (m, 1 H), 3.81-3.72 (m, 1 H), 
3.74 (s, 3 H), 1.38-1.29 (m, 5 H), 1.21-1.09 (m, 2 H), 0.89 (t, J = 6.7 Hz, 3 H), 0.74-0.64 (m, 1 
H), 0.30 (dt, J = 8.5, 4.7 Hz, 1 H), 0.13 (dt, J = 8.4, 5.0 Hz, 1 H); 13C NMR δ 156.84, 132.76, 
132.63, 132.19, 132.06, 131.74, 131.71, 131.57, 131.54, 128.56, 128.44, 128.40, 128.34, 128.19, 
120.73, 110.97, 57.09, 55.32, 33.67, 31.98, 25.89, 25.83, 22.76, 19.45, 14.37, 10.86; MS (EI) m/z 
(intensity) 433 (M+, 5), 336 (100), 256 (25), 232 (23), 201 (97); HRMS (EI) m/z calculated for 





1-Iodo-2-methyloct-1-ene (187).225  A cooled (0 °C) solution of Me3Al (2.2 g, 30 mmol) and 
Cp2ZrCl2 (0.58 g, 2.0 mmol) in dry CH2Cl2 (50 mL) was treated dropwise (Caution:  
exothermic)226 with H2O (0.27 mL, 15 mmol).  The reaction mixture was warmed to room 
temperature for 20 min, treated at 0 °C with 1-octyne (1.5 mL, 10 mmol), stirred for 30 min and 
quenched with a solution of I2 (3.0 g, 12 mmol) in dry THF (15 mL).  The solution was stirred 
for 30 min, poured into saturated K2CO3, filtered through Celite and extracted with Et2O.  The 
combined organic layers were washed with brine, dried (MgSO4) and concentrated.  The residue 
was purified by chromatography on SiO2 (hexanes) to give 187 (2.1 g, 85%) as a light yellow oil:  
1H NMR δ 5.87-5.86 (m, 1 H), 2.20 (t, J = 7.2 Hz, 2 H), 1.83 (d, J = 0.9 Hz, 3 H), 1.48-1.38 (m, 




Trimethyl-(4-methyldec-3-en-1-ynyl)silane (189).227  To a cooled (0 °C) suspension of 
(Ph3P)4Pd  (0.46 g, 0.40 mmol), CuI (0.15 g, 0.79 mmol) and xx (2.0 g, 7.9 mmol) in freshly 
distilled i-Pr2NH (20 mL) was added trimethylsilylacetylene (1.7 mL, 12 mmol) and the reaction 
was stirred for 5 min, quenched with saturated NH4Cl and extracted with Et2O (4x).  The 
combined organic layers were washed with 10% HCl (3x), brine, dried (Na2SO4) and 
concentrated.  The residue was purified by chromatography on SiO2 (hexanes) to give xx (1.8 g, 
100%) as a colorless oil:  1H NMR δ 5.31-5.30 (m, 1 H), 2.07 (t, J = 7.0 Hz, 2 H), 1.91 (d, J = 
0.9 Hz, 3 H), 1.46-1.36 (m, 2 H), 1.13-1.26 (m, 6 H), 0.89 (t, J = 7.0 Hz, 3 H), 0.20 (s, 9 H). 
C6H13
143  
4-Methyldec-3-en-1-yne (143).228  To a cooled solution (0 °C) of 189 (4.2 g, 19 mmol) in THF 
(30 mL) and MeOH (10 mL) was added TBAF (21 mL, 21 mmol, 1.0 M in THF).  The reaction 
                                                 
225 Iwasawa, N.; Maeyama, K. J. Org. Chem. 1997, 62, 1918. 
226 While under positive N2 pressure, the flask was equipped with three outlets to reduce the build-up of pressure in 
the during the H2O addition.  These outlets tend to clog with a colorless solid and need to be replaced periodically. 
227 Zweifel, G.; Leong, W. J. Am. Chem. Soc. 1987, 109, 6409. 
228 Negishi, E.; Kotora, M.; Xu, C. J. Org. Chem. 1997, 62, 8957. 
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mixture was warmed to room temperature, stirred for 2 h, quenched with sat. NH4Cl and 
extracted with Et2O.  The combined organic layers were washed with brine, dried (Na2SO4) and 
concentrated.  The residue was purified by chromatography on SiO2 (petroleum ether, bp 30-60 
°C) to give 143 (2.8 g, 96%) as a colorless oil:  1H NMR δ 5.28-5.26 (m, 1 H), 3.01 (dd, J = 2.2, 
0.4 Hz, 1 H), 2.09 (bt, J = 6.9 Hz, 2 H), 1.91 (d, J = 0.7 Hz, 3 H), 1.48-1.36 (m, 2 H), 1.34-1.27 
(m, 6 H), 0.89 (t, J = 6.9 Hz, 3 H). 
NHP(O)Ph2
C6H13
MeO2C 190  
(R*)-(1R*,2S*)-4-[P,P-diphenylphosphinoylamino-(1'R*,2'S*)-(2'-hexyl-2'-methylbicyclo-
propyl-2-yl)methyl]benzoic acid methyl ester (190).  According to the General Protocol E, 143 
(62 mg, 0.41 mmol), Cp2ZrHCl (0.11 g, 0.41 mmol), Me2Zn (0.21 mL, 0.41 mmol, 2.0 M in 
toluene) and 119 (50 mg, 0.14 mmol) dry CH2Cl2 (1.5 mL) followed by CH2I2 (56 µL, 0.69 
mmol) afforded 190 (52 mg, 70 %) as a colorless solid:  mp 154.0-155.0 °C (hexanes/EtOAc); 
IR (neat) 3179, 2951, 2922, 2854, 1728, 1437, 1277, 1189, 1122, 1108 cm-1; 1H NMR δ 7.97-
7.90 (m, 2 H), 7.90-7.83 (m, 2 H), 7.72-7.65 (m, 2 H), 7.52-7.38 (m, 4 H), 7.31-7.26 (m, 4 H), 
3.92 (s, 3 H), 3.87-3.80 (m, 1 H), 3.41 (dd, J = 8.8, 5.6 Hz, 1 H), 1.27-1.23 (m, 9 H), 1.17-1.10 
(m 1 H), 1.07 (s, 3 H), 1.02-0.94 (m, 1 H), 0.87 (t, J = 6.9 Hz, 3 H), 0.65-0.57 (m, 1 H), 0.55-
0.49 (m, 1 H), 0.42-0.33 (m, 2 H), 0.18-0.06 (m, 2 H); 13C NMR δ 167.12, 148.51, 148.45, 
134.08, 133.03, 132.65, 132.52, 132.39, 132.08, 131.95, 131.91, 131.31, 129.88, 129.81, 129.04, 
128.78, 128.61, 128.51, 128.34, 126.99, 58.49, 52.25, 41.32, 32.14, 29.66, 27.37, 27.30, 27.08, 
26.94, 22.84, 20.47, 18.99, 18.27, 18.10, 14.28, 11.35; MS (EI) m/z (intensity) 543 (M+, 6), 378 
(26), 364 (23), 218 (54), 201 (92), 164 (26), 129 (27), 91 (52), 77 (49); HRMS (EI) m/z 




(E)-4-iodo-3-methylbut-3-en-1-ol (192).229  A solution of Me3Al (12 g, 0.17 mol) and Cp2ZrCl2 
(3.3 g, 11 mmol) in dry CH2Cl2 (0.15 L) was treated at -78 °C with 3-butyn-1-ol (4.0 g, 57 
mmol), warmed to room temperature and stirred for 12 h.  The solution was treated at 0 °C with 
                                                 
229 Negishi, E.; Liu, F.; Choueiry, D.; Mohamud, M. M.; Silveira, A.; Reeves, M. J. Org. Chem. 1996, 61, 8325. 
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a solution of I2 (16 g, 63 mmol) in dry THF (50 mL), stirred for 10 min, and poured into ice/sat. 
NaHCO3.230  The mixture was acidified with conc. HCl and extracted with Et2O.  The combined 
organic layers were washed with brine, dried (MgSO4) and concentrated.  The residue was 
purified by chromatography on SiO2 (1:1, hexanes/EtOAc) followed by Kugelrohr distillation 
(90-110 °C, ~0.10 mm Hg) to give 192 (4.2 g, 35%) as a light yellow oil:  1H NMR δ 6.04-6.03 




tert-Butyl-(4-iodo-3-methylbut-3-enyloxy)diphenylsilane (193).231  To a cooled (0 °C) solution 
of 192 (4.2 g, 20 mmol) was added imidazole (1.9 g, 28 mmol), DMAP (0.24 g, 2.0 mmol) and a 
solution of TBDPS-Cl (5.6 g, 20 mmol) in dry CH2Cl2 (20 mL).  The reaction mixture was 
warmed to room temperature, stirred for 4 h and filtered through Celite.  The filter cake was 
washed with CHCl3 and the combined organic washings were washed with H2O, 10% HCl, and 
brine, dried (MgSO4) and concentrated.  The residue was purified by chromatography on SiO2 
(hexanes) to give 193 (8.1 g, 91%) as a colorless oil:  1H NMR δ 7.71-7.64 (m, 4 H), 7.47-7.35 
(m, 6 H), 5.94-5.93 (m, 1 H), 3.73 (t, J = 6.4 Hz, 2 H), 2.44 (td, J = 6.4, 0.9 Hz, 2 H), 1.76 (d, J = 




(E)-tert-Butyl-(3-Methyl-6-(trimethylsilanyl)hex-3-en-5-ynyloxy)diphenylsilane (194).  To a 
mixture of Pd(Ph3P)4 (0.90 g, 0.78 mmol) and CuI (0.30 g, 1.6 mmol) in freshly distilled i-Pr2NH 
(50 mL) at 0 °C was added a solution of 193 (7.0 g, 16 mmol) in i-Pr2NH (20 mL) followed by 
188 (3.3 mL, 23 mmol).  The reaction mixture was stirred for 10 min, quenched with saturated 
NH4Cl and extracted with Et2O (3x).  The combined organic layers washed with H2O, 10% HCl 
(2x), brine, dried (MgSO4) and concentrated.  The residue was purified by chromatography on 
SiO2 (hexanes, then 97:3, hexanes/EtOAc) to give 194 (6.5 g, 99%) as a colorless oil:  IR (neat) 
3071, 3050, 2958, 2932, 2897, 2858, 2133, 2068, 1473, 1428, 1389, 1250, 1111 cm-1; 1H NMR δ 
7.71-7.64 (m, 4 H), 7.46-7.36 (m, 6 H), 5.32 (m, 1 H), 3.73 (t, J = 6.7 Hz, 2 H), 2.32 (t, J = 6.6 
                                                 
230 Significant material was lost during the quench due to a broken flask. 
231 Bick, S.; Zimmermann, S.; Meuer, H.; Sheldrick, W. S.; Welzel, P. Tetrahedron 1993, 49, 2457. 
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Hz, 2 H), 1.85 (d, J = 1.0 Hz, 2 H), 1.05 (s, 9 H), 0.20 (s, 9 H); 13C NMR δ 150.85, 135.57, 
133.72, 129.61, 127.64, 106.79, 103.32, 96.85, 62.39, 41.62, 26.83, 19.76, 19.15, 0.11; MS (EI) 
m/z (intensity) 405 ((M-CH3)+, 1), 363 (100), 197 (35), 174 (25), 135 (87), 73 (55); HRMS (EI) 
m/z calculated for C25H33OSi2 (M-CH3) 405.2070, found 405.2085. 
TBDPSO
195  
(E)-tert-Butyl-(3-methyl-hex-3-en-5-ynyloxy)diphenylsilane (195).  To a vigorously stirred 
mixture of 194 (1.8 g, 4.2 mmol) in MeOH (17 mL) was added K2CO3 (0.64 g, 4.6 mmol).  The 
reaction mixture was stirred for 12 h, quenched with saturated NH4Cl, diluted with H2O, and 
extracted with EtOAc (3x).  The combined organic layers were washed with brine, dried 
(MgSO4) and concentrated.  The residue was purified by chromatography on SiO2 (95:5, 
Hexanes/EtOAc) to give 195 (1.5 g, 100%) as a colorless oil:  IR (neat) 3308, 3071, 3050, 2932, 
2858, 1472, 1428, 1389, 1191, 1111 cm-1; 1H NMR δ 7.67-7.64 (m, 4 H), 7.44-7.37 (m, 6 H), 
5.94-5.93 (m, 1 H), 3.73 (t, 2 H, J = 6.4 Hz), 2.44 (td, 2 H, J = 6.4, 1.0 Hz), 1.75 (s, 3 H), 1.05 (s, 
9 H); 13C NMR δ 145.04, 135.56, 133.63, 129.63, 127.67, 76.58, 61.81, 42.26, 26.81, 24.02, 
19.12; MS (EI) m/z (intensity) 291 ((M-C4H9)+, 20), 199 (100), 181 (38), 135 (20), 105 (58), 91 





propyl-2-yl]phenylmethyl}-P,P-diphenylphosphinamide (196).  To a suspension of Cp2ZrHCl 
(0.51 g, 2.0 mmol) of in CH2Cl2 (3.0 mL) was added a solution of 195 (0.69 g, 2.0 mmol) of in 
dry CH2Cl2 (2.0 mL).  The reaction was stirred for 10 min, cooled to -78 °C, treated with Me2Zn 
(0.98 mL, 2.0 mmol, 2.0 M in toluene), and warmed to 0 °C.  After addition of imine (0.20 g, 
0.66 mmol), the solution was heated at reflux for 3 h then treated over 75 h with CH2I2 (3 x 0.26 
mL, 3 x 3.3 mmol) in 24 h intervals.  The reaction mixture was cooled to 0 °C, quenched with 
saturated NH4Cl, filtered through Celite.  The aqueous layer was extracted with EtOAc (2x) and 
the combined organic layers were washed with brine, dried (MgSO4), filtered through a pad of 
Florisil and concentrated.  The residue was purified by chromatography on deactivated SiO2 (1:1, 
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Hexanes/EtOAc containing 1% Et3N) to give 196 (0.24 g, 53%) as a colorless foam:  IR (neat) 
3169, 3056, 2929, 2857, 1590, 1472, 1455, 1437, 1428, 1187, 1110 cm-1; 1H NMR δ 7.89-7.83 
(m, 2 H), 7.73-7.65 (m, 6 H), 7.44-7.37 (m, 10 H), 7.29-7.19 (m, 7 H), 3.83-3.63 (m, 3 H), 3.35 
(dd, J = 9.0, 5.8 Hz, 1 H), 1.54-1.45 (m. 1 H), 1.39-1.27 (m, 1 H), 1.15-0.93 (m, 13 H), 0.55-0.45 
(m, 2 H), 0.38-0.28 (m, 2 H), 0.14-0.05 (m, 2 H); 13C NMR δ 142.95, 142.88, 135.51, 134.19, 
133.97, 133.02, 132.48, 132.35, 131.84, 131.72, 131.54, 131.30, 129.46, 128.45, 128.28, 128.17, 
128.03, 127.52, 126.94, 126.73, 62.49, 58.39, 43.57, 27.14, 27.07, 26.81, 26.54, 19.05, 18.59, 
18.35, 17.85, 17.45, 10.97; MS (EI) m/z (intensity) 683 (M+, 15), 640 (10), 626 (79), 548 (12), 
627 (16), 320 (59), 306 (100), 218 (73), 201 (93), 183 (34), 135 (46), 106 (44), 91 (28), 77 (31); 





methyl}-P,P-diphenylphosphinamide (197).  To a solution of 196 (0.15 g, 0.22 mmol) in THF 
(1.0 mL) was added AcOH (25 µL, 0.44 mmol) followed by TBAF (0.44 mL, 0.44 mmol, 1.0 M 
in THF).  The reaction mixture was stirred for 12 h, quenched with saturated NH4Cl and 
extracted with EtOAc (3x).  The combined organic layers were washed with saturated NaHCO3, 
brine, dried (MgSO4) and concentrated.  The residue was purified by chromatography on 
deactivated SiO2 (4:1, then 3:2, CH2Cl2/Acetone, containing 1% Et3N) to give 197 (97 mg, 99%) 
as a colorless foam:  IR (neat) 3363, 3059, 2990, 2926, 2872, 1640, 1454, 1438, 1189, 1124, 
1110 cm-1; 1H NMR (500 MHz) δ 7.87 (dd, J = 11.7, 7.2 Hz, 2 H), 7.71 (dd, J = 11.9, 7.5 Hz, 2 
H), 7.52-7.49 (m, 1 H), 7.46-7.39 (m, 3 H), 7.31-7.27 (m, 4 H), 7.24-7.20 (m, 3 H), 3.79-3.68 (m, 
3 H), 3.39-3.36 (m, 1 H), 1.72 (bs, 1 H), 1.53 (dt, J = 13.6, 6.8 Hz, 1 H), 1.35 (dt, J = 14.0, 7.1 
Hz, 1 H), 1.20-1.10 (m, 1 H), 1.13 (s, 3 H), 0.68-0.64 (m, 1 H), 0.54-0.51 (m, 1 H), 0.43-0.37 (m, 
2 H), 0.29-0.25 (m, 1 H), 0.16 (t, J = 4.8 Hz, 1 H); 13C NMR (126 MHz) δ 143.08, 143.04, 
133.99, 132.98, 132.63, 132.55, 131.94, 131.86, 131.73, 131.71, 131.63, 128.59, 128.49, 128.38, 
128.35, 128.25, 127.15, 126.79, 58.76, 43.67, 27.14, 27.11, 26.60, 18.24, 17.61, 17.53, 11.20; 
MS (EI) m/z (intensity) 445 (M+, 4), 427 (1), 414 (6), 320 (53), 306 (49), 218 (78), 216 (50), 201 






diphenylphosphinamide (202).  Method I.  General Protocol F.  To a suspension of Cp2ZrHCl 
(0.12 g, 0.46 mmol) in CH2Cl2 (2.0 mL) was added 108 (52 µL, 0.46 mmol) and the reaction 
mixture was stirred for 5 min.  The solvent was removed in vacuo and the residue was dissolved 
in dry Cl(CH2)2Cl (2.0 mL), cooled to –30 °C, treated with Me2Zn (0.23 mL, 0.46 mmol, 2.0 M 
in toluene) and warmed to 0 °C.  After addition of 201 (0.10 g, 0.30 mmol), the reaction mixture 
was stirred at 0 °C for 2 h, cooled to –20 °C and transferred via canula to a mixture of Zn(CH2I)2 
(1.2 mmol) in Cl(CH2)2Cl (1.0 mL).  The reaction mixture was warmed to 0 °C and stirred for 6 
h.  The reaction was quenched with saturated NH4Cl, diluted with EtOAc, filtered through 
Celite/Florisil (1:1) and the layers were separated.  The aqueous layer was extracted with EtOAc 
(2x) and the combined organic layers were washed with brine, dried (MgSO4) and concentrated.  
The residue was purified by chromatography on deactivated SiO2 (3:2, hexanes/EtOAc 
containing 1% v/v Et3N) to yield 202 (0.10 g, 68%) as a colorless foam:  IR (neat) 3209, 3077, 
3057, 2995, 2955, 2924, 2855, 1622, 1592, 1437, 1186, 1123 cm-1; 1H NMR (C6D6) δ 8.11-8.01 
(m, 5 H), 7.43-7.39 (m, 3 H), 7.12-7.04 (m, 7 H), 5.28 (d, J = 1.6 Hz, 1 H), 5.12 (d, J = 0.9 Hz, 1 
H), 3.11 (d, J = 14.8 Hz, 1 H), 2.98 (dd, J = 9.3, 6.7 Hz, 1 H), 2.52 (d, J = 14.8 Hz, 1 H), 2.41 
(app. q, J = 9.2 Hz, 1 H), 1.43-1.30 (m, 6 H), 0.93 (t, J = 6.7 Hz, 3 H), 0.78-0.70 (m, 1 H), 0.56-
0.46 (m, 2 H), 0.40-0.21 (m, 4 H), 0.15 (dt, J = 9.5, 4.9 Hz, 1 H); 13C NMR (C6D6) δ 146.24, 
142.49, 136.20, 135.98, 134.52, 134.29, 132.74, 132.62, 132.51, 131.35, 131.32, 128.49, 128.43, 
127.54, 126.67, 115.06, 61.57, 37.90, 33.97, 32.16, 24.50, 24.43, 23.58, 23.52, 23.04, 18.07, 
14.42, 11.97, 10.76, 10.04; MS (EI) m/z (intensity) 483 (M+, 25), 326 (37), 266 (36), 230 (23), 
218 (71), 201 (100), 170 (20), 91 (31); HRMS (EI) m/z calculated for C32H38NOP 483.2691, 
found 483.2684. 
N-(S*)-{((1S*,2S*)-2-Butylcyclopropyl)-[1-(2-phenylallyl)cyclopropyl]methyl}-P,P-
diphenylphosphinamide (202).  Method II.  To a suspension of Cp2ZrHCl (0.24 g, 0.91 mmol) 
in dry CH2Cl2 (2.0 mL) was added 108 (0.10 mL, 0.91 mmol) and the reaction was stirred for 5 
min., cooled to -78 °C, treated with Me2Zn (0.46 mL, 0.91 mmol, 2.0 M in toluene) and warmed 
to 0 °C.  After addition of 201 (0.10 g, 0.30 mmol), the reaction was heated at reflux for 2h, 
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cooled to 0 °C and added via canula to a mixture of Zn(CH2I)2 (0.91 mmol) in dry CH2Cl2 (1.0 
mL + 1.0 mL for flask washing) and the reaction was stirred for 1 h and quenched with sat. 
NH4Cl.  The mixture was diluted with EtOAc, filtered through Celite/Florisil (1:1) and the layers 
were separated.  The aqueous layer was extracted with EtOAc (2x) and the combined organic 
layers were washed with brine, dried (MgSO4) and concentrated.  The residue was purified by 
chromatography on deactivated SiO2 (1:1, hexanes/EtOAc containing 1% v/v Et3N) to afford x 
(88 mg, 60%) as a light yellow oil. 
N-(S*)-{((1S*,2S*)-2-Butylcyclopropyl)-[1-(2-phenylallyl)cyclopropyl]methyl}-P,P-
diphenylphosphinamide (202).  Method III.  To a solution of 228 (77 mg, 0.19 mmol) in dry 
Cl(CH2)2Cl (1.0 mL) was added Me2Zn (0.14 mL, 0.28 mmol, 2.0 M in toluene) and the reaction 
was stirred for 1 h, cooled to -20 °C and transferred via canula to a mixture of Zn(CH2I)2 (0.74 
mmol) in dry Cl(CH2)2Cl (1.0 mL).  The mixture was warmed to 0 °C, stirred for 6 h, quenched 
with sat. NH4Cl, diluted with EtOAc and filtered through Celite/Florisil (1:1).  The mixture was 
extracted with EtOAc and the combined organic layers washed with brine, dried (MgSO4) and 
concentrated.  The residue was purified by chromatography on deactivated SiO2 (1:1, 
hexanes/EtOAc containing 1% v/v Et3N) to afford 202 (65 mg, 72%) as a colorless foam. 
NP(O)Ph2
MeO 205  
N-[3-(4-Methoxyphenyl)prop-2-ynylidene]-P,P-diphenylphosphinamide (205). General 
Protocol G.  To a cooled (0 °C) solution of 118 (2.3 g, 11 mmol), DIPEA (5.6 mL, 32 mmol) 
and 204 (1.9 g, 11 mmol) in dry CH2Cl2 (35 mL) was dropwise added a solution of TiCl4 (0.71 
mL, 6.5 mmol) in CH2Cl2 (5 mL).  The reaction was slowly warmed to r.t., stirred for 12 h, 
poured into dry Et2O, filtered through Celite/Florisil (1:1) and concentrated.  The residue was 
purified by chromatography on dry SiO2 (1:1, hexanes/EtOAc containing 1% v/v Et3N) followed 
by precipitation from CH2Cl2 with excess hexanes to yield 205 (2.1 g, 49%) as a light yellow 
solid:  mp 128.8-130.5 °C (hexanes/CH2Cl2); IR (KBr) 3053, 3019, 2191, 1579, 1567, 1512, 
1437, 1304, 1266, 1210, 1189, 1180, 1125 cm-1; 1H NMR δ 8.72 (d, J = 31.3 Hz, 1 H), 7.94-7.87 
(m, 4 H), 7.59-7.44 (m, 8 H), 6.93-6.88 (m, 2 H), 3.85 (s, 3 H); 13C NMR δ 161.64, 158.18, 
158.11, 134.91, 132.75, 131.93, 131.89, 131.57, 131.44, 131.07, 128.52, 128.35, 114.28, 112.11, 
102.07, 88.34, 87.86, 55.30; MS (EI) m/z (intensity) 360 ([M+H]+, 22), 359 (M+, 67), 358 (64), 
 97
208 (32), 202 (100), 201 (72), 160 (27), 155 (36), 125 (21); HRMS (EI) m/z calculated for 
C22H18NO2P 359.1075, found 359.1058. 
NP(O)Ph2MeO
207  
N-[3-(3-Methoxyphenyl)prop-2-ynylidene]-P,P-diphenylphosphinamide (207). According to 
the General Protocol G, 118 (2.0 g, 9.0 mmol), DIPEA (4.7 mL, 27 mmol), 206 (1.4 g, 9.0 
mmol), TiCl4 (0.60 mL, 5.4 mmol), and CH2Cl2 (50 mL) afforded 207 (0.70 g, 21%) as an 
orange/brown solid:  mp 109.2-112.5 °C (hexanes/CH2Cl2); IR (KBr) 3144, 3055, 3007, 2965, 
2934, 2205, 1656, 1589, 1491, 1465, 1436, 1420, 1322, 1298, 1207, 1125, 1109 cm-1; 1H NMR δ 
8.74 (d, J = 31.2 Hz, 1 H), 7.9-7.88 (m, 4 H), 7.53-7.44 (m, 6 H), 7.30 (t, J = 7.8 Hz, 1 H), 7.21 
(dt, J = 7.6, 1.2 Hz, 1 H), 7.13-7.12 (m, 1 H), 7.01 (ddd, J = 8.2, 2.6, 1.1 Hz, 1 H), 3.81 (s, 3 H); 
13C NMR δ 159.42, 158.13, 158.06, 132.74, 132.03, 132.00, 131.68, 131.55, 131.06, 129.68, 
128.60, 128.43, 125.45, 121.36, 117.62, 117.31, 100.52, 88.06, 87.58, 55.33; MS (EI) m/z 
(intensity) 360 ([M+H]+, 23), 359 (M+, 77), 358 (91), 208 (40), 202 (94), 201 (100), 155 (28); 





N-[3-(2-Methoxyphenyl)-prop-2-ynylidene]-P,P-diphenylphosphinamide (209).  According 
to the General Protocol G, 118 (2.7 g, 12 mmol), DIPEA (6.5 mL, 38 mmol), 208 (2.0 g, 12 
mmol), TiCl4 (0.82 mL, 7.5 mmol), and CH2Cl2 (85 mL) afforded 209 (2.2 g, 50%) as a 
yellow/orange foam:  IR (neat) 3058, 2945, 2838, 2194, 1656, 1584, 1490, 1464, 1438, 1271, 
1206, 1164, 1124, 1107 cm-1; 1H NMR δ 8.78 (d, J = 31.3 Hz, 1 H), 7.98-7.88 (m, 4 H), 7.57-
7.40 (m, 8 H), 6.96 (t, J = 7.5 Hz, 1 H), 6.91 (d, J = 8.5 Hz, 1 H), 3.90 (s, 3 H); 13C NMR δ 
164.44, 158.62, 158.55, 135.04, 132.95, 132.78, 132.21, 132.17, 131.90, 131.78, 131.27, 128.78, 
128.61, 120.79, 111.00, 109.82, 98.27, 92.66, 92.17, 55.99; MS (EI) m/z (intensity) 360 
([M+H]+, 15), 359 (M+, 62), 201 (100), 185 (21), 158 (60), 105 (59), 94 (22), 91 (35); HRMS 
(EI) m/z calculated for C22H18NO2P 359.1075 found 359.1085. 
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NP(O)Ph2
Cl 211  
N-[3-(4-Chlorophenyl)prop-2-ynylidene]-P,P-diphenylphosphinamide (211).  According to 
the General Protocol G, 118 (0.52 g, 3.2 mmol), DIPEA (1.7 mL, 9.6 mmol), 210 (0.52 g, 3.2 
mmol), TiCl4 (0.21 mL, 1.9 mmol), and CH2Cl2 (20 mL) afforded 211 (0.42 g, 36%) as an 
orange/brown foam:  IR (neat) 3131, 3056, 2197, 1658, 1582, 1488, 1437, 1193, 1124 cm-1; 1H 
NMR δ 8.70 (d, J = 31.2 Hz, 1 H), 7.92-7.85 (m, 4 H), 7.51-7.39 (m, 8 H), 7.32 (d, J = 8.6 Hz, 2 
H); 13C NMR δ 157.69, 157.62, 136.99, 133.90, 132.36, 132.00, 131.96, 131.49, 131.36, 130.68, 
128.92, 128.51, 128.34, 118.66, 98.92, 98.89, 88.91, 88.43; MS (EI) m/z (intensity) 364 
([M+H]+, 20), 363 (M+, 40), 212 (27), 202 (71), 201 (100); HRMS (EI) m/z calculated for 




N-(3-Furan-2-ylprop-2-ynylidene)-P,P-diphenylphosphinamide (213). According to the 
General Protocol G, 118 (2.7 g, 12 mmol), DIPEA (6.5 mL, 38 mmol), 212 (1.5 g, 12 mmol), 
TiCl4 (0.81 mL, 7.5 mmol), and CH2Cl2 (85 mL) afforded 213 (0.96 g, 24%) as a crude 
orange/brown oil.  This material was used without purification for the following reaction:  1H 
NMR (C6D6) δ 8.75 (d, J = 31.1 Hz, 1 H), 8.09-8.01 (m, 4 H), 7.11-7.01 (m, 6 H), 7.30 (d, J = 
1.6 Hz, 1 H), 6.35 (d, J = 3.5 Hz, 1 H), 5.75 (dd, J = 3.5, 1.7 Hz, 1 H); 13C NMR (C6D6) δ 
156.73, 156.66, 146.78, 132.09, 132.05, 131.98, 131.93, 131.88, 131.84, 128.75, 128.59, 121.28, 
111.96, 94.72, 94.23, 89.62; MS (EI) m/z (intensity) 320 ([M+H]+, 26), 319 (M+, 55), 217 (48), 




MeO 214  
N-(S*)-(((1S*,2S*)-2-Butylcyclopropyl)(1-(2-(4-methoxyphenyl)allyl)cyclopropyl)methyl)-
P,P-diphenylphosphinamide (214).  According to the General Protocol F, Cp2ZrHCl (0.16 g, 
0.63 mmol), 108 (72 µL, 0.63 mmol), Me2Zn (0.31 mL, 0.63 mmol, 2.0 M in toluene), 205 (0.15 
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g, 0.42 mmol), CH2I2 (0.27 mL, 3.3 mmol) and Et2Zn (0.21 g, 1.7 mmol) in Cl(CH2)2Cl (5.0 mL) 
afforded 214 (0.11 g, 50 %) as a colorless foam:  IR (neat) 3230, 3059, 2998, 2955, 2926, 2854, 
1674, 1601, 1512, 1438, 1250, 1180, 1123, 1110 cm-1; 1H NMR (C6D6) δ 8.11-7.98 (m, 4 H), 
7.43-7.38 (m, 2 H), 7.13-7.05 (m, 6 H), 6.80-6.75 (m, 2 H), 5.28 (d, J = 1.7 Hz, 1 H), 5.07 (bs, 1 
H), 3.31 (s, 3 H), 3.15 (d, J = 14.8 Hz, 1 H), 3.12-3.06 (m, 1 H), 2.56 (d, J = 14.6 Hz, 1 H), 2.40 
(app. q, J = 9.1 Hz, 1 H), 1.39-1.33 (m, 6 H), 0.93 (t, J = 6.8 Hz, 3 H), 0.76-0.71 (m, 1 H), 0.60-
0.53 (m, 2 H), 0.46-0.37 (m, 2 H), 0.34-0.29 (m, 2 H), 0.18 (dt, J = 8.3, 4.9 Hz, 1 H); 13C NMR 
(C6D6) δ 159.67, 145.60, 136.27, 136.11, 134.80, 134.59, 134.42, 132.78, 132.70, 132.66, 
132.58, 131.37, 128.47, 127.84, 113.99, 113.49, 61.94, 54.75, 37.95, 34.01, 32.21, 24.58, 24.51, 
23.63, 23.56, 23.08, 18.16, 14.44, 11.96, 10.92, 10.21; MS (EI) m/z (intensity) 514 ([M+H]+, 4), 
513 (M+, 11), 326 (45), 296 (63), 239 (33), 218 (60), 201 (100), 121 (35), 77 (39); HRMS (EI) 





P,P-diphenylphosphinamide (215). According to the General Protocol F, Cp2ZrHCl (0.16 g, 
0.63 mmol), 108 (72 µL, 0.63 mmol), Me2Zn (0.31 mL, 0.63 mmol, 2.0 M in toluene), 207 (0.15 
g, 0.42 mmol), CH2I2 (0.27 mL, 3.3 mmol) and Et2Zn (0.21 g, 1.7 mmol) in Cl(CH2)2Cl (5.0 mL) 
afforded 215 (0.11 g, 50%) as a colorless foam:  IR (neat) 3213, 3057, 2996, 2955, 2925, 2855, 
1597, 1576, 1488, 1437, 1287, 1186, 1123 cm-1; 1H NMR (C6D6) δ 8.12-8.01 (m, 4 H), 7.22-7.21 
(m, 1 H), 7.12-7.04 (m, 8 H), 6.71 (dt, J = 9.2, 2.6 Hz, 1 H), 5.33 (d, J = 1.6 Hz, 1 H), 5.12 (s, 1 
H), 3.38 (s, 3 H), 3.13 (d, J = 14.8 Hz, 1 H), 2.94 (dd, J = 9.4, 6.9 Hz, 1 H), 2.52 (d, J = 14.7 Hz, 
1 H), 2.41 (app. q, J = 9.2 Hz, 1 H), 1.37-1.23 (m, 7 H), 0.95-0.88 (m, 1H), 0.93 (t, J = 6.6 Hz, 1 
H), 0.76-0.72 (m, 1 H), 0.53-0..44 (m, 2 H), 0.42-0.35 (m, 2 H), 0.32-0.24 (m, 2 H), 0.17 (dt, J = 
13.1, 5.0 Hz, 1 H); 13C NMR (C6D6) δ 160.25, 146.24, 144.13, 136.18, 135.98, 134.50, 134.29, 
132.81, 132.66, 132.53, 131.37, 129.51, 128.47, 119.19, 115.26, 112.98, 112.85, 61.61, 54.84, 
37.93, 34.03, 32.20, 24.57, 24.50, 23.64, 23.57, 23.08, 18.08, 14.44, 12.06, 10.81, 10.05; MS 
(EI) m/z (intensity) 513 (M+, 2), 416 (3), 296 (28), 218 (47), 216 (63), 201 (100); HRMS (EI) m/z 







P,P-diphenylphosphinamide (216).  According to the General Protocol F, Cp2ZrHCl (0.11 g, 
0.42 mmol), 108 (48 µL, 0.42 mmol), Me2Zn (0.21 mL, 0.42 mmol, 2.0 M in toluene), 209 (0.10 
g, 0.28 mmol), CH2I2 (0.18 mL, 2.2 mmol) and Et2Zn (0.14 g, 1.1 mmol) in Cl(CH2)2Cl (3.5 mL) 
afforded 216 (76 mg, 53%) as a colorless foam:  IR (neat) 3221, 3057, 2996, 2955, 2924, 2854, 
1626, 1597, 1576, 1490, 1464, 1437, 1241, 1192, 1122 cm-1; 1H NMR (C6D6) δ 8.12-7.99 (m, 4 
H), 7.13-7.01 (m, 8 H), 6.77 (dt, J = 7.4, 0.9 Hz, 1 H), 6.48 (d, J = 8.2 Hz, 1 H), 5.45 (s, 1 H), 
5.19 (d, J = 2.2 Hz, 1 H), 3.29 (d, J = 15.2 Hz, 1 H), 3.26-3.21 (m, 1 H), 3.21 (s, 3 H), 2.57 (d, J 
= 15.1 Hz, 1 H), 2.47 (app. q, J = 9.1 Hz, 1 H), 1.54-1.42 (m, 1 H), 1.39-1.30 (m, 4 H), 0.92 (t, J 
= 6.8 Hz, 3 H), 0.81-0.72 (m, 2 H), 0.65-0.54 (m, 2 H), 0.47-0.37 (m, 2 H), 0.36-0.22 (m, 2 H), 
0.12 (dt, J = 8.3, 4.7 Hz, 1 H); 13C NMR (C6D6) δ 156.84, 146.90, 136.74, 136.19, 135.06, 
134.51, 133.10, 132.84, 132.72, 132.68, 132.56, 131.30, 131.26, 131.22, 130.43, 120.89, 117.54, 
111.06, 61.16, 54.79, 40.68, 33.99, 32.15, 25.04, 24.96, 23.83, 23.78, 23.07, 18.23, 14.44, 11.90, 
11.35, 10.98; MS (EI) m/z (intensity) 513 (M+, 15), 326 (40), 296 (63), 239 (26), 218 (67), 201 






diphenylphosphinamide (217).  According to the General Protocol F, Cp2ZrHCl (0.17 g, 0.66 
mmol), 108 (76 µL, 0.66 mmol), Me2Zn (0.33 mL, 0.66 mmol, 2.0 M in toluene), 207 (0.16 g, 
0.44 mmol), CH2I2 (0.28 mL, 3.5 mmol) and Et2Zn (0.22 g, 1.8 mmol) in Cl(CH2)2Cl (5.0 mL) 
afforded 217 (0.13 g, 58%) as a colorless foam:  IR (neat) 3211, 3058, 2995, 2955, 2924, 2855, 
1493, 1437, 1185, 1123, 1108 cm-1; 1H NMR (acetone-d6) δ 7.93-7.83 (m, 4 H), 7.53-7.40 (m, 8 
H), 7.33-7.27 (m, 2 H), 5.33 (d, J = 1.5 Hz, 1 H), 5.13 (d, J = 1.3 Hz, 1 H), 4.29 (t, J = 9.9 Hz, 1 
H), 3.14 (d, J = 14.9 Hz, 1 H), 2.71 (d, J = 14.9 Hz, 1 H), 2.37 (app. q, J = 9.4 Hz, 1 H), 1.33-
1.24 (m 6 H), 0.85 (t, J = 6.8 Hz, 3 H), 0.79-0.71 (m, 1 H), 0.63-0.49 (m, 3 H), 0.37 (dt, J = 8.3, 
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4.6 Hz, 1 H), 0.27-0.15 (m, 3 H); 13C NMR (acetone-d6) δ 145.53, 141.81, 137.12, 137.00, 
135.44, 135.33, 133.37, 132.99, 132.96, 132.87, 132.83, 132.02, 131.99, 129.00, 128.82, 115.67, 
61.40, 37.97, 34.38, 32.47, 24.77, 24.71, 23.85, 23.78, 23.30, 18.18, 14.42, 12.32, 10.46, 9.87; 
MS (EI) m/z (intensity) 518 ([M+H]+, 2), 517 (M+, 5), 218 (44), 201 (100), 77 (24); HRMS (EI) 





diphenylphosphinamide (218).  According to the General Protocol F, Cp2ZrHCl (0.12 g, 0.47 
mmol), 108 (54 µL, 0.47 mmol), Me2Zn (0.24 mL, 0.47 mmol, 2.0 M in toluene), 217 (0.10 g, 
0.31 mmol), CH2I2 (0.20 mL, 2.5 mmol) and Et2Zn (0.15 g, 1.2 mmol) in Cl(CH2)2Cl (3.0 mL) 
afforded 218 (69 mg, 47%) as a colorless foam:  IR (KBr) 3198, 3055, 2922, 1625, 1591, 1438, 
1186, 1123, 1111 cm-1; 1H NMR (C6D6) δ 8.12-8.04 (m, 3 H), 7.12-7.04 (m, 7 H), 7.00-6.99 (m, 
1 H), 6.51 (d, J = 2.9 Hz, 1 H), 6.13 (dd, J = 3.3, 1.8 Hz, 1 H), 5.70 (d, J = 1.5 Hz, 1 H), 5.00 (d, 
J = 1.1 Hz, 1 H), 2.98-2.93 (m, 1 H), 2.93 (d, J = 14.6 Hz, 1 H), 2.48 (d, J = 14.4 Hz, 1 H), 2.32 
(app. q, J = 8.8 Hz, 1 H), 1.39-1.33 (m, 6 H), 0.93 (t, J = 6.7 Hz, 3 H), 0.75-0.74 (m, 1 H), 0.56-
0.47 (m, 2 H), 0.45-0.28 (m, 4 H), 0.17 (dt, J = 8.3, 4.9 Hz, 1 H); 13C NMR (C6D6) δ 155.78, 
141.93, 136.03, 135.90, 135.04, 134.34, 134.21, 132.72, 132.60, 131.45, 131.41, 128.21, 112.10, 
111.50, 107.20, 62.28, 62.25, 35.24, 33.96, 32.24, 24.10, 24.03, 23.58, 23.51, 23.07, 18.09, 
14.43, 11.97, 10.71, 9.85; MS (EI) m/z (intensity) 474 ([M+H]+, 5), 473 (M+, 16), 326 (23), 256 






cyclopropyl]methyl}-P,P-diphenylphosphinamide (219).  To a suspension of Cp2ZrHCl (0.35 
g, 1.4 mmol) in dry CH2Cl2 (4.0 mL) was added a solution of 125 (0.42 g, 1.4 mmol) in dry 
CH2Cl2 (2.0 mL).  The reaction mixture was stirred for 5 min, solvent was removed in vacuo and 
the residue was dissolved in Cl(CH2)2Cl (4.0 mL), cooled to –30 °C, treated with Me2Zn (0.69 
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mL, 1.4 mmol, 2.0 M in toluene) and warmed to 0 °C.  After addition of 201 (0.30 g, 0.91 
mmol), the mixture was stirred at 0 °C for 2 h, cooled to –30 °C and treated with a solution of 
Zn(CH2I)2•DME (3.6 mmol) in Cl(CH2)2Cl (3.0 mL).  The reaction mixture was warmed to 0 °C, 
stirred for 3 h, quenched with saturated NH4Cl, diluted with EtOAc, and filtered through 
Celite/Florisil (1:1).  The aqueous layer was extracted with EtOAc (2x) and the combined 
organic layers were washed with brine, dried (MgSO4) and concentrated.  The residue was 
purified by chromatography on deactivated SiO2 (3:2, hexanes/EtOAc containing 1% v/v Et3N) 
to yield 219 (0.36 g, 55%) as a colorless foam:  IR (neat) 3208, 3054, 2929, 2857, 1437, 1428, 
1185, 1109 cm-1; 1H NMR (C6D6) δ 8.09-7.99 (m, 4 H), 7.83-7.79 (m, 4 H), 7.41-7.38 (m, 2 H), 
7.27-7.22 (m, 8 H), 7.10-7.00 (m, 7 H), 5.26 (d, J = 1.5 Hz, 1 H), 5.08 (bs, 1 H), 3.90-3.76 (m, 2 
H), 3.09 (d, J = 14.9 Hz, 1 H), 2.88 (dd, J = 9.6, 6.1 Hz, 1 H), 2.48 (d, J = 14.8 Hz, 1 H), 2.37 
(app. q, J = 9.2 Hz, 1 H), 1.89-1.78 (m, 1 H), 1.29-1.13 (m, 1 H), 1.20 (s, 9 H), 0.80-0.72 (m, 1 
H), 0.53-0.43 (m, 2 H), 0.39-0.31 (m, 2 H), 0.29-0.20 (m, 2 H), 0.16-0.10 (m, 1 H); 13C NMR 
(C6D6) δ 146.30, 142.51, 136.01, 135.85, 135.52, 134.16, 132.78, 132.66, 132.61, 132.48, 
131.37, 129.88, 126.70, 115.06, 64.51, 61.33, 38.02, 37.36, 27.18, 24.53, 23.40, 23.34, 19.43, 
14.75, 11.54, 10.78, 10.08; MS (ESI) m/z (rel. intensity) 710 ([M+H]+, 100); HRMS (ESI) m/z 





methyl}cyclopropyl)propionic acid triisopropylsilyl ester (220).  According to the General 
Protocol F, Cp2ZrHCl (0.12 g, 0.46 mmol), 139 (0.12 g, 0.46 mmol), Me2Zn (0.23 mL, 0.46 
mmol, 2.0 M in toluene), 201 (0.10 g, 0.30 mmol), CH2I2 (0.20 mL, 2.4 mmol) and Et2Zn (0.15 
g, 1.2 mmol) in Cl(CH2)2Cl (3.0 mL) afforded 220 (0.11 g, 55%) as a colorless foam:  IR (neat) 
3207, 3057, 2945, 2867, 1716, 1622, 1464, 1438, 1269, 1186, 1123 cm-1; 1H NMR (C6D6) δ 
8.12-7.97 (m, 5 H), 7.40-7.35 (m, 3 H), 7.13-7.02 (m, 7 H), 5.25 (d, J = 1.6 Hz, 1 H), 5.06 (d, J = 
1.1 Hz, 1 H), 3.06 (dd, J = 9.6, 6.2 Hz, 1 H), 3.00 (d, J = 15.2 Hz, 1 H), 2.51 (d, J = 14.0 Hz, 1 
H), 2.52-2.34 (m, 2 H), 2.36 (app q, J = 9.2 Hz, 1 H), 1.82-1.68 (m, 1 H), 1.45-1.24 (m, 4 H), 
1.12 (d, J = 6.8 Hz, 18 H), 0.92-0.82 (m, 1 H), 0.57-0.44 (m, 2 H), 0.36-0.21 (m, 4 H), 0.14 (dt, J 
= 8.4, 4.9 Hz, 1 H); 13C NMR (C6D6) δ 173.63, 146.10, 142.50, 136.10, 135.60, 134.42, 133.91, 
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132.85, 132.73, 132.66, 132.54, 131.45, 129.33, 126.67, 115.08, 61.27, 38.00, 35.88, 30.17, 
29.81, 24.44, 24.36, 23.85, 23.79, 18.06, 17.70, 12.28, 11.93, 10.57, 10.01; MS (EI) m/z 
(intensity) 655 (M+, 55), 612 (89), 498 (17), 454 (13), 438 (20), 330 (49), 218 (90), 201 (100); 





1-But-3-ynyl-5-methyl-2,7,8-trioxabicyclo[3.2.1]octane (221).  To a solution of 4-pentynoic 
acid (1.0 g, 10 mmol) in dry CH2Cl2 (27 mL) and DMF (3.0 mL) was added DCC (2.1 g, 10 
mmol), DMAP (84 mg, 0.68 mmol) and 2-(2-methyloxiranyl)ethanol232 (0.70 g, 0.68 mmol) and 
the reaction mixture was stirred for 6 h, filtered through Celite, washed with 10% HCl and brine, 
dried (MgSO4) and concentrated.  The residue was purified by chromatography on SiO2 (4:1, 
hexanes/EtOAc) to give 2-(2-methyloxiran-2-yl)ethyl pent-4-ynoate (0.92 g, 74%):  IR (neat) 
3284, 2967, 1736, 1423, 1391, 1167 cm-1; 1H NMR δ 4.31-4.15 (m, 2 H), 2.67-2.47 (m, 3 H), 
2.66 (d, J = 4.7 Hz, 1 H), 2.61 (d, J = 4.8 Hz, 1 H), 2.02-1.82 (m, 2 H), 1.98 (t, J = 2.1 Hz, 1 H), 
1.63-1.60 (m, 1 H), 1.37 (s, 3H); 13C NMR δ 171.44, 82.26, 69.01, 61.06, 54.72, 53.44, 35.41, 
33.18, 21.06, 14.18; MS (EI) m/z (intensity) 182 (M+, 3), 181 (5), 152 (96), 137 (36), 124 (54), 
111 (92), 109 (100); HRMS (EI) m/z calculated for C9H12O2 (M-CH2O) 152.0837 found 
152.0835.  To a solution of 2-(2-methyloxiran-2-yl)ethyl pent-4-ynoate (0.50 g, 2.7 mmol) in dry 
CH2Cl2 (15 mL) at 0 °C was added Cp2ZrCl2 (80 mg, 0.27 mmol) and AgClO4 (6.0 mg, 29 
µmol).  The reaction was stirred for 4 h, filtered through a pad of Florisil, washed with sat. 
NaHCO3 and brine, dried (MgSO4) and concentrated.  The residue was purified by 
chromatography on dry SiO2 (7:3, hexanes/EtOAc containing 1% v/v Et3N) to yield 221 as a 
colorless oil which solidified on standing (0.46 g, 91%):  IR (neat) 3289, 2976, 2953, 2888, 
1447, 1392, 1305, 1266, 1203, 1190, 1143, 1074, 1055 cm-1; 1H NMR (C6D6) δ 3.76 (ddd, J = 
12.5, 11.4, 4.3 Hz, 1 H), 3.50 (dd, J = 11.3, 6.7 Hz, 1 H), 3.41 (d, J = 7.0 Hz, 1 H), 3.09 (dd, J = 
7.0, 2.2 Hz, 1 H), 2.63-2.57 (m, 2 H), 2.41-2.35 (m, 2 H), 1.71 (t, J = 2.7 Hz, 1 H), 1.57 (ddt, J = 
12.8, 6.7, 2.2 Hz, 1 H), 0.88 (s, 3 H), 0.60 (dd, J = 13.1, 4.2 Hz, 1 H); 13C NMR (C6D6) δ 120.02, 
83.92, 78.50, 73.60, 68.72, 59.04, 35.52, 33.69, 21.75, 13.57; MS (EI) m/z (intensity) 183 
                                                 
232 Bats, J.-P.; Moulines, J.; Picard, P.; Leclercq, D.; Tetrahedron 1982, 38, 2139. 
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([M+H]+, 4), 181 (2), 152 (30), 109 (32), 99 (44), 84 (51), 81 (100); HRMS (EI) m/z calculated 








According to the General Protocol F, Cp2ZrHCl (0.11 g, 0.42 mmol), 221 (76 mg, 0.42 mmol), 
Me2Zn (0.21 mL, 0.42 mmol, 2.0 M in toluene), 205 (0.10 g, 0.28 mmol), CH2I2 (0.18 mL, 2.2 
mmol) and Et2Zn (0.14 g, 1.1 mmol) in Cl(CH2)2Cl (3.0 mL) afforded 222 (75 mg, 44%) as a 
colorless oil:  IR (neat) 3218, 3058, 2933, 2885, 1608, 1513, 1438, 1248, 1189, 1123, 1109 cm-1; 
1H NMR (C6D6) δ 8.15-8.08 (m, 6 H), 7.44 (d, J = 8.7 Hz, 2 H), 7.15-7.08 (m, 4 H), 6.79 (d, J = 
8.7 Hz, 2 H), 5.27 (s, 1 H), 5.05 (s, 1 H), 3.88 (dt, J = 11.7, 4.1 Hz, 1 H), 3.62 (dd, J = 11.2, 6.7 
Hz, 1 H), 3.52 (dd, J = 6.7, 2.3 Hz, 1 H), 3.32 (s, 3 H), 3.31-3.19 (m, 2 H), 3.11 (d, J = 14.7 Hz, 
1 H), 2.57 (d, J = 14.7 Hz, 1 H), 2.39-2.25 (m, 4 H), 1.77-1.57 (m, 3 H), 0.99 (s, 3 H), 0.81-0.64 
(m, 3 H), 0.58-0.52 (m, 1 H), 0.50-0.43 (m, 1 H), 0.31-0.15 (m, 3 H); 13C NMR (C6D6) δ 159.69, 
145.56, 134.95, 132.90, 132.78, 131.32, 130.29, 121.40, 114.04, 113.91, 113.46, 78.36, 78.28, 
73.65, 62.16, 59.05, 54.79, 37.65, 36.16, 33.95, 28.36, 21.97, 17.92, 14.17, 12.17, 10.91, 10.11; 
MS (ESI) m/z (intensity) 632 ([M+H+H2O]+, 100), 614 ([M+H]+, 88), 397 (84), 313 (30), 218 





methyl}cyclopropyl)ethyl]-(4-methylphenylsulfonyl)carbamic acid ethyl ester (224). 
According to the General Protocol F, Cp2ZrHCl (0.12 g, 0.46 mmol), 223 (0.14 g, 0.46 mmol), 
Me2Zn (0.23 mL, 0.46 mmol, 2.0 M in toluene), 201 (0.10 g, 0.30 mmol), CH2I2 (0.20 mL, 2.4 
mmol) and Et2Zn (0.15 g, 1.2 mmol) in Cl(CH2)2Cl (3.0 mL) afforded 225 (92 mg, 43%) as a 
colorless foam:  IR (neat) 3218, 3057, 2993, 2926, 1731, 1624, 1597, 1438, 1371, 1353, 1266, 
1186, 1171, 1123 cm-1; 1H NMR (C6D6) δ 8.16-8.00 (m, 7 H), 7.39-7.35 (m, 2 H), 7.23-7.04 (m, 
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8 H). 6.77 (d, J = 8.1 Hz, 2 H), 5.26 (d, J = 1.4 Hz, 1 H), 5.09 (bs, 1 H), 4.16 (t, J = 7.4 Hz, 2 H), 
3.83-3.73 (m, 2 H), 3.11-3.03 (m, 2 H), 2.45 (d, J = 14.8 Hz, 1 H), 2.36 (app q, J = 9.4 Hz, 1 H), 
2.18-2.07 (m, 1 H), 1.85 (s, 3 H), 1.69-1.56 (m, 1 H), 0.76 (t, J = 7.1 Hz, 3 H), 0.67-0.58 (m, 1 
H), 0.54-0.48 (m, 1 H), 0.39-0.18 (m, 6 H); 13C NMR (C6D6) δ 152.61, 146.40, 143.81, 142.53, 
138.33, 136.27, 135.52, 134.58, 133.83, 132.87, 132.75, 132.67, 132.55, 131.56, 131.53, 131.46, 
131.43, 129.29, 128.78, 128.66, 128.53, 126.72, 115.13, 62.92, 61.39, 47.64, 38.34, 35.06, 24.64, 
24.55, 23.58, 23.53, 21.12, 15.80, 13.88, 11.86, 10.70, 10.16; MS (EI) m/z (intensity) 696 (M+, 
1), 494 (3), 353 (3), 216 (54), 199 (63), 105 (100); HRMS (EI) m/z calculated for C40H45N2O5PS 




N-[1-(2-Phenylallyl)cyclopropylmethyl]-P,P-diphenylphosphinamide (227). To a solution of 
226 (65 mg, 0.20 mmol) at 0 °C in Cl(CH2)2Cl (1.0 mL) was added Me2Zn (98 µL, 0.20 mmol, 
2.0 M in toluene).  The reaction mixture was warmed to r.t., stirred for 1 h, cooled to –20 °C, 
transferred via canula to a mixture of Zn(CH2I)2 (0.59 mmol) in Cl(CH2)2Cl (1.0 mL), warmed to 
r.t. and stirred for 4 h.  The solution was quenched with saturated NH4Cl, diluted with EtOAc 
and filtered through Celite/Florisil (1:1).  The aqueous layer was extracted with EtOAc (2x) and 
the combined organic layers were washed with brine, dried (MgSO4) and concentrated.  The 
residue was purified by chromatography on deactivated SiO2 (2:3, hexanes/EtOAc containing 
1% Et3N) to yield 227 (45 mg, 61%) as a colorless oil:  IR (neat) 3203, 2955, 2924, 2854, 1437, 
1186, 1162, 1123, 1108 cm-1; 1H NMR (C6D6) δ 8.04-7.96 (m, 4 H), 7.35-7.28 (m, 2 H), 7.13-
7.04 (m, 9 H), 5.21 (d, J = 1.6 Hz, 1 H), 5.06 (d, J = 1.3 Hz, 1 H), 2.88-2.74 (m, 3 H), 2.58 (s, 2 
H), 0.21-0.13 (m, 4 H); 13C NMR (C6D6) δ 146.61, 142.69, 135.21, 133.52, 132.69, 132.57, 
131.50, 131.46, 126.72, 114.66, 47.75, 39.16, 20.44, 20.33, 10.90; MS (EI) m/z (intensity) 387 
(M+, 4), 359 (5), 318 (5), 230 (43), 218 (93), 201 (100), 170 (63), 155 (27); HRMS (EI) m/z 









diethylcyclopropyl)methyl]-P,P-diphenylphosphinamide (229).  General Protocol H.  To a 
suspension of Cp2ZrHCl (80 mg, 0.31 mmol) in CH2Cl2 (2.0 mL) was added 136 (35 µL, 0.31 
mmol) and the reaction mixture was stirred for 10 min.  The solvent was removed in vacuo and 
the residue was dissolved in Cl(CH2)2Cl (1.0 mL), cooled to –30 °C, treated with Me2Zn (0.16 
mL, 0.31 mmol, 2.0 M in toluene) and warmed to 0 °C.  After addition of 211 (75 mg, 0.21 
mmol), the reaction mixture was stirred for 2 h, cooled to –20 °C and transferred via canula to a 
mixture of Zn(CH2I)2 (0.52 mmol) in Cl(CH2)2Cl (1.0 mL).  The solution was warmed to 0 °C 
and stirred for 4 h.  Zn(CH2I)2 was prepared by dropwise addition of CH2I2 (83 µL, 1.0 mmol) to 
a freshly prepared solution of Et2Zn (64 mg, 0.52 mmol) in Cl(CH2)2Cl (1.0 mL) at –20 °C. The 
reaction mixture was quenched with saturated NH4Cl, diluted with EtOAc, filtered through 
Celite/Florisil (1:1) and the layers were separated.  The aqueous layer was extracted with EtOAc 
(2x) and the combined organic layers were washed with brine, dried (MgSO4) and concentrated.  
The crude reaction was dissolved in acetone (1.0 mL) and H2O (1.0 mL) and treated with OsO4 
(11 mg, 43 µmol) and NMO (48 mg, 0.42 mmol) and the reaction was stirred for 1.5 h.  The 
mixture was extracted with EtOAc (3x) and the combined organic layers were washed with 
brine, dried (MgSO4) and concentrated.  The residue was purified by chromatography on 
deactivated SiO2 (3:2, hexanes/EtOAc containing 1% Et3N) to yield 229 (52 mg, 51%) as a 
colorless foam:  IR (neat) 3226, 3055, 2959, 2928, 2871, 1592, 1486, 1438, 1189, 1123, 1108 
cm-1; 1H NMR (C6D6) δ 7.90-7.82 (m, 2 H), 7.65-7.56 (m, 2 H), 7.15-7.12 (m, 2 H), 7.07-6.94 
(m, 8 H), 2.88 (dd, J = 10.4, 7.7 Hz, 1 H), 2.59 (dd, J = 10.4, 3.7 Hz, 1 H), 2.06, 2.04 (AB, J = 
6.7 Hz, 2 H), 1.80-7.74 (m, 1 H), 1.72-1.60 (m, 1 H), 1.36-1.22 (m, 1 H), 1.03-0.81 (m, 1 H), 
1.00 (t, J = 7.0 Hz, 3 H), 0.90 (s, 1 H), 0.84 (t, J = 7.5 Hz, 3 H), 0.81 (s, 1 H), 0.42-0.32 (m, 2 H), 
-0.09--0.16 (m, 1 H); 13C NMR (C6D6) δ 136.53, 135.54, 134.36, 133.83, 132.72, 132.60, 
132.56, 132.44, 131.49, 131.12, 128.74, 128.58, 56.87, 32.72, 31.54, 30.32, 30.28, 29.63, 29.51, 
26.29, 22.52, 21.11, 19.38, 15.93, 14.55, 12.81; MS (EI) m/z (intensity) 489 (M+, 5), 460 (5), 432 
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(6), 326 (31), 288 (25), 218 (52), 201 (100), 124 (24), 77 (44); HRMS (EI) m/z calculated for 






diethylcyclopropyl)methyl]-P,P-diphenylphosphinamide (230).  According to the General 
Protocol H, Cp2ZrHCl (80 mg, 0.31 mmol), 136 (35 µL, 0.31 mmol), Me2Zn (0.16 mL, 0.31 
mmol, 2.0 M in toluene), 207 (75 mg, 0.21 mmol), CH2I2 (83 µL, 1.0 mmol) and Et2Zn (64 mg, 
0.52 mmol) in Cl(CH2)2Cl (2.0 mL) afforded 230 (54 mg, 53%) as a colorless oil:  IR (neat) 
3212, 3057, 2960, 2930, 2872, 1683, 1599, 1485, 1463, 1454, 1438, 1287, 1193, 1123, 1109 cm-
1; 1H NMR (C6D6) δ 8.00-7.92 (m, 2 H), 7.66-7.57 (m, 2 H), 7.13-7.06 (m, 4 H), 7.03-6.98 (m, 4 
H), 6.90-6.87 (m, 1 H), 6.65 (ddd, J = 8.2, 2.5, 0.8 Hz, 1 H), 3.40 (s, 3 H), 2.92 (dd, J = 10.3, 7.0 
Hz, 1 H), 2.66 (dd, J = 10.3, 3.4 Hz, 1 H), 2.16 (d, J = 6.6 Hz, 1 H), 2.03 (d, J = 6.6 Hz, 1 H), 
1.97-1.88 (m, 1 H), 1.82-1.70 (m, 1 H), 1.41-1.28 (m, 1 H), 1.05 (t, J = 7.1 Hz, 3 H), 1.00-0.91 
(m, 1 H), 0.96 (s, 1 H), 0.87 (t, J = 7.5 Hz, 3 H), 0.82 (s, 1 H), 0.46 (dd, J = 8.9, 4.5 Hz, 1 H), 
0.39-0.35 (m, 1 H), -0.10 (t, J = 5.3 Hz, 1 H); 13C NMR (C6D6) δ 160.57, 139.58, 135.93, 
134.21, 134.17, 132.94, 132.82, 132.48, 131.43, 131.39, 131.33, 129.68, 118.67, 112.18, 110.95, 
57.43, 54.75, 32.66, 30.98, 30.42, 30.39, 29.36, 29.23, 26.63, 22.59, 21.08, 19.39, 15.82, 14.56, 
12.83; MS (EI) m/z (intensity) 485 (M+, 4), 218 (25), 201 (100), 124 (34), 91 (45); HRMS (EI) 





yl)methyl]-P,P-diphenylphosphonamide (232). To a suspension of Cp2ZrHCl (78 mg, 0.30 
mmol) in dry THF (2.0 mL) was added 231 (33 mg, 0.24 mmol).  The reaction mixture was 
heated at 50 °C for 1.5 h, treated with an additional portion of 231 (8.0 mg, 59 µmol) and stirred 
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for 10 min.  The mixture was cooled to r.t., all volatile material was removed in vacuo and the 
residue was dissolved in Cl(CH2)2Cl (1.0 mL), cooled to –30 °C, treated with Me2Zn (0.15 mL, 
0.30 mmol, 2.0 M in toluene) and warmed to 0 °C.  After addition of 201 (50 mg, 0.15 mmol), 
the reaction mixture was heated in a microwave (300W, 90 °C) for 0.5 h, cooled to –20 °C and 
transferred via canula to a precooled flask containing Zn(CH2I)2 (1.5 mmol) in Cl(CH2)2Cl (1.0 
mL).  The mixture was stirred at -20 °C 6 h, carefully quenched with saturated NH4Cl, diluted 
with EtOAc and filtered through Celite/Florisil (1:1).  The aqueous layer was extracted with 
EtOAc (2x) and the combined organic layers were washed with brine, dried (MgSO4) and 
concentrated.  The crude reaction was dissolved in acetone (1.0 mL) and H2O (1.0 mL) and 
treated with OsO4 (7.6 mg, 30 µmol) and NMO (35 mg, 0.30 mmol) and the reaction was stirred 
for 1.5 h.  The mixture was extracted with EtOAc (3x) and the combined organic layers were 
washed with brine, dried (MgSO4) and concentrated.  The residue was purified by 
chromatography on deactivated SiO2 (3:2, hexanes/EtOAc containing 1% Et3N) to yield 232 (42 
mg, 55%) as a colorless oil:  IR (neat) 3212, 3056, 2960, 2922, 2848, 1602, 1438, 1194, 1122, 
1109 cm-1; 1H NMR (C6D6) δ 7.85-7.78 (m, 2 H), 7.70-7.63 (m, 2 H), 7.29-7.17 (m, 4 H), 7.07-
6.94 (m, 7 H), 3.08 (dd, J = 10.9, 8.2 Hz, 1 H), 2.60 (dd, J = 10.9, 4.0 Hz, 1 H), 2.12-2.07 (m, 1 
H), 2.12 (d, J = 6.6 Hz, 1 H), 2.01 (d, J = 6.6 Hz, 1 H), 1.81-1.64 (m, 5 H), 1.35-1.03 (m, 7 H), 
0.93-0.88 (m, 2 H), 0.86-0.74 (m, 1 H), 0.80 (t, J = 7.4 Hz, 3 H), 0.37 (dt, J = 9.3, 6.0 Hz, 1 H), -
0.044 (t, J = 5.8 Hz, 1 H); 13C NMR (C6D6) δ 137.79, 133.11, 132.99, 132.91, 132.79, 131.37, 
131.33, 131.30, 128.59, 128.51, 126.70, 125.45, 55.49, 38.79, 34.45, 33.96, 32.54, 31.25, 31.22, 
30.61, 30.26, 30.14, 29.41, 27.05, 27.00, 26.91, 21.78, 20.21, 15.09, 12.32; MS (EI) m/z 
(intensity) 509 (M+, 12), 480 (8), 426 (10), 398 (15), 392 (20) 380 (25), 308 (38), 218 (65), 201 











Deuterated 202 (233).  To a suspension of Cp2ZrHCl (0.12 g, 0.46 mmol) in CD2Cl2 (1.0 mL) 
was added 108 (52 µL, 0.46 mmol).  The reaction mixture was stirred for 5 min, cooled to -78 
°C, treated with Me2Zn (0.23 mL, 0.46 mmol, 2.0 M in toluene) and warmed to 0 °C.  After 
addition of 201 (50 mg, 0.15 mmol), the solution was heated at reflux for 2 h, cooled to 0 °C and 
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added via canula to a cooled (-20 °C) mixture of Zn(CD2I)2 (0.61 mmol) in dry CD2Cl2 (1.0 mL 
+ 0.50 mL for flask washing).  The reaction mixture was warmed to r.t., stirred for 3 h and 
quenched with sat. NH4Cl.  Zn(CD2I)2 was prepared by dropwise addition of CD2I2 (99 µL, 1.2 
mmol) to a cooled (-20 °C) solution of Et2Zn (75 mg, 0.61 mmol) in dry CD2Cl2 (1.0 mL).  The 
reaction mixture was diluted with EtOAc, filtered through Celite/Florisil (1:1) and the layers 
were separated.  The aqueous layer was extracted with EtOAc (2x) and the combined organic 
layers were washed with brine, dried (MgSO4) and concentrated.  The residue was purified by 
chromatography on deactivated SiO2 (1:1, hexanes/EtOAc containing 1% v/v Et3N) to afford 233 
(38 mg, 51%) as a light yellow oil:  IR (neat) 3210, 3056, 2955, 2924, 2870, 2854, 1438, 1187, 
1123, 1109 cm-1; 1H NMR δ 8.10-7.99 (m, 5 H), 7.41 (d, J = 7.0 Hz, 3 H), 7.12-7.05 (m, 7 H), 
3.14 (bt, J = 7.7 Hz, 1 H), 2.39 (q, J = 9.1 Hz, 1 H), 1.48-1.35 (m, 6 H), 0.93 (t, J = 6.7 Hz, 3 H), 
0.74-0.70 (m, 1 H), 0.51 (dd, J = 9.0, 4.2 Hz, 1 H); 13C NMR δ 146.07, 142.50, 135.98, 135.70, 
134.29, 134.01, 132.78, 132.67, 132.56, 131.86, 131.72, 131.44, 61.60, 33.89, 32.19, 24.05, 
23.98, 23.40, 23.34, 23.06, 17.92, 14.42, 9.86; MS (EI) m/z (intensity) 493 (M+, 17), 328 (26), 






diphenylphosphinamide (251).  General Protocol I.  To a suspension of NaH (50 mg, 2.1 
mmol) in dry THF (3.0 mL) was added 202 (0.20 g, 0.41 mmol).  The reaction mixture was 
stirred for 20 min, treated with HMPA (0.36 mL, 2.1 mmol) and allyl iodide (0.38 mL, 4.1 
mmol), heated at 70 °C for 1 h, cooled to r.t., quenched with sat. NH4Cl and extracted with 
EtOAc (3x).  The combined organic layers were washed with H2O and brine, dried (Na2SO4) and 
concentrated.  The residue was purified by chromatography on deactivated SiO2 (3:1, 
hexanes/EtOAc containing 1% v/v Et3N) to afford 251 (0.21 g, 95%) as a colorless foam:  IR 
(neat) 3057, 2955, 2924, 2854, 1438, 1203, 1118, 1104 cm-1; 1H NMR (C6D6) δ 8.05-7.98 (m, 4 
H), 7.56-7.52 (m, 2 H), 7.21-7.15 (m, 2 H), 7.12-7.02 (m, 7 H), 6.19-6.05 (m, 1 H), 5.37 (d, J = 
1.4 Hz, 1 H), 5.10 (d, J = 1.2 Hz, 1 H), 4.81-4.75 (m, 2 H), 4.01-3.78 (m, 2 H), 3.53-3.46 (m, 1 
H), 3.38 (d, J = 15.5 Hz, 1 H), 2.54 (d, J = 15.6 Hz, 1 H), 1.84-1.76 (m, 1 H), 1.43-1.29 (m, 4 H), 
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1.09-0.88 (m, 3 H), 0.95 (t, J = 6.9 Hz, 3 H), 0.70-0.51 (m, 2 H), 0.45-0.36 (m, 2 H), 0.22-0.16 
(m, 1 H), 0.14-0.08 (m, 1 H); 13C NMR (C6D6) δ 145.86, 142.79, 139.72, 139.68, 135.59, 
135.02, 133.95, 133.36, 133.17, 133.10, 133.05, 132.98, 131.31, 131.27, 128.58, 126.61, 115.11, 
114.43, 63.38, 47.45, 47.39, 39.78, 33.71, 31.95, 23.01, 19.98, 19.91, 17.61, 15.14, 14.43, 10.03, 
7.61; MS (EI) m/z (rel. intensity) 523 (M+, 3), 366 (75), 201 (100); HRMS (EI) m/z calculated for 








non-7-ene (252).  General Protocol J.  To a solution of 251 (0.15 g, 0.29 mmol) in dry CH2Cl2 
(57 mL) was added 1,3-bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene)dichloro-
(phenylmethylene)tricyclohexylphosphine)ruthenium (24 mg, 0.029 mmol).  The reaction 
mixture was heated at reflux for 7 h, cooled to r.t., filtered through Celite and concentrated.  The 
residue was purified by chromatography on deactivated SiO2 (3:2, hexanes/EtOAc containing 
1% v/v Et3N) to afford 252 (0.11 g, 75%) as a colorless foam:  IR (neat) 3057, 2998, 2954, 2924, 
2870, 2853, 1635, 1592, 1492, 1437, 1205, 1120, 1107 cm-1; 1H NMR (C6D6) δ 8.06-7.92 (m, 4 
H), 7.20-7.03 (m, 11 H), 5.49 (dd, J = 6.4, 3.5 Hz, 1 H), 3.98-3.88 (m, 1 H), 3.61 (ddd, J = 17.4, 
9.9, 6.9 Hz, 1 H), 3.03 (t, J = 8.9 Hz, 1 H), 2.78 (d, J = 16.5 Hz, 1 H), 2.48 (d, J = 16.5 Hz, 1 H), 
1.65-1.56 (m, 1 H), 1.40-1.35 (m, 4 H), 1.03-0.85 (m, 3 H), 0.94 (t, J = 6.3 Hz, 3 H), 0.81-0.78 
(m, 1 H), 0.67-0.63 (m, 1 H), 0.39-0.26 (m, 4 H); 13C NMR (C6D6) δ 144.86, 144.22, 135.39, 
135.34, 133.71, 133.06, 132.93, 132.80, 131.42, 131.38, 131.33, 131.30, 127.13, 127.08, 126.22, 
65.18, 65.14, 41.85, 41.78, 40.30, 34.22, 32.02, 23.98, 23.91, 23.09, 22.99, 19.55, 17.21, 14.42, 
13.56, 13.16, 12.30; MS (EI) m/z (rel. intensity) 495 (M+, 12), 398 (9), 294 (45), 201 (100); 







phenylallyl)cyclopropyl]methyl}-P,P-diphenylphosphinamide (253).  According to the 
General Protocol I, 219 (0.15 g, 0.21 mmol), NaH (25 mg, 1.1 mmol), and HMPA (0.19 mL, 1.1 
mmol), allyl iodide (0.18 mL, 2.1 mmol) in dry THF (2.0 mL) afforded 253 (0.14 g, 88%) as a 
colorless foam:  IR (neat) 3055, 3013, 2929, 2857, 1625, 1472, 1438, 1428, 1204, 1112 cm-1; 1H 
NMR (C6D6) δ 8.07-7.97 (m, 4 H), 7.87-7.84 (m, 4 H), 7.57-7.54 (m, 2 H), 7.29-7.18 (m, 8 H), 
7.11-6.99 (m, 7 H), 6.15-6.02 (m, 1 H), 5.35 (d, J = 1.1 Hz, 1 H), 5.06 (s, 1 H), 4.79-4.74 (m, 2 
H), 3.97-3.75 (m, 4 H), 3.42-3.33 (m, 2 H), 2.56 (d, J = 15.7 Hz, 1 H), 2.29-2.18 (m, 1 H), 1.22 
(s, 9 H), 1.14-1.08 (m, 1 H), 1.02-0.87 (m, 3 H), 0.60-0.51 (m, 1 H), 0.42-0.34 (m, 2 H), 0.16-
0.07 (m, 2 H); 13C NMR (C6D6) δ 145.87, 142.75, 139.54, 136.02, 135.33, 135.00, 134.51, 
134.46, 133.68, 133.34, 133.22, 133.11, 132.99, 131.29, 129.91, 128.55, 126.61, 115.26, 114.38, 
64.34, 63.49, 47.43, 39.69, 37.25, 27.18, 19.99, 19.92, 19.48, 14.89, 14.58, 10.03, 7.58; MS 
(ESI) m/z (rel. intensity) 750 ([M+H]+, 100), 672 (58); HRMS (ESI) m/z calculated for 









phosphinoyl)-8-phenyl-5-azaspiro[2.6]non-7-ene (254).  According to the General Protocol J, 
253 (0.13 g, 0.17 mmol) and 1,3-bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene)dichloro-
(phenylmethylene)tricyclohexylphosphine)ruthenium (15 mg, 0.017 mmol) in CH2Cl2 (35 mL) 
afforded 254 (89 mg, 71%) as a colorless foam:  IR (neat) 3070, 2998, 2929, 2856, 1437, 1428, 
1206, 1108 cm-1; 1H NMR (C6D6) δ 8.02-7.93 (m, 5 H), 7.85-7.80 (m, 4 H), 7.28-7.22 (m, 8 H), 
7.18-7.12 (m, 2 H), 7.10-7.07 (m, 3 H), 7.03-7.00 (m, 3 H), 5.48 (dd, J = 6.6, 3.7 Hz, 1 H), 3.88-
3.71 (m, 3 H), 3.53 (ddd, J = 17.3, 10.2, 7.2 Hz, 1 H), 2.91 (app t, J = 8.8 Hz, 1 H), 2.74 (d, J = 
16.4 Hz, 1 H), 2.44 (d, J = 16.5 Hz, 1 H), 2.02-1.91 (m, 1 H), 1.34-1.25 (m, 1 H), 1.21 (s, 9 H), 
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1.01-0.82 (2 H), 0.75-0.71 (m, 1 H), 0.59-0.55 (m, 1 H), 0.32-0.23 (m, 4 H); 13C NMR (C6D6) 
δ 144.85, 144.17, 136.06, 135.34, 135.26, 134.56, 133.67, 133.62, 132.98, 132.85, 131.43, 
131.29, 129.87, 127.25, 127.20, 127.08, 126.21, 65.17, 64.48, 41.72, 41.66, 40.20, 37.61, 27.17, 
23.93, 23.85, 19.45, 19.33, 13.96, 13.21, 13.17, 12.27;  MS (ESI) m/z (rel. intensity) 744 
([M+Na]+, 100), 722 ([M+H]+, 27); HRMS (ESI) m/z calculated for C47H53NO2PSi (M+H) 






methyl)cyclopropyl)propanoate (255).  To a solution of 220 (90 mg, 0.14 mmol) in dry THF 
(2.0 mL) was added TBAF (0.21 mL, 0.21 mmol, 1.0 M in THF).  The reaction mixture was 
stirred for 1 h, diluted with water and 10% HCl and extracted with EtOAc (3x).  The combined 
organic layers were washed with brine, dried (Na2SO4) and concentrated.  The residue was 
dissolved in MeOH (2.0 mL) and treated with TMSCHN2 (0.14 mL, 0.27 mmol, 2.0 M in 
hexanes).  The mixture was stirred for 1 h, quenched with sat. NH4Cl and extracted with EtOAc 
(3x).  The combined organic layers were washed with brine, dried (Na2SO4) and concentrated.  
The residue was purified by chromatography on deactivated SiO2 (2:3, hexanes/EtOAc 
containing 1% v/v Et3N) to afford 255 (61 mg, 87%) as a colorless oil:  IR (neat) 3209, 3057, 
2997, 2949, 2925, 2861, 1736, 1437, 1187, 1123, 1109 cm-1; 1H NMR (C6D6) δ 8.11-7.98 (m, 4 
H), 7.41-7.37 (m, 2 H), 7.18-7.04 (m, 9 H), 5.26 (d, J = 1.5 Hz, 1 H), 5.04 (bs, 1 H), 3.41 (dd, J = 
9.6, 6.0 Hz, 1 H), 3.30 (s, 3 H), 3.01 (d, J = 14.8 Hz, 1 H), 2.59 (d, J = 14.8 Hz, 1 H), 2.41-2.28 
(m, 3 H), 1.64-1.52 (m, 1 H), 1.47-1.33 (m, 1 H), 0.93-0.83 (m, 1 H), 0.66-0.57 (m, 1 H), 0.47-
0.43 (m, 1 H), 0.39-0.25 (m, 4 H), 0.14 (dt, J = 8.3, 5.0 Hz, 1 H); 13C NMR (C6D6) δ 173.89, 
146.05, 142.51, 136.16, 135.63, 134.48, 133.93, 132.92, 132.79, 132.64, 132.52, 131.44, 131.40, 
131.35, 128.52, 128.47, 127.59, 126.66, 115.00, 61.30, 50.92, 37.97, 34.08, 29.53, 24.35, 24.27, 
24.09, 24.04, 17.59, 12.26, 10.43, 10.00; MS (EI) m/z (rel. intensity) 513 (M+, 32), 356 (29), 296 







cyclopropyl)methyl)cyclopropyl)propanoate (256).  To a suspension of NaH (23 mg, 0.58 
mmol) in dry THF (1.0 mL) was added a solution of 255 (60 mg, 0.12 mmol) in dry THF (0.50 
mL).  The reaction mixture was stirred for 20 min, treated with HMPA (0.36 mL, 2.1 mmol) and 
allyl iodide (0.38 mL, 4.1 mmol), heated at 70 °C for 1 h, cooled to r.t., quenched with sat. 
NH4Cl and extracted with EtOAc (3x).  The combined organic layers were washed with H2O and 
brine, dried (Na2SO4) and concentrated.  The residue was dissolved in MeOH (2.0 mL) and 
treated with TMSCHN2 (0.12 mL, 0.23 mmol, 2.0 M in hexanes) and the mixture was stirred for 
1 h, quenched with sat. NH4Cl and extracted with EtOAc (3x).  The combined organic layers 
were washed with brine, dried (Na2SO4) and concentrated.  The residue was purified by 
chromatography on deactivated SiO2 (3:2, hexanes/EtOAc containing 1% v/v Et3N) to afford 256 
(42 mg, 65%) as a colorless oil:  IR (neat) 3057, 2994, 2923, 1736, 1438, 1199, 1118 cm-1; 1H 
NMR (C6D6) δ 8.07-7.98 (m, 4 H), 7.54-7.51 (m, 2 H), 7.21-7.03 (m, 9 H), 6.14-6.01 (m, 1 H), 
5.35 (s, 1 H), 5.05 (d, J = 1.1 Hz, 1 H), 4.78-4.73 (m, 2 H), 3.98-3.73 (m, 2 H), 3.40 (s, 3 H), 
3.40-3.31 (m, 2 H), 2.49 (d, J = 15.7 Hz, 1 H), 2.37-2.31 (m, 2 H), 2.12-2.02 (m, 1 H), 1.15-0.91 
(m, 2 H), 0.87-0.84 (m, 2 H), 0.57-0.48 (m, 1 H), 0.38-0.35 (m, 2 H), 0.11--0.01 (m, 2 H); 13C 
NMR (C6D6) δ 173.54, 139.50, 135.35, 134.72, 133.70, 133.25, 133.14, 133.06, 133.02, 131.38, 
131.34, 131.31, 128.60, 126.56, 115.33, 114.35, 105.50, 63.28, 50.98, 47.33, 47.27, 39.70, 33.87, 
29.37, 20.28, 19.85, 19.78, 17.08, 14.80, 10.00, 7.57; MS (ESI) m/z (rel. intensity) 576 
([M+Na]+, 92), 554 ([M+H]+, 100), 258 (57); HRMS (ESI) m/z calculated for C35H41NO3P 









yl]cyclopropyl}propionic acid methyl ester (257).  According to the General Protocol J, 256 
(16 mg, 0.029 mmol) and 1,3-bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene)dichloro-
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(phenylmethylene)tricyclohexylphosphine)ruthenium (2.5 mg, 2.9 µmol) in CH2Cl2 (6.0 mL) 
afforded 9c (9.6 mg, 63%) as a colorless oil:  IR (neat) 3048, 2999, 2925, 1734, 1437, 1195, 
1120, 1107 cm-1; 1H NMR (C6D6) δ 8.08-7.92 (m, 4 H), 7.20-7.09 (m, 7 H), 7.04-7.01 (m, 3 H), 
5.49 (dd, J = 6.7, 3.9 Hz, 1 H), 3.92-3.79 (m, 1 H), 3.58 (ddd, J = 17.5, 10.3, 7.1 Hz, 1 H), 3.40 
(s, 1 H), 2.83 (app t, J = 8.8 Hz, 1 H), 2.71 (d, J = 16.6 Hz, 1 H), 2.47-2.26 (m, 3 H), 1.87-1.75 
(m, 1 H), 1.40-1.28 (m, 1 H), 1.02-0.95 (m, 1 H), 0.93-0.84 (m, 1 H), 0.69-0.62 (m, 1 H), 0.60-
0.52 (m, 1 H), 0.30-0.18 (m, 4 H); 13C NMR (C6D6) δ 173.61, 144.77, 144.24, 135.36, 135.01, 
133.67, 133.37, 133.12, 133.00, 132.87, 131.50, 131.46, 131.33, 131.30, 128.51, 127.23, 127.18, 
127.10, 126.21, 65.28, 50.93, 41.62, 41.56, 40.17, 33.98, 29.73, 23.92, 23.83, 19.67, 16.78, 
13.21, 13.12, 12.16; MS (EI) m/z (rel. intensity) 525 (M+, 16), 324 (38), 201 (100); HRMS (EI) 







methyl)-P,P-diphenylphosphinamide (258).  According to the General Protocol I, 217 (0.10 g, 
0.19 mmol), NaH (23 mg, 0.97 mmol), HMPA (0.17 mL, 0.97 mmol), and allyl iodide (0.18 mL, 
1.9 mmol) in dry THF (2.0 mL) afforded 258 (81 mg, 75%) as a colorless oil:  IR (neat) 3058, 
2991, 2955, 2924, 2854, 1493, 1437, 1202, 1118, 1102 cm-1; 1H NMR (C6D6) δ 7.99-7.92 (m, 4 
H), 7.28 (d, J = 8.6 Hz, 2 H), 7.15-7.12 (m, 2 H), 7.05-7.03 (m, 6 H), 6.10-5.97 (m, 1 H), 5.23 (s, 
1 H), 5.06 (s, 1 H), 4.80-4.75 (m, 2 H), 3.96-3.74 (m, 2 H), 3.49 (t, J = 9.8 Hz, 1 H), 3.29 (d, J = 
15.7 Hz, 1 H), 2.36 (d, J = 15.7 Hz, 1 H), 1.77-1.72 (m, 1 H), 1.36-1.34 (m, 4 H), 1.04-0.87 (m, 6 
H), 0.67-0.59 (m, 1 H), 0.56-0.47 (m, 1 H), 0.37-0.31 (m, 2 H), 0.22-0.17 (m, 1 H), 0.14-0.08 (m, 
1 H); 13C NMR (C6D6) δ 144.69, 141.20, 139.50, 133.38, 133.30, 133.03, 132.91, 131.40, 
131.36, 131.32, 128.67, 115.21, 114.76, 62.94, 62.91, 47.39, 47.33, 39.69, 33.71, 31.96, 23.02, 
19.97, 19.77, 19.71, 17.57, 15.18, 14.42, 10.03, 7.70; MS (EI) m/z (rel. intensity) 557 (M+, 7), 










azaspiro[2.6]non-7-ene (259).  According to the General Protocol J, 258 (80 mg, 0.14 mmol) 
and 1,3-bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene)dichloro(phenylmethylene)tricyclo-
hexylphosphine)ruthenium (12 mg, 0.014 mmol) in CH2Cl2 (29 mL) afforded 259 (55 mg, 72%) 
as a colorless foam:  IR (neat) 3058, 2955, 2924, 2854, 1490, 1437, 1204, 1120, 1107 cm-1; 1H 
NMR (C6D6) δ 8.00-7.88 (m, 4 H), 7.15-7.02 (m, 8 H), 6.83-6.78 (m, 2 H), 5.31 (dd, J = 6.5, 3.6 
Hz, 1 H), 3.89 (b app t, J = 14.7 Hz, 1 H), 3.62-3.50 (m, 1 H), 3.05 (t, J = 8.4 Hz, 1 H), 2.58 (d, J 
= 16.6 Hz, 1 H), 2.37 (d, J = 16.7 Hz, 1 H), 1.64-1.54 (m, 1 H), 1.40-1.30 (m, 5 H), 0.96-0.91 
(m, 4 H), 0.88-0.78 (m, 2 H), 0.67-0.63 (m, 1 H), 0.38-0.33 (m, 1 H), 0.31-0.22 (m, 3 H); 13C 
NMR (C6D6) δ 143.12, 142.86, 135.32, 135.27, 133.69, 133.59, 133.03, 132.90, 132.87, 132.74, 
131.47, 131.44, 131.35, 128.54, 127.50, 64.93, 41.82, 41.76, 40.26, 34.24, 32.01, 23.88, 23.81, 
23.09, 19.49, 17.15, 14.40, 13.54, 12.89, 12.27; MS (EI) m/z (rel. intensity) 529 (M+, 11), 328 







methyl)-P,P-diphenylphosphinamide (260).  According to the General Protocol I, 214 (0.10 g, 
0.19 mmol), NaH (23 mg, 0.19 mmol), HMPA (0.17 mL, 0.97 mmol), and allyl iodide (0.18 mL, 
2.0 mmol) in dry THF (3.0 mL) afforded 260 (75 mg, 69%) as a colorless foam:  IR (neat) 3058, 
2955, 2924, 2854, 1606, 1512, 1437, 1248, 1201, 1118 cm-1; 1H NMR (C6D6) δ 8.07-8.00 (m, 4 
H), 7.55-7.50 (m, 2 H), 7.09-7.03 (m, 6 H), 6.84-6.79 (m, 2 H), 6.20-6.08 (m, 1 H), 5.36 (d, J = 
1.4 Hz, 1 H), 5.04 (d, J = 1.0 Hz, 1 H), 4.83-4.77 (m, 2 H), 4.04-3.80 (m, 2 H), 3.48 (app. t, J = 
9.6 Hz, 1 H), 3.40 (d, J = 15.4 Hz, 1 H), 3.32 (s, 3 H), 2.60 (d, J = 15.4 Hz, 1 H), 1.85-1.77 (m, 1 
H), 1.43-1.29 (m, 4 H), 1.08-0.89 (m, 6 H), 0.71-0.52 (m, 2 H), 0.49-0.42 (m, 2 H), 0.23-0.18 (m, 
1 H), 0.15-0.09 (m, 1 H); 13C NMR (C6D6) δ 159.70, 145.16, 139.74, 139.70, 135.53, 135.06, 
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135.00, 133.89, 133.34, 133.23, 133.14, 133.02, 131.32, 131.28, 115.14, 114.06, 112.77, 63.73, 
54.77, 47.46, 47.40, 39.79, 33.71, 31.96, 23.02, 20.05, 19.98, 19.92, 17.64, 15.17, 14.42, 9.97, 
7.61; MS (EI) m/z (rel. intensity) 553 (M+, 1), 366 (26), 201 (100); HRMS (EI) m/z calculated for 








azaspiro[2.6]non-7-ene (261).  According to the General Protocol J, 260 (70 mg, 0.13 mmol) 
and 1,3-bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene)dichloro(phenylmethylene)tricyclo-
hexylphosphine)ruthenium (11 mg, 0.013 mmol) in CH2Cl2 (25 mL) afforded 261 (53 mg, 80%) 
as a colorless foam:  IR (neat) 3057, 2998, 2954, 2926, 2853, 1606, 1510, 1437, 1284, 1247, 
1204, 1181, 1120 cm-1; 1H NMR (C6D6) δ 8.07-7.92 (m, 4 H), 7.15-7.03 (m, 8 H), 6.82-6.77 (m, 
2 H), 5.51-5.47 (m, 1 H), 4.03-3.91 (m, 1 H), 3.63 (ddd, J = 17.1, 9.9, 7.1 Hz, 1 H), 3.35 (s, 3 H), 
3.01 (t, J = 8.8 Hz, 1 H), 2.84 (d, J = 16.4 Hz, 1 H), 2.46 (d, J = 16.4 Hz, 1 H), 1.62-1.53 (m, 1 
H), 1.44-1.30 (m, 4 H), 1.04-0.88 (m, 3 H), 0.94 (t, J = 6.5 Hz, 3 H), 0.82-0.79 (m, 1 H), 0.67-
0.63 (m, 1 H), 0.40-0.27 (m, 4 H); 13C NMR (C6D6) δ 159.34, 143.77, 135.55, 135.51, 133.88, 
133.10, 132.98, 132.85, 131.33, 131.27, 128.42, 128.10, 127.31, 125.64, 125.59, 113.97, 65.31, 
65.28, 54.84, 41.81, 41.75, 40.26, 34.27, 32.05, 23.93, 23.86, 23.11, 19.68, 17.25, 14.43, 13.61, 
13.37, 12.28; MS (EI) m/z (rel. intensity) 525 (M+, 17), 324 (51), 201 (100); HRMS (EI) m/z 







methyl)-P,P-diphenylphosphinamide (262).  According to the General Protocol I, 214 (0.14 g, 
0.26 mmol), NaH (52 mg, 1.3 mmol), HMPA (0.23 mL, 1.3 mmol), and allyl iodide (0.24 mL, 
2.6 mmol) in dry THF (3.0 mL) afforded 262 (0.14 g, 96%) as a colorless foam:  IR (neat) 3058, 
2954, 2923, 2854, 1597, 1576, 1437, 1202, 1118 cm-1; 1H NMR (C6D6) δ 8.07-7.99 (m, 5 H), 
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7.37-7.36 (m, 1 H), 7.22-7.12 (m, 1 H), 7.08-7.06 (m, 6 H), 6.80-6.77 (m, 1 H), 6.19-6.06 (m, 1 
H), 5.43 (d, J = 1.2 Hz, 1 H), 5.11 (d, J = 0.9 Hz, 1 H), 4.83-4.77 (m, 2 H), 4.03-3.80 (m, 2 H), 
3.51-3.45 (m, 1 H), 3.48 (s, 3 H), 3.40 (d, J = 15.6 Hz, 1 H), 2.61 (d, J = 15.5 Hz, 1 H), 1.83-1.75 
(m, 1 H), 1.38-1.31 (m, 4 H), 1.06-0.89 (m, 3 H), 0.96 (t, J = 6.9 Hz, 3 H), 0.71-0.52 (m, 2 H), 
0.49-0.39 (m, 2 H), 0.22-0.10 (m, 2 H); 13C NMR (C6D6) δ 160.39, 146.05, 144.48, 139.68, 
139.64, 135.58, 135.07, 133.94, 133.40, 133.20, 133.14, 133.08, 133.02, 131.36, 131.32, 131.26, 
131.23, 129.53, 119.13, 115.12, 114.61, 113.41, 112.56, 63.66, 63.63, 54.96, 47.50, 47.44, 39.72, 
33.73, 31.92, 23.00, 20.11, 20.05, 17.65, 15.15, 14.37, 10.04, 7.62; MS (EI) m/z (rel. intensity) 









azaspiro[2.6]non-7-ene (263).  According to the General Protocol J, 262 (80 mg, 0.14 mmol) 
and 1,3-bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene)dichloro(phenylmethylene)tricyclo-
hexylphosphine)ruthenium (12 mg, 0.014 mmol) in CH2Cl2 (29 mL) afforded 263 (57 mg, 75%) 
as a colorless foam:  IR (neat) 3059, 2998, 2955, 2924, 2853, 1597, 1437, 1203, 1121, 1107 cm-
1; 1H NMR (C6D6) δ 8.04-7.94 (m, 4 H), 7.15-7.03 (m, 7 H), 6.87-6.85 (m, 1 H), 6.81-6.79 (m, 1 
H), 6.71-6.68 (m, 1 H), 5.53 (dd, J = 6.3, 3.8 Hz, 1 H), 3.99-3.87 (m, 1 H), 3.59 (ddd, J = 17.1, 
10.0, 7.1 Hz, 1 H), 3.38 (s, 3 H), 3.00 (t, J = 8.7 Hz, 1 H), 2.81 (d, J = 16.4 Hz, 1 H), 2.48 (d, J = 
16.5 Hz, 1 H), 1.61-1.52 (m, 1 H), 1.43-1.30 (m, 4 H), 1.01-0.81 (m, 3 H), 0.93 (t, J = 6.6 Hz, 3 
H), 0.80-0.73 (m, 1 H), 0.65-0.62 (m, 1 H), 0.38-0.25 (m, 4 H); 13C NMR (C6D6) δ 160.32, 
146.57, 144.39, 135.62, 135.55, 133.92, 133.12, 133.00, 132.88, 131.35, 131.30, 129.48, 128.45, 
128.14, 127.23, 127.19, 118.78, 112.71, 112.35, 65.34, 54.89, 41.94, 41.87, 40.46, 34.27, 34.10, 
32.03, 24.06, 23.98, 23.10, 22.98, 19.74, 17.30, 14.37, 13.65, 13.34, 12.37; MS (EI) m/z (rel. 
intensity) 525 (M+, 10), 324 (40), 201 (100); HRMS (EI) m/z calculated for C34H40NO2P 








methyl)-P,P-diphenylphosphinamide (264).  According to the General Protocol I, 216 (57 mg, 
0.11 mmol), NaH (22 mg, 0.56 mmol), HMPA (97 µL, 0.56 mmol), and allyl iodide (0.10 mL, 
1.1 mmol) in dry THF (2.0 mL) afforded 264 (54 mg, 89%) as a colorless foam:  IR (neat) 3046, 
2950, 2923, 1489, 1436, 1204, 1117 cm-1; 1H NMR (C6D6) δ 8.07-7.99 (m, 4 H), 7.42 (dd, J = 
7.4, 1.7 Hz, 1 H), 7.11-7.05 (m, 7 H), 6.86 (td, J = 7.4, 0.7 Hz, 1 H), 6.55 (d, J = 8.1 Hz, 1 H), 
6.02-5.89 (m, 1 H), 5.24 (s, 1 H), 5.22 (s, 1 H), 4.81-4.72 (m, 2 H), 4.04-3.79 (m, 2 H), 3.61 (dd, 
J = 10.1, 9.1 Hz, 1 H), 3.39 (d, J = 15.6 Hz, 1 H), 3.34 (s, 3 H), 2.66 (d, J = 15.3 Hz, 1 H), 1.79-
1.73 (m, 1 H), 1.36-1.31 (m, 4 H), 1.19-1.05 (m, 1 H), 0.95-0.91 (m, 5 H), 0.58-0.40 (m, 4 H), 
0.24-0.18 (m, 1 H), 0.10-0.04 (m, 1 H); 13C NMR (C6D6) δ 157.09, 146.30, 139.84, 136.56, 
135.55, 134.93, 133.90, 133.69, 133.23, 133.10, 133.06, 132.93, 131.25, 131.10, 130.77, 120.97, 
117.42, 114.84, 111.05, 63.03, 55.04, 47.62, 41.74, 33.70, 31.94, 23.03, 20.79, 20.72, 20.23, 
17.82, 15.14, 14.39, 10.63, 8.12; MS (EI) m/z (rel. intensity) 553 (M+, 1), 366 (55), 296 (30), 257 








azaspiro[2.6]non-7-ene (265).  According to the General Protocol J, 264 (50 g, 0.090 mmol) 
and 1,3-bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene)dichloro(phenylmethylene)tricyclo-
hexylphosphine)ruthenium (8.0 mg, 9.0 µmol) in CH2Cl2 (18 mL) afforded 265 (40 mg, 84%) as 
a colorless foam:  IR (neat) 3058, 2997, 2954, 2925, 2853, 1488, 1437, 1249, 1204, 1119 cm-1; 
1H NMR (C6D6) δ 8.08-8.05 (m, 4 H), 7.15-7.06 (m, 8 H), 6.92-6.88 (m, 1 H), 6.50 (d, J = 8.3 
Hz, 1 H), 5.42 (dd, J = 5.7, 3.5 Hz, 1 H), 4.05-3.96 (m, 1 H), 3.65-3.53 (m, 1 H), 3.29 (s, 3 H), 
3.15-2.99 (m, 1 H), 3.09 (d, J = 16.7 Hz, 1 H), 2.45 (d, J = 16.6 Hz, 1 H), 1.57-1.46 (m, 1 H), 
1.50-1.25 (m, 6 H), 1.06-0.83 (m, 4 H), 0.93 (t, J = 6.7 Hz, 1 H), 0.68-0.63 (m, 1 H), 0.50-0.42 
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(m, 2 H), 0.41-0.35 (m, 1 H), 0.33-0.29 (m, 1 H); 13C NMR (C6D6) δ 156.71, 144.62, 135.78, 
135.67, 135.49, 134.14, 134.00, 133.10, 132.97, 131.28, 131.24, 131.19, 129.57, 120.84, 110.79, 
65.59, 65.56, 54.72, 41.77, 41.70, 40.87, 34.25, 32.07, 24.32, 24.25, 23.11, 19.56, 17.23, 14.42, 
13.60, 13.05, 11.83; MS (EI) m/z (rel. intensity) 525 (M+, 12), 523 (22), 324 (36), 201 (100); 







diphenylphosphinamide (266).  To a solution of 202 (0.15 g, 0.31 mmol) in THF (2.0 mL) and 
water (1.0 mL) was added NaIO4 (0.33 g, 1.6 mmol) and OsO4 (8.0 mg, 0.031 mmol).  The 
reaction mixture was stirred for 3 h, diluted with water and extracted with EtOAc (3x).  The 
combined organic layers were washed with brine, dried (Na2SO4) and concentrated.  The residue 
was purified by chromatography on deactivated SiO2 (3:2 then 2:3, hexanes/EtOAc containing 
1% v/v Et3N) to afford 266 (0.12 g, 77%) as a colorless foam:  IR (neat) 3220, 3064, 2999, 2953, 
2923, 2848, 1677, 1435, 1184, 1124 cm-1; 1H NMR (C6D6) δ 8.18-8.08 (m, 4 H), 7.88-7.86 (m, 2 
H), 7.12-7.03 (m, 9 H), 4.64 (t, J = 8.7 Hz, 1 H), 3.86 (d, J = 17.6 Hz, 1 H), 2.49 (app q, J = 9.0 
Hz, 1 H), 2.31 (d, J = 17.6 Hz, 1 H), 1.39-1.27 (m, 5 H), 1.18-1.09 (m, 1 H), 0.90-0.86 (m, 3 H), 
0.78-0.71 (m, 1 H), 0.61-0.47 (m, 3 H), 0.42-0.35 (m, 2 H), 0.26-0.19 (m, 1 H), 0.16-0.12 (m, 1 
H); 13C NMR (C6D6) δ 200.57, 137.82, 136.50, 136.32, 134.84, 134.62, 132.96, 132.81, 132.69, 
132.38, 132.25, 131.31, 131.27, 131.19, 131.15, 128.62, 128.56, 128.21, 61.42, 44.37, 33.89, 
32.05, 23.64, 23.57, 23.01, 22.69, 22.63, 18.19, 14.39, 13.24, 11.52, 11.05; MS (EI) m/z (rel. 
intensity) 485 (M+, 10), 326 (42), 268 (34), 218 (64), 201 (100); HRMS (EI) m/z calculated for 








methyl}-P,P-diphenylphosphinamide (267).  To a solution of 215 (0.18 g, 0.35 mmol) in THF 
(3.0 mL) and water (1.5 mL) was added NaIO4 (0.38 g, 1.8 mmol) and OsO4 (10 mg, 0.035 
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mmol).  The reaction mixture was stirred for 3 h, diluted with water and extracted with EtOAc 
(3x).  The combined organic layers were washed with brine, dried (Na2SO4) and concentrated.  
The residue was purified by chromatography on deactivated SiO2 (1:1, hexanes/EtOAc 
containing 1% v/v Et3N) to afford 267 (0.10 g, 56%) as a colorless oil:  IR (neat) 3228, 3059, 
2998, 2955, 2924, 2854, 1676, 1596, 1582, 1464, 1437, 1258, 1191, 1123 cm-1; 1H NMR (C6D6) 
δ 8.18-8.08 (m, 4 H), 7.66 (bs, 1 H), 7.50-7.47 (m, 1 H), 7.10-7.00 (m, 7 H), 6.90-6.86 (m, 1 H), 
4.55 (t, J = 8.4 Hz, 1 H), 3.89 (d, J = 17.4 Hz, 1 H), 3.27 (s, 3 H), 2.49 (app q, J = 9.4 Hz, 1 H), 
2.36 (d, J = 17.5 Hz, 1 H), 1.46-1.28 (m, 6 H), 1.16-1.10 (m, 1 H), 0.88 (t, J = 6.8 Hz, 3 H), 0.78-
0.76 (m, 1 H), 0.61-0.50 (m, 2 H), 0.45-0.35 (m, 2 H), 0.26-0.13 (m, 2 H); 13C NMR (C6D6) 
δ 200.10, 159.98, 139.00, 136.15, 135.99, 134.49, 134.29, 132.42, 132.30, 132.03, 131.91, 
130.91, 130.81, 129.35, 120.90, 119.36, 112.50, 61.15, 54.57, 44.03, 33.53, 31.68, 23.31, 22.63, 
22.48, 17.83, 13.99, 12.74, 11.20, 10.79; MS (EI) m/z (rel. intensity) 515 (M+, 0.4), 449 (10), 223 










268a 268b  
1-[(4S*,6S*)-4-((1S*,2S*)-2-Butylcyclopropyl)-6-phenyl-5-azaspiro[2.4]hept-5-yl]ethanone 
(268a) and 1-[(4S*,6R*)-4-((1S*,2S*)-2-butylcyclopropyl)-6-phenyl-5-azaspiro[2.4]hept-5-
yl]ethanone (268b).  A solution of 266 (0.14 g, 0.29 mmol) in MeOH (2.0 mL) was treated at 0 
°C with a solution of HCl (2.0 mL, 2.0 M in MeOH).  The reaction mixture was stirred for 1 h 
and concentrated.  The residue was dissolved in MeOH (2.0 mL), treated with NaBH3CN (91 
mg, 1.44 mmol), stirred for 4 h and concentrated.  The residue was suspended in dry CH2Cl2 (4.0 
mL), cooled to 0 °C, and treated with DIPEA (0.50 mL, 2.9 mmol) and AcCl (0.20 mL, 2.9 
mmol).  The reaction mixture was stirred for 4 h, quenched with sat. NH4Cl and extracted with 
EtOAc (3x).  The combined organic layers were washed with water, 10% HCl and brine, dried 
(Na2SO4) and concentrated.  The residue was purified by chromatography on deactivated SiO2 
(9:1 then 4:1 then 3:2, hexanes/EtOAc containing 1% v/v Et3N) to afford the desired pyrrolidines 
268a (43 mg, 48%) and 268b (20 mg, 22%) as a mixture of colorless oils. 
268a (major isomer):  IR (neat) 3062, 2994, 2956, 2925, 2871, 1650, 1398, 1346 cm-1; 1H NMR 
(5.7:1 mixture of amide bond rotamers) major rotamer δ 7.38-7.27 (m, 5 H), 4.94 (t, J = 8.4 Hz, 
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1 H), 3.29 (d, J = 9.6 Hz, 1 H), 2.41 (dd, J = 11.8, 8.4 Hz, 1 H), 1.92 (dd, J = 12.8, 7.6 Hz, 1 H), 
1.78 (s, 3 H), 1.42-1.15 (m, 7 H), 0.93-0.79 (m, 5 H), 0.90 (t, J = 7.1 Hz, 3 H), 0.56-0.39 (m, 4 
H), 0.34-0.28 (m, 1 H); minor rotamer (representative signals) δ 5.24 (bt, 1 H), 2.86 (bd, 1 H); 
13C NMR δ 171.05, 144.08, 128.85, 127.12, 125.53, 68.50, 63.18, 44.99, 33.83, 31.68, 25.71, 
23.07, 22.87, 22.61, 16.06, 14.16, 13.99, 10.99, 5.27; MS (EI) m/z (rel. intensity) 311 (M+, 100), 
255 (49), 214 (70), 172 (57); HRMS (EI) m/z calculated for C21H29NO 311.2249, found 
311.2244. 
268b (minor isomer):  IR (neat) 3061, 2994, 2957, 2923, 2855, 1650, 1397 cm-1; 1H NMR (6.9:1 
mixture of amide bond rotamers) major rotamer δ 7.34-7.21 (m, 5 H), 5.02 (d, J = 8.6 Hz, 1 H), 
3.54 (d, J = 8.2 Hz, 1 H), 3.06 (dd, J = 12.5, 8.8 Hz, 1 H), 1.74 (s, 3 H), 1.35-1.22 (m, 5 H), 1.24-
1.18 (m, 1 H), 1.13-1.09 (m, 1 H), 0.90 (t, J = 6.9 Hz, 3 H), 0.86-0.79 (m, 1 H), 0.73-0.68 (m, 1 
H), 0.66-0.59 (m, 1 H), 0.44-0.35 (m, 2 H), 0.26-0.17 (m, 2 H); minor rotamer (representative 
signals) δ 5.18 (d, J = 9.2 Hz, 1 H)), 3.27 (d, J = 6.0 Hz, 1 H), 2.90 (dd, J = 12.8, 9.4 Hz, 1 H), 
2.16 (s, 3 H); 13C NMR major rotamer δ 170.78, 144.57, 128.51, 126.93, 125.59, 67.48, 62.90, 
42.57, 34.01, 31.67, 23.99, 23.53, 23.45, 22.60, 16.75, 16.17, 14.17, 9.78, 3.39; MS (EI) m/z (rel. 











yl]ethanone (269a) and 1-[(4S*,6R*)-4-((1S*,2S*)-2-butylcyclopropyl)-6-(3-methoxy-
phenyl)-5-azaspiro[2.4]hept-5-yl]ethanone (269b).  A solution of 267 (60 mg, 0.12 mmol) in 
MeOH (1.5 mL) was treated at 0 °C with a solution of HCl (1.5 mL, 2.0 M in MeOH).  The 
reaction mixture was stirred for 1 h and concentrated.  The residue was dissolved in MeOH (1.0 
mL), treated with NaBH3CN (37 mg, 0.58 mmol), stirred for 4 h and concentrated.  The residue 
was suspended in dry CH2Cl2 (2.0 mL), cooled to 0 °C, and treated with DIPEA (0.20 mL, 1.2 
mmol) and AcCl (82 µL, 1.2 mmol).  The reaction mixture was stirred for 4 h, quenched with 
sat. NH4Cl and extracted with EtOAc (3x).  The combined organic layers were washed with 
water, 10% HCl and brine, dried (Na2SO4) and concentrated.  The residue was purified by 
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chromatography on deactivated SiO2 (9:1 then 4:1 then 3:2, hexanes/EtOAc containing 1% v/v 
Et3N) to afford a mixture of 269a and 269b (27 mg, 68%) as a colorless oil.  The diastereomers 
were separated by chromatography on SiO2 (4:1, hexanes/EtOAc) to afford 269a (16 mg) and 
269b (9.0 mg). 
269a (major isomer):  IR (neat) 2995, 2956, 2925, 1648, 1601, 1397, 1262 cm-1; 1H NMR (5.9:1 
mixture of amide bond rotamers) major rotamer δ 7.28 (t, J = 7.8 Hz, 1 H), 6.97 (d, J = 7.6 Hz, 1 
H), 6.93 (s, 1 H), 6.81 (dd, J = 8.2, 2.2 Hz, 1 H), 4.91 (t, J = 8.3 Hz, 1 H), 3.81 (s, 3 H), 3.27 (d, 
J = 9.6 Hz, 1 H), 2.41 (dd, J = 12.8, 9.3 Hz, 1 H), 1.90 (dd, J = 12.8, 7.5 Hz, 1 H), 1.81 (s, 3 H), 
1.52-1.22 (m, 6 H), 1.12-1.10 (m, 1 H), 0.92-0.79 (m, 2 H), 0.90 (t, J = 7.1 Hz, 3 H), 0.56-0.39 
(m, 4 H), 0.34-0.30 (m, 1 H);  minor rotamer (representative signals) δ 5.20 (bt, 1 H), 2.86 (bd, 1 
H); 13C NMR δ 171.15, 160.15, 145.85, 121.95, 117.84, 112.22, 111.42, 68.52, 63.20, 55.18, 
44.96, 33.88, 31.62, 25.67, 23.07, 22.84, 22.64, 16.19, 14.07, 13.96, 10.86, 5.33; MS (EI) m/z 
(rel. intensity) 341 (M+, 70), 244 (48), 202 (100); HRMS (EI) m/z calculated for C22H31NO2 
341.2355, found 341.2355. 
269b (minor isomer):  IR (neat) 2995, 2956, 2923, 2854, 1651, 1601, 1397, 1261 cm-1; 1H NMR 
(8.1:1 mixture of amide bond rotamers) major rotamer δ 7.25-7.19 (m, 1 H), 6.85-6.76 (m, 3 H), 
4.98 (d, J = 8.8 Hz, 1 H), 3.79 (s, 3 H), 3.53 (d, J = 8.3 Hz, 1 H), 3.06 (dd, J = 12.5, 9.1 Hz, 1 H), 
1.76 (s, 3 H), 1.33-1.23 (m, 6 H), 1.27-1.19 (m, 1 H), 1.13-1.07 (m, 1 H), 0.89 (t, J = 6.8 Hz, 3 
H), 0.85-0.80 (m, 1 H), 0.74-0.61 (m, 2 H), 0.45-0.35 (m, 1 H), 0.30-0.20 (m, 2 H); minor 
rotamer (representative signals) δ 5.15 (d, J = 9.5 Hz, 1 H)), 3.26 (d, J = 5.7 Hz, 1 H), 2.89 (dd, J 
= 13.3, 9.6 Hz, 1 H), 2.16 (s, 3 H); 13C NMR δ 170.80, 1159.82, 146.38, 129.60, 118.07, 112.28, 
111.38, 67.54, 62.87, 55.20, 42.56, 34.03, 31.69, 24.14, 23.49, 22.62, 16.78, 16.32, 14.18, 9.82, 
3.54; MS (EI) m/z (rel. intensity) 341 (M+, 38), 244 (58), 202 (100); HRMS (EI) m/z calculated 









270a 270b  
N-(S*)-{[(1S*,2S*)-2-Butylcyclopropyl](1-{[(S*)-2-phenyloxiran-2-yl]methyl}cyclopropyl)-
methyl}-P,P-diphenylphosphinamide (270a) and N-(S*)-{[(1S*,2S*)-2-butylcyclopropyl](1-
{[(R*)-2-phenyloxiran-2-yl]methyl}cyclopropyl)methyl}-P,P-diphenylphosphinamide 
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(270b).  To a solution of 202 (0.15 g, 0.30 mmol) in dry CH2Cl2 (3.0 mL) was added m-CPBA 
(0.34 g, 1.2 mmol, ~60 wt%) in two portions (over 2 h).  The reaction mixture was stirred for 4 h 
at r.t., filtered through basic alumina and concentrated.  The residue was purified by 
chromatography on deactivated SiO2 (1:1 hexanes/EtOAc containing 1% v/v Et3N) to afford a 
1:1 mixture of 270a and 270b (0.12 g, 77%) as a colorless oil.  The diastereomers were separated 
by chromatography on deactivated SiO2 (2:3 then 1:1, hexanes/EtOAc containing 1% v/v Et3N) 
to afford diastereomerically pure epoxides 270a and 270b. 
270a:  IR (neat) 3225, 3058, 2995, 2955, 2923, 2854, 1437, 1188, 1123 cm-1; 1H NMR (C6D6) 
δ 8.18-8.11 (m, 2 H), 8.04-7.97 (m, 2 H), 7.26-7.23 (m, 2 H), 7.13-7.04 (m, 9 H), 4.25 (t, J = 
10.5 Hz, 1 H), 2.60 (d, J = 5.7 Hz, 1 H), 2.33 (d, J = 15.6 Hz, 1 H), 2.28-2.21 (m, 1 H), 2.22 (d, J 
= 5.7 Hz, 1 H), 1.81 (d, J = 15.4 Hz, 1 H), 1.49-1.29 (m, 5 H), 1.01-0.89 (m, 1 H), 0.93 (t, J = 6.9 
Hz, 3 H), 0.87-0.73 (m, 2 H), 0.61-0.51 (m, 2 H), 0.29 (dt, J = 9.2, 5.5 Hz, 1 H), 0.24-0.17 (m, 2 
H), 0.10-0.07 (m, 1 H); 13C NMR (C6D6) δ 140.96, 136.82, 136.38, 135.14, 134.70, 132.86, 
132.74, 132.56, 132.43, 131.21, 128.23, 127.40, 126.35, 61.76, 60.17, 57.69, 39.68, 34.32, 32.22, 
23.91, 23.85, 23.77, 23.11, 18.11, 14.43, 13.76, 11.45, 11.33; MS (EI) m/z (rel. intensity) 499 
(M+, 8), 481 (27), 326 (46), 218 (43), 201 (100); HRMS (EI) m/z calculated for C32H38NO2P 
499.2640, found 499.2628. 
270b:  IR (neat) 3226, 3058, 2995, 2955, 2923, 2854, 1438, 1188, 1123 cm-1; 1H NMR (C6D6) 
δ 8.19-8.11 (m, 4 H), 7.29-7.26 (m, 2 H), 7.14-7.01 (m, 9 H), 4.56 (dd, J = 10.2, 7.9 Hz, 1 H), 
3.26 (d, J = 5.2 Hz, 1 H), 2.98 (d, J = 15.9 Hz, 1 H), 2.28 (d, J = 5.2 Hz, 1 H), 2.09 (app q, J = 
10.1 Hz, 1 H), 1.60 (d, J = 15.9 Hz, 1 H), 1.41-1.26 (m, 6 H), 1.16-1.10 (m, 1 H), 0.91 (t, J = 6.8 
Hz, 3 H), 0.73-0.66 (m, 1 H), 0.65-0.57 (m, 1 H), 0.55-0.48 (m, 1 H), 0.31-0.19 (m, 3 H), 0.05 
(dt, J = 8.3, 4.9 Hz, 1 H); 13C NMR (C6D6) δ 141.70, 136.62, 135.99, 134.94, 134.29, 135.06, 
132.94, 132.35, 132.23, 131.39, 131.35, 131.28, 131.25, 128.62, 128.45, 128.40, 127.51, 126.28, 
61.80, 60.67, 54.10, 39.57, 34.13, 32.24, 24.05, 23.95, 23.40, 23.36, 23.07, 18.15, 14.44, 14.41, 
12.04, 11.14; MS (EI) m/z (rel. intensity) 499 (M+, 4), 481 (53), 326 (28), 218 (33), 201 (100); 











[2.5]octan-7-ol (271). To a suspension of NaH (14 mg, 0.35 mmol) in dry THF (1.0 mL) was 
added a solution of 270a (35 mg, 0.070 mmol) in dry THF (0.40 mL) and HMPA (61 µL, 0.35 
mmol).  The reaction mixture was heated at 70 °C for 30 min, cooled to 0 °C, quenched with sat. 
NH4Cl solution and extracted with EtOAc (3x).  The combined organic layers were washed with 
H2O and brine, dried (Na2SO4) and concentrated.  The residue was purified by chromatography 
on deactivated SiO2 (7:3, hexanes/EtOAc containing 1% v/v Et3N) to afford 271 (25 mg, 71%) 
as a colorless oil:  IR (neat) 3331, 3059, 3003, 2954, 2923, 2852, 1439, 1179, 1120, 1105 cm-1; 
1H NMR δ 8.01-7.94 (m, 2 H), 7.91-7.84 (m, 2 H), 7.60-7.56 (m, 2 H), 7.49-7.40 (m, 6 H), 7.35-
7.32 (m, 2 H), 7.25-7.19 (m, 1 H), 6.21 (s, 1 H), 3.66 (dd, J = 22.1, 14.5 Hz, 1 H), 3.28-3.20 (m, 
1 H), 2.86 (d, J = 14.0 Hz, 1 H), 1.67-1.39 (m, 6 H), 1.32-1.23 (m, 2 H), 1.11 (d, J = 14.0 Hz, 1 
H), 1.01 (t, J = 7.0 Hz, 3 H), 0.86 (dt, J = 8.8, 5.6 Hz, 1 H), 0.61-0.52 (m, 2 H), 0.49-0.43 (m, 1 
H), 0.35-0.28 (m, 1 H), 0.27-0.22 (m, 1 H), 0.20-0.14 (m, 1 H); 13C NMR δ 145.42, 133.00, 
132.88, 132.74, 132.62, 132.18, 132.06, 132.02, 131.94, 131.91, 131.02, 130.39, 129.32, 128.82, 
128.65, 128.51, 128.34, 128.01, 126.78, 125.28, 71.18, 64.53, 52.99, 42.63, 34.20, 32.53, 22.77, 
19.49, 19.37, 19.07, 16.98, 14.22, 13.89, 13.12, 8.93; MS (EI) m/z (rel. intensity) 499 (M+, 15), 










[2.4]hept-6-yl]methanol (272).  To a suspension of NaH (18 mg, 0.45 mmol) in dry THF (1.3 
mL) was added a solution of 270b (45 mg, 0.090 mmol) in dry THF (0.50 mL) and HMPA (78 
µL, 0.45 mmol).  The reaction mixture was heated at 70 °C for 30 min, cooled to 0 °C, quenched 
with sat. NH4Cl solution and extracted with EtOAc (3x).  The combined organic layers were 
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washed with H2O and brine, dried (Na2SO4) and concentrated.  The residue was purified by 
chromatography on deactivated SiO2 (1:1, hexanes/EtOAc containing 1% v/v Et3N) to afford 
270b (34 mg, 75%) as a colorless oil:  IR (neat) 3289, 3058, 3000, 2954, 2925, 2855, 1438, 
1184, 1119, 1105 cm-1; 1H NMR δ 7.83-7.74 (m, 4 H), 7.50-7.35 (m, 9 H), 7.26-7.19 (m, 2 H), 
3.50 (d, J = 7.3 Hz, 2 H), 3.02 (b, 1 H), 2.36 (dd, J = 9.3, 8.1 Hz, 1 H), 2.13-1.96 (m, 2 H), 1.45-
1.34 (m, 1 H), 1.26-1.12 (m, 4 H), 0.96-0.90 (m, 1 H), 0.85 (t, J = 6.7 Hz, 3 H), 0.80-0.74 (m, 1 
H), 0.62-0.55 (m, 2 H), 0.53-0.45 (m, 2 H), 0.28 (app t, J = 6.4 Hz, 2 H), 0.14-0.07 (m, 1 H); 13C 
NMR δ 145.30, 134.27, 133.89, 132.82, 132.70, 132.58, 132.46, 132.20, 131.51, 131.48, 131.40, 
131.37, 128.32, 128.24, 128.15, 128.07, 128.03, 127.20, 125.70, 72.24, 72.16, 67.01, 55.23, 
45.73, 32.83, 31.30, 22.50, 20.60, 20.52, 18.73, 18.13, 14.07, 13.30, 11.96, 9.64; MS (EI) m/z 
(rel. intensity) 499 (M+, 13), 481 (19), 230 (31), 201 (100); HRMS (EI) m/z calculated for 




(E)-N-(1-Phenylhept-2-enyl)-P,P-diphenylphosphinamide (110).133  General Protocol K.  To 
a suspension of Cp2ZrHCl (0.13 g, 0.49 mmol) in dry toluene (2.0 mL) was added 108 (60 µL, 
0.52 mmol).  The reaction mixture was heated in the microwave reactor (60 °C, 150 W) for 5 
min, cooled to –78 °C, treated with Me2Zn (0.16 mL, 0.33 mmol, 2.0 M in toluene), and warmed 
to 0 °C.  After addition of 21 (0.10 g, 0.33 mmol), the mixture was heated in the microwave 
reactor (100 °C, 150 W) for 5 min, cooled to 0 °C, quenched with MeOH (0.25-0.50 mL), diluted 
with EtOAc, filtered through SiO2 and concentrated.  The residue was purified by 
chromatography on deactivated SiO2 (3:7, hexanes/EtOAc containing 1% v/v Et3N) to afford 110 
(93 mg, 73%) as a colorless solid: 1H NMR δ 7.97-7.90 (m, 2 H), 7.87-7.80 (m, 2 H), 7.53-7.21 
(m, 11 H), 5.66 (ddt, J = 15.3, 6.2, 1.3 Hz, 1 H), 5.51 (dtd, J = 15.3, 6.4, 0.9 Hz, 1 H), 4.81 (td, J 
= 9.4, 6.4 Hz, 1 H), 3.25 (dd, J = 9.2, 6.1 Hz, 1 H), 1.99 (q, J = 6.2 Hz, 2 H), 1.31-1.26 (m, 4 H), 









(277).163  According to the General Protocol K, Cp2ZrHCl (0.13 g, 0.49 mmol), 125 (0.16 g, 0.52 
mmol), Me2Zn (0.16 mL, 0.33 mmol, 2.0 M in toluene) and 21 (0.10 g, 0.33 mmol) afforded 277 
(0.12 g, 62%) as a colorless foam: 1H NMR δ 7.94-7.79 (m, 4 H), 7.63 (d, J = 6.4 Hz, 4 H), 7.45-
7.23 (m, 17 H), 5.74 (dd, J = 15.4, 6.0 Hz, 1 H), 5.52 (dt, J = 15.5, 6.5 Hz, 1 H), 4.85-4.76 (m, 1 





(280). General Protocol L. To a suspension of Cp2ZrHCl (0.14 g, 0.55 mmol) in dry toluene 
(1.5 mL) was added a freshly prepared solution of 279 (0.25 mL, 0.28 mmol, 1.1 M in toluene).  
The reaction mixture was heated in the microwave reactor (60 °C, 150 W) for 30 min, treated 
with 279 (0.25 mL, 0.28 mmol, 1.1 M in toluene), heated in the microwave reactor (60 °C) for 
15 min, cooled to –78 °C, treated with Me2Zn (0.14 mL, 0.28 mmol, 2.0 M in toluene), and 
warmed to 0 °C.  After addition of 119 (0.10 g, 0.28 mmol), the solution was heated in the 
microwave reactor (100 °C, 150 W) for 5 min, cooled to 0 °C, quenched with MeOH (0.25-0.50 
mL), diluted with EtOAc, filtered through SiO2 and concentrated. The residue was purified by 
chromatography on deactivated SiO2 (3:7, hexanes/EtOAc containing 1% v/v Et3N) to afford 280 
(81 mg, 60%) as a colorless foam: mp 147.0-148.6 °C (hexanes/EtOAc); IR (KBr) 3165, 3057, 
2926, 2849, 1721, 1609, 1438, 1273, 1199, 1183, 1108 cm-1; 1H NMR δ 7.96-7.87 (m, 4 H), 
7.85-7.77 (m, 2 H), 7.50-7.31 (m, 8 H), 5.24 (d, J = 9.1 Hz, 1 H), 4.71 (t, J = 10.7 Hz, 1 H), 3.88 
(s, 3 H), 3.43 (dd, J = 10.5, 6.8 Hz, 1 H), 2.27-2.14 (m, 1 H), 1.73-1.62 (m, 5 H), 1.51 (d, J = 1.0 
Hz, 3 H), 1.35-1.19 (m, 3 H), 1.15-0.98 (m, 2 H); 13C NMR δ 166.83, 147.46, 147.40, 134.47, 
133.38, 132.98, 132.61, 132.55, 132.47, 132.34, 131.94, 131.82, 131.68, 131.25, 129.61, 128.76, 
128.42, 128.38, 128.26, 128.21, 127.02, 61.23, 51.95, 36.75, 32.83, 32.74, 25.91, 25.81, 13.30; 
MS (EI) m/z (intensity) 487 (M+, 27), 404 (50), 364 (22), 286 (100), 218 (81), 201 (100); HRMS 






According to the General Protocol L, Cp2ZrHCl (0.17 g, 0.66 mmol), 231 (89 mg, 0.66 mmol), 
Me2Zn (0.16 mL, 0.33 mmol, 2.0 M in toluene) and 21 (0.10 g, 0.33 mmol) afforded 278 (91 mg, 
63%) as a colorless solid: mp 135.5-137.2 °C (hexanes/EtOAc); IR (KBr) 3207, 3056, 2962, 
2923, 2849, 1491, 1447, 1437, 1185, 1123, 1108 cm-1; 1H NMR δ 7.99-7.92 (m, 2 H), 7.89-7.82 
(m, 2 H), 7.51-7.33 (m, 8 H), 7.31-7.18 (m, 3 H), 5.44 (d, J = 9.5 Hz, 1 H), 4.72 (t, J = 11.0 Hz, 
1 H), 3.23 (dd, J = 10.2, 6.1 Hz, 1 H), 2.34-2.23 (m, 1 H), 2.17-2.05 (m, 1 H), 1.74-1.62 (m, 6 
H), 1.37-1.07 (m, 5 H), 0.68 (t, J = 7.5 Hz, 3 H); 13C NMR δ 142.57, 142.52, 139.39, 139.33, 
133.70, 133.19, 132.82, 132.66, 132.53, 131.99, 131.86, 131.73, 131.69, 131.65, 131.45, 128.37, 
128.30, 128.22, 128.13, 127.79, 127.53, 127.04, 58.74, 36.77, 33.44, 26.01, 25.95, 22.16, 13.92; 
MS (EI) m/z (intensity) 443 (M+, 23), 360 (28), 306 (28), 242 (94), 218 (78), 201 (100); HRMS 







benzoate (282).  General Protocol M.   A microwave tube equipped with a rubber septa was 
flame-dried under vacuum and purged with N2 upon cooling to r.t.  The tube was charged with 
Cp2ZrHCl (0.54 g, 2.1 mmol) and the solid was suspended in CH2Cl2 (3.0 mL).  Upon addition 
of 281 (0.31 mL, 2.1 mmol) the reaction mixture was stirred for 20 min.  The yellow-orange 
solution was cooled to –78 °C, treated sequentially with a solution of 119 (0.25 g, 0.70 mmol) in 
dry CH2Cl2 (0.5 mL) and Me2Zn (1.0 mL, 2.1 mmol, 2.0 M in toluene) and warmed to 0 °C.  The 
reaction mixture was heated in the microwave reactor (300 W, 100 °C) for 5 min and cooled to 0 
°C.  After treatment with CH2I2 (0.28 mL, 3.5 mmol), the mixture was heated in the microwave 
reactor (300 W, 60 °C) for 30 min, cooled to 0 °C, quenched with MeOH (ca. 0.50 mL), diluted 
with EtOAc (10 mL, 50 mL for washing), filtered through SiO2 and concentrated.  The residue 
was purified by chromatography on SiO2 using the ISCO (0:1 to 1:0 hexanes/EtOAc, 40 g 
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column) to afford the desired amino cyclopropane 282 (0.21 g, 61%) as a colorless solid:  mp 
126.0-128.0 °C (hexanes/EtOAc); IR (KBr) 3195, 2956, 2930, 2871, 1722, 1610, 1437, 1277, 
1183, 1108 cm-1; 1H NMR δ 7.94 (d, J = 8.2 Hz, 2 H), 7.83 (dd, J = 11.8, 6.9 Hz, 2 H), 7.68 (dd, 
J = 11.7, 7.3 Hz, 2 H), 7.53-7.38 (m, 4 H), 7.31-7.21 (m, 4 H), 4.19 (t, J = 10.4 Hz, 1 H), 3.92 (s, 
3 H), 3.24 (dd, J = 9.7, 6.8 Hz, 1 H), 1.59-1.23 (m, 6 H), 1.16-1.03 (m, 3 H), 0.87 (t, J = 7.3 Hz, 
3 H), 0.79 (t, J = 7.2 Hz, 3 H), 0.70-0.61 (m, 1 H), 0.01 (t, J = 5.0 Hz, 1 H); 13C NMR δ 166.94, 
147.81, 147.77, 132.43, 132.31, 131.94, 131.81, 131.71, 131.68, 129.37, 128.83, 128.55, 128.38, 
128.27, 128.10, 127.23, 58.91, 51.98, 32.36, 31.06, 29.57, 29.51, 23.12, 21.91, 20.57, 15.09, 
14.45, 14.09; MS (EI) m/z (intensity) 489 (M+, 5), 364 (53), 298 (55), 288 (28), 218 (48), 201 






diphenylphosphinamide (177).  According to the General Protocol M, Cp2ZrHCl (0.63 g, 2.5 
mmol), 125 (0.76 g, 2.5 mmol), Me2Zn (1.2 mL, 2.5 mmol, 2.0 M in toluene), 21 (0.25 g, 0.82 




N-(R*)-(((1R*,2R*)-2-Butylcyclopropyl)(phenyl)methyl)-P,P-diphenylphosphinamide (111).  
According to the General Protocol M, Cp2ZrHCl (0.63 g, 2.5 mmol), 108 (0.28 mL, 2.5 mmol), 
Me2Zn (1.2 mL, 2.5 mmol, 2.0 M in toluene), 21 (0.25 g, 0.82 mmol), and CH2I2 (0.33 mL, 4.1 
mmol) afforded 111 (0.20 g, 61%) as a colorless solid: 1H NMR δ 7.97-7.90 (m, 2 H), 7.80-7.73 
(m, 2 H), 7.53-7.40 (m, 4 H), 7.36-7.22 (m, 7 H), 3.80 (q, 1 H, J = 8.9 Hz), 3.33 (t, J = 6.6 Hz, 1 
H), 1.36-1.29 (m, 5 H), 1.10-0.98 (m, 2 H), 0.89 (t, J = 7.0 Hz, 3 H), 0.78-0.72 (m, 1 H), 0.41 







Methyl 4-[(R*)-benzoylamino((1R*,2R*)-1,2-dipropylcyclopropyl)methyl]benzoate (284).  
To a solution of 282 (50 mg, 0.10 mmol) in dry MeOH (1.0 mL) was added a solution of HCl 
(1.0 mL, 4.0 M in MeOH).  The reaction mixture was stirred for 12 h and concentrated to afford 
a colorless solid.  The residue was dissolved in dry CH2Cl2 (1.0 mL), cooled to 0 °C and treated 
with DMAP (1.0 mg, 10 µmol), DIPEA (53 µL, 0.31 mmol) and BzCl (24 µL, 0.20 mmol).  The 
mixture was warmed to r.t., stirred for 3 h and concentrated.  The residue was purified by 
chromatography on SiO2 (9:1, hexanes/EtOAc) to afford 284 (40 mg, 100%) as a colorless oil:  
IR (neat) 3303, 2955, 2930, 2871, 1725, 1635, 1528, 1280, 1110 cm-1; 1H NMR δ 8.01-7.74 (m, 
2 H), 7.81-7.78 (m, 2 H), 7.56-7.43 (m, 3 H), 7.39 (d, J = 8.2 Hz, 2 H), 6.52 (d, J = 7.8 Hz, 1 H), 
5.19 (d, J = 7.9 Hz, 1 H), 3.91 (s, 3 H), 1.56-1.33 (m, 6 H), 1.27-1.16 (m, 2 H), 0.91 (t, J = 7.1 
Hz, 3 H), 0.84 (t, J = 6.9 Hz, 3 H), 0.80-0.71 (m, 2 H), 0.14 (t, J = 4.9 Hz, 1 H); 13C NMR δ 
166.86, 166.67, 145.76, 134.33, 131.63, 129.64, 129.03, 128.66, 126.98, 126.85, 58.02, 52.02, 
32.92, 30.94, 27.76, 23.14, 21.69, 20.82, 15.65, 14.59, 14.08; MS (EI) m/z (intensity) 393 (M+, 








benzoate (285).  To a solution of 282 (50 mg, 0.10 mmol) in dry MeOH (1.0 mL) was added a 
solution of HCl (1.0 mL, 4.0 M in MeOH).  The reaction mixture was stirred for 12 h and 
concentrated to afford a colorless solid.  The residue was dissolved in dry CH2Cl2 (1.0 mL), 
cooled to 0 °C and treated with DMAP (1.0 mg, 10 µmol), DIPEA (53 µL, 0.31 mmol) and 
PhSO2Cl (26 µL, 0.20 mmol).  The mixture was warmed to r.t., stirred for 3 h and concentrated.  
The residue was purified by chromatography on SiO2 (9:1, hexanes/EtOAc) to afford 285 (43 
mg, 98%) as a colorless oil:  IR (neat) 3281, 2956, 2871, 1724, 1612, 1448, 1436, 1327, 1281, 
1163, 1111 cm-1; 1H NMR δ 7.80 (d, J = 8.4 Hz, 2 H), 7.71-7.67 (m, 2 H), 7.49-7.44 (m, 1 H), 
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7.37-7.31 (m, 2 H), 7.08 (d, J = 8.2 Hz, 2 H), 5.32 (d, J = 7.3 Hz, 1 H), 4.32 (d, J = 7.3 Hz, 1 H), 
3.89 (s, 3 H), 1.42-1.12 (m, 6 H), 1.09-0.95 (m, 3 H), 0.82 (t, J = 7.2 Hz, 3 H), 0.72 (t, J = 7.0 
Hz, 3 H), 0.46-0.36 (m, 1 H), -0.02 (t, J = 5.4 Hz, 1 H); 13C NMR δ 166.75, 144.48, 140.14, 
132.44, 129.29, 128.95, 128.76, 127.06, 126.97, 61.68, 52.06, 32.32, 30.72, 28.48, 22.98, 21.60, 
20.39, 14.99, 14.36, 14.00; MS (EI) m/z (intensity) 429 (M+, 11), 304 (100), 272 (45), 229 (46), 








benzoate (286).  To a solution of 282 (50 mg, 0.10 mmol) in dry MeOH (1.0 mL) was added a 
solution of HCl (1.0 mL, 4.0 M in MeOH).  The reaction mixture was stirred for 12 h and 
concentrated to afford a colorless solid.  The residue was dissolved in dry CH2Cl2 (1.0 mL), 
cooled to 0 °C and treated with DMAP (1.0 mg, 10 µmol), DIPEA (53 µL, 0.31 mmol) and 
ClCO2Ph (26 µL, 0.20 mmol).  The mixture was warmed to r.t., stirred for 3 h and concentrated.  
The residue was purified by chromatography on SiO2 (9:1, hexanes/EtOAc) to afford 286 (39 
mg, 94%) as a colorless solid:  mp 140.0-141.5 °C (hexanes/EtOAc); IR (neat) 3317, 3005, 2955, 
2933, 2871, 1713, 1611, 1520, 1491, 1468, 1456, 1433, 1282, 1204, 1116 cm-1; 1H NMR δ 8.03 
(d, J = 8.2 Hz, 2 H), 7.38 (d, J = 8.3 Hz, 2 H), 7.38-7.32 (m, 2 H), 7.21-7.11 (m, 3 H), 5.46 (d, J 
= 8.1 Hz, 1 H), 4.83 (d, J = 8.1 Hz, 1 H), 3.93 (s, 3 H), 1.65-1.10 (m, 8 H), 0.93 (t, J = 7.2 Hz, 3 
H), 0.85 (t, J = 6.8 Hz, 3 H), 0.78-0.62 (m, 2 H), 0.11 (t, J = 4.8 Hz, 1 H); 13C NMR δ 166.84, 
154.00, 150.88, 129.64, 129.21, 129.14, 126.94, 125.28, 121.42, 59.33, 52.08, 32.66, 30.87, 
27.71, 23.09, 21.54, 20.62, 15.19, 14.52, 14.08; MS (EI) m/z (intensity) 409 (M+, 3), 284 (58), 
273 (54), 218 (100), 191 (47), 94 (81); HRMS (EI) m/z calculated for C25H31NO4 409.2253, 
found 409.2271. 
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 Peptides are the natural ligands for various enzymes and have been found to exhibit broad 
physiological effects.  However, they are not useful drug substances since they often suffer from 
poor bioavailability and transport through membranes and have very short half-lives due to 
degradation by peptidases.  Modification of native peptide sequences is a promising avenue for 
the development of novel pharmaceuticals to circumvent some of these issues, the majority of 
which target the scissile peptide bond.  The favorable interactions of native peptides with 
proteins are due in large part to their ability to adopt complementary secondary structures to 
enhance binding.  In recent years, the structural motifs of β- and γ-amino acids233 have been 
studied extensively and with greater understanding of their unique folding properties coupled 
with the power of chemical genetics,234 the structure based design235 of new therapeutic agents is 
possible.  Much like their natural counterparts, β- and γ-amino acids have been found to form a 
variety of helical and pleated sheet-like structural motifs.  One of the most intriguing aspects of 
β- and γ-amino acids is the increased structural diversity that can be attained since more sp3-
carbons are present in the peptide backbone.  For example, Seebach and co-workers have 
recently described the synthesis and structural properties of a series of substituted γ-amino acid 
derivatives.236  A diasteroselective conjugate addition of acyloxazolidinone 298 to nitroalkene 
299 affords a mixture of α-NO2 diastereomers.  Hydrogenation and acidic opening of lactam 301 
gave the hydrochloride salt 302 which crystallizes in an extended conformation forming long 
stacks of parallel sheet-like structures.  Conversely, tetrapeptide 303 forms a helical structure 
                                                 
233 For some recent reviews on β- and γ-amino acids, see (a) Seebach, D.; Matthews, J. L. Chem. Commun. 1997, 
2015. (b) Cheng, R. P.; Gellman, S. H.; DeGrado, W. F. Chem. Rev. 2001, 101, 3219. (c) Hill, D. J.; Mio, M. J.; 
Prince, R. B.; Hughes, T. S.; Moore, J. S. Chem. Rev. 2001, 101, 3893. 
234 Stockwell, B. R. Nat. Rev. Gen. 2000, 1, 116. 
235 Anderson, A. C. Chem. Biol. 2003, 10, 787. 
236 Seebach, D.; Brenner, M.; Rueping, M.; Jaun, B. Chem. Eur. J. 2002, 8, 573. 
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(2.614 helix)237 in the solid state, and NMR studies of the related hexapeptide 304 found a 
conformational preference for a family of helical structures. 
 







303; n = 2, R1 = Boc, R2 = Bn
304; n = 3, R1 = R2 = H





























Scheme 2.1. γ-Amino acids can adopt both extended and helical structures 
 
 A new family of γ-amino acid derivatives was reported by Schreiber and Clardy in 1992.  
The vinylogous amino acids 307 were designed on the basis of allylic strain to favor the 
formation of extended structures (Figure 2.1).238  The protected building blocks were easily 
prepared from the corresponding α-amino acid derivatives via reduction and homologation using 
a Horner-Wadsworth-Emmons olefination.  Under standard coupling conditions, oligopeptides 
such as 369 (a vinylogous dipeptide) were prepared and found to form extended, sheet-like 
structures in the solid state.  One of the major drawbacks of the use of these derivatives is the 
reactivity of the alkene towards conjugate additions, and a β-methoxy-γ-amino acid was formed 
during saponification of an amino ester in methanol.  In fact, this undesired side reaction became 
                                                 
237 The notation nm is used to describe helical structures where n represents the number of residues per helical turn 
and m is the number of atoms involved in the ring containing the hydrogen bond.  For example, the traditional α-
helix can also be called a 3.614 helix. Voet, D.; Voet, J. G., Biochemistry, 2nd Ed.; John Wiley & Sons, Inc.: New 
York, 1995; p 146. 
238 Hagihara, M.; Anthony, N. J.; Stout, T. J.; Clardy, J.; Schreiber, S. L. J. Am. Chem. Soc. 1992, 114, 6568. 
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a fortuitous discovery as the incorporation of this amino acid into a tetrapeptide resulted in the 










































Figure 2.1. Schreiber's vinylogous polypeptides as β-sheet mimetics 
 
2.1.2 Peptidomimetics 
  An alternate approach to the problems associated with native peptides is the isosteric 
replacement of the peptide bond.  A number of these peptide isosteres239 have been designed to 
maintain the excellent binding capabilities of peptides, but replace the amide bond with a rigid, 
hydrolytically stable moiety (Figure 2.2).240  Some of the most commonly used amide bond 
isosteres include the ketomethylene, hydroxyethylene, dihydroxyethylene, hydroxyethylamino 
and E-alkene peptide isosteres.  A number of these isosteric replacements function as transition 
state analogs for the hydrolysis of the peptide bond.  Short peptides incorporating 
hydroxyethylene or hydroxymethylene isosteres, such as Indinavir, have found use as inhibitors 
of proteases, such as HIV-I.241 
 
                                                 
239 (a) Horwell, D. C. Biorg. Med. Chem. 1996, 4, 1573. (b) Venkatesan, N.; Kim, B. H. Curr. Med. Chem. 2002, 9, 
2243. 
240 Hanessian, S.; McNaughton-Smith, G.; Lombart, H.-G.; Lubell, W. D. Tetrahedron 1997, 53, 12789. 











































Figure 2.2. The peptide bond and representative isosteres 
 
 (E)-Alkene peptide isosteres (EAPIs) are closely related to the cyclopropyl peptide 
mimics that we have prepared and most accurately mimic the amide bond in terms of geometry, 
rigidity, bond angle and length, but lack hydrogen bonding capability.  EAPIs have been found to 
be particularly effective in promoting β-turns and in initiating β-hairpin motifs.242,243  Most 
peptide isosteres shown in Figure 2.2 fail to account for the resonance contribution of the 
zwitterionic form of the amide bond which imparts both rigidity to the peptide backbone and 
significant dipole moment (µ) to the amide bond.  In an effort to incorporate a mimic for the 
dipole moment into an EAPI, Wipf and Henninger reported the synthesis and evaluation of 
trifluoromethyl-substituted (E)-alkenes as β-turn mimetics (Scheme 2.2).244  Of the alkene 
isosteres prepared to date, a CF3-substituted alkene most accurately mimics the dipole moment of 
the amide bond (2.3 D vs. 3.6 D).  The intermediate epoxide 311 is prepared in 4 steps from 
enoate 310 via a Sharpless asymmetric dihyroxylation245 followed by a Mitsunobu reaction246 to 
                                                 
242 (a) Gardner, R. R.; Liang, G.-B.; Gellman, S. H. J. Am. Chem. Soc. 1995, 117, 3280. 
243 (a) Wipf, P.; Henninger, T. C. J. Org. Chem. 1997, 62, 1586. (b) Wipf, P.; Henninger, T. C.; Geib, S. J. J. Org. 
Chem. 1998, 63, 6088. 
244 Wipf and Xiao have recently applied the Zr→Zn methodologies developed in Chapter 1 to the preparation of a 
library of substituted trisubstituted (E)-alkene peptide isosteres for evaluation as β-turn mimics and structural 
replacements of a dipeptide segment of the antibiotic Gramicidin S. 
245 Kolb, H. C.; VanNieuwenhze, M. S.; Sharpless, K. B. Chem. Rev. 1994, 94, 2483. 
246 Mitsunobu, O. Synthesis 1981, 1. 
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form the epoxide, reduction and chain homologation with a stabilized Wittig reagent.  Azide 
opening of the epoxide, Staudinger reduction and N-protection followed by activation of the 3° 
alcohol afforded the allylic mesylate 312.  Allylic displacement of the mesylate with the mixed 
cuprate reagent followed by amidation afforded the dipeptide isostere of L-Ala-D-Ala.  Indeed, in 
the solid state, 313 and the corresponding methyl-substituted alkene peptide isostere fold into 
very similar stable type II β-turns.  Interestingly, the use of an (E)-disubstituted alkene resulted 
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Scheme 2.2. Synthesis and crystal structure of a CF3-substituted (E)-alkene dipeptide isostere of 
L-Ala-D-Ala as a β-turn mimetic 
 
 There have been numerous systems designed to mimic α-helices or β-turn motifs, 
however, there have been far fewer studies on β-sheet mimetics.247  Unlike helical or turn motifs, 
                                                 
247 For selected examples of β-sheet mimics, see (a) Diaz, H.; Tsang, K. Y.; Choo, D.; Espina, J. R.; Kelly, J. W. J. 
Am. Chem. Soc. 1993, 115, 3790. (b) Chen, L.; Trilles, R. V.; Tilley, J. W. Tetrahedron Lett. 1995, 36, 8715. (c) 
Boumendjel, A.; Roberts, J. C.; Hu, E.; Pallai, P. V.; Rebek, Jr., J. J. Org. Chem. 1996, 61, 4434. (d) Seebach, D.; 
Abele, S.; Gademann, K.; Jaun, B. Angew. Chem., Int. Ed. Engl. 1999, 38, 1595. (e) Nowick, J. S.; Lam, K. S.; 
Khasanova, T. V.; Kemnitzer, W. E.; Maitra, S.; Mee, H. T.; Liu, R. J. Am. Chem. Soc. 2002, 124, 4972. 
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extended structures can not be readily characterized using NMR techniques and the reliance 
upon x-ray crystallography raises issues of whether the structure arises solely from favorable 
packing interactions in the solid state or a genuine conformational preference.  On the basis of 
preliminary molecular modeling, Smith and co-workers developed pyrrolidinone scaffolds to 
mimic the extended conformation of β-sheets.248  Indeed, the minimum energy conformation of 
an oligopyrrolidinone scaffold in an extended conformation249 was found to overlay extremely 
well with the crystal structure of the corresponding α-peptide.  Synthetically, the α,α-
disubstituted amino acid 316 was prepared using Seebach’s self-regeneration of stereocenters 
methodology and was subjected to an iterative protocol for the preparation of oligopyrrolidinone 
319.  Formation of the Schiff base of 316 with amine 317 followed by cyclization with KHMDS, 
and oxidative cleavage of the isoprenyl olefin afforded aldehyde 318.  Repetition of this protocol 
afforded the tetrapeptide mimic 319.  They observed excellent correlation of the x-ray structure 
















































Scheme 2.3. Smith and co-worker’s scaffold for mimicking β-sheets formed by α-peptides 
                                                 
248 Smith, III, A. B.; Guzman, M. C.; Sprengeler, P. A.; Keenan, T. P.; Holcomb, R. C.; Wood, J. L.; Carroll, P. J.; 
Hirschmann, R. J. Am. Chem. Soc. 1994, 116, 9947. 
249 Three families of conformations were found, including “linear”, “turned” and “twisted” conformations. 
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2.1.3 Cyclopropyl Amino Acids and Peptide Isosteres 
 While there are not many examples of naturally occurring amino acids containing 
alkenes, a number of naturally occurring cyclopropane-containing amino acids and peptides have 
been isolated (Figure 2.3).250  The most common are the 2,3-methanoamino acids where a 
cyclopropane has been inserted between the α- and β- positions of an α-amino acid.  For 
example, the most common cyclopropyl amino acid, Acc, could also be called 2,3-
methanoalanine (Figure 2.3).  The conformational preferences of 2,3-methanoamino acids have 
been studied by Burgess and co-workers using a combination of computational and experimental 
techniques.251  The local conformational preference of the constituent amino acid residues of 
cyclopropyl peptides can be more easily rationalized than the overall secondary structures.  
However, the de novo prediction of secondary structures should prove to be considerably more 















Figure 2.3. Some naturally occurring cyclopropane-containing amino acids 
 
 There have been many examples of syntheses of cyclopropane-containing amino acids 
via alkylation,252 conjugate addition,253 or diazoester chemistry.254  Charette and Côté have 
                                                 
250 For reviews on cyclopropane-containing amino acids, see (a) Stammer, C. H. Tetrahedron 1990, 46, 2231. (b) 
Burgess, K.; Ho, K.-K.; Moye-Sherman, D. Synlett 1994, 575. (c) Gnad, F.; Reiser, O. Chem. Rev. 2003, 103, 1603. 
251 (a) Burgess, K.; Ho, K.-K. J. Org. Chem. 1992, 57, 5931. (b) Burgess, K.; Ho, K.-K. Tetrahedron Lett. 1992, 33, 
5677. (c) Burgess, K.; Ho, K.-K.; Ke, C.-Y. J. Org. Chem. 1993, 58, 3767. (d) Burgess, K.; Lim, D.; Ho, K.-K.; Ke, 
C.-Y. J. Org. Chem. 1994, 59, 2179. 
252 Groth, U.; Halfbrodt, W.; Schollkopf, U. Liebigs Ann. Chem. 1992, 351. 
253 (a) Williams, R. M.; Fegley, G. J. J. Am. Chem. Soc. 1991, 113, 8796. (b) Williams, R. M.; Fegley, G. J. J. Org. 
Chem. 1993, 58, 6933. 
254 Davies, H. L. M.; Hutcheson, D. K. Tetrahedron Lett. 1993, 34, 7243. 
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recently reported a nice application of their asymmetric cyclopropanation methodology to the 



















































Scheme 2.4. Synthesis of all four isomers of coronamic acid: Charette's general approach to 2,3-
methanoamino acids 
 
 Starting from allylic alcohol 320, protective group manipulations and asymmetric 
cyclopropanation affords the cyclopropylmethanols 321 and 322.  Depending upon the ordering 
of the subsequent oxidation and deprotection steps, (+)- and (-)-coronamic acid derivatives, 323 
and 324, and (+)- and (-)-allo-coronamic acid derivatives, 325 and 326, can be prepared from 
321 and 322 in 5 chemical steps.  This diversity-oriented approach to the preparation of 
cyclopropyl amino acids could be easily expanded to the generation of an impressive library of 
analogs for biological evaluation or incorporation into known biologically active peptide 
sequences. 
                                                 
255 Charette, A. B.; Côté, B. J. Am. Chem. Soc. 1995, 117, 12721. 
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 Martin and co-workers have been interested in the insertion of conformationally 
restricted cyclopropyl amino acids into biologically relevant peptide sequences in the hope to 
increase both the stability of the peptide and its binding affinity (Figure 2.4).256  Interestingly, 
they have not only chosen to rigidify the peptide backbone, but have also attempted to mimic the 
side chain position of the residue which has been replaced.256d  At the outset of their studies, it 
was not known whether 327 was bound to its target (in this case, Ras farnesyltransferase) in an 
extended or folded conformation.  They introduced both cis- and trans-trisubstituted cyclopropyl 
peptide isosteres in order to account for each binding possibility along with the hydroxyethylene 
isostere 331 as a control element.  Unfortunately, the introduction of all three isosteres appears to 
have deleterious effects on the bioactivity of the peptides compared to the native ligand 327 (38 
nM).  It may be more instructional to test libraries of cyclopropyl peptide mimetics against a 
variety of biological targets rather than attempting to ‘rationally design’ a peptide-like inhibitor 
by modifiying the constituent amino acids.  Considerable synthetic effort was required to prepare 
the required cyclopropyl amino acid residues (9-10 steps) and it stands to reason that using this 
design principle, one would prefer to choose a target such that the binding mode of the native 
peptide is well understood. 
                                                 
256 (a) Martin, S. F.; Austin, R. E.; Oalmann, C. J. Tetrahedron Lett. 1990, 31, 4731. (b) Martin, S. F.; Oalmann, C. 
J.; Liras, S. Tetrahedron 1993, 49, 3521. (c) Martin, S. F.; Dwyer, M. P.; Hartmann, B.; Knight, K. S. J. Org. Chem. 
2000, 65, 1305. (d) Hillier, M. C.; Davidson, J. P.; Martin, S. F. J. Org. Chem. 2001, 66, 1657. (e) Davidson, J. P.; 
Lubman, O.; Rose, T.; Waksman, G.; Martin, S. F. J. Am. Chem. Soc. 2002, 124, 205. (f) Reichelt, A.; Gaul, C.; 
Frey, R. R.; Kennedy, A.; Martin, S. F. J. Org. Chem. 2002, 67, 4062. (g) Franklin, C. L.; Li, H.; Martin, S. F. J. 
Org. Chem. 2003, 68, 7298. (h) Plake, H. R.; Sundberg, T. H.; Woodward, A. R.; Martin, S. F. Tetrahedron Lett. 




















































331 (0.32 µM)  
Figure 2.4. Martin's cyclopropane-derived peptidomimetics as Ras farnesyltransferase inhibitors 
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2.2 Synthetic Approaches to α,β-Cyclopropl-γ-Amino Acids 
There have been many attempts to use amide bond isosteres as potential therapeutic agents, 
however limited success has been achieved.  A selection of the numerous methods available for 
the preparation of structurally diverse peptides and peptide mimetics was highlighted in the 
introduction for this chapter.  Some of the most interesting examples, in terms of medicinal 
potential, arise from the preparation of novel amino acid scaffolds which are capable of adopting 
stable folded structures.  With methodology in place for the stereoselective synthesis of C-
cyclopropylalkylamides (see Chapter 1.3.1), we wanted to utilize this process for the preparation 
of novel amino acid scaffolds for potential use as β-sheet mimics.  As shown in the introductory 
section, there has been widespread use of alkenes as replacements for the scissile peptide bond.  
One of the major disadvantages of olefins is their inherent reactivity257 along with possibilities 
for isomerization and allylic oxidation.  On the other hand, cyclopropanes maintain the rigidity 
of the peptide backbone but are inherently less reactive under the conditions employed in 
traditional peptide synthesis.  We hypothesized that the incorporation of a cyclopropyl spacer in 
α-amino acids would confer structural rigidity into the peptide backbone (as was observed for 
Schreiber’s vinylogous amino acids) while significantly decreasing the reactivity of the subunits 
during oligopeptide synthesis.  In order to test our hypothesis, we set out to prepare a small 
family of di- and tri-substituted cyclopropyl amino acids and survey the effect of substitution on 
the conformation of simple amide derivatives (Figure 2.5).  On the basis of minimization of A1,3-
strain arguments (arrows indicate minimized interactions), the syn-cyclopropyl amino amide 336 
should adopt the most extended structure.  The substitution of R3=Me will re-enforce this 
conformation in order to minimize interactions across the cyclopropane.  Using the same 
arguments for the anti-diastereomer 337, we can envisage that these compounds will also adopt 
an extended structure based on allylic strain.  However, the relative stereochemistry appears to 
impose a turn about the N-C1-C2-C3 dihedral angle.  The introduction of a β-methyl substituent 
                                                 
257 This disadvantage is nicely displayed in the work of Schreiber and co-workers where methanol added in a 1,4 
fashion to their designed amino acid during ester saponification.  See reference 238 for details. 
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(ie, βMe∆Phg) will introduce significant A1,2-strain in conformer 337, potentially resulting in a 





































































































Figure 2.5. Proposed Cyclopropyl Amino Acids 
 
2.2.1 Synthesis of Cyclopropyl Amino Acids 
 Our first-generation approach to ∆Phg involved the use of TBDPS-protected propargyl 
ether 341 in the Zr→Zn three-component condensation reaction (Scheme 2.5).  Hydrozirconation 
of 341 followed by transmetalation to dimethylzinc, followed by the addition to imine 21 in 
CH2Cl2 at reflux was significantly slower than observed for the alkynes used thus far, however, a 
                                                 
258 For the synthesis of γ-unsubstituted-α-,β-cyclopropyl-γ-amino acids, see Baxendale, I. R.; Ernst, M.; Krahnert, 
W.-R.; Ley, S. V. Synlett 2002, 1641. 
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single product (presumably the allylic amide) was observed by TLC.  Unfortunately, upon 
treatment with CH2I2, the desired amino cyclopropane 342 was not formed259 and allylic amide 
343 was isolated in good yield.  It was believed that the σ-electron withdrawing character of the 
allylic ether sufficiently deactivated the alkene towards cyclopropanation under these conditions.  
While we had since moved on to another approach to this problem, the in situ cyclopropanation 
issue for propargyl ethers has also been rectified.  Under otherwise identical conditions, the 
intermediate allylic phosphinamide was treated with Zn(CH2I)274 at 0 °C for 4 h, and the desired 
cyclopropane 342 was isolated as a single diastereomer in good yield.  One could argue that the 
most direct route to the desired amino acid would be using a protected propynoic acid derivative 
(ie, an ABO or OBO ester); however since one oxygen sufficiently deactivated the alkyne 
towards cyclopropanation, we believed that the addition of more oxygenation at the propargylic 



















2) Me2Zn, -78 °C to 0 °C
3) 21, reflux
4) Zn(CH2I)2•DME



















Scheme 2.5. First generation approach to cyclopropyl amino acids from propargyl ethers 
 
 A related idea for the preparation of an amino cyclopropane which was amenable to 
further functionalization to an amino acid relied on the propargyl sulfide 344 (Scheme 2.6).  The 
sulfide could be converted to an aldehyde using the Pummerer rearrangement.  However, 
                                                 
259 Only traces of amino cyclopropane 342 were observed in the crude 1H NMR. 
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attempts to use this alkyne in the three-component formation of amino cyclopropanes failed, and 
upon work-up of the reaction there was a strong odor of thiophenol.260  Hydrozironation of 344 
and quenching with I2 afforded the expected vinyl iodide suggesting that the addition of 























Scheme 2.6. Attempted cyclopropane formation using propargyl phenyl sulfide 
 
 Our third approach hinged on the use of enynes as the nucleophilic component of the 
dimethylzinc-mediated cyclopropanation reaction (Scheme 2.7).  As previously discussed (see 
Scheme 1.26, Chapter 1.3.1), enynes 143 and 195 did not afford the desired vinylcyclopropanes, 
instead giving exclusively biscyclopropanes 190 and 196 as single diastereomers.261  Given our 
experience with the resistance of propargyl ethers to reaction under the cyclopropanation 
conditions, enyne 350 was prepared.262  Unfortunately the deactivation extended to the allylic 
amide and the major product observed was dienyl amide 351 (55%) along with the desired 
vinylcyclopropane 352 (19%).  Forcing this reaction by extending the reaction time (>72h) 
afforded greater quantities (ca. 35%) of 352, however, this material was not easily separated 
from diene 351 and the corresponding biscyclopropane (not shown).  Enynes 353 and 354 were 
also prepared and evaluated in this reaction, however mixtures of mono- and biscyclopropane, 




                                                 
260 Imine was still present when the reaction was quenched, but not quantified due to its facile hydrolysis. 
261 As observed by crude 1H NMR. 
262 Enyne’s 350, 353 and 354 were prepared in an analogous fashion to 143 and 195 (See Scheme 1.25). 
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1) Cp2Zr(H)Cl, CH2Cl2



























Scheme 2.7. Second generation approach employing enynes 
 
 After preparation of amino cyclopropane 177, we sought to take advantage of the 
functional groups present and transform the primary alcohol into an olefin by dehydration 
(Scheme 2.8).  On modest scale (ca. 1.0 g of 21), the desired amino cyclopropane 177 could be 
prepared in good yield (76%).  On preparative scale (ca. 3.5 g imine), a marginal decrease in 
isolated yield (55-61%) was observed, however the overall throughput263 was sufficient for our 
studies.  Desilylation (TBAF, AcOH) afforded the requisite alcohol 355 for dehydration studies 

























Scheme 2.8. Preparation of alcohol 355 
 
                                                 
263 Two 3.5 g scale reactions were run in parallel affording 8 g of 177 after combined work-up and purification. 
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 The dehydration of alcohol 355 was anticipated to proceed without significant difficulty; 
in practice, this transformation was more challenging than expected (Table 2.1).  Activation of 
the primary alcohol for elimination using a number of reagent combinations failed to afford the 
desired vinylcyclopropane in acceptable yield.  Sulfonates (entries 1-3) were consistently poor 
and afforded, under optimal conditions (entry 2), only 20% of 356.  Conversion to the primary 
iodide (Ph3P, I2, imidazole) followed by elimination with DBU (entry 4) afforded only 35% of 
356.  Furukawa’s reagent,264 DCC/CuCl,265 and Ph3P/DEAD (entries 5-8) failed to produce any 
detectable amounts of 356, while an attempted Chugaev elimination266 resulted in decomposition 
(Entry 9). 
 
Table 2.1. Attempted dehydration of alcohol 355 to form vinylcyclopropane 356 
entry dehydration conditions yield of 356 
(%)a 
1 1) MsCl, Et3N, THF, 0 °C 
2) DBU, DMF, r.t to 120 °C 
no desired product
2 1) MsCl, TEA, THF, 0 °C 
2) K-Ot-Bu, 18-crown-6, r.t 
20% 
3 1) Tf2O, Et3N, CH2Cl2, -78 °C 
2) Warm to 0 °C  
decomposition 
4 1) Ph3P, I2, Imidazole, CH3CN/Et2O 
2) DBU, DMF 
35% 
5 Furukawa’s reagent (MsCl, DMAP, H2O)267 no desired product
6 Furukawa’s reagent, reflux decomposition 
7 DCC, CuCl, PhH, reflux265 no desired product
8 DEAD, Ph3P, toluene, 90 °C no desired product
9 1) NaH, CS2 
2) MeI 
3) Xylenes, reflux266 
decomposition 
aYield of isolated, analytically pure product based on alcohol 355. 
  
                                                 
264 (a) Furukawa, J.; Morisaki, N.; Kobayashi, H.; Iwasaki, S.; Nozoe, S.; Okuda, S. Chem. Pharm. Bull. 1985, 33, 
440. (b) Comins, D. L.; Hong, H.; Salvador, J. M. J. Org. Chem. 1991, 56, 7197. 
265 (a) Alexandre, C.; Rouessac, F. Bull. Soc. Chim. Fr. 1971, 1837. (b) Knight, S. D.; Overman, L. E.; Pairaudeau, 
G. J. Am. Chem. Soc. 1995, 117, 5776. 
266 Bordwell, F. G.; Landis, P. S. J. Am. Chem. Soc. 1959, 81, 228. 
267 Furukawa’s reagent was prepared by addition of H2O (0.29 mL) to a solution of DMAP (2.4 g) in dry CH2Cl2 (52 
mL).  The mixture was treated with MsCl (3.1 mL) and stirred until all solid was dissolved (~2 days). 
  147
 We turned our attention to the conditions developed by Grieco268 for the dehydration of 
alcohols (Table 2.2).  The intermediate selenide 357 was prepared in excellent yield (80-88%) 
with little variation, however there was significant deviation (0-57%) in the isolated yield of 
vinylcyclopropane 356 (entries 1-4).  After searching the literature for the reactivity of selenium 
and selenoxides, we were delighted to discover that the low temperature oxidation of the selenide 
357 followed by treatment with i-Pr2NH and warming to r.t. reproducibly afforded 356 in 
excellent isolated yield (88%) (entry 5).  In fact, the reaction could be carried out without 
chromatographic purification of 357 and the crude selenide was dissolved in dry CH2Cl2 and 
treated at -40 °C with buffered m-CPBA.   
 























entry oxidation protocol yield of 356 
(%) 
1 H2O2, THF 25-43% a 
2 NaIO4, THF/H2O 57% a 
3 Bu4NIO4, THF/H2O no desired product 
4 m-CPBA, CH2Cl2, 0 °C to r.t 35% a 
5 1) m-CPBA, Na2HPO4, CH2Cl2, -40 °C 
2) i-Pr2NH, -40 °C to r.t 
88%  
aYield of isolated, analytically pure product based upon selenide 357 
 
Upon consumption of 357,269 i-Pr2NH was added and the reaction mixture was warmed to r.t. 
and the elimination proceeded to afford 356 (86%, 2 steps).270  The presumed failure of the 
selenoxide elimination was due to the presence of the by-product of elimination, arylselenenic 
                                                 
268 (a) Grieco, P. A.; Miyashita, M. J. Org. Chem. 1974, 39, 120. (b) Grieco, P. A.; Gilman, S.; Nishizawa, M. J. 
Org. Chem. 1976, 41, 1485. 
269 The formation of 357 was not observed at -40 °C. 
270 (a) Reich, H. J.; Renga, J. M.; Reich, I. L. J. Am. Chem. Soc. 1975, 97, 5434. (b) Reich, H. J.; Wollowitz, S.; 
Trend, J. E.; Chow, F.; Wendelborn, D. F. J. Org. Chem. 1978, 43, 1697. 
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acid 359.  Reich and others have shown that arylselenenic acids disproportionate into 
arylseleninic acids and diaryldiselenides (Figure 2.6).  Fortunately, 359 can be trapped with a 
secondary amine (ie, i-Pr2NH) forming the stable diisopropyl-selenenamide 362, retarding 




















Figure 2.6. Trapping of the byproduct of selenoxide elimination 
 
 After the efficient preparation of 356, the synthesis of our ∆Phg derivative continued with 
the oxidative cleavage of the terminal olefin (Scheme 2.9).  According to the ozonlysis protocol 
developed by Marshall,52 a solution of 356 in basic methanol (4:1, CH2Cl2/2.5 M NaOH in 
MeOH) was ozonized at -78 °C affording the fully protected amino acid ester 363.  Crude 363 
was treated with a solution of HCl in MeOH to remove the phosphinoyl protective group, and 
when the deprotection was judged to be complete by TLC analysis, the MeOH solution was 
poured into dry Et2O and the pure hydrochloride salt 364 was isolated by filtration (76%, 2 
steps).  The amino function was re-protected under bi-phasic conditions (Cbz-Cl, NaHCO3) to 
afford racemic Cbz-H2∆Phg-OMe.  Saponification (KOTMS/Et2O)273 and coupling with i-
PrNH2•HCl (EDCI/DMAP/DIPEA) afforded the isopropylamide derivative 366.  We were able 
to obtain crystals suitable for x-ray diffraction by the slow evaporation of a solution of 366 in a 
mixture of CH2Cl2 and toluene affording long stacks of molecules arranged in a parallel 
assembly.  The general structure observed is extended as desired; however there is a considerable 
                                                 
271 359 and 361 are electrophilic sources of selenium while 360 is acidic (pKa ~3.8)272  
272 The pKa of o-NO2C6H4SeOH has been measured to be 10.45 (ref. 272b) while PhSeO2H has a measured pKa of 
4.79 (ref. 272a).  The pKa of PhSeOH has been approximated to be ~11.5 (ref. 272b).  On the basis of this 
approximation, the pKa of o-NO2C6H4SeO2H can be estimated to be ~3.8.  Cf. (a) McCullogh, J. D.; Gould, E. S. J. 
Am. Chem. Soc. 1949, 71, 674. (b) Kang, S.-I.; Kice, J. L. J. Org. Chem. 1986, 51, 287. 
273 Laganis, E. D.; Chenard, B. L. Tetrahedron Lett. 1984, 25, 5831. 
  149
turn initiated about the N-C4-C3-C2 dihedral angle (-88.6°).  The remaining dihedral angles are 
within the range of angles observed in extended peptides (ie, β-sheets).  As part of our 
continuing evaluation of our allylic- and C-cyclopropylalkylamides in various biological 
screens,274 phosphinamide 363 was found to inhibit pre-mRNA splicing of CD45 (~5 µM) with a 
novel mechanism of action.  A focused library of analogues will be prepared in the UPCMLD 
with the aim increasing the potency and develop a biological probe with hopes of determining 
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Scheme 2.9. Synthesis of Cbz-H2∆Phg-NHiPr, 366 
 
  
                                                 
274 A library of allylic and C-cyclopropylalkylamides prepared during the development of the methodologies 
described in Chapter 1 was evaluated for anti-estrogenic activity in collaboration with Professor Billy Day.  An 
interesting lead structure prepared by Dr. Chris Kendall was discovered amongst the compounds.  A preliminary 
communication detailing these efforts has recently been published.  Janjic, J. M.; Mu, Y.; Kendall, C.; Stephenson, 
C. R. J.; Balachandran, B.; Raccor, B. S.; Lu, Y.; Zhu, G.; Xie, W.; Wipf, P.; Day, B. W. Biorg. Med. Chem. 2005, 
13, 157. 
275 This work has been carried out in collaboration with Prof. Kristen Lynch at the University of Texas, 
















Figure 2.7. Stereoview of the Chem3D representation of the x-ray crystal structure of 366 and 
representative dihedral angles276 
 
 The β-methyl-substituted-γ-amino acid derivative 371 was prepared in an analogous 
fashion to 178 beginning with the previously described C-cyclopropylalkylamide 178 (Scheme 
2.10).  Desilylation (TBAF, AcOH) afforded alcohol 367 in excellent yield.  Under the optimized 
Grieco elimination conditions,268 vinylcyclopropane 368 was prepared in very good yield.  
Oxidative cleavage52 of the olefin afforded ester 369 which was dephosphinoylated without 
purification to afford the hydrochloride salt 370 (75%, two steps).  N-Protection as a benzyl 
carbamate followed by saponification (NaOH/MeOH/THF) and BOP coupling with i-
PrNH2•HCl afforded the amide derivative Cbz-βMe∆Phg-NHiPr.  A sheet-like structure is once 
again found in the crystal structure of 372,277 however, the arrangement is anti-parallel and the β-
methyl substituent appears to preclude the formation of higher order sheets.  A more pronounced 
                                                 
276 See Appendix B for crystal coordinates. 
277 Crystals suitable for x-ray diffraction studies were obtained from slow evaporation of a solution of 372 in CH2Cl2 
and toluene (ca. 3 drops). 
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turn is initiated about the N-C4-C3-C2 dihedral angle (-77.6°) such that the compound nearly 













     THF, 0 °C
2) m-CPBA, Na2HPO4
     CH2Cl2, -40 °C












































Figure 2.8. Stereoview of the Chem3D representation of the x-ray crystal structure of 372 and 
representative dihedral angles279 
 
                                                 
278 Indeed, peptide mimetics with an extra carbon atom in the backbone sequence have been prepared by Mr. Jingbo 
 Xiao and β-turn motifs have been observed.  For example, see Wipf, P.; Xiao, J. Org. Lett. 2005, 7, 103. 
279 See Appendix C for crystal coordinates. 
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 The final cyclopropyl amino acid derivative that we wanted to prepare bears a methyl 
substituent in the α-position and required the use of the tandem water-accelerated methyl 
alumination-imine addition reaction developed in the Wipf group in 2002.168,280 It has been 
demonstrated that the vinylalanes generated under these conditions could be added to N-
diphenylphosphinoyl imines,281 although the reaction was slow (ca. 24-48 h for complete 
conversion) even at r.t.  Given our success with the application of microwave technology to the 
vinylzinc additions to imines, we attempted the addition of the vinylalane derived from 125 to 
imine 21 in the microwave.  Indeed, the addition proceeds smoothly at 100 °C in only 7.5 
minutes, however reaction throughput was limited to ~0.25 g of 21 per reaction (Scheme 2.11).  
Fortunately this issue was resolved using the automated Personal Chemistry microwave reactor.  
Alkyne 125 was treated under water-accelerated carboalumination conditions on preparative 
scale and added in equal portions to sixteen microwave tubes containing 0.25 g of 21.  The 
automated reactor heated each vessel at 100 °C for the required time and, upon completion of the 
sequence (~2.5 h), the reactions were combined for work-up and purification affording 373 in 
excellent yield (85%).  Simmons-Smith cyclopropanation74 using the DME complex of 
Zn(CH2I)2282 gave amino cyclopropane 374 (95%, dr >95:5).  Not surprisingly, the 
stereochemical outcome of this cyclopropanation reaction was in favor of the syn-diastereomer 
while the anti-diastereomer was favored using the Zr→Zn methodology (see Figure 1.7, Chapter 
1.3.1).  Desilylation (TBAF/AcOH, 91%) followed by Grieco elimination268 afforded 376 (81%).  
Ozonolysis in basic methanol52 followed by removal of the diphenylphosphinoyl protective 
group gave hydrochloride salt 378 (78%, two steps).  Protection of the amino functionality as the 
benzyl carbamate (NaHCO3, Cbz-Cl) followed by saponification (NaOH/MeOH/THF) and BOP 
coupling afforded racemic Cbz-αMe∆Phg-NHiPr (97%).  The structural arrangement in the solid 
state of 380 is similar to that observed for 372, the α-methyl-substituted i-Pr amide derivative 
(+/-)-380 crystallized as a dimer, also in an anti-parallel array.  However, the dihedral angles are 
all >125° and the overall structural is nearly fully extended via three-fold minimization of A1,3-
strain across the carbamate, the cyclopropane and the amide bond.  Interestingly, the methyl 
                                                 
280 Wipf, P.; Nunes, R. L.; Ribe, S. Helv. Chim. Acta 2002, 85, 3478. 
281 Ribe, S. D. Ph.D Dissertation, University of Pittsburgh, 2003. 
282 Zn(CH2I)2 has been reported as an explosion hazard and the DME complex is suggested as a safe alternative for 
reactions run using ≥1 mmol of reagent.  For the original report, see Charette, A. B.; Prescott, S.; Brochu, C. J. Org. 
Chem. 1995, 60, 1081. 
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group once again prohibits higher order sheet formation, limiting aggregation to dimers.  We 
were very excited about the potential of oligopeptides based on this scaffold to adopt an 
extended conformation.  The racemic amide 380 was found to be an agonist of the Pregnane X 
receptor (PXR), a xenobiotic nuclear receptor which regulates the expression of many genes 
responsible for drug metabolism.283  The optically pure amides (-)-380 and (+)-380 were also 
prepared for biological evaluation under analogous conditions beginning with optically pure 
tartrate salts 385 or 386 (vide infra).  An interesting species-dependent stereoselectivity was 
observed for the enantiomeric amides; (+)-380 was more active for hPXR, whereas (-)-380 
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Scheme 2.11. Microwave-assisted synthesis of Cbz-αMe∆Phg-NHiPr ((+/-)-380) 
                                                 
283 Mu, Y.; Stephenson, C. R. J.; Kendall, C.; Saini, S. P. S.; Toma, D.; Ren, S.; Cai, H.; Strom, S. C.; Day, B. W.; 















Figure 2.9. Stereoview of the Chem3D representation of the x-ray crystal structure of (+/-)-380 
and representative dihedral angles284 
 
2.2.2 Resolution of the Racemates and Determination of Absolute Configuration 
In order to prepare oligomers of α,β-cyclopropyl-γ-amino acids and examine their 
conformational preferences, we required access to optically pure building blocks.  Unfortunately, 
we are currently unable to add alkenylzirconocenes to imines to afford optically enriched allylic- 
or C-cyclopropylalkylamides.285  A classical resolution by fractional crystallization seemed to be 
the most straightforward solution to this problem (Scheme 2.12).286  On the basis of the crystal 
structures of simple amide derivatives that we had obtained, we chose to resolve only amino 
esters 365 and 379 since they appeared to possess the attributes that we desired in our building 
blocks.  That is, they seemed to favor formation of organized secondary structures in the 
crystalline states.  Accordingly, hydrogenolysis of (+/-)-365 and heating the resultant amino 
cyclopropane in EtOH/H2O with L-tartaric acid followed by concentration to dryness afforded a 
diastereomeric mixture of tartrate salts 383 and 384.  Fractional crystallization from EtOH/H2O 
afforded predominantly 383 which was re-crystallized until the optical rotation was constant 
                                                 
284 See Appendix D for crystal coordinates. 
285 For a stimulating discussion of the attempted solutions to this problem, see Kendall, C., Ph.D Dissertation, 
University of Pittsburgh, 2004. 
286 Jacques, J.; Collet, A.; Wilen, S. H. Enantiomers, Racemates, and Resolutions, Wiley, New York, 1981. 
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(40%, [α]D -25.6, c 0.57 H2O).  The mother liquor from the first crystallization contained mostly 
384, which was highly soluble in EtOH.  Re-crystallization of 384 from EtOH/Et2O (2x) 





















































Scheme 2.12. Resolution of (+/-)-381  
 
 The resolution of (+/-)-379 was carried out under otherwise identical conditions as shown 

























Scheme 2.13. Resolution of (+/-)-379 
                                                 
287 The resolution was not optimized, and it is expected optimization of the acid could improve the recovery. 
288 See experimental section for details. 
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 After the tartrate salts were resolved, the only information concerning the stereochemistry 
of the amino acids was their optical rotations.  In order to ascertain the absolute stereochemistry 
of 383 and 384, a number of derivatives were prepared for analysis by x-ray diffraction (Scheme 
2.15).289  The tartrate salts were easily N-protected to give (-)-365 and (+)-365 in excellent 
yields.  Saponification with KOTMS in Et2O followed by EDCI coupling with L-Phe-OMe•HCl 
afforded the dipeptides 388 and 389 in good yields (73 and 75%, respectively).  Unfortunately, 
these dipeptides did not afford crystals suitable for x-ray diffraction studies, but they were useful 
for the HPLC determination of enantiomeric purity.  The crude coupling reactions of L-
phenylalanine with (+)-365 and (-)-365 were analyzed by HPLC and compared with the mixture 
of diastereomers prepared by coupling with (+/-)-365.290  In the analysis of the reaction of (-)-
365, the minor diastereomer was not detected by HPLC ((-)-356 de >99%) while the ratio for the 
corresponding coupling of (+)-365 was 99.3:0.7 (de 98.6%).  
 We were happy to find that the p-bromobenzamide derivative 390 could be prepared 
directly from 383 (p-BrC6H4COCl, DMAP, 70%) to afford a colorless crystalline solid.  Crystals 
suitable for single crystal x-ray diffraction analysis were obtained from a mixture of CH2Cl2 and 
toluene, confirming the absolute configuration291 of 390 (Scheme 2.15).  Although the 
configuration at the nitrogen-bearing stereocenter is R, it has the same sense of chirality (L) as 










































(c 0.83, CHCl3)  
Scheme 2.14. Preparation of phenylalanine derivatives 388 and 389 for HPLC analysis 
                                                 
289 Attempts to obtain crystals suitable for x-ray diffraction analysis from 383, 384, 385 and 386 were unsuccessful. 
290 HPLC conditions: Microsorb-MV 100 column, 3:1 hexanes/EtOAc, 388 13.2 min; 389 10.8 min. 
291 For the use of x-ray for the determination of absolute stereochemistry using heavy atoms, see Flack, H. D. Acta 
Cryst. 1983, A39, 876. 
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 A similar analysis was carried out on the tartrate salts 385 and 386.  Benzyl carbamate 
formation (Cbz-Cl, NaHCO3) afforded (-)-379 and (+)-379 in excellent yields (Scheme 2.16).  In 
this case, the coupling reaction of (-)-379 with L-Phe-OMe•HCl afforded only modest yield of 
391 (59%).  Saponification of (+)-379 with 2N NaOH solution in MeOH/THF followed by BOP 
coupling afforded 392 as a colorless solid in very good yield (85%).  The NaOH conditions are 
the best developed thus far and would be the method of choice for future coupling reactions since 
fewer side products are observed during the saponification compared with the KOTMS 
reaction.292  The diastereomeric purity of 391 and 392 was established using HPLC analysis of 












Scheme 2.15. Synthesis of derivative 390 for determination of absolute configuration294 
 
 The absolute configuration of the αMe∆Phg scaffold was determined by x-ray 
crystallographic analysis of 391 (Figure 2.10).295  In terms of the solid state structure of our 
peptide mimics, this compound also crystallized as a dimer in an anti-parallel arrangement.  
While this represents the largest linear peptide which we have been able to crystallize to date, the 
                                                 
292 LiOH mediated saponifications are slow at r.t. and reagents which require warming above r.t. lead to the 
formation of unidentified side products. 
293 HPLC conditions: Microsorb-MV 100 column, 7:3 hexanes/EtOAc, 392 4.5 min; 391 5.9 min. 
294 See Appendix E for crystal coordinates. 
295 We were able to grow crystals suitable for x-ray diffraction analysis from a mixture of hexanes and ethyl acetate. 
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extension of the linear structure into the second amino acid is encouraging for future analysis of 
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2) L-Phe-OMe•HCl

















Scheme 2.16. Synthesis of derivatives of 391 and 392 for determination of absolute 









Figure 2.10. Stereoview of the Chem3D representation of the x-ray crystal structure of 391296 
 
                                                 
296 See Appendix F for crystal coordinates. 
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2.2.3 Synthesis of Cyclopropyl-γ-Amino Amide Oligomers 
 The structural data that we have amassed to date indicates that the αMe∆Phg scaffold is 
the most promising for stabilization of extended structures.  It was our intention to prepare the 
dimer, tetramer and octamer of 335 for x-ray diffraction studies (Scheme 2.17).  Saponification 
of (-)-379 (NaOH/MeOH/THF) and coupling (BOP, DIPEA, DMF) with the free amine derived 
from Cbz-deprotection (H2, Pd/C, MeOH) afforded the dipeptide (-)-393 in excellent yield 
(91%).  The dimer was divided into two portions for the preparation of tetramer 397.  
Saponification (KOTMS, Et2O) of (-)-393 followed by coupling with MeNH2•HCl (BOP, 
DIPEA, DMF) afforded the methyl amide 394 in modest yield (62%).  The benzyl carbamate 
was removed (H2, Pd/C, MeOH) to afford the intermediate amine 395.  Dipeptide (-)-393 was 
saponified (2 N NaOH, MeOH, THF) and coupled to 395 (BOP, DIPEA, DMF) to give 397 in 
moderate yield (62%). 
 While preparing 397, it quickly became apparent that there would not be enough material 
in this enantiomeric series to complete the synthesis of the desired octapeptide 399.  Thus, 399 
was prepared in the antipodal series beginning with (+)-379 (Scheme 2.18).  Saponification 
(NaOH, MeOH, THF) and deprotection of the carbamate afforded the coupling partners for 
dimer preparation.  The amine and the acid were coupled in DMF (BOP, DIPEA) to afford the 
dimer (+)-379 (80%).  In much the same fashion as shown in Scheme 2.17, tetrapeptide 398 was 
prepared in good yield (73%).  At this stage, a small amount of 398 was kept for crystallization.   
 The majority of the material was split into two flasks for the preparation of the amine and 
acid coupling partners (NaOH, MeOH, THF or H2, Pd/C, MeOH).  BOP coupling afforded 
excellent mass recovery of the desired octapeptide.  The crude material was shown to contain 
>90% of the desired peptide by 1H NMR analysis in CDCl3.  However, upon concentration of 
this sample and solvent removal under high vacuum, the resultant colorless solid could not be 
dissolved in any solvent suitable for further purification.297 
 
                                                 











































































































































Scheme 2.18. Attempted synthesis of octamer 399 
 
2.2.4 Synthesis of Minimal β-Hairpins 
 We were forced to rely heavily upon x-ray crystallography to study the linear peptides 
prepared in the previous section; however we were unable to secure a crystal structure for 
anything larger than a dipeptide.  In order to establish the structural preferences of our 
cyclopropyl amino acid derivatives in solution, we decided to study their effects on stabilizing β-
hairpin formation.  The β-hairpin is a common structural motif found in peptides and proteins 
where two anti-parallel β-strands are connected by a two-amino acid loop known as a β-turn.  
Due to the structural similarities between our cyclopropyl amino acids and the vinylogous amino 
acids prepared by Schreiber and co-workers, we decided to use an L-Pro-Gly insert to induce β-
turn formation.  Rather than a linear synthesis of tetrapeptide 408, we chose a convergent 
approach disconnecting into two fragment peptides at the Pro-Gly linkage (Scheme 2.19).  Thus, 
beginning with Cbz-L-H2∆Phg-OMe, saponification (KOTMS, Et2O) and coupling with either L-
Pro-OMe•HCl, 400, or Me2NH•HCl (EDCI, DMAP, DIPEA) afforded the dipeptide 401 (84%) 
and the dimethylamide (-)-403 (85%).  Deprotection of the benzyl carbamate of (-)-403 (H2, 
Pd/C, MeOH) followed by coupling with Fmoc-Gly-OH, 404 (BOP, DIPEA) afforded dipeptide 
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(-)-405 in good yield (73%).  Fmoc deprotection (10% piperidine in DMF) of (-)-405 and 
saponification of methyl ester 401 (KOTMS, Et2O) afforded the coupling partners 406 and 407.  
Fragment coupling (EDCI, DMAP) afforded the desired tetrapeptide 408 (60%) as a colorless 
solid.  We were also able to secure the solid state structure of the supposed β-hairpin 408 as 
crystals were grown from a standing solution in DMSO.  Interestingly, the β-turn structure that 
was built into the system (Pro-Gly) is preserved in the x-ray structure, however the lack of 
hydrogen bonding at the termini which would be necessary to extend the β-hairpin is obvious 
(vide infra).  In fact, the amino acid residues are arranged such that intramolecular contact 
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Figure 2.11. Stereoview of the Chem3D representation of the x-ray crystal structure of 408298 
 
 We thought it might be possible to favor interaction between the ∆Phg residues by 
incorporating the enantiomeric amino acid ((+)-365) while keeping the β-turn motif constant 
(Scheme 2.20).   A sample of (+)-365 was divided into two portions and after saponification with 
KOTMS in Et2O, the crude acid was coupled with 402 and 400 to give peptides (+)-403 and 409 
in 86% and 76% yield, respectively.  Cbz-deprotection (H2, Pd/C, MeOH), coupling with 404 
(BOP, DIPEA, 76%) and Fmoc-deprotection afforded the intermediate amine ent-406.  
Saponification of 409 and coupling with ent-406 (EDCI, DMAP) afforded the tetrapeptide 411 in 
modest yield (49%). 
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Scheme 2.21. Synthesis of tetrapeptide 415 
 
 To examine the effect of the amide at the C-terminus and potentially favor an alternate 
hydrogen bonding motif between the C- and N-termini, we prepared C-terminal capped methyl 
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amide 415 (Scheme 2.21).  Saponification of (-)-365 (KOTMS, Et2O) and coupling with 
MeNH2•HCl afforded 412 in 72% yield.  Deprotection of the benzyl carbamate and coupling 
with Cbz-Gly-OH (BOP, DIPEA, DMF) gave 80% of dipeptide 414.  Hydrogenolysis of the 
benzyl carbamate followed by BOP coupling with 407 (see Scheme 2.19) in the presence of 
DIPEA afforded the desired tetrapeptide 415 in good yield (70%). 
 On the basis of the solid state analysis of the isopropylamide of (+/-)-379 (Figure 2.9), a 
β-hairpin containing two αMe∆Phg residues was prepared (Scheme 2.22).  The proline and 
methyl amide peptides were prepared in good yields using analogous protocols to those seen in 
the previous schemes.  Deprotection of the benzyl carbamate of 417 and coupling with 413 
(BOP, DIPEA, DMF) afforded the depeptide 418 (78%).  Hydrogenolysis of the Cbz group and 
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Scheme 2.22. Synthesis of tetrapeptide 421 
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 The final β-hairpin that was prepared was an extended version of 421 composed of two 
αMe∆Phg dimers linked via a Pro-Gly dipeptide (Scheme 2.23).  Beginning with dipeptide (-)-
393 (see Scheme 2.17), saponification (2 N NaOH, MeOH/THF) and coupling with i-PrNH2•HCl 
(BOP, DIPEA, DMF) afforded isopropylamide 422.  Hydrogenolysis of the Cbz group and 
coupling with 413 afforded tripeptide 423 in 92% yield.  Deprotection of the benzyl carbamate 
afforded the amine 424 required for segment condensation.  Dipeptide (-)-393 was saponified    
(2 N NaOH, MeOH/THF) and coupled with 400 in the presence of BOP and DIPEA to give 72% 
of tripeptide 425.  Deprotection of methyl ester and coupling with 424 (BOP, DIPEA, DMF) 
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Scheme 2.23. Synthesis of hexapeptide 426 
                                                 
299 We have been able to grow crystals of 426 from CH2Cl2/toluene and EtOAc/hexanes, however, the structure 
could not be solved. 
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2.3 Structural Analyses of Cyclopropyl Peptides 
2.3.1 Molecular Modeling 
 The molecular modeling (MM2*) of our simple phenylalanine derivatives 388 and 389 
(Figure 2.12) led to what appears to be a matched and mismatched set of dipeptides.  A tight 
pseudo-β-turn (Table 2.3) is well conserved for the low energy conformers of 388, however the 
lowest energy conformations of 389 display a much more disordered arrangement, although the 
pseudo-β-turn family is also present and is represented by the lowest energy conformer.  We 
have observed two different pseudo-β-turn structures (type I and II) which have major 
differences in the δ and ψ dihedral angles.  The NH-CO hydrogen bond is explicitly conserved in 
all of the minimum energy conformations which incorporate a pseudo-β-turn motif. 
Interestingly, 110 and 155 unique conformations of 388 and 389 fell within an imposed 5 kJ/mol 
window of the lowest energy conformation.300,301 
 The phenylalanine derivatives of αMe∆Phg amino acids also have a noticeable preference 
for the formation of a pseudo-β-turn (Figure 2.13).  The energy well is significantly restricted 
compared with 388 and 389, however 50 and 25 structures were found within our imposed 5 
kJ/mol cut-off for 391 and 392 respectively.  The proclivity for turn formation appears to be 
favored for the L-amino acid, though the overlay for the D-amino acid is also quite good, there is 
considerably more disorder at the termini.  Unfortunately, we were unable to confirm this 
preferred turn conformation for 392 using NMR techniques (vide infra).  For both NH 
resonances, the temperature shift coefficients were >7 ppb/K in DMSO-d6.  It is also interesting 
to note that 391 was used to confirm the absolute stereochemistry of our resolved amino acids, 
and an extended structure was favored in the solid state, although this preference could be 
attributed to crystal packing forces favoring intermolecular interactions. 
 
 
                                                 
300 A Monte-Carlo search routine was used to find the lowest energy conformations and only those within 5 kJ/mol 
of the lowest energy conformer were included in the overlay representations for all the peptides presented herein.  
For 388, 389, 391, 392, 397, 408, 411, 415, 421 and 422, 10,000 conformations were analyzed.  In the case of 426, 
25,000 structures were analyzed. 




Figure 2.12. Stereoview of the Macromodel-generated overlays of the lowest energy 
conformations for dipeptides 388 and 389 
 









pseudo β-turn  
 δ (°) χ (°) ψ (°) φ (°) NH-CO 
distance (Å) 
typea 
388 76.3 -144.8 104.0 -49.2 1.828 I 
389 -88.4 136.7 -103.9 67.3 1.907 I’ 
391 73.5 -146.9 104.0 -37.0 1.849 I 
392 -80.4 144.9 -103.5 37.1 1.843 I’ 
397 80.1 -143.3 109.2 -43.6 1.873 I 
422 63.4/54.0 -144.6/-146.4 49.0/47.4 40.1/39.7 1.851/1.857 II/II 
426 67.1/81.6 -144.8/-142.6 48.8/109.1 41.8/-44.0 1.862/1.854 II/I 






















 The linear peptides 397 and 422 also demonstrate a preference for a β-turn like structure 
about the trans-cyclopropane residue.  Interestingly, the lowest energy structure of 422 (of 28 
total) consists of two pseudo-β-turns motifs forming a helical strand (Figure 2.14).  However, as 
we can see in the overlay structure, there is considerable disorder in the C-terminal residue and 
the helical strand family of structures does not represent the majority of conformations.  The 
lowest energy conformation of 397 is a β-hairpin, although there are two major families of 
structures; approximately half of the structures (out of 41) pick up the second hydrogen bond (as 
drawn), while the NH-carbonyl interaction is not observed for the remaining conformations. 
 
 
Figure 2.13. Stereoview of the Macromodel-generated overlays for the lowest energy 
conformations of dipeptides 391 and 392 
 
 On the basis of our modeling work, these β-hairpin mimics are predicted to be very 
conformationally mobile in solution.  For all examples of H2∆Phg-containing tetrapeptides 408 
(Figure 2.15), 411 (Figure 2.16), and 415 (Figure 2.17), two main families of structures are 
observed about the Pro-Gly linkage.  In one family, a turn is initiated at the Pro-Gly linkage, 
however, the i/(i+3) hydrogen bond is not explicitly conserved.  Alternatively, two successive γ-






















flexible Gly residue causing considerable disorder in the C- and N-terminal residues.  Perhaps a 
more judicious choice of amino acid in place of Gly (for example D-Phe) may impart a more 
rigidly controlled β-turn to these peptides.  Schreiber and co-workers report that a vinylogous 
amino acid derivative similar to 408 affords a β-hairpin in solution.238  However, the only 
experiment that is used to support this conjecture is the dependence (or lack thereof) of NH 
chemical shifts with dilution in CDCl3.  Our model peptides (ie, 366, 372, 380 and 391) have 
structural properties analogous to those prepared by Schreiber and co-workers, and it was 



























Figure 2.14. Stereoview of the Macromodel-generated overlays of the lowest energy 
















further experimental evidence to support the secondary structural claims for the vinylogous 
peptides, we must conclude that the cyclopropyl substitution drastically effects the overall 
conformation of tetrapeptide 408.    At this stage, β-hairpins 411 and 415 were prepared in hopes 
of reversing this trend.  However, we have been unable to grow crystals of these compounds and 
the solution hydrogen bonding patterns are not unlike those observed for compound 408. 
 
 
Figure 2.15. Stereoview of the Macromodel-generated overlay of the lowest energy 




Figure 2.16. Stereoview of the Macromodel-generated overlay of the lowest energy 




























Figure 2.17. Stereoview of the Macromodel-generated overlay of the lowest energy 
conformations for tetrapeptide 415 
 
 On the basis of our conformational analysis, of all β-hairpin mimics that we have 
prepared, tetrapeptide 421 appears to adopt the most stable β-hairpin structure (Figure 2.18).  
The backbone of the β-turn is well conserved in all of the calculated low energy structures and 
while there is variation in the N- and C-terminal residues, two major families of structures are 
observed.  Both of these conformational families have a hydrogen bonding interaction between 
the C- and N-terminal residues.  The presence of the closed β-hairpin indicates that the 
cyclopropyl amino acid residues play a critical role in the stabilization of this secondary 
structural motif since the Pro-Gly linkage present in 408, 411 and 415 was in itself insufficient to 
nucleate the hairpin structure. 
 The hexapeptide 426 is simply an extended version of tetrapeptide 421 and we 
anticipated that we should be able to observe an extended β-hairpin.  In fact, after 
conformational searching (25,000 structures), only four conformations fell within 5 kJ/mol of the 
minimum energy conformation.  Of the four structures, the three lowest energy conformations 
are nearly super-imposable, adopting the general structure shown in Figure 2.19.  This family of 
conformers forms an extended strand of hydrogen bonded turns initiated at the proline residue 
with two γ-turns followed by the pseudo-β-turn that has been found in a the majority of 
structures calculated thus far.  Interestingly, the C-terminal residue also appears to participate in 
a bifurcated hydrogen bonding interaction with the carbonyl of the glycine residue.  The N-
terminal residue is involved in a pseudo-β-turn conformation which does not appear to interact 
with the main strand.  The fourth conformation (4.9 kJ/mol above the minima) adopts a β-turn 














arranged in a pseudo-β-turn and positions the terminal NH within hydrogen bonding contact of 
the Cbz carbonyl group. 
 
 
Figure 2.18. Stereoview of the Macromodel-generated overlay of the calculated lowest energy 































Figure 2.19. Stereoview of the Macromodel-generated overlay of the lowest energy 



















2.3.2 Solution Studies of Oligopeptides Containing Cyclopropyl Amino Acids 
 Of the larger peptides that we have prepared, we have only been able to obtain crystals 
suitable for x-ray diffraction studies for dipeptide 391 and tetrapeptide 408.  In order to evaluate 
the secondary structures formed by our peptide mimetics, we decided to attempt structural 
studies in solution using NMR and circular dichroism.  NMR studies of peptides at variable 
temperatures can provide a wealth of structural information and coupled with precise nOe 
measurements, a family of solution structures can be generated.  In particular, the temperature 
dependence of amide NH chemical shift can provide valuable information concerning their 
availability for intermolecular hydrogen bonding with solvent.302,303  Typically, these values 
range from 0 to -8 ppb/K in DMSO; a small co-efficient (0 to -3 ppb/K) is indicative of a proton 
which is strongly shielded from solvent exposure; an intermediate value (-3 to -4.5 ppb/K) 
indicates moderate shielding whereas values from -4.5 to -8 ppb/K indicate that the proton is 




































Figure 2.20. Amide proton chemical shift dependence on temperature for a 5.0 mM solution of 
tetraapeptide 408 in DMSO-d6 
                                                 
302 For the interpretation of temperature shift coefficients in polar aprotic solvents such as DMSO-d6, see Smith, J. 
A.; Pease, L. G. Crit. Rev. Bioch. 1980, 8, 315. 
303 For the interpretation of temperature shift coefficients in non-polar solvents such as CDCl3, see Stevens, E. S.; 
Sugawara, N.; Bonora, G. M.; Toniolo, C. J. Am. Chem. Soc. 1980, 102, 7048. 
304 Imperiali, B.; Fisher, S. L.; Moats, R. A.; Prins, T. J. J. Am. Chem. Soc. 1992, 114, 3182. 
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 We measured temperature shift coefficients for a number of oligopeptides and plotted the 
amide NH chemical shift vs. temperature for each amide in the peptide.  In all but one case 
(426), all NH resonances could be assigned using a combination of 2D-NMR techniques (COSY, 
HMQC and HMBC).  For example, the NH chemical shifts for 408 were measured from 298 K 
to 358 K in 10 K increments (Figure 2.20, entry 1, Table 2.4).  Using linear regression analysis, 
the slope of the correlation between chemical shift and temperature represents the temperature 
shift coefficient for the amide NH.  From this plot, we can see that only the NH of the C-terminal 
residue is involved in intramolecular hydrogen bonding interactions.  The diastereomeric 
tetrapeptide, 411 (Table 2.4, entry 2) exhibits a similar pattern where the β-turn has been 
conserved, yet there is no evidence for attractive interactions between the terminal residues.  It is 
interesting to note that the local conformational preference for the β-turn structure has been 
observed in the x-ray structure of 408 (Figure 2.11) and in the NH chemical shift correlation 
experiments for 408 and 411.  However, given that modeling indicates potential for γ-turns about 
the Pro-Gly linkage, we can not rule out the possibility that the observed low temperature shift 
co-efficients (<3.5 ppb/K) are part of a γ-turn motif.  The methylamide-capped tetrapeptide 415 
(Table 2.4, entry 3) was prepared in the hope of picking up an alternate interaction between the 
C- and N-terminal residues.  In fact, not only is hydrogen bonding not observed between the 
termini, but this change drastically affected the overall conformation of the molecule and the β-
turn is no longer present.  On the basis of molecular modeling, the αMe∆Phg-derived peptide 421 
was predicted to prefer a conformation consistent with a β-hairpin.  Gratifyingly, the temperature 
shift co-efficients for both the Gly amide NH (i+3) and the N-terminal carbamate NH (i) are <3.5 
ppb/K providing strong evidence for the formation of a stabilized minimal β-hairpin motif in 
DMSO solution.  Unfortunately, we were unable to corroborate this evidence with long range 
NOE data, and attempts to crystallize 421 have been unsuccessful to date.  The hexapeptide 426 
could not be fully assigned by 2D-NMR techniques due to overlapping signals in the 
cyclopropane region.  However, the temperature shift coefficients do not indicate an extended β-
hairpin as we had hoped (Table 2.4, entry 5).  Unfortunately, only the (i+3) residue appears to be 
involved in a hydrogen bond, although all of the coefficients are lower than previously observed 
(<5.6 ppb/K) which may indicate that the preferred conformation easily unfolds to expose the 
amide bonds with increased temperature. 
 
  176
Table 2.4. Temperature shift coefficients for 5.0 mM solutions in DMSO-d6 
  observed temperature shift coefficients 
(ppb/K)a 
entry compound i-1305 i i+2 i+3 i+4 i+5 
1 408 n/a 6.6 5.7 2.8 n/a n/a 
2b 411 n/a 7.5 7.2 3.3 n/a n/a 
3b 415 n/a 7.0 5.9 6.4 7.2 n/a 
4b 421 n/a 3.1 5.4 2.5 n/a n/a 
5b 426c 5.6 4.9 5.6 2.1 4.5 5.0 
6b 422d 7.6 7.2 7.0 n/a n/a n/a 
7b 392d 7.7 7.6 n/a n/a n/a n/a 
aAbsolute values; bSee Appendix I for the chemical shift temperature correlations for entries 2-7; cThe i and 
i+4 NH resonances could not be unambiguously assigned using 2D-NMR; dThe temperature shift coefficients for 
422 and 392 are given beginning with the N-terminal residue. 
 




388 215 40.8 
389 221 18.5 
391a -- -- 
392 219 25.0 
397 217 -83.2 
422 217 -56.4 
408 213 42.9 
411a -- -- 
415 229 11.5 
421 230 9.29 
426 219 -74.4 
aA distinct transition was not observed. 
 
 On the basis of the circular dichroism data, we can conclude that the structures of 408 
and 415 are similar in MeOH solution, while the CD data seems to indicate a random coil for 
both 411 and 421.  The random orientation of 411 is in accord with our molecular mechanics 
calculations while the data for 421 is puzzling and is not in agreement with the modeling or 
variable temperature NMR data.  It is possible that the relatively flat curve for 421 is the result of 
the additive effects of two opposing Cotton effects. 
 
                                                 























































Figure 2.22. Circular dichroism spectra for peptides 397 and 422306 
                                                 






























Figure 2.23. Circular dichroism spectra for phenylalanine derivatives 388, 389, 391 and 392306 
 
 Finally, the temperature shift co-efficients observed for 422 and 392 do not support the 
calculated preferred conformations (Table 2.4, entry 6 and 7), and may indicate a preference for 
an extended structure for these small peptides in solution.  Interestingly, there is excellent 
correlation between the CD spectra of 422 and 397 indicating that these two peptides may share 
similar conformations in solution (Figure 2.22).  Likewise, the phenylalanine derivatives 389 and 
392 have very similar CD spectra (Figure 2.23), and while this seems to agree very well with our 
calculated structures, we were unable to observe the intramolecular hydrogen bonding for 392 in 
DMSO (Table 2.4, entry 7). 
 At this stage, the structural information that we have been able to collect thus far tends to 
indicate a preference for extended structures in the solid state, while our calculations have 
predicted a strong preference for reverse turn-like conformations.  In the solid state, the crystal 
packing forces and the stabilization via intermolecular interactions may be the driving force for 
the formation of the observed sheet-like arrangements.  However, we have not been able to 
unambiguously determine the conformational preference in solution. 
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2.4 Conclusions 
 We have achieved a concise synthesis of a family of cyclopropyl amino acids (H2∆Phg, 
αMe∆Phg, βMe∆Phg) in 6-7 steps and 30-45% overall yield highlighting some of the 
methodology presented in the first chapter of this dissertation.  Simple amide derivatives were 
found to fold into stable sheet-like structures in the solid state.  After this preliminary evaluation, 
the H2∆Phg and αMe∆Phg scaffolds were resolved via fractional crystallization for further 
assessment of their potential to induce extended structures in oligopeptides.  A number of linear 
oligopeptides were prepared, however, we were unable to grow crystals suitable for x-ray 
diffraction studies of anything larger than a dimer.  Circular dichroism studies of these linear 
peptides coupled with molecular modeling allowed for a correlation of the observed CD spectra 
with the calculated conformational minima. 
 Solution studies were also undertaken for the designed β-hairpin structures 408, 411, 415, 
421 and 426 and while the built-in β-turn was observed by variable temperature NMR studies in 
nearly every case, only the αMe∆Phg scaffold picked up the hydrogen bonding contact between 
the C- and N-termini.  Similar to the studies of the linear peptides, the CD spectra of the minimal 
β-hairpins were interpreted using molecular modeling. 
 Finally, the isopropyl amide 380 has been found to be a pregnane X receptor agonist 
which exhibits differential activity between human and mouse based assays.  In fact, (+)-380 has 
been found to be more active in hPXR whereas (-)-380 was a better agonist for mPXR.  
Similarly, phosphinamide 363 has been shown to suppress pre-mRNA splicing of CD45.  
Unfortunately, the molecular target of 363 is unclear, although it appears to act via a novel 
mechanism/target.  Focused libraries of analogs of 363 and 380 will improve our understanding 
of the origin of the species-dependent stereoselectivity of 380 and hopefully improve activity for 
RNA splicing as well as allow the determination of the molecular target. 
 Despite the conformational rigidity of our new amino acid scaffold, the rational 
prediction of secondary structure remains difficult as the peptides appear to possess significant 
conformational freedom.  The most promising aspect of this work lies in the continued 
evaluation of cyclopropyl amino acid derivatives in a biological context.  An expanded library of 
analogs related to amino acids other than phenylglycine should be evaluated and could lead to 
the discovery of interesting lead structures. 
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2.5 Experimental Part 
General.  All general comments from Chapter 1.6 pertain also to this experimental section.  CD 





diphenylphosphinamide (342).  To a suspension of Cp2ZrHCl (0.69 g, 2.7 mmol) in dry CH2Cl2 
(5.0 mL) was added 341 (0.79 g, 2.7 mmol).  The reaction mixture was stirred for 10 min, cooled 
to -78 °C, treated with Me2Zn (1.3 mL, 2.7 mmol, 2.0 M in toluene) and warmed to 0 °C.  After 
addition of 21 (0.27 g, 0.89 mmol), the mixture was heated at reflux for 12 h, cooled to 0 °C, 
treated with a solution of Zn(CH2I)2•DME307 (4.5 mmol in 2.5 mL CH2Cl2) and stirred for 5 h.  
The solution was quenched with sat. NH4Cl, diluted with EtOAc and filtered through a mixture 
of Celite and SiO2 (~1:1).  The aqueous layer was extracted with EtOAc (3x) and the combined 
organic layers were washed with brine, dried (Na2SO4) and concentrated.  The residue was 
purified by chromatography on SiO2 (2:3, hexanes/EtOAc) to afford 342 (0.30 g, 56%) as a 
colorless foam:  IR (neat) 3189, 3070, 3028, 2930, 2857, 1590, 1471, 1455, 1438, 1428, 1190, 
1111 cm-1; 1H NMR δ 7.93-7.86 (m, 2 H), 7.75-7.62 (m, 7 H), 7.47-7.33 (m, 12 H), 7.31-7.24 
(m, 4 H), 3.80 (dt, J = 10.0, 7.9 Hz, 1 H), 3.63 (dd, J = 10.6, 5.4 Hz, 1 H), 3.42 (dd, J = 10.6, 6.2 
Hz, 1 H), 3.32-3.28 (m, 1 H), 1.23-1.08 (m, 2 H), 1.01 (s, 9 H), 0.51 (dt, J = 8.5, 5.1 Hz, 1 H), 
0.42 (dt, J = 8.5, 5.2 Hz, 1 H); 13C NMR δ 143.35, 143.30, 135.53, 135.50, 133.82, 132.30, 
132.17, 131.97, 131.85, 131.62, 131.59, 131.41, 129.48, 128.37, 128.20, 128.13, 127.96, 127.53, 
126.96, 126.79, 66.15, 58.16, 26.83, 24.76, 24.68, 20.33, 19.09, 8.45; MS (ESI) m/z (intensity) 
1253 ([2M+Na]+, 23), 1231 ([2M+H]+, 20), 638 ([M+Na]+, 35), 616 ([M+H]+, 100), 538 (29); 
HRMS (ESI) m/z calculated for C39H43NO2PSi (M+H) 616.2801, found 616.2799. 
                                                 
307 Zn(CH2I)2•DME complex was prepared by dropwise addition of CH2I2 (0.72 mL, 8.9 mmol) to a cooled (-20 °C) 
solution of Et2Zn (0.55 g, 4.5 mmol) and DME (0.46 mL, 4.5 mmol) in dry CH2Cl2 (2.5 mL).  The solution was 






diphenylphosphinamide (355).  General Protocol N.  To a solution of 177 (7.0 g, 11 mmol) in 
dry THF (0.11 L) was added AcOH (1.3 mL, 22 mmol) and TBAF (22 mL, 22 mmol, 1.0 M in 
THF).  The reaction mixture was stirred for 12 h, quenched with sat. NH4Cl and extracted with 
EtOAc (3x).  The combined organic layers were washed with brine, dried (MgSO4) and 
concentrated.  The residue was purified by chromatography on deactivated SiO2 (65:35, 
CH2Cl2/acetone containing 1% v/v Et3N) to afford 355 (3.3 g, 76%) as a colorless foam:  IR 
(neat) 3218, 3048, 2924, 2863, 1438, 1180, 1123, 1111 cm-1; 1H NMR δ 7.92-7.81 (m, 4 H), 
7.50-7.25 (m, 11 H), 4.68 (bs, 1 H), 3.84-3.73 (m, 3 H), 3.28-3.15 (m, 1 H), 2.18-2.07 (m, 1 H), 
1.32-1.22 (m, 1 H), 1.09-1.00 (m, 1 H), 0.80-0.69 (m, 1 H), 0.42-0.30 (m, 2 H); 13C NMR δ 
143.76, 143.64, 133.68, 133.02, 132.89, 132.07, 132.02, 131.97, 131.78, 131.65, 131.46, 129.69, 
128.63, 128.48, 128.44, 127.21, 126.11, 61.71, 61.20, 37.56, 28.01, 17.95, 12.23; MS (EI) m/z 
(intensity) 391 (M+, 0.5), 306 (27), 255 (71), 216 (68), 201 (100), 143 (79), 125 (63); HRMS 
(EI) m/z calculated for C24H26NO2P 391.1701, found 391.1686. 
NHP(O)Ph2
356  
N-(R*)-(Phenyl((1R*,2S*)-2-vinylcyclopropyl)methyl)-P,P-diphenylphosphinamide (356).  
General Protocol O.  To a cooled (0 °C) solution of 355 (1.8 g, 4.6 mmol) and                        
o-NO2C6H4SeCN (2.1 g, 9.2 mmol) in dry THF (75 mL) was added dropwise a solution of 
Bu3P308 (1.9 g, 9.2 mmol) in dry THF (10 mL).  The reaction mixture was stirred for 1 h, 
quenched with sat. NaHCO3 and extracted with EtOAc (3x).  The combined organic layers were 
washed with brine, dried (MgSO4) and concentrated.  The residue was dissolved in dry CH2Cl2 
(0.10 L), cooled to -40 °C and treated with Na2HPO4 (3.3 g, 23 mmol) and m-CPBA (2.7 g, 11 
mmol, ~70% w/w m-CPBA).  The reaction mixture was stirred until the selenide was consumed 
(as judged by TLC analysis), treated with freshly distilled i-Pr2NH (3.2 mL, 23 mmol), warmed 
to r.t. and stirred for 12 h.  The solution was quenched with sat. NaHCO3 and extracted with 
                                                 
308 Tri-n-butylphosphine was stored in a glove box. 
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EtOAc (3x).  The combined organic layers were washed with brine, dried (MgSO4) and 
concentrated.  The residue was purified by chromatography on deactivated SiO2 (1:1, 
hexanes/EtOAc containing 1% v/v Et3N) to afford 356 (1.5 g, 88%) as a colorless solid:  mp 
166.8-169.2 °C (hexanes/EtOAc);  IR (KBr) 3198, 3076, 3026, 3000, 2871, 1636, 1456, 1436, 
1183, 1124, 1107 cm-1; 1H NMR δ 7.94-7.88 (m, 2 H), 7.77-7.71 (m, 2 H), 7.52-7.40 (m, 4 H), 
7.35-7.22 (m, 7 H), 5.45-5.30 (m, 1 H), 5.03 (dd, J = 17.0, 0.8 Hz, 1 H), 4.84 (d, J = 10.2, 1.2 
Hz, 1 H), 3.85 (app q, J = 8.8 Hz, 1 H), 3.40-3.35 (m, 1 H), 1.48 (septet, J = 4.8 Hz, 1 H), 1.36-
1.27 (m, 1 H), 0.71 (dt, J = 8.5, 5.1 Hz, 1 H), 0.63 (dt, J = 8.5, 5.1 Hz, 1 H); 13C NMR δ 143.08, 
143.01, 140.18, 132.25, 132.22, 132.09, 132.00, 131.74, 131.71, 131.63, 128.50, 128.40, 128.33, 
128.16, 127.20, 126.83, 112.38, 58.39, 28.60, 28.54, 22.09, 12.33; MS (EI) m/z (intensity) 373 






oxylate (Dpp-H2∆Phg-OMe) (363).  General Protocol P.  A solution of 356 (1.5 g, 4.0 mmol) 
in dry CH2Cl2 (0.10 L) was treated with a solution of NaOH (25 mL, 2.5 M in MeOH) and 
cooled to -78 °C.  The reaction mixture was treated with a stream of O3 (~4.5% v/v O3 in O2) for 
6 h (until a faint blue color persisted), diluted with water and EtOAc and warmed to r.t.  The 
mixture was extracted with EtOAc (3x) and the combined organic layers were washed with 
brine, dried (MgSO4) and concentrated to afford 363 (1.6 g, quant) as a colorless solid which was 
used without further purification.  An analytical sample was purified by crystallization from 
hexanes/EtOAc:  mp 187.5-188.5 °C (hexanes/EtOAc); IR (KBr) 3211, 3051, 3007, 2948, 1713, 
1438, 1213, 1176, 1121, 1110 cm-1; 1H NMR δ 7.94-7.88 (m, 2 H), 7.75-7.69 (m, 2 H), 7.55-7.42 
(m, 4 H), 7.36-7.27 (m, 7 H), 3.87 (app q, J = 8.9 Hz, 1 H), 3.62 (s, 3 H), 3.35 (t, J = 7.5 Hz, 1 
H), 1.97-1.88 (m, 1 H), 1.78 (dt, J = 8.5, 4.6 Hz, 1 H), 1.13 (dt, J = 8.8, 4.8 Hz, 1 H), 0.92-0.86 
(m, 1 H); 13C NMR δ 173.90, 142.38, 142.31, 132.30, 132.21, 132.07, 132.04, 131.92, 131.83, 
131.80, 131.76, 131.73, 131.62, 128.63, 128.56, 128.40, 128.24, 127.58, 126.80, 57.52, 51.69, 
29.08, 29.02, 20.07, 13.92; MS (EI) m/z (intensity) 405 (M+, 2), 319 (41), 306 (46), 201 (100), 





(1R*,2R*)-Methyl 2-((R*)-amino(phenyl)methyl)cyclopropanecarboxylate hydrochloride 
(H2∆Phg-OMe•HCl) (364).  General Protocol Q.  To a cooled (0 °C) solution of 363 (1.6 g, 
4.0 mmol) in MeOH (20 mL) was added a freshly prepared solution of HCl (20 mL, 1.0 M in 
MeOH).  The reaction mixture was warmed to r.t., stirred for 12 h, and poured into dry Et2O 
(~0.30 L).  The suspension was cooled to 0 °C and filtered to afford 364 (0.74 g, 76%) as a 
colorless solid:  mp 289.0-291.5 °C (dec., ether/MeOH);  IR (KBr) 3419, 2963, 2875, 1719, 
1605, 1507, 1458, 1371, 1239, 1213, 1172 cm-1; 1H NMR (CD3OD) δ 7.49-7.43 (m, 5 H), 3.82 
(d, J = 9.5 Hz, 1 H), 3.71 (s, 3 H), 2.05-1.95 (m, 2 H), 1.24-1.17 (m, 1 H), 1.08-1.02 (m, 1 H); 




(+/-)-Cbz-H2∆Phg-OMe ((+/-)-365).  General Protocol R.  To a cooled (0 °C) biphasic mixture 
of 364 (50 mg, 0.21 mmol) in EtOAc (1.0 mL) and H2O (1.0 mL) was added NaHCO3 (87 mg, 
1.0 mmol) and Cbz-Cl (35 µL, 0.25 mmol).  The reaction mixture was vigorously stirred for 2 h, 
diluted with H2O and extracted with EtOAc (3x).  The combined organic layers were washed 
with brine, dried (MgSO4) and concentrated.  The residue was purified by chromatography on 
SiO2 (4:1, hexanes/EtOAc) to afford (+/-)-365 (66 mg, 95%) as a colorless oil that solidified on 
standing:  IR (neat) 3348, 3063, 3032, 2952, 1721, 1690, 1526, 1454, 1347, 1258, 1242, 1207, 
1179 cm-1; 1H NMR δ 7.39-7.30 (m, 10 H), 5.20 (bs, 1 H), 5.17, 5.08 (AB, J = 12.2 Hz, 2 H), 
4.32 (bm, 1 H), 3.69 (s, 3 H), 1.90-1.80 (m, 2 H), 1.29-1.23 (m, 1 H), 0.98-0.92 (m, 1 H); 13C 
NMR δ 173.94, 155.70, 140.78, 136.28, 128.70, 128.48, 128.10, 128.04, 127.76, 126.51, 66.93, 
57.45, 51.85, 27.29, 19.02, 13.78; MS (EI) m/z (intensity) 248 ([M-C7H7]+, 2), 145 (22), 91 





Cbz-L-H2∆Phg ((-)-365).  According to the General Protocol R, 383 (80 mg, 0.22 mmol), 
NaHCO3 (95 mg, 1.1 mmol) and Cbz-Cl (40 µL, 0.27 mmol) in EtOAc/H2O (1:1, 4.0 mL) 




Cbz-D-H2∆Phg ((+)-365).  According to the General Protocol R, 384 (0.14 g, 0.39 mmol), 
NaHCO3 (0.16 g, 2.0 mmol) and Cbz-Cl (70 µL, 0.47 mmol) in EtOAc/H2O (1:1, 4.0 mL) 







Cbz-DL-H2∆Phg-NHPri (366).  To a solution of 365 (19 mg, 0.056 mmol) in dry Et2O (0.50 mL) 
was added KOTMS (14 mg, 0.11 mmol).  The reaction mixture was stirred for 1.5 h, diluted with 
water, acidified with 10 % HCl and extracted with EtOAc (3x).  The combined organic layers 
were washed with brine, dried (Na2SO4) and concentrated.  The residue was dissolved in dry 
CH2Cl2 (0.50 mL) and treated with EDCI (14 mg, 0.073 mmol), DMAP (1.0 mg, 8.2 µmol), 
DIPEA (49 µL, 0.28 mmol) and i-PrNH2•HCl (27 mg, 0.28 mmol).  The reaction mixture was 
stirred for 12 h, diluted with EtOAc and washed with water, 10% HCl and brine, dried (MgSO4) 
and concentrated.  The residue was purified by chromatography on SiO2 (3:2, hexanes/EtOAc) to 
give 366 (15 mg, 75%) as a colorless solid:  mp 197.5-200.3 °C (hexanes/EtOAc);  IR (KBr) 
3323, 3060, 3032, 2968, 2929, 1693, 1637, 1542, 1291, 1263, 1227, 1150 cm-1; 1H NMR δ 7.36-
7.29 (m, 10 H), 5.59 (bs, 1 H), 5.39 (bd, J = 7.0 Hz, 1 H), 5.12, 5.07 (AB, J = 12.1 Hz, 2 H), 4.17 
(t, J = 8.7 Hz, 1 H), 4.06 (octet, J = 6.7 Hz, 1 H), 1.85-1.76 (m, 1 H), 1.35-1.19 (m, 2 H), 1.14 (d, 
J = 6.5 Hz, 6 H), 0.76 (ddd, J = 8.3, 5.9, 4.6 Hz, 1 H); 13C NMR δ 171.08, 155.90, 140.93, 
136.36, 128.69, 128.52, 128.16, 128.00, 127.73, 126.66, 66.80, 58.33, 41.53, 25.89, 22.82, 22.05, 
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12.36; MS (ESI) m/z (intensity) 389 ([M+Na]+, 100); HRMS (ESI) m/z calculated for 





diphenylphosphinamide (367).  According to the General Protocol N, 179 (1.8 g, 2.8 mmol), 
AcOH (0.32 mL, 5.5 mmol) and TBAF (5.5 mL, 5.5 mmol, 1.0 M in THF) in dry THF (30 mL) 
afforded 367 (1.1 g, 96%) as a colorless foam:  IR (KBr) 3307, 3167, 3077, 3056, 2979, 2960, 
2862, 1451, 1438, 1184, 1122 cm-1; 1H NMR δ 7.98-7.91 (m, 2 H), 7.79-7.72 (m, 2 H), 7.55-7.29 
(m, 11 H), 3.83-3.65 (m, 3 H), 3.37 (t, J = 11.4 Hz, 1 H), 2.08-1.98 (m, 1 H), 1.41-1.31 (m, 1 H), 
1.23-1.12 (m, 1 H), 0.95 (s, 3 H), 0.84 (dd, J = 9.1, 4.8 Hz, 1 H), 0.15 (t, J = 5.4 Hz, 1 H); 13C 
NMR δ 141.96, 141.85, 133.98, 132.86, 132.73, 132.26, 132.01, 131.98, 131.85, 131.32, 129.54, 
128.74, 128.58, 128.41, 128.26, 127.00, 126.50, 64.90, 61.99, 33.27, 26.59, 22.25, 20.25, 12.46; 
MS (ESI) m/z (intensity) 833 ([2M+Na]+, 53), 428 ([M+Na]+, 100); HRMS (ESI) m/z calculated 




diphenylphosphinamide (368).  According to the General Protocol O, 367 (1.1 g, 2.7 mmol),  
o-NO2C6H4SeCN (1.2 g, 5.3 mmol) and Bu3P (1.1 g, 5.3 mmol) in dry THF (50 mL) followed by 
Na2HPO4 (1.9 g, 13 mmol), m-CPBA (1.6 g, 13 mmol, ~70 wt % m-CPBA) and i-Pr2NH (1.9 
mL, 13 mmol) in dry CH2Cl2 (50 mL) afforded 368 (0.85 g, 82%) as a colorless solid: mp 166.7-
168.5 °C (hexanes/EtOAc);  IR (KBr) 3179, 3058, 2994, 2968, 1634, 1452, 1436, 1184, 1177, 
1124, 1106 cm-1; 1H NMR δ 7.91-7.84 (m, 2 H), 7.78-7.71 (m, 2 H), 7.53-7.41 (m, 4 H), 7.35 (m, 
7 H), 5.62 (ddd, J = 17.1, 10.2, 8.1 Hz, 1 H), 5.15 (ddd, J = 17.0, 2.0, 0.8 Hz, 1 H), 5.04 (ddd, J 
= 10.2, 2.0, 0.6 Hz, 1 H), 3.85 (t, J = 10.4 Hz, 1 H), 3.35 (dd, J = 9.9, 7.1 Hz, 1 H), 1.64 (dt, J = 
8.3, 5.7 Hz, 1 H), 1.13 (dd, J = 8.8, 5.0 Hz, 1 H), 1.01 (s, 3 H), 0.50 (t, J = 5.4 Hz, 1 H); 13C 
NMR δ 142.01, 141.95, 137.46, 137.42, 134.26, 134.17, 133.15, 133.04, 132.52, 132.40, 132.00, 
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131.88, 131.79, 131.74, 131.68, 131.44, 128.56, 128.54, 128.37, 128.32, 128.17, 127.17, 127.01, 
115.24, 62.20, 27.73, 27.68, 26.66, 18.98, 14.92; MS (EI) m/z (intensity) 387 (M+, 17), 346 (20), 
333 (28), 306 (3), 270 (37), 218 (55), 201 (100), 186 (40), 170 (40), 155 (42), 132 (62); HRMS 





anecarboxylate (Dpp-βMe∆Phg-OMe) (369).  According to the General Protocol P, 368 (0.50 
g, 1.3 mmol) in dry CH2Cl2 (35 mL) and NaOH (9.0 mL, 2.5M in MeOH) was treated with a 
stream of O3 (~4.5% v/v O3 in O2) to afford 369 as a colorless solid which was used in the 
subsequent step without further purification. An analytical sample was purified by 
recrystallization (hexanes/EtOAc):  mp 220.0-222.3 °C (hexanes/EtOAc); IR (KBr) 3203, 3061, 
2450, 2878, 1722, 1456, 1437, 1177, 1125, 1109 cm-1; 1H NMR δ 7.83 (dd, J = 11.9, 7.1 Hz, 2 
H), 7.73 (dd, J = 12.0, 7.4 Hz, 2 H), 7.53-7.43 (m, 4 H), 7.36-7.23 (m, 7 H), 3.92 (t, J = 10.6 Hz, 
1 H), 3.69 (s, 3 H), 3.38 (t, J = 8.8 Hz, 1 H), 1.99 (dd, J = 8.4, 5.9 Hz, 1 H), 1.41 (dd, J = 8.3, 4.9 
Hz, 1 H), 1.16-1.11 (m, 1 H), 1.11 (s, 3 H); 13C NMR δ 172.74, 141.28, 141.22, 133.60, 132.56, 
132.43, 131.87, 131.74, 130.88, 128.57, 128.39, 128.19, 127.37, 127.04, 61.21, 51.70, 31.06, 
31.00, 24.52, 19.14, 13.80; MS (ESI) m/z (intensity) 861 ([2M+Na]+, 60), 442 ([M+Na]+, 100); 





chloride (βMe∆Phg-OMe•HCl) (370).  According to the General Protocol Q, 369 (0.54 g, 1.3 
mmol) and HCl (10 mL, 1.0 M in MeOH) afforded 370 (0.25 g, 75% (2 steps)) as a colorless 
solid:  mp 226.2-228.8 °C (dec., Et2O/MeOH); IR (KBr) 3430, 2952, 1724, 1596, 1517, 1442, 
1196, 1176 cm-1; 1H NMR (CD3OD) δ 7.51-7.38 (m, 5 H), 4.01 (s, 1 H), 3.71 (s, 3 H), 2.02 (dd, 
J = 8.7, 5.9 Hz, 1 H), 1.41 (dd, J = 8.8, 5.3 Hz, 1 H), 1.19 (s, 3 H), 1.12 (t, J = 5.7 Hz, 1 H); 13C 
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Cbz-βMe∆Phg-OMe•HCl (371).  According to the General Protocol R, 370 (75 mg, 0.29 
mmol), NaHCO3 (0.12 g, 1.5 mmol) and Cbz-Cl (50 mL, 0.35 mmol) in EtOAc/H2O (1:1, 3.0 
mL) afforded 370 (86 mg, 83%) as a colorless oil:  IR (neat) 3342, 3064, 3032, 3005, 2952, 
1716, 1531, 1497, 1441, 1241, 1197, 1174 cm-1; 1H NMR δ 7.39-7.28 (m, 10 H), 5.27 (bd, J = 
8.3 Hz, 1 H), 5.14, 5.10 (AB, J = 12.2 Hz, 2 H), 4.50 (d, J = 6.4 Hz, 1 H), 3.70 (s, 3 H), 1.94 
(bm, 1 H), 1.28-1.17 (m, 2 H), 1.11 (s, 3 H); 13C NMR δ 172.39, 155.94, 139.53, 136.31, 128.59, 
128.51, 128.16, 128.07, 127.64, 126.82, 67.05, 61.35, 51.69, 29.61, 24.21, 18.95, 13.60; MS (EI) 
m/z (intensity) 262 ([M-C7H7]+, 20), 91 (100); HRMS (EI) m/z calculated for C21H23NO4 







Cbz-(+/-)-βMe∆Phg-NHPri (372).  General Protocol S.  To a solution of 371 (30 mg, 0.085 
mmol) in MeOH (1.0 mL) was added NaOH (1.0 mL, 2.0 M in H2O) and THF (0.20 mL).  The 
reaction mixture was stirred for 3 h, acidified with 10% HCl and extracted with EtOAc (3x).  
The combined organic layers were washed with brine, dried (Na2SO4) and concentrated.  The 
residue was dissolved in dry DMF (1.0 mL) and treated at 0 °C with BOP (56 mg, 0.13 mmol), i-
PrNH2•HCl (41 mg, 0.42 mmol) and DIPEA (74 µL, 0.42 mmol).  The mixture was stirred for 30 
min, warmed to r.t. and stirred for 4 h, diluted with EtOAc and washed with 10% HCl, H2O and 
brine, dried (Na2SO4) and concentrated.  The residue was purified by chromatography on SiO2 
(3:2, hexanes/EtOAc) to afford 372 (27 mg, 84%) as a colorless solid:  mp 149.5-152.1 °C 
(hexanes/EtOAc);  IR (KBr) 3333, 3301, 3063, 3033, 2971, 2943, 1709, 1644, 1544, 1454, 1252 
cm-1; 1H NMR δ 7.39-7.30 (m, 10 H), 5.79 (bs, 1 H), 5.36 (d, J = 7.1 Hz, 1 H), 5.16, 5.13 (AB, J 
= 12.6 Hz, 2 H), 4.21 (d, J = 7.6 Hz, 1 H), 4.06 (octet, J = 6.6 Hz, 1 H), 1.86-1.80 (m, 1 H), 1.19 
(t, J = 5.4 Hz, 1 H), 1.15 (d, J = 6.5 Hz, 3 H), 1.10 (d, J = 7.4 Hz, 3 H), 1.09 (s, 3 H), 1.02-0.97 
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(m, 1 H); 13C NMR δ 169.33, 156.17, 139.24, 136.28, 128.60, 128.27, 127.96, 127.65, 126.79, 
66.92, 62.92, 41.41, 28.90, 27.03, 23.06, 22.74, 16.41, 12.17; MS (ESI) m/z (intensity) 403 






diphenylphosphinamide (373).  To a solution of Cp2ZrCl2 (0.77 g, 2.6 mmol) in dry CH2Cl2 (50 
mL) was added a freshly prepared solution of Me3Al (3.8 g, 52 mmol) in dry CH2Cl2 (10 mL).  
The light yellow reaction mixture was cooled to 0 °C, treated dropwise with H2O (0.47 mL, 26 
mmol) (Caution: exothermic), warmed to r.t., stirred for 10 min, cooled to 0 °C and treated 
dropwise with a solution of 125 (8.1 g, 26 mmol) in dry CH2Cl2 (20 mL).  The solution was 
stirred for 40 min and distributed equally via syringe to 16 10 mL microwave tubes containing 
21 (0.25 g, 0.82 mmol).  The microwave tubes were heated in the microwave reactor for 7.5 min 
(100 °C, 300W) then poured into an ice/sat. NaHCO3 mixture and filtered through Celite.  The 
aqueous layer was extracted with EtOAc (3x) and the combined organic layers were washed with 
brine, dried (MgSO4) and concentrated.  The residue was purified by chromatography on SiO2 
(2:3 then 1:4, then 0:1 hexanes/EtOAc) to give 373 (7.0 g, 85%) as a colorless foam:  IR (neat) 
3241, 3070, 2930, 2857, 1438, 1428, 1184, 1111 cm-1; 1H NMR δ 7.96-7.81 (m, 4 H), 7.67-7.63 
(m, 4 H), 7.45-7.30 (m, 14 H), 7.29-7.16 (m, 3 H), 5.40 (d, J = 9.3 Hz, 1 H), 5.08 (app. q, J = 9.1 
Hz, 1 H), 3.64 (t, J = 6.7 Hz, 2 H), 3.41 (bm, 1 H), 2.32-2.10 (m, 2 H), 1.36 (d, J = 1.0 Hz, 3 H), 
1.01 (s, 9 H); 13C NMR δ 135.56, 134.57, 133.97, 132.64, 132.51, 132.10, 131.98, 131.85, 
129.54, 128.68, 128.53, 128.38, 128.30, 128.21, 127.60, 127.07, 126.92, 62.55, 53.11, 42.48, 
26.84, 19.12, 16.58; MS (EI) m/z (intensity) 629 (M+, 1), 572 (44), 416 (15), 355 (65), 216 (31), 





methyl)-P,P-diphenylphosphinamide (374).  To a freshly prepared solution of Et2Zn (13 g, 
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0.10 mol) in dry CH2Cl2 (65 mL) was added dry DME (11 mL, 0.10 mol).  The reaction mixture 
was cooled to -20 °C, treated dropwise with CH2I2 (17 mL, 0.21 mol), stirred for 10 min and 
treated with a solution of 373 (6.6 g, 10 mmol) in dry CH2Cl2 (40 mL).  The solution was stirred 
for 48 h, quenched with sat. NH4Cl and extracted with CH2Cl2 (2x).  The combined organic 
layers were washed with brine, dried (MgSO4) and concentrated.  The residue was purified by 
chromatography on SiO2 (2:3 then 1:4, then 0:1 hexanes/EtOAc) to give 374 (6.4 g, 95%) as a 
colorless foam:  IR (neat) 3183, 3056, 2930, 2857, 1438, 1428, 1188, 1110 cm-1; 1H NMR δ 
7.97-7.90 (m, 2 H), 7.79-7.73 (m, 2 H), 7.62-7.57 (m, 4 H), 7.48-7.31 (m, 13 H), 7.23-7.19 (m, 4 
H), 3.80 (t, J = 10.0 Hz, 1 H), 3.56-3.41 (m, 2 H), 3.29 (bs, 1 H), 1.55-1.45 (m, 1 H), 1.40-1.28 
(m, 1 H), 1.04-0.94 (m, 1 H), 1.00 (s, 9 H), 0.80 (s, 3 H), 0.56 (dd, J = 8.5, 5.0 Hz, 1 H), 0.35 (t, 
J = 5.2 Hz, 1 H); 13C NMR δ 144.40, 144.32, 135.49, 134.03, 133.94, 132.28, 132.22, 132.15, 
132.10, 131.68, 131.57, 131.54, 129.47, 128.39, 128.30, 128.21, 128.14, 127.53, 126.98, 126.66, 
62.23, 56.66, 43.46, 31.64, 31.58, 26.82, 19.95, 19.60, 19.04, 18.27; MS (EI) m/z (intensity) 643 
(M+, 2), 586 (97), 508 (16), 369 (35), 319 (40), 306 (100), 218 (32), 201 (84), 183 (26), 135 (29); 





diphenylphosphinamide 375.  According to the General Protocol N, 374 (6.4 g, 9.9 mmol),  
AcOH (1.1 mL, 20 mmol) and TBAF (20 mL, 20 mmol, 1.0 M in THF) in dry THF (50 mL) 
afforded 375 (3.6 g, 91%) as a colorless foam:  IR (neat) 3237, 3058, 2928, 1438, 1188 cm-1; 1H 
NMR δ 7.96-7.90 (m, 2 H), 7.78-7.71 (m, 2 H), 7.53-7.39 (m, 4 H), 7.45-7.24 (m, 7 H), 3.87 (bt, 
J = 9.4 Hz, 1 H), 3.49-3.39 (m, 3 H), 1.59-1.50 (m, 2 H), 1.18-1.10 (m, 1 H), 0.93 (s, 3 H), 0.55 
(dd, J = 8.3, 4.9 Hz, 1 H), 0.46 (t, J = 5.3 Hz, 1 H); 13C NMR δ 144.28, 144.21, 132.14, 132.01, 
131.98, 131.85, 131.56, 131.43, 128.38, 128.25, 128.14, 128.08, 127.98, 127.00, 126.45, 60.12, 
56.59, 43.25, 31.67, 31.61, 19.35, 19.01, 17.88; MS (EI) m/z (intensity) 405 (M+, 1), 374 (4), 306 
(31), 216 (40), 201 (59), 149 (41), 59 (100); HRMS (EI) m/z calculated for C25H28NO2P 







diphenylphosphinamide (376).  According to the General Protocol O, 375 (3.5 g, 8.6 mmol),  
o-NO2C6H4SeCN (3.9 g, 17 mmol) and Bu3P (3.5 g, 17 mmol) in dry THF (0.15 L) followed by 
Na2HPO4 (6.1 g, 43 mmol), m-CPBA (5.1 g, 21 mmol, ~70% w/w m-CPBA) and i-Pr2NH (6.0 
mL, 43 mmol) in dry CH2Cl2 (0.15 L) afforded crude 376.  The residue was purified by 
chromatography on deactivated SiO2 (9:1 then 4:1 CH2Cl2/acetone containing 1% v/v Et3N) to 
afford a yellow/orange solid which was re-purified by chromatography on deactivated SiO2 (2:3, 
then 25:75 then 1:4 hexanes/EtOAc containing 1% v/v Et3N) to afford 376 (2.7 g, 81%) as a 
colorless solid:  mp 190.6-192.2 °C (hexanes/EtOAc); IR (KBr) 3259, 3058, 3002, 2975, 2944, 
1630, 1438, 1185, 1123 cm-1; 1H NMR δ 8.00-7.94 (m, 2 H), 7.87-7.80 (m, 2 H), 7.54-7.22 (m, 
11 H), 5.39 (dd, J = 16.8, 11.0 Hz, 1 H), 4.85-4.79 (m, 2 H), 3.96 (app q, J = 8.7 Hz, 1 H), 3.35-
3.25 (m, 1 H), 1.31 (dt, J = 9.5, 6.1 Hz, 1 H), 0.94 (s, 3 H), 0.86 (dd, J = 8.6, 5.1 Hz, 1 H), 0.63 
(t, J = 5.7 Hz, 1 H); 13C NMR δ 145.97, 143.93, 143.85, 132.32, 132.20, 132.08, 131.75, 131.71, 
131.68, 128.47, 128.44, 128.40, 128.27, 128.23, 127.14, 126.92, 109.92, 56.20, 32.75, 32.70, 
23.98, 21.33, 15.94; MS (EI) m/z (intensity) 387 (M+, 28), 319 (80), 396 (41), 218 (35), 201 





anecarboxylate (Dpp-αMe∆Phg-OMe) (377).  According to the General Protocol P, 376 (2.6 g, 
6.7 mmol) and NaOH (50 mL, 2.5 M in MeOH) in dry CH2Cl2 (0.20 L) was treated with O3 
(~4.5% v/v O3 in O2) to afford 377 (2.8 g, 98%) as a colorless foam that was used in the next 
reaction without further purification.  An analytical sample was purified by chromatography on 
deactivated SiO2 (1:9, hexanes/EtOAc containing 1% v/v Et3N) to afford a colorless foam: IR 
(neat) 3181, 1720, 1438, 1192, 1123, 1110 cm-1; 1H NMR δ 7.97-7.90 (m, 2 H), 7.80-7.73 (m, 2 
H), 7.51-7.42 (m, 4 H), 7.38-7.24 (m, 7 H), 3.92 (app q, J = 9.8 Hz, 1 H), 3.58 (s, 3 H), 3.47 (bt, 
J = 7.5 Hz, 1 H), 2.04 (dt, J = 9.3, 6.7 Hz, 1 H), 1.36 (dd, J = 9.1, 4.6 Hz, 1 H), 1.08 (s, 3 H), 
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0.76 (dd, J = 6.6, 4.6 Hz, 1 H); 13C NMR δ 175.48, 143.26, 143.19, 134.02, 133.19, 132.31, 
132.19, 132.06, 131.84, 131.80, 131.75, 131.72, 131.49, 128.66, 128.45, 128.41, 128.28, 128.24, 
127.39, 126.71, 55.57, 51.92, 33.17, 33.11, 24.52, 22.86, 14.30; MS (ESI) m/z (intensity) 861 
([2M+Na]+, 95), 442 ([M+Na]+, 100), 420 ([M+H]+, 29); HRMS (EI) m/z calculated for 





chloride (αMe∆Phg-OMe•HCl) (378).  According to the General Protocol Q, 377 (2.7 g, 6.6 
mmol) in HCl (50 mL, 2.0 M in MeOH) afforded 378 (1.3 g, 80%) as a colorless solid:  mp 
279.8-281.2 °C (dec., Et2O/MeOH); IR (KBr) 3437, 3026, 2903, 1721, 1597, 1512, 1499, 1458, 
1438, 1200, 1166 cm-1; 1H NMR (MeOD) δ 7.51-7.42 (m, 5 H), 4.11 (d, J = 11.0 Hz, 1 H), 3.63 
(s, 3 H), 2.18 (ddd, J = 11.0, 8.8, 6.4 Hz, 1 H),  1.58 (dd, J = 8.8, 4.6 Hz, 1 H), 1.23 (s, 3 H), 1.06 
(dd, J = 6.4, 4.7 Hz, 1 H); 13C NMR δ 176.15, 137.98, 130.58, 130.48, 128.36, 57.10, 52.88, 




Cbz-(+/-)-αMe∆Phg-OMe ((+/-)-379).  According to the General Protocol R, 378 (1.2 g, 4.9 
mmol), NaHCO3 (2.0 g, 24 mmol) and Cbz-Cl (0.84 mL, 5.9 mmol) in EtOAc/H2O (1:1, 50 mL) 
afforded (+/-)-379 (1.7 g, 97%) as a colorless oil which solidified on standing:  IR (neat) 3343, 
3064, 3032, 2952, 1719, 1526, 1455, 1284, 1257, 1199, 1166 cm-1; 1H NMR δ 7.36-7.28 (m, 10 
H), 5.24 (bd, J = 6.4 Hz, 1 H), 5.12, 5.11 (AB, J = 12.3 Hz, 2 H), 4.50 (bt, J = 9.2 Hz, 1 H), 3.65 
(s, 3 H), 1.96 (dt, J = 9.2, 7.0 Hz, 1 H), 1.47 (dd, J = 9.1, 4.3 Hz, 1 H), 1.33 (s, 3 H), 0.97-0.91 
(m, 1 H); 13C NMR δ 175.50, 155.87, 141.62, 136.39, 128.78, 128.52, 128.14, 128.05, 127.65, 
126.51, 66.94, 55.03, 52.10, 31.44, 23.82, 21.30, 14.40; MS (EI) m/z (intensity) 353 (M+, 2), 253 
(16), 209 (12), 176 (7), 143 (8), 113 (12), 91 (100); HRMS (EI) m/z calculated for C21H23NO4 





Cbz-D-αMe∆Phg-OMe ((-)-379).  According to the General Protocol R, 385 (0.30 g, 0.81 
mmol), NaHCO3 (0.34 g, 4.1 mmol) and Cbz-Cl (0.14 mL, 0.98 mmol) in EtOAc/H2O (1:1, 8.0 




Cbz-L-αMe∆Phg-OMe ((+)-379).  According to the General Protocol R, 386 (0.25 g, 0.68 
mmol), NaHCO3 (0.28 g, 3.4 mmol) and Cbz-Cl (0.12 mL, 0.81 mmol) in EtOAc/H2O (1:1, 6.0 







Cbz-DL-αMe∆Phg-NHPri ((+/-)-380).  According to the General Protocol S, (+/-)-379 (20 mg, 
0.057 mmol) and NaOH (1.0 mL, 2.0 M in H2O) in MeOH (1.0 mL) and THF (0.20 mL) 
followed by i-PrNH2•HCl (16 mg, 0.17 mmol), BOP (38 mg, 0.085 mmol) and DIPEA (44 µL, 
0.26 mmol) in dry DMF (0.50 mL) {Reaction time for coupling = 10 h} afforded, after 
purification by chromatography on deactivated SiO2 (3:2, hexanes/EtOAc containing 1% v/v 
Et3N), (+/-)-380 (20 mg, 94%) as a colorless solid:  mp 129.0-131.5 °C (hexanes/EtOAc);  IR 
(KBr) 3372, 3264, 3032, 2973, 1700, 1634, 1530, 1455, 1281, 1258, 1213 cm-1; 1H NMR δ 7.36-
7.28 (m, 10 H), 5.49-5.43 (m, 2 H), 5.11, 5.10 (AB, J = 12.3 Hz, 2 H), 4.49 (bt, J = 9.1 Hz, 1 H), 
4.05 (octet, J = 6.6 Hz, 1 H), 2.00-1.92 (m, 1 H), 1.48 (dd, J = 9.1, 4.1 Hz, 1 H), 1.27 (s, 3 H), 
1.11 (d, J = 6.5 Hz, 3 H), 1.10 (d, J = 6.5 Hz, 3 H), 0.85-0.78 (m, 1 H); 13C NMR δ 173.10, 
155.99, 142.05, 136.46, 128.64, 128.48, 128.07, 128.01, 127.51, 126.69, 66.84, 55.11, 41.66, 
30.19, 24.01, 22.77, 22.72, 20.24, 14.82; MS (ESI) m/z (intensity) 403 ([M+Na]+, 100); HRMS 








Cbz-D-αMe∆Phg-NHPri prepared from (-)-379 ((-)-380).  According to the General Protocol 
S, (-)-379 (10 mg, 27 µmol), BOP (18 mg, 41 µmol), i-PrNH2•HCl (13 mg, 0.14 mmol), and 
DIPEA (28 µL, 0.16 mmol) in dry DMF (0.50 mL) afforded (-)-380 (8.4 mg, 82%) as a colorless 







Cbz-L-αMe∆Phg-NHPri prepared from (+)-379 ((+)-380). According to the General Protocol 
S, (+)-379 (10 mg, 27 µmol), BOP (18 mg, 41 µmol), i-PrNH2•HCl (13 mg, 0.14 mmol), and 
DIPEA (28 µL, 0.16 mmol) in dry DMF (0.50 mL) afforded (+)-380 (9.7 mg, 94%) as a 















(1R,2R)-Methyl 2-((R)-amino(phenyl)methyl)cyclopropanecarboxylate L-tartaric acid salt 
(383) and (1S,2S)-Methyl 2-((S)-amino(phenyl)methyl)cyclopropanecarboxylate L-tartaric 
acid salt (384).  General Protocol T.  To a mixture of (+/-)-365 (1.3 g, 3.9 mmol) and Pd/C 
(0.41 g, 0.39 mmol) was added under N2 MeOH (30 mL).  The flask was evacuated and purged 
with H2 (1 atm), and the reaction mixture was vigorously stirred for 2 h, filtered through Celite 
and concentrated to afford a colorless oil.  The residue was dissolved in EtOH, treated with L-
tartaric acid (0.59 g, 3.9 mmol) and H2O, and heated until all solid material was dissolved and 
concentrated to dryness.  The resultant colorless solid was suspended in EtOH and heated at 
reflux.  A minimal amount of H2O was added until all solid material dissolved.  The solution was 
allowed to stand for 48 h during which time 383 slowly crystallized from the solution.  The 
mixture was filtered and the filter cake was recrystallized from EtOH/H2O until the optical 
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rotation was constant affording 383 (0.76 g, 40%) as a colorless solid.  The filtrate from the first 
crystallization was concentrated, dissolved in EtOH and heated at reflux.  Dry Et2O was added 
until a precipitate was observed.  Sufficient EtOH was added to dissolve all solid material and 
the solution was cooled to r.t. and allowed to stand for 24 h.  The colorless solid was filtered and 
recrystallized from EtOH/Et2O to afford 384 (0.70 g, 37%) as a colorless solid.  383:  mp 199.5-
201.7 °C (EtOH/H2O); [α]D -26.4 (c 0.57, H2O); IR (KBr) 3488, 3321, 3271, 2961, 2903, 1887, 
1712, 1595, 1503, 1412, 1304, 1237, 1176, 1135 cm-1; 1H NMR (MeOD) δ 7.47-7.41 (m, 5 H), 
4.38 (s, 2 H), 3.84-3.80 (m, 1 H), 3.70 (s, 3 H), 2.05-1.95 (m, 2 H), 1.19 (dt, J = 8.6, 5.2 Hz, 1 
H), 1.03 (ddd, J = 8.3, 6.6, 4.7 Hz, 1 H); 13C NMR δ 176.95, 174.70, 137.70, 130.36, 128.19, 
74.14, 59.11, 52.57, 26.03, 21.06, 13.86. 
384:  mp 174.2-176.4°C (EtOH/Et2O); [α]D +46.0 (c 0.51, H2O); IR (KBr) 3320, 3273, 2960, 
1875, 1713, 1595, 1412, 1304, 1216, 1175, 1135 cm-1; 1H NMR (MeOD) δ 7.50-7.40 (m 5 H), 
4.40 (s, 2 H), 3.84 (d, J = 9.3 Hz, 1 H), 3.69 (s, 3 H), 2.06-1.97 (m, 2 H), 1.21-1.14 (m, 1 H), 
1.06-1.00 (m, 1 H); 13C NMR δ 177.06, 174.79, 137.72, 130.29, 128.25, 74.17, 59.02, 52.58, 















(1R,2R)-Methyl 2-((S)-amino(phenyl)methyl)-1-methylcyclopropanecarboxylate L-tartaric 
acid salt (385) and (1S,2S)-Methyl 2-((R)-amino(phenyl)methyl)-1-methylcyclopropane-
carboxylate L-tartaric acid salt (386).  According to the General Protocol T, (+/-)-379 (1.6 g, 
4.6 mmol), Pd/C (0.48 g, 0.46 mmol), and L-tartaric acid (0.68 g, 4.6 mmol) afforded 385 (0.63 
g, 38%) and 386 (0.55 g, 32%) as colorless solids.  385:  mp 172.1-174.1 °C (EtOH/H2O);     
[α]D -22.3 (c 0.45, H2O); IR (KBr) 3322, 3272, 3029, 2975, 2912, 1728, 1698, 1589, 1499, 1412, 
1305, 1264, 1214 cm-1; 1H NMR (MeOD) δ 7.50-7.39 (m, 5 H), 4.39 (s, 2 H), 4.09 (d, J = 11.0 
Hz, 1 H), 3.62 (s, 3 H), 2.17 (ddd, J = 10.9, 8.8, 6.5 Hz, 1 H), 1.57 (dd, J = 8.9, 4.6 Hz, 1 H), 
1.22 (s, 3 H), 1.07 (dd, J = 6.3, 4.8 Hz, 1 H); 13C NMR (MeOD) δ 176.99, 176.29, 138.23, 
130.46, 130.42, 128.36, 74.16, 56.97, 52.85, 29.51, 24.82, 22.09, 14.35. 
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386:  mp 194.2-196.0 °C (EtOH/Et2O); [α]D +52.2 (c 0.51, H2O); IR (KBr) 3439, 3322, 3273, 
3028, 2975, 2906, 1729, 1590, 1499, 1412, 1306, 1265, 1215 cm-1; 1H NMR (MeOD) δ 7.50-
7.40 (m, 5 H), 4.39 (s, 2 H), 4.09 (d, J = 11.0 Hz, 1 H), 3.62 (s, 3 H), 2.17 (ddd, J = 10.9, 8.9, 6.5 
Hz, 1 H), 1.57 (dd, J = 8.8, 4.6 Hz, 1 H), 1.22 (s, 3 H), 1.07 (dd, J = 6.3, 4.7 Hz, 1 H); 13C NMR 










Cbz-L-H2∆Phg-L-Phe-OMe (388).  General Protocol U.  To a solution of (-)-365 (19 mg, 56 
µmol) in dry Et2O (1.0 mL) was added KOTMS (14 mg, 0.11 mmol).  The reaction mixture was 
stirred for 12 h, diluted with H2O, acidified with 10% HCl and extracted with EtOAc (3x).  The 
combined organic layers were washed with brine, dried (MgSO4) and concentrated.  The residue 
was dissolved in dry CH2Cl2 (1.0 mL) and treated with L-Phe-OMe•HCl (12 mg, 56 µmol), 
EDCI (13 mg, 0.067 mmol), DMAP (1.0 mg, 8.2 µmol) and DIPEA (25 µL, 0.14 mmol).  The 
reaction mixture was stirred for 12 h, diluted with H2O and extracted with EtOAc (3x).  The 
combined organic layers were washed with brine, dried (MgSO4) and concentrated.  The crude 
residue was analyzed by HPLC (Microsorb-MV 100 column, 3:1, hexanes/EtOAc, 1.0 mL/min), 
indicating >99% de (Rt 13.2 min (mixture of 388 and 389, Rt 10.6, 13.2 min)).  The residue was 
purified by chromatography on deactivated SiO2 (2:1, hexanes/EtOAc containing 1% v/v Et3N) 
to afford 388 (20 mg, 73%) as a colorless solid:  mp 166.0-168.4 °C (hexanes/EtOAc); [α]D 
+35.2 (c 0.4, CHCl3);  IR (KBr) 3322, 3031, 2951, 1736, 1688, 1644, 1535, 1248 cm-1; 1H NMR 
δ 7.37-7.20 (m, 13 H), 7.12-7.09 (m, 2 H), 6.24 (bd, J = 7.3 Hz, 1 H), 5.29 (d, J = 7.8 Hz, 1 H), 
5.15-5.06 (m, 2 H), 4.95-4.88 (m, 1 H), 4.21 (t, J = 8.2 Hz, 1 H), 3.73 (s, 3 H), 3.16, 3.04 (AB of 
ABX, JAB = 13.8 Hz, JAX = 5.8 Hz, JBX = 6.1 Hz, 2 H), 1.78-1.65 (m, 2 H), 1.27-1.23 (m, 1 H), 
0.84-0.77 (m, 1 H); 13C NMR δ 171.95, 171.50, 155.80, 140.85, 136.24, 135.85, 129.29, 128.68, 
128.51, 128.17, 128.10, 127.73, 127.04, 126.55, 66.90, 57.97, 53.11, 52.28, 38.03, 26.45, 21.47, 
12.58; MS (EI) m/z (intensity) 486 (M+, 2), 91 (100); HRMS (EI) m/z calculated for C29H30N2O5 










Cbz-D-H2∆Phg-L-Phe-OMe (389).  According to the General Protocol U, (+)-365 (18 mg, 53 
µmol) and KOTMS (14 mg, 0.11 mmol) in dry Et2O (1.0 mL) followed by L-Phe-OMe•HCl (13 
mg, 58 µmol), EDCI (12 mg, 64 µmol), DMAP (1.0 mg, 8.2 µmol) and DIPEA (24 µL, 0.13 
mmol) in dry CH2Cl2 (1.0 mL) afforded 389 (19 mg, 75%) as a colorless solid.  The crude 
reaction mixture was analyzed by HPLC (Microsorb-MV 100 column, 3:1, hexanes/EtOAc, 1.0 
mL/min), indicating 98.6% de (Rt 10.8 min (mixture of 388 and 389, Rt 10.6, 13.2 min)):  mp 
174.7-176.6 °C (hexanes/EtOAc); [α]D +70.6 (c 0.93, CHCl3);  IR (KBr) 3321, 3063, 3030, 
2951, 1742, 1687, 1638, 1543, 1261, 1219 cm-1; 1H NMR δ 7.33-7.23 (m, 13 H), 7.12-7.10 (m, 2 
H), 6.30 (d, J = 7.7 Hz, 1 H), 5.32 (d, J = 7.9 Hz, 1 H), 5.06 (s, 2 H), 4.90 (dt, J = 7.8, 5.9 Hz, 1 
H), 4.21 (bt, J = 7.9 Hz, 1 H), 3.72 (s, 3 H), 3.13, 3.10 (AB of ABX, JAB = 13.9 Hz, JAX = JBX = 
5.9 Hz, 2 H), 1.84-1.74 (m, 2 H), 1.27-1.22 (m, 1 H), 0.85-0.79 (m, 1 H); 13C NMR δ 172.00, 
171.72, 155.91, 140.82, 136.36, 135.92, 129.28, 128.72, 128.54, 128.47, 128.08, 128.04, 127.76, 
127.08, 126.65, 66.92, 58.04, 53.35, 52.21, 38.04, 26.25, 21.56, 12.44; MS (EI) m/z (intensity) 









(390).  To a cooled (0 °C) solution of 383 (26 mg, 0.073 mmol) in dry CH2Cl2 (1.0 mL) was 
added DMAP (1 mg, 8.1 µmol), Et3N (0.10 mL, 0.72 mmol) and p-bromobenzoyl chloride (80 
mg, 0.36 mmol).  The reaction mixture was warmed to r.t., stirred for 2 h, quenched with sat. 
NaHCO3 and extracted with CH2Cl2 (3x).  The combined organic layers were washed with brine, 
dried (MgSO4) and concentrated.  The residue was purified by chromatography on SiO2 (7:3, 
hexanes/EtOAc) to give 390 (20 mg, 70%) as a colorless solid:  mp 179.8-181.6 °C 
(hexanes/EtOAc); [α]D -58.1 (c 0.38, CHCl3);  IR (KBr) 3337, 3088, 3027, 2947, 1724, 1635, 
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1530, 1206, 1183 cm-1; 1H NMR δ 7.66-7.64 (m, 2 H), 7.59-7.56 (m, 2 H), 7.43-7.30 (m, 5 H), 
6.53 (d, J = 8.2 Hz, 1 H), 4.79 (t, J = 8.4 Hz, 1 H), 3.68 (s, 3 H), 2.02-1.94 (m, 2 H), 1.36-1.30 
(m, 1 H), 1.07-1.00 (m, 1 H); 13C NMR δ 174.08, 165.79, 140.45, 133.02, 131.84, 128.88, 
128.64, 127.96, 126.75, 126.39, 55.88, 51.93, 26.79, 19.18, 14.22; MS (EI) m/z (intensity) 389 
(M+, 2), 387 (M+, 2), 303 (37), 301 (35), 204 (59), 185 (98), 183 (100), 157 (40), 155 (43), 129 








Cbz-D-αMe∆Phg-L-Phe-OMe (391).  According to the General Protocol U, (-)-379 (24 mg, 
0.068 mmol) and KOTMS (35 mg, 0.27 mmol) in dry Et2O (1.0 mL) followed by L-Phe-
OMe•HCl (23 mg, 0.11 mmol), EDCI (16 mg, 0.085 mmol), DMAP (1.0 mg, 7.1 µmol) and 
DIPEA (18 µL, 0.11 mmol) in dry CH2Cl2 (1.0 mL) afforded 391 (20 mg, 59%) as a colorless 
solid.  The crude reaction mixture was analyzed by HPLC (Microsorb-MV 100 column, 7:3, 
hexanes/EtOAc, 1.0 mL/min) indicating >99% de (Rt 6.0 min (mixture of 391 and 392, Rt 4.5, 
5.9 min)):  mp 94.0-95.5 °C (hexanes/EtOAc); [α]D +41.1 (c 0.95, CHCl3); IR (KBr) 3393, 3367, 
3316, 3062, 3031, 3004, 2953, 1742, 1696, 1645, 1525, 1496, 1455, 1435, 1266, 1240, 1211   
cm-1; 1H NMR δ 7.38-7.33 (m, 10 H), 7.21-7.12 (m, 3 H), 6.90 (d, J = 6.7 Hz, 2 H), 6.11 (d, J = 
7.4 Hz, 1 H), 5.33-5.25 (m, 1 H), 5.12, 5.10 (AB, J = 12.2 Hz, 2 H), 4.87 (dt, J = 7.6, 5.3 Hz, 1 
H), 4.47 (bt, J = 8.9 Hz, 1 H), 3.73 (s, 3 H), 3.09, 3.07 (AB of ABX, JAB = 13.7 Hz, JAX = JBX = 
5.5 Hz, 2 H), 1.98 (dt, J = 9.1, 7.7 Hz, 1 H), 1.48 (dd, J = 9.1, 4.3 Hz, 1 H), 1.25 (s, 3 H), 0.91-
0.82 (m, 1 H); 13C NMR δ 173.50, 171.84, 155.89, 142.02, 136.42, 135.59, 129.14, 128.73, 
128.44, 127.98, 127.59, 127.00, 126.64, 66.81, 55.33, 53.18, 52.24, 37.60, 30.76, 23.94, 20.62, 
14.35; MS (EI) m/z (intensity) 500 (M+, 74), 260 (20), 91 (100); HRMS (EI) m/z calculated for 








Cbz-L-αMe∆Phg-L-Phe-OMe (392).  According to the General Protocol S, (+)-379 (27 mg, 
0.076 mmol) and NaOH (0.50 mL, 2.0 M in H2O) in MeOH (0.50 mL) and THF (0.20 mL) 
  198
followed by L-Phe-OMe•HCl (25 mg, 0.11 mmol), BOP (40 mg, 0.091 mmol), and DIPEA (33 
µL, 0.19 mmol) in dry DMF (1.0 mL) afforded 392 (33 mg, 85%) as a colorless solid.  The crude 
reaction mixture was analyzed by HPLC (Microsorb-MV 100 column, 7:3, hexanes/EtOAc, 1 
mL/min) indicating >99% de (Rt 4.6 min (mixture of 391 and 392, Rt 4.5, 5.9 min)):  mp 108.0-
110.5 °C (hexanes/EtOAc); [α]D +73.0 (c 0.33, CHCl3); IR (KBr) 3379, 3065, 3031, 2953, 1720, 
1700, 1651, 1521, 1455, 1289, 1277, 1256, 1211 cm-1; 1H NMR δ 7.37-7.20 (m, 13 H), 7.06-7.03 
(m, 2 H), 6.07 (d, J = 7.6 Hz, 1 H), 5.37 (bd, J = 7.7 Hz, 1 H), 5.11, 5.10 (AB, J = 12.2 Hz, 2 H), 
4.82 (dt, J = 5.9, 5.8 Hz, 1 H), 4.48 (bt, J = 9.2 Hz, 1 H), 3.69 (s, 3 H), 3.12, 3.06 (AB of ABX, 
JAB = 13.8 Hz, JAX = JBX = 5.8 Hz, 2 H), 1.90 (dt, J = 9.6, 6.7 Hz, 1 H), 1.47 (dd, J = 9.0, 4.3 Hz, 
1 H), 1.22 (s, 3 H), 0.88-0.82 (bm, 1 H); 13C NMR δ 173.69, 171.89, 155.97, 141.66, 136.42, 
135.80, 129.19, 128.71, 128.54, 128.48, 128.08, 128.00, 127.56, 127.13, 126.63, 66.86, 54.99, 
53.34, 52.23, 37.65, 30.44, 24.17, 20.44, 14.43; MS (ESI) m/z (intensity) 523 ([M+Na]+, 100); 








Cbz-D-αMe∆Phg-D-αMe∆Phg-OMe ((-)-393). Saponification of (-)-379:  To a solution of (-)-
379 (45 mg, 0.13 mmol) in MeOH (0.50 mL) was added 2N NaOH (0.50 mL) and THF (0.20 
mL).  The reaction mixture was stirred for 2 h, acidified with 10% HCl and extracted with 
EtOAc (3x).  The combined organic layers were washed with brine, dried (Na2SO4) and 
concentrated. 
N-Cbz deprotection of (-)-379:  A round bottom flask containing a mixture of (-)-379 (49 mg, 
0.14 mmol) and 10% Pd/C (15 mg, 14 µmol) was evacuated, purged with N2 and suspended in 
MeOH (1.5 mL).  The flask was evacuated and purged with H2 (1 atm), and stirred under an 
atmosphere of H2 for 1 h.  The mixture was filtered through Celite and concentrated.   
Fragment Coupling:  The acid and amine were dissolved in dry CH2Cl2 and concentrated into a 
10 mL round bottom flask.  The residue was dissolved in dry DMF (1.0 mL), cooled to 0 °C, 
treated with BOP (67 mg, 0.15 mmol) and DIPEA (33 µL, 0.19 mmol), warmed slowly to r.t. 
and stirred for 10 h.  The reaction mixture was diluted with EtOAc, washed with water, 10% HCl 
and brine, dried (Na2SO4) and concentrated.  The residue was purified by chromatography on 
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deactivated SiO2 (13:7, hexanes/EtOAc containing 1% v/v Et3N) to give (-)-393 (63 mg, 91%) as 
a colorless foam:  [α]D -70.9 (c 1.0, CHCl3); IR (KBr) 3348, 3031, 2951, 1708, 1625, 1522, 
1455, 1306, 1286, 1258, 1198, 1167 cm-1; 1H NMR δ 7.40-7.27 (m, 15 H), 6.20 (d, J = 8.6 Hz, 1 
H), 5.59 (d, J = 8.2 Hz, 1 H), 5.12, 5.10 (AB, J = 12.2 Hz, 2 H), 4.86 (t, J = 9.7 Hz, 1 H), 4.53 (t, 
J = 9.5 Hz, 1 H), 3.66 (s, 3 H), 2.02-1.89 (m, 2 H), 1.55 (dd, J = 9.0, 4.2 Hz, 1 H), 1.36 (dd, J = 
9.0, 4.1 Hz, 1 H), 1.29 (s, 3 H), 1.28 (s, 3 H), 0.87 (bm, 1 H), 0.81 (dd, J = 6.4, 4.4 Hz, 1 H); 13C 
NMR δ 175.56, 173.49, 156.02, 141.96, 141.45, 136.45, 128.72, 128.64, 128.43, 128.02, 127.94, 
127.60, 127.49, 126.61, 126.49, 66.79, 54.88, 52.53, 52.08, 31.33, 30.81, 24.04, 23.98, 20.73, 
20.30, 14.69, 14.16; MS (EI) m/z (intensity) 540 (M+, 47), 332 (16), 330 (19), 171 (40), 143 








Cbz-L-αMe∆Phg-L-αMe∆Phg-OMe ((+)-393).  Saponification of (+)-379:  To a solution of (+)-
379 (0.12 g, 0.34 mmol) in MeOH (1.5 mL) was added THF (0.20 mL) and 2N NaOH (1.5 mL).  
The reaction mixture was stirred for 4 h, acidified with 10% HCl and extracted with EtOAc (3x).  
The combined organic layers were washed with brine, dried (Na2SO4) and concentrated. 
N-Cbz-Deprotection of (+)-379:  To a mixture of (+)-379 (0.10 g, 0.30 mmol) and 10% Pd/C (32 
mg, 0.030 mmol) under N2 was added MeOH (3 mL).  The flask was evacuated, purged with H2 
(1 atm), and vigorously stirred under an atmosphere of H2 for 1 h.  The mixture was filtered 
through Celite and concentrated into a flask containing the acid prepared above. 
Fragment coupling:  The mixture of amine and acid was dissolved in dry DMF (2.0 mL), cooled 
to 0 °C and treated with BOP (0.23 g, 0.51 mmol) and DIPEA (78 µL, 0.45 mmol).  The solution 
was warmed to r.t., stirred for 10 h, diluted with EtOAc and washed with H2O, 10% HCl and 
brine, dried (Na2SO4) and concentrated.  The residue was purified by chromatography on 
deactivated SiO2 (2:1, hexanes/EtOAc containing 1% v/v Et3N) to give (+)-393 (0.13 g, 80%) as 










Cbz-D-αMe∆Phg-D-αMe∆Phg-NHMe (394).  To a solution of (-)-393 (50 mg, 0.092 mmol) in 
dry Et2O (1.0 mL) was added KOTMS (95 mg, 0.74 mmol).  The reaction mixture was stirred for 
12 h, acidified with 10% HCl and extracted with EtOAc (3x).  The combined organic layers were 
washed with brine, dried (Na2SO4) and concentrated.  The residue was dissolved in dry CH2Cl2 
(1.0 mL), treated with EDCI (21 mg, 0.11 mmol), MeNH2•HCl (37 mg, 0.56 mmol), DMAP (1.0 
mg, 7.1 µmol), and DIPEA (48 µL, 0.28 mmol), stirred for 12 h and diluted with EtOAc.  The 
solution was washed with 10% HCl, H2O and brine, dried (MgSO4) and concentrated.  The 
residue was purified by chromatography on deactivated SiO2 (EtOAc containing 1% v/v Et3N) to 
afford 394 (31 mg, 62%) as a colorless foam:  [α]D -88.0 (c 0.15, CHCl3); IR (KBr) 3032 2928, 
1700, 1653, 1635, 1522, 1258, 1206 cm-1; 1H NMR (500 MHz) δ 7.37-7.27 (m, 15 H), 6.12 (d, J 
= 8.0 Hz, 1 H), 5.75 (d, J = 3.9 Hz, 1 H), 5.22 (d, J = 7.7 Hz, 1 H), 5.15-5.10 (m, 2 H), 4.86 (t, J 
= 9.6 Hz, 1 H), 4.53 (bt, 1 H), 2.84 (d, J = 4.6 Hz, 3 H), 2.00-1.89 (m, 2 H), 1.56-1.55 (m, 1 H), 
1.42-1.41 (m, 1 H), 1.31 (s, 3 H), 1.29 (s, 3 H), 0.94-0.88 (m, 1 H), 0.77-0.73 (m, 1 H); 13C NMR 
(125 MHz) δ 174.72, 173.60, 155.99, 141.68, 136.38, 128.76, 128.52, 128.14, 128.06, 127.79, 
127.52, 126.70, 126.61, 66.91, 54.86, 52.84, 30.81, 30.24, 26.91, 24.22, 24.02, 20.30, 20.00, 
14.73, 14.60; MS (ESI) m/z (intensity) 562 ([M+Na]+, 100); HRMS (ESI) m/z calculated for 













Cbz-D-αMe∆Phg-D-αMe∆Phg-D-αMe∆Phg-D-αMe∆Phg-NHMe (397).  Saponification of (-)-
393:  To a solution of (-)-393 (28 mg, 52 µmol) in dry Et2O (1.0 mL) was added KOTMS (53 
mg, 0.41 mmol).  The reaction mixture was stirred for 12 h, acidified with 10% HCl and 
extracted with EtOAc (3x).  The combined organic layers were washed with brine, dried 
(Na2SO4) and concentrated. 
N-Cbz deprotection of 394:  A round bottom flask containing a mixture of 394 (31 mg, 57 µmol) 
and 10% Pd/C (6.0 mg, 5.7 µmol) was evacuated, purged with N2, suspended in MeOH (1.0 
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mL), evacuated and purged with H2 (1 atm) and stirred under an atmosphere of H2 for 1 h.  The 
mixture was filtered through Celite and concentrated. 
Fragment coupling:  The amine and acid were concentrated into a 25 mL flask and dissolved in 
dry DMF (1.0 mL).  The mixture was treated at 0 °C with BOP (27 mg, 62 µmol) and DIPEA 
(11 µL, 65 µmol), warmed to r.t., stirred for 10 h, diluted with EtOAc and washed with water, 
10% HCl and brine, dried (MgSO4) and concentrated.  The residue was purified by 
chromatography on deactivated SiO2 (EtOAc containing 1% v/v Et3N) to give 397 (29 mg, 62%) 
as a colorless foam:  [α]D -105.9 (c 0.44, CHCl3); IR (KBr) 3399, 3030, 2939, 1718, 1654, 1638, 
1508, 1193 cm-1; 1H NMR δ 7.36-7.24 (m, 25 H), 6.38-6.25 (m, 3 H), 5.79-5.78 (m, 1 H), 5.53 
(bd, J = 7.9 Hz, 1 H), 5.16-5.07 (m, 2 H), 4.93-4.84 (m, 3 H), 4.52 (bt, J = 9.1 Hz, 1 H), 2.80 (d, 
J = 4.7 Hz, 3 H), 2.07-1.87 (m, 4 H), 1.56-1.40 (m, 4 H), 1.29 (s, 3 H), 1.25 (s, 6 H), 1.22 (s, 3 
H), 0.89-0.86 (m, 1 H), 0.78-0.70 (m, 3 H); 13C NMR δ 174.65, 173.67, 173.62, 156.02, 141.86, 
141.73, 141.68, 141.61, 136.49, 128.78, 128.74, 128.49, 128.08, 128.00, 127.70, 127.63, 127.52, 
126.73, 126.65, 66.86, 54.96, 52.92, 52.53, 52.49, 30.89, 30.30, 26.87, 24.31, 24.24, 24.09, 
20.43, 20.00, 19.76, 14.74, 14.62; MS (ESI) m/z (intensity) 936 ([M+Na]+, 34), 914 ([M+H]+, 
100), 763 (24), 596 (40), 562 (44), 382 (60), 202 (83); HRMS (ESI) m/z calculated for 













Cbz-L-αMe∆Phg-L-αMe∆Phg-L-αMe∆Phg-L-αMe∆Phg-OMe (398).  Saponification of (+)-393:  
To a solution of (+)-393 (67 mg, 0.12 mmol) in MeOH (1.0 mL) was added THF (0.20 mL) and 
2N NaOH (1.0 mL).  The reaction was stirred for 4 h, acidified with 10% HCl and extracted with 
EtOAc (3x).  The combined organic layers were washed with brine, dried (Na2SO4) and 
concentrated. 
N-Cbz-Deprotection of (+)-393:  To a mixture of (+)-393 (70 mg, 0.13 mmol) and 10% Pd/C (14 
mg, 0.013 mmol) under N2 was added MeOH (1.5 mL).  The flask was evacuated, purged with 
H2 (1 atm), and the mixture was vigorously stirred under an atmosphere of H2 for 2 h.  The 
mixture was filtered through Celite and concentrated into a flask containing the acid prepared 
above. 
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Fragment coupling:  The mixture of amine and acid was dissolved in dry DMF (1.5 mL), cooled 
to 0 °C, treated with BOP (82 mg, 0.19 mmol) and DIPEA (34 µL, 0.19 mmol), warmed to r.t. 
and stirred for 10 h.  The solution was diluted with EtOAc and washed with H2O, 10% HCl and 
brine, dried (Na2SO4) and concentrated.  The residue was purified by chromatography on 
deactivated SiO2 (2:3, hexanes/EtOAc containing 1% v/v Et3N) to give 398 (82 mg, 73%) as a 
colorless solid:  mp 159.4-161.0 °C (hexanes/EtOAc); [α]D +109.7 (c 0.66, CHCl3); IR (KBr) 
3422, 3031, 2951, 1719, 1654, 1646, 1637, 1508, 1499, 1458, 1306, 1258, 1194 cm-1; 1H NMR δ 
7.38-7.28 (m, 25 H), 6.19-6.12 (m, 3 H), 5.31 (bd, J = 8.4 Hz, 1 H), 5.13, 5.12 (AB, J = 12.3 Hz, 
2 H), 4.96-4.86 (m, 3 H), 4.53 (bt, J = 9.6 Hz, 1 H), 3.69 (s, 3 H), 2.00-1.86 (m, 4 H), 1.58-1.42 
(m, 4 H), 1.34 (s, 3 H), 1.31 (s, 3 H), 1.27 (s, 6 H), 0.95-0.78 (m, 4 H); 13C NMR δ 175.56, 
173.72, 173.58, 156.06, 141.92, 141.68, 141.36, 136.49, 128.78, 128.68, 128.44, 128.02, 127.96, 
127.59, 126.66, 126.60, 126.50, 66.77, 54.89, 52.60, 52.45, 52.14, 31.40, 30.84, 30.81, 24.25, 
24.05, 23.99, 20.74, 20.35, 19.73, 14.67, 14.55, 14.48, 14.22; MS (ESI) m/z (intensity) 953 
([M+K]+, 100), 937 ([M+Na]+, 85), 915 ([M+H]+, 30); HRMS (ESI) m/z calculated for 

















αMe∆Phg-L-αMe∆Phg-OMe (399).  Saponification of 398:  To a solution of 398 (32 mg, 35 
µmol) in MeOH (0.50 mL) was added THF (0.20 mL) and 2N NaOH (0.50 mL).  The reaction  
mixture was stirred for 4 h, acidified with 10% HCl and extracted with EtOAc (3x).  The 
combined organic layers were washed with brine, dried (Na2SO4) and concentrated. 
N-Cbz-Deprotection of 398:  To a mixture of 398 (36 mg, 39 µmol) and 10% Pd/C (4.0 mg, 3.9 
µmol) under N2 was added MeOH (1.0 mL).  The flask was evacuated, purged with H2 (1 atm), 
and the mixture was vigorously stirred under an atmosphere of H2 for 2 h.  The suspension was 
filtered through Celite and concentrated into a flask containing the acid prepared above. 
Fragment coupling:  The amine and acid were dissolved in dry DMF (1.0 mL), cooled to 0 °C 
and treated with BOP (23 mg, 52 µmol) and DIPEA (9.0 µL, 52 µmol).  The reaction mixture 
was warmed to r.t., stirred for 10 h, diluted with EtOAc and washed with H2O, 10% HCl and 
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brine, dried (Na2SO4) and concentrated to give crude 399.  1H NMR δ 7.36-7.77 (m, 45 H), 6.17-
6.08 (m, 7 H), 5.25 (d, J = 8.6 Hz, 1 H), 5.17-5.08 (m, 2 H), 4.97-4.87 (m, 7 H), 4.53 (t, J = 10.5 
Hz, 1 H), 3.70 (s, 3 H), 2.03-1.90 (m, 8 H), 1.57-1.49 (m, 8 H), 1.35-1.26 (m, 24 H), 0.93-0.87 






Cbz-L-H2∆Phg-L-Pro-OMe (401).  To a solution of (-)-365 (35 mg, 0.10 mmol) in dry Et2O (1.0 
mL) was added KOTMS (26 mg, 0.21 mmol).  The reaction mixture was stirred for 6 h, 
quenched with 10% HCl, extracted with CH2Cl2 (3x), and the combined organic layers were 
washed with brine, dried (Na2SO4) and concentrated.  The residue was dissolved in dry CH2Cl2 
(1.0 mL) and treated at 0 °C with EDCI (24 mg, 0.12 mmol), DMAP (1.0 mg, 0.010 mmol), 
DIPEA (0.11 mL, 0.62 mmol) and L-Pro-OMe•HCl (34 mg, 0.21 mmol).  The solution was 
warmed to r.t., stirred for 12 h, diluted with H2O and extracted with CH2Cl2 (2x) and EtOAc 
(2x), and the combined organic layers were washed with 10% HCl (2x) and brine, dried 
(MgSO4) and concentrated.  The residue was purified by chromatography on deactivated SiO2 
(19:1, CH2Cl2/acetone containing 1% v/v Et3N) to afford 401 (38 mg, 84%) as a colorless oil:  
[α]D -68.2 (c 0.76, CHCl3); IR (neat) 3315, 3063, 3030, 2953, 1742, 1712, 1627, 1528, 1456, 
1236 cm-1; 1H NMR (3.5:1 mixture of amide bond rotamers) major rotamer δ 7.36-7.31 (m, 10 
H), 5.34 (d, J = 8.1 Hz, 1 H), 5.17 (d, J = 12.3 Hz, 1 H), 5.03 (d, J = 12.3 Hz, 1 H), 4.46 (dd, J = 
8.2, 4.0 Hz, 1 H), 4.26 (t, J = 8.9 Hz, 1 H), 3.77-3.74 (m, 1 H), 3.70 (s, 3 H), 3.65-3.55 (m, 1 H), 
2.35-1.79 (m, 5 H), 1.35-1.27 (m, 2 H), 0.91-0.84 (m, 1 H); minor rotamer (representative 
signals) δ 5.54-5.52 (m, 1 H), 4.61 (dd, J = 8.3, 2.8 Hz, 1 H), 4.12-4.06 (m, 1 H); 13C NMR δ 
172.77, 171.05, 155.82, 140.69, 136.40, 128.67, 128.46, 128.10, 127.96, 127.72, 126.62, 66.69, 
58.76, 58.14, 52.11, 46.87, 29.17, 27.01, 24.61, 22.51, 19.42, 13.55; MS (EI) m/z (intensity) 436 









Cbz-L-H2∆Phg-NMe2 ((-)-403).  To a solution of (-)-365 (35 mg, 0.10 mmol) in dry Et2O (1.0 
mL) was added KOTMS (26 mg, 0.21 mmol).  The reaction mixture was stirred for 6 h, 
quenched with 10% HCl, extracted with CH2Cl2 (3x), and the combined organic layers were 
washed with brine, dried (Na2SO4) and concentrated.  The residue was dissolved in dry CH2Cl2 
(1.0 mL) and treated at 0 °C with EDCI (24 mg, 0.12 mmol), DMAP (1.0 mg, 0.010 mmol), 
DIPEA (0.11 mL, 0.62 mmol) and Me2NH•HCl (25 mg, 0.31 mmol).  The solution was warmed 
to r.t., stirred for 12 h, diluted with H2O and extracted with CH2Cl2 (2x) and EtOAc (2x).  The 
combined organic layers were washed with 10% HCl (2x) and brine, dried (MgSO4) and 
concentrated.  The residue was purified by chromatography on deactivated SiO2 (19:1, 
CH2Cl2/acetone containing 1% v/v Et3N) to afford (-)-403 (31 mg, 85%) as a colorless oil:     
[α]D -28.1 (c 0.62, CHCl3); IR (neat) 3283, 3031, 2928, 1710, 1624, 1529, 1497, 1257 cm-1; 1H 
NMR δ 7.37-7.27 (m, 10 H), 5.43 (bd, J = 8.0 Hz, 1 H), 5.15, 5.05 (AB, J = 12.3 Hz, 2 H), 4.24 
(t, J = 9.1 Hz, 1 H), 3.05 (s, 3 H), 2.93 (s, 3 H), 2.10-2.07 (m, 1 H), 1.86-1.78 (m, 1 H), 1.30-1.24 
(m, 1 H), 0.89-0.81 (m, 1 H); 13C NMR δ 172.13, 155.90, 140.87, 136.44, 128.65, 128.46, 
128.08, 128.00, 127.67, 126.63, 66.73, 58.28, 37.06, 35.80, 26.94, 17.97, 13.34; MS (EI) m/z 







Cbz-D-H2∆Phg-NMe2 ((+)-403).  According to the protocol for the preparation of (-)-403,     
(+)-365 (40 mg, 0.12 mmol), KOTMS (30 mg, 0.24 mmol) in Et2O (1.0 mL), EDCI (27 mg, 0.14 
mmol), DMAP (2.0 mg, 0.012 mmol), DIPEA (0.13 mL, 0.71 mmol) and Me2NH•HCl (29 mg, 











Fmoc-Gly-L-H2∆Phg-NMe2 ((-)-405).  A flask containing a mixture of (-)-403 (30 mg, 0.085 
mmol) and Pd/C (9.0 mg, 0.0085 mmol, 10 wt% Pd/C) in MeOH (2.0 mL) was evacuated and 
purged with H2 (1 atm).  The suspension was stirred under an atmosphere of H2 for 1.5 h, filtered 
through Celite and concentrated.  The residue was dissolved in dry DMF (1.0 mL), cooled to      
0 °C, treated with Fmoc-Gly-OH (51 mg, 0.17 mmol), BOP (45 mg, 0.10 mmol) and DIPEA (18 
µL, 0.10 mmol), stirred for 30 min, and warmed to r.t.  After stirring for 4 h, the reaction mixture 
was diluted with H2O and extracted with EtOAc (3x).  The combined organic layers were 
washed with brine, dried (MgSO4) and concentrated.  The residue was purified by 
chromatography on deactivated SiO2 (7:3, CH2Cl2/acetone containing 1% v/v Et3N) to afford (-)-
405 (31 mg, 73%) as a colorless oil:  [α]D -21.5 (c 0.63, CHCl3); IR (neat) 3416, 3290, 3065, 
3009, 2926, 2854, 1722, 1667, 1621, 1538, 1248, 1154 cm-1; 1H NMR δ 7.76 (d, J = 7.5 Hz, 2 
H), 7.57 (d, J = 7.3 Hz, 2 H), 7.40 (t, J = 7.4 Hz, 2 H), 7.35-7.23 (m, 7 H), 7.10 (bd, J = 7.8 Hz, 1 
H), 5.67-5.63 (m, 1 H), 4.51 (t, J = 9.2 Hz, 1 H), 4.37 (d, J = 7.0 Hz, 2 H), 4.18 (t, J = 7.0 Hz, 1 
H), 3.92, 3.85 (AB of ABX, JAB = 16.9 Hz, JAX = 5.5 Hz, JBX = 5.2 Hz, 2 H), 3.11 (s, 3 H), 2.90 
(s, 3 H), 2.08-2.03 (m, 1 H), 1.89-1.86 (m, 1 H), 1.32-1.20 (m, 1 H), 0.91-0.85 (m, 1 H); 13C 
NMR δ 172.20, 168.20, 156.47, 147.42, 143.66, 141.23, 140.58, 128.68, 127.72, 127.04, 126.69, 
124.99, 119.96, 67.13, 56.28, 46.98, 44.41, 37.25, 35.84, 26.33, 18.20, 13.71; MS (EI) m/z 










Fmoc-Gly-D-H2∆Phg-NMe2 ((+)-405).  According to the protocol for the preparation of (-)-405, 
(+)-403 (24 mg, 0.068 mmol), Pd/C (7.0 mg, 6.8 µmol) in MeOH (1.0 mL), BOP (33 mg, mmol), 
DIPEA (13 µL, 0.074 mmol) and Fmoc-Gly-OH (61 mg, 0.21 mmol) afforded (+)-405 (26 mg, 















Cbz-L-H2∆Phg-L-Pro-OMe-Gly-L-H2∆Phg-NMe2 (408).  Saponification of 401:  To a solution 
of 401 (38 mg, 0.087 mmol) in dry Et2O (1.0 mL) was added KOTMS (22 mg, 0.17 mmol).  The 
reaction mixture was stirred for 12 h, acidified with 10% HCl and extracted with EtOAc (3x).  
The combined organic layers were washed with brine, dried (MgSO4) and concentrated. 
N-Fmoc deprotection of (-)-405:  To a solution of (-)-405 (31 mg, 0.062 mmol) in dry DMF 
(0.90 mL) was added piperidine (0.10 mL).  The mixture was stirred for 1 h, concentrated and 
the residue was dissolved in dry toluene (ca. 10 mL) and concentrated (repeat 10 times) to give a 
yellow/orange solid. 
Fragment coupling:  The amine and acid were concentrated into a 25 mL flask.  The residue was 
dissolved in dry CH2Cl2 (1.0 mL), treated with DMAP (1.0 mg, 0.0087 mmol) and EDCI (18 mg, 
0.096 mmol), and the reaction mixture wasc stirred for 12 h, diluted with H2O and extracted with 
CH2Cl2.  The combined organic layers were washed with 10% HCl (2x) and brine, dried 
(MgSO4) and concentrated.  The residue was purified by chromatography on deactivated SiO2 
(3:2, CH2Cl2/acetone containing 1% Et3N) to afford 408 (25 mg, 60%):  [α]D -55.4 (c 0.28, 
CHCl3); IR (KBr) 3420, 3282, 3031, 2928, 1720, 1683, 1647, 1621, 1530, 1455, 1259 cm-1; 1H 
NMR (DMSO-d6) δ 8.31 (t, J = 6.2 Hz, 1 H), 8.04 (d, J = 8.7 Hz, 1 H), 7.97 (d, J = 8.8 Hz, 1 H), 
7.34-7.15 (m, 15 H), 5.08 (d, J = 12.5 Hz, 1 H), 4.95 (d, J = 12.6 Hz, 1 H), 4.60 (t, J = 8.1 Hz, 1 
H), 4.22-4.13 (m, 1 H), 4.19 (t, J = 8.9 Hz, 1 H), 3.68-3.63 (m, 1 H), 3.64 (d, J = 5.7 Hz, 1 H), 
3.57-3.49 (m, 1 H), 3.38-3.31 (m, 1 H), 3.02 (s, 3 H), 2.75 (s, 3 H), 2.07-1.98 (m, 2 H), 1.95-1.90 
(m, 2 H), 1.83-1.78 (m, 2 H), 1.53-1.41 (m, 2 H), 0.96-0.90 (m, 1 H), 0.84-0.74 (m, 3 H); 13C 
NMR (125 MHz, DMSO-d6) δ 171.99, 171.20, 170.97, 168.15, 155.68, 142.46, 142.31, 137.11, 
128.28, 128.23, 128.08, 127.76, 127.63, 126.94, 126.81, 126.46, 126.40, 65.26, 60.29, 56.93, 
53.68, 47.06, 42.17, 36.71, 35.15, 29.19, 27.75, 26.35, 24.29, 18.86, 16.25, 12.35, 11.89; MS 
(ESI) m/z (intensity) 702 ([M+Na]+, 100); HRMS (ESI) m/z calculated for C39H45N5O6Na 







Cbz-D-H2∆Phg-L-Pro-OMe (409).  To a solution of (+)-365 (40 mg, 0.12 mmol) in dry Et2O 
(1.0 mL) was added KOTMS (30 mg, 0.24 mmol).  The reaction mixture was stirred for 6 h, 
quenched with 10% HCl and extracted with CH2Cl2 (3x).  The combined organic layers were 
washed with brine, dried (Na2SO4) and concentrated.  The residue was dissolved in dry CH2Cl2 
(1.0 mL) and treated at 0 °C with EDCI (27 mg, 0.14 mmol), DMAP (2.0 mg, 0.012 mmol), 
DIPEA (0.13 mL, 0.71 mmol) and L-Pro-OMe•HCl (59 mg, 0.35 mmol).  The reaction mixture 
was warmed to r.t., stirred for 12 h, diluted with H2O and extracted with CH2Cl2 (2x) and EtOAc 
(2x).  The combined organic layers were washed with 10% HCl (2x) and brine, dried (MgSO4) 
and concentrated.  The residue was purified by chromatography on deactivated SiO2 (19:1, 
CH2Cl2/acetone containing 1% v/v Et3N) to afford 409 (39 mg, 76%) as a colorless oil:  [α]D -
13.1 (c 0.67, CHCl3); IR (neat) 3301, 3030, 2953, 1713, 1626, 1530, 1455, 1433, 1237, 1200, 
1176 cm-1; 1H NMR (2.3:1 mixture of amide bond rotamers) major rotamer δ 7.36-7.27 (m, 10 
H), 5.51 (d, J = 8.3 Hz, 1 H), 5.17 (d, J = 12.3 Hz, 1 H), 5.05 (d, J = 12.3 Hz, 1 H), 4.46 (dd, J = 
8.3, 3.8 Hz, 1 H), 4.28 (t, J = 8.9 Hz, 1 H), 3.73 (s, 3 H), 3.71-3.48 (m, 2 H), 2.21-2.11 (m, 1 H), 
2.07-1.91 (m, 2 H), 1.89-1.87 (m, 1 H), 1.32-1.26 (m, 1 H), 0.90-0.83 (m, 1 H); 13C NMR (major 
rotamer) δ 172.84, 170.95, 155.97, 140.95, 136.49, 128.63, 128.46, 128.01, 127.94, 127.64, 
126.62, 66.75, 58.85, 58.10, 52.06, 46.85, 29.17, 27.03, 24.65, 19.24, 13.19; MS (EI) m/z 
(intensity) 436 (M+, 3), 377 (10), 269 (5), 128 (50), 91 (95), 70 (100); HRMS (EI) m/z calculated 














Cbz-D-H2∆Phg-L-Pro-OMe-Gly-D-H2∆Phg-NMe2 (411).  Saponification of (+)-405:  To a 
solution of (+)-405 (33 mg, 0.076 mmol) in dry Et2O (1.0 mL) was added KOTMS (19 mg, 0.15 
mmol).  The reaction mixture was stirred for 12 h, acidified with 10% HCl and extracted with 
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EtOAc (3x).  The combined organic layers were washed with brine, dried (MgSO4) and 
concentrated. 
N-Fmoc deprotection of 409:  To a solution of 409 (44 mg, 0.088 mmol) in dry DMF (0.90 mL) 
was added piperidine (0.10 mL).  The reaction mixture was stirred for 1 h and concentrated.  The 
residue was dissolved in dry toluene (ca. 10 mL) and concentrated (repeated 10 times) to afford a 
light yellow solid. 
Fragment coupling:  The amine and acid were concentrated into a 25 mL flask and the residue 
was dissolved in dry CH2Cl2 (1.0 mL), treated with DMAP (1.0 mg, 0.0087 mmol) and EDCI 
(17 mg, 0.089 mmol) and stirred for 12 h.  The mixture was diluted with H2O and extracted with 
CH2Cl2.  The combined organic layers were washed with 10% HCl (2x) and brine, dried 
(MgSO4) and concentrated.  The residue was purified by chromatography on deactivated SiO2 
(3:2, CH2Cl2/acetone containing 1% Et3N) to afford 411 (24 mg, 49%) as a colorless solid:    
[α]D +74.0 (c 0.26, CHCl3); IR (neat) 3291, 2923, 2852, 1716, 1695, 1619, 1540, 1456, 1258, 
1155 cm-1; 1H NMR (3:1 mixture of amide bond rotamers, DMSO-d6) major rotamer δ 8.42 (t, J 
= 5.6 Hz, 1 H), 8.20 (d, J = 9.0 Hz, 1 H), 8.17 (d, J = 8.7 Hz, 1 H), 7.42-7.17 (m, 15 H), 5.05 (d, 
J = 12.5 Hz, 1 H), 4.91 (d, J = 12.5 Hz, 1 H), 4.42 (t, J = 9.4 Hz, 1 H), 4.18-4.08 (m, 1 H), 4.11 
(t, J = 9.0 Hz, 1 H), 3.82 (dd, J = 16.9, 6.8 Hz, 1 H), 3.67-3.46 (m, 3 H), 3.06 (s, 3 H), 2.72 (s, 3 
H), 2.02-1.93 (m, 2 H), 1.91-1.81 (m, 3 H), 1.67-1.49 (m, 2 H), 0.98-0.80 (m, 5 H); minor 
rotamer (representative signals) δ 8.52 (d, J = 8.5 Hz, 1 H), 8.05 (d, J = 8.5 Hz, 1 H), 3.08 (s, 3 
H), 2.80 (s, 3 H); 13C NMR (76 MHz, CDCl3) δ 172.44, 172.35, 172.10, 168.39, 156.46, 142.60, 
141.18, 136.79, 128.47, 128.43, 128.23, 128.13, 127.77, 127.28, 127.12, 126.99, 126.63, 66.35, 
61.06, 59.35, 56.15, 47.62, 43.19, 37.52, 36.10, 29.21, 28.23, 28.06, 25.12, 20.06, 17.74, 14.99, 
8.45; MS (ESI) m/z (intensity) 702 ([M+Na]+, 100); HRMS (ESI) m/z calculated for 







Cbz-L-H2∆Phg-NHMe (412).  To a solution of (-)-365 (0.10 g, 0.31 mmol) in dry Et2O (4.0 mL) 
was added KOTMS (79 mg, 0.62 mmol).  The reaction mixture was stirred for 7 h, acidified with 
10% HCl and extracted with EtOAc.  The combined organic layers were washed with brine, 
dried (Na2SO4) and concentrated.  The residue was dissolved in dry CH2Cl2 (3.0 mL), treated 
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with EDCI (74 mg, 0.39 mmol), DMAP (4.0 mg, 0.033 mmol), DIPEA (0.16 mL, 0.93 mmol), 
and MeNH2•HCl (0.10 g, 1.6 mmol), stirred for 12 h, diluted with H2O and extracted with 
EtOAc.  The combined organic layers were washed with 10% HCl, H2O and brine, dried 
(MgSO4) and concentrated.  The residue was purified by chromatography on deactivated SiO2 
(EtOAc containing 1% v/v Et3N) to afford 412 (75 mg, 72%) as a colorless solid:  mp 200.7-
202.9 °C (hexanes/EtOAc); [α]D -41.1 (c 0.45, CHCl3); IR (KBr)  3315, 1686, 1640, 1554, 1260 
cm-1; 1H NMR (acetone-d6) δ 7.44-7.41 (m, 2 H), 7.35-7.16 (m, 10 H), 5.08, 5.01 (AB, J = 12.6 
Hz, 2 H), 4.16 (t, J = 8.5 Hz, 1 H), 2.68 (d, J = 4.7 Hz, 3 H), 1.74-1.66 (m, 2 H), 1.01-0.95 (m, 1 
H), 0.85-0.79 (m, 1 H); 13C NMR δ 172.70, 155.93, 140.81, 136.38, 128.69, 128.49, 128.14, 
128.11, 127.74, 126.62, 66.77, 58.31, 26.51, 26.15, 21.69, 12.51; MS (EI) m/z (intensity) 338 









Cbz-Gly-L-H2∆Phg-NHMe (414).  A suspension of 412 (73 mg, 0.22 mmol) and Pd/C (23 mg, 
0.022 mmol, 10 wt% Pd/C) in N2 purged MeOH (3.0 mL) was evacuated and purged with H2.  
The reaction mixture was vigorously stirred under an atmosphere of H2 for 1.5 h, filtered through 
Celite and concentrated.  The residue was dissolved in dry DMF (2.0 mL), cooled to 0 °C and 
treated with Cbz-Gly-OH (90 mg, 0.43 mmol), BOP (210 mg, 0.48 mmol) and DIPEA (83 µL, 
0.32 mmol).  The mixture was stirred for 30 min, warmed to r.t., stirred for 10 h, diluted with 
EtOAc, washed with H2O (4x), 10% HCl and brine, dried (MgSO4) and concentrated.  The 
residue was purified by chromatography on deactivated SiO2 (1:1, CH2Cl2/acetone containing 
1% v/v Et3N) to afford 414 (68 mg, 80%) as a colorless foam:  [α]D -16.0 (c 0.93, MeOH); IR 
(KBr) 3296, 3064, 3032, 2927, 1713, 1646, 1544, 1245, 1159 cm-1; 1H NMR δ 7.45 (d, J = 8.2 
Hz, 1 H), 7.37-7.27 (m, 10 H), 6.57-6.56 (m, 1 H), 5.84 (t, J = 5.7 Hz, 1 H), 5.10-5.02 (m, 2 H), 
4.39 (t, J = 9.1 Hz, 1 H), 3.91 (dd, J = 16.6, 5.9 Hz, 1 H), 3.71 (dd, J = 16.6, 5.4 Hz, 1 H), 2.71 
(d, J = 4.7 Hz, 3 H), 1.76-1.67 (m, 1 H), 1.62-1.59 (m, 1 H), 1.30-1.23 (m, 1 H), 0.84-0.78 (m, 1 
H); 13C NMR δ 172.96, 168.67, 156.80, 140.79, 136.18, 128.66, 128.54, 128.21, 127.90, 127.62, 
126.56, 67.10, 56.39, 44.58, 26.45, 26.12, 21.30, 13.33; MS (EI) m/z (intensity) 395 (M+, 23), 
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Cbz-L-H2∆Phg-L-Pro-OMe-Gly-L-H2∆Phg-NHMe (415).  Saponification of 401:  To a solution 
of 401 (58 mg, 0.13 mmol) in dry Et2O (1.5 mL) was added KOTMS (34 mg, 0.27 mmol).  The 
reaction mixture was stirred for 12 h, acidified with 10% HCl and extracted with EtOAc (3x).  
The combined organic layers were washed with brine, dried (MgSO4) and concentrated. 
N-Cbz deprotection of 414:  To a mixture of 414 (68 mg, 0.17 mmol) and Pd/C (18 mg, 0.017 
mmol, 10 wt% Pd/C) was added under N2 MeOH (2.0 mL).  The suspension was evacuated and 
purged with H2 and the mixture was vigorously stirred under an atmosphere of H2 for 1.5 h, 
filtered through Celite and concentrated. 
Fragment coupling:  The amine and acid were concentrated into a 25 mL flask and the residue 
was dissolved in dry DMF (2.0 mL), cooled to 0 °C and treated with BOP (83 mg, 0.19 mmol) 
and DIPEA (35 µL, 0.74 mmol).  The reaction mixture was warmed to r.t., stirred for 12 h, 
diluted with H2O and extracted with CH2Cl2.  The combined organic layers were washed with 
10% HCl (2x) and brine, dried (MgSO4) and concentrated.  The residue was purified by 
chromatography on deactivated SiO2 (4:1, CH2Cl2/acetone containing 1% Et3N) to afford 415 
(62 mg, 70%) as a colorless solid:  [α]D -54.6 (c 0.35, CHCl3); IR (KBr) 3304, 3062, 3030, 2938, 
1715, 1651, 1623, 1533, 1454, 1239 cm-1; 1H NMR (DMSO-d6, 8:1 mixture of amide bond 
rotamers) δ 8.31 (t, J = 5.7 Hz, 1 H), 8.27 (d, J = 8.6 Hz, 1 H), 8.05 (d, J = 8.9 Hz, 1 H), 7.88 (q, 
J = 4.6 Hz, 1 H), 7.33-7.16 (m, 15 H), 5.08 (d, J = 12.6 Hz, 1 H), 4.95 (d, J = 12.6 Hz, 1 H), 4.32 
(t, J = 8.4 Hz, 1 H), 4.23-4.17 (m, 2 H), 3.76 (dd, J = 16.9, 6.7 Hz, 1 H), 3.74-3.67 (m, 1 H), 
3.57-3.50 (m, 2 H), 2.54 (d, J = 4.5 Hz, 3 H), 2.02-1.80 (m, 5 H), 1.60-1.48 (m, 3 H), 0.87-0.76 
(m, 4 H); 13C NMR (DMSO-d6) δ 172.13, 171.81, 170.67, 167.97, 155.72, 142.62, 137.16, 
128.35, 128.29, 128.18, 128.07, 127.82, 127.69, 127.00, 126.79, 126.51, 126.45, 65.32, 60.03, 
57.02, 54.85, 47.11, 42.16, 29.26, 27.80, 25.69, 25.22, 24.36, 20.34, 18.87, 12.50, 11.97; MS 
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(ESI) m/z (intensity) 688 ([M+Na]+, 100); HRMS (ESI) m/z calculated for C38H43N5O6Na 






Cbz-D-αMe∆Phg-L-Pro-OMe (416).  To a solution of (-)-379 (45 mg, 0.13 mmol) in dry Et2O 
(1.0 mL) were added two portions of KOTMS (66 mg, 0.51 mmol) over 4 h.  The reaction 
mixture was stirred for 10 h, diluted with H2O, acidified with 10% HCl and extracted with 
EtOAc (3x).  The combined organic layers were washed with brine, dried (Na2SO4) and 
concentrated.  The residue was dissolved in dry CH2Cl2 (1.0 mL) and treated with L-Pro-
OMe•HCl (42 mg, 0.25 mmol), EDCI (29 mg, 0.15 mmol), DMAP (2.0 mg, 0.015 mmol) and 
DIPEA (0.11 mL, 0.64 mmol), stirred for 12 h, diluted with EtOAc and washed with 10% HCl, 
H2O and brine, dried (MgSO4) and concentrated.  The residue was purified by chromatography 
on deactivated SiO2 (1:4, hexanes/EtOAc containing 1% v/v Et3N) to afford 416 (43 mg, 75%) 
as a colorless foam:  [α]D -105.6 (c 1.0, CHCl3); IR (neat) 3315, 3058, 3027, 2954, 1739, 1715, 
1624, 1526, 1425, 1244 cm-1; 1H NMR (8.0:1 mixture of rotamers) major rotamer δ 7.57-7.54 
(m, 2 H), 7.38-7.29 (m, 8 H), 5.38 (bd, J = 7.2 Hz, 1 H), 5.12, 5.09 (AB, J = 12.2 Hz, 2 H), 4.48-
4.40 (m, 1 H), 4.35 (dd, J = 8.5, 4.6 Hz, 1 H), 3.68 (s, 3 H), 3.47-3.38 (m, 1 H), 3.11 (bs, 1 H), 
2.15-2.05 (m, 1 H), 1.85-1.77 (m, 2 H), 1.72-1.61 (m, 2 H), 1.43-1.33 (m, 1 H), 1.36 (s, 3 H), 
0.85-0.79 (m, 1 H); minor rotamer (representative peaks) δ 4.23 (dd, J = 5.6, 3.4 Hz, 1 H); 13C 
NMR δ 172.72, 172.46, 155.94, 142.06, 136.46, 128.66, 128.45, 128.04, 127.97, 127.55, 127.00, 
66.81, 59.09, 55.35, 52.01, 46.81, 28.78, 27.86, 26.15, 24.96, 17.52, 15.27; MS (ESI) m/z 
(intensity) 473 ([M+Na]+, 100), 451 ([M+H]+, 5); HRMS (ESI) m/z calculated for C26H30N2O5Na 






Cbz-D-αMe∆Phg-NMe2 (417).  To a solution of (-)-379 (45 mg, 0.13 mmol) in dry Et2O (1.0 
mL) were added two portions of KOTMS (66 mg, 0.51 mmol) over 4 h.  The reaction mixture 
was stirred for 10 h, diluted with H2O, acidified with 10% HCl, and extracted with EtOAc (3x).  
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The combined organic layers were washed with brine, dried (Na2SO4) and concentrated.  The 
residue was dissolved in dry CH2Cl2 (1.0 mL) and treated with Me2NH•HCl (52 mg, 0.64 mmol), 
EDCI (29 mg, 0.15 mmol), DMAP (2.0 mg, 0.015 mmol) and DIPEA (0.11 mL, 0.64 mmol), 
stirred for 12 h, diluted with EtOAc and washed with 10% HCl, H2O and brine, dried (MgSO4) 
and concentrated.  The residue was purified by chromatography on deactivated SiO2 (1:4, 
hexanes/EtOAc containing 1% v/v Et3N) to afford 417 (33 mg, 70%) as a colorless foam:      
[α]D -71.1 (c 0.71, CHCl3); IR (neat) 3294, 3064, 3031, 2933, 1716, 1622, 1527, 1497, 1454, 
1258, 1130 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.63-7.60 (m, 2 H), 7.40-7.25 (m, 8 H), 5.29 
(bd, J = 6.7 Hz, 1 H), 5.12, 5.10 (AB, J = 12.2 Hz, 2 H), 4.46 (bt, J = 8.6 Hz, 1 H), 2.83 (s, 6 H), 
1.71-1.62 (m, 1 H), 1.32 (s, 3 H), 1.22 (dd, J = 8.9, 5.0 Hz, 1 H), 0.90-0.84 (m, 1 H); 13C NMR 
(126 MHz, CDCl3) δ 173.69, 156.02, 141.87, 136.41, 128.66, 128.47, 128.04, 127.56, 127.08, 
66.80, 55.20, 36.28 (b), 27.47, 25.58, 18.00, 16.16; MS (ESI) m/z (intensity) 389 ([M+Na]+, 









Cbz-Gly-D-αMe∆Phg-NMe2 (418).  To a mixture of 417 (83 mg, 0.23 mmol) and Pd/C (24 mg, 
0.023 mmol, 10 wt% Pd/C) was added under N2 MeOH (2.0 mL).  The flask was evacuated and 
purged with H2 (1 atm), and the reaction mixture was stirred under an atmosphere of H2 for 2 h, 
filtered through Celite and concentrated.  The residue was dissolved in dry DMF (2.0 mL) and 
treated at 0 °C with Cbz-Gly-OH (95 mg, 0.45 mmol), BOP (0.12 g, 0.27 mmol) and DIPEA (79 
µL, 0.45 mmol).  The mixture was stirred for 30 min, warmed to r.t., stirred for 10 h, diluted with 
EtOAc, washed with H2O (5x) and brine, dried (MgSO4) and concentrated.  The residue was 
purified by chromatography on deactivated SiO2 (7:3, CH2Cl2/acetone containing 1% v/v Et3N) 
to afford 418 (75 mg, 78%) as a colorless foam:  [α]D -68.9 (c 0.92, CHCl3); IR (neat) 3416 cm-1; 
1H NMR δ 7.60 (d, J = 7.4 Hz, 2 H), 7.36-7.21 (m, 8 H), 6.83 (bd, J = 7.3 Hz, 1 H), 5.53 (bs, 1 
H), 5.14-5.06 (m, 2 H), 4.81-4.74 (m, 1 H), 3.96-3.82 (m, 2 H), 2.85 (s, 6 H), 1.70 (dt, J = 9.4, 
6.4 Hz, 1 H), 1.30 (s, 3 H), 1.17-1.12 (m, 1 H), 0.82 (t, J = 5.5 Hz, 1 H); 13C NMR δ 173.88, 
168.19, 156.51, 141.27, 136.14, 128.68, 128.51, 128.19, 128.04, 127.59, 127.24, 67.14, 53.03, 
44.61, 36.48 (b), 26.92, 25.59, 18.13, 16.10; MS (ESI) m/z (intensity) 446 ([M+Na]+, 100), 424 
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Cbz-D-αMe∆Phg-L-Pro-Gly-D-αMe∆Phg-NMe2 (421).  Saponification of 417:  To a solution of 
417 (64 mg, 0.14 mmol) in dry Et2O (1.5 mL) was added KOTMS (37 mg, 0.28 mmol).  The 
reaction mixture was stirred for 4 h, acidified with 10% HCl and extracted with EtOAc (3x).  
The combined organic layers were washed with brine, dried (Na2SO4) and concentrated. 
N-Cbz Deprotection of 418:  To a mixture of 418 (75 mg, 0.18 mmol) and Pd/C (19 mg, 0.018 
mmol, 10 wt% Pd) was added under N2 MeOH (2 mL).  The flask was evacuated, purged with 
H2 (1 atm) and the mixture was stirred under an atmosphere of H2 for 1.5 h, filtered through 
Celite and concentrated. 
Fragment coupling:  The amine and acid were concentrated into a 25 mL flask and the residue 
was dissolved in dry CH2Cl2 (1.5 mL) and treated with EDCI (33 mg, 0.17 mmol) and DMAP 
(2.0 mg, 0.018 mmol).  The reaction mixture was stirred for 12 h, diluted with EtOAc, washed 
with H2O (2x) and brine, dried (MgSO4) and concentrated.  The residue was purified by 
chromatography on deactivated SiO2 (3:2, CH2Cl2/acetone containing 1% v/v Et3N) to give 421 
(51 mg, 56%) as a colorless solid.  The solid was further purified by reverse phase HPLC (55:45, 
CH3CN/H2O, Rainin 10 mm x 25 cm C18 column) to afford 421 (33 mg) as a colorless solid:  
[α]D -21.5 (c 0.40, CHCl3); IR (KBr) 3326, 3061, 2927, 1718, 1686, 1670, 1655, 1620, 1527, 
1243 cm-1; 1H NMR (600 MHz, DMSO-d6) δ 8.40-8.38 (m, 1 H), 8.07 (d, J = 8.7 Hz, 1 H), 7.74 
(d, J = 8.9 Hz, 1 H), 7.58 (d, J = 7.5 Hz, 2 H), 7.51 (d, J = 7.4 Hz, 2 H), 7.37-7.23 (m, 11 H), 
5.04-4.99 (m, 2 H), 4.56 (app t, J = 10.1 Hz, 1 H), 4.25 (t, J = 9.9 Hz, 1 H), 4.11 (app t, J = 6.3 
Hz, 1 H), 3.77 (dd, J = 17.0, 6.9 Hz, 1 H), 3.48 (dd, J = 16.9, 5.0 Hz, 1 H), 3.42-3.38 (m, 1 H), 
3.18-3.17 (m, 1 H), 2.37 (bs, 6 H), 2.03-1.97 (m, 1 H), 1.85-1.81 (m, 1 H), 1.73-1.67 (m, 2 H), 
1.65-1.62 (m, 1 H), 1.54-1.49 (m, 1 H), 1.20 (s, 3 H), 1.19 (s, 3 H), 1.10 (dd, J = 8.6, 4.4 Hz, 1 
H), 0.99 (dd, J = 9.0, 4.7 Hz, 1 H), 0.59 (bt, 1 H), 0.40 (bt, 1 H); 13C NMR (151 MHz, DMSO-
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d6) δ 172.73, 172.27, 172.25, 167.54, 155.77, 142.99, 142.80, 137.05, 128.36, 128.28, 128.17, 
127.73, 127.65, 127.08, 126.99, 126.87, 65.37, 60.38, 54.46, 52.27, 47.09, 42.22, 28.68, 27.48, 
26.29, 25.42, 25.10, 24.75, 17.39, 17.29, 15.73, 14.79; MS (ESI) m/z (intensity) 730 ([M+Na]+, 











Cbz-D-αMe∆Phg-D-αMe∆Phg-NHPri (422).  To a solution of (-)-393 (34 mg, 0.063 mmol) in 
MeOH (0.50 mL) was added NaOH (0.50 mL, 2.0 M in H2O) and THF (0.20 mL).  The reaction 
mixture was stirred for 2 h, acidified with 10% HCl and extracted with EtOAc (3x).  The 
combined organic layers were washed with brine, dried (Na2SO4) and concentrated.  The residue 
was dissolved in dry DMF (1.0 mL) and treated at 0 °C with i-PrNH2•HCl (18 mg, 0.19 mmol), 
BOP (33 mg, 0.076 mmol) and DIPEA (16 µL, 0.094 mmol).  The mixture was stirred for 30 
min, warmed to r.t., stirred for 10 h, diluted with EtOAc, washed with H2O (5x) and brine, dried 
(MgSO4) and concentrated.  The residue was purified by chromatography on deactivated SiO2 
(3:7, hexanes/EtOAc containing 1% v/v Et3N) to afford 422 (24 mg, 67%) as a colorless foam:  
[α]D -82.4 (c 0.85, CHCl3); IR (neat) 3316, 3031, 2971, 1705, 1630, 1522, 1456, 1258, 1205   
cm-1; 1H NMR δ 7.37-7.24 (m, 15 H), 6.23 (d, J = 8.2 Hz, 1 H), 5.48 (d, J = 8.0 Hz, 1 H), 5.43 
(d, J = 8.0 Hz, 1 H), 5.16-5.07 (m, 2 H), 4.89-4.83 (m, 1 H), 4.52 (bt, J = 9.6 Hz, 1 H), 4.06 (app. 
sextet, J = 6.6 Hz, 1 H), 1.99-1.88 (m, 2 H), 1.55 (dd, J = 8.9, 4.2 Hz, 1 H), 1.40 (dd, J = 9.0, 3.9 
Hz, 1 H), 1.27 (s, 3 H), 1.25 (s, 3 H), 1.14 (d, J = 6.5 Hz, 3 H), 1.13 (d, J = 6.5 Hz, 3 H), 0.95-
0.87 (m, 1 H), 0.70 (dd, J = 6.2, 4.2 Hz, 1 H); 13C NMR (126 MHz, CDCl3) δ 173.58, 173.14, 
155.99, 141.71, 136.38, 128.77, 128.68, 128.52, 128.13, 128.04, 127.79, 127.50, 126.71, 126.60, 
66.91, 54.86, 52.67, 41.71, 30.82, 30.14, 24.21, 24.02, 22.85, 22.79, 20.28, 19.72, 14.67; MS 
(ESI) 590 ([M+Na]+, 48), 568 ([M+H]+, 51), 547 (80), 359 (100); HRMS (ESI) m/z calculated 















Cbz-Gly-D-αMe∆Phg-D-αMe∆Phg-NHPri (423).  To a mixture of 422 (24 mg, 0.042 mmol) and 
Pd/C (5.0 mg, 0.0042 mmol, 10 wt% Pd/C) was added under N2 MeOH (1.0 mL).  The flask was 
evacuated and purged with H2 (1 atm), and the reaction mixture was stirred under an atmosphere 
of H2 for 2 h, filtered through Celite and concentrated.  The residue was dissolved in dry DMF 
(1.0 mL), treated at 0 °C with BOP (47 mg, 0.11 mmol), Cbz-Gly-OH (22 mg, 0.11 mmol) and 
DIPEA (18 µL, 0.11 mmol), stirred for 30 min, warmed to r.t., and stirred for 10 h.  The solution 
was diluted with EtOAc, washed with H2O (5x) and brine, dried (MgSO4) and concentrated.  The 
residue was purified by chromatography on deactivated SiO2 (4:1, CH2Cl2/acetone containing 
1% v/v Et3N) to give 423 (24 mg, 92%) as a colorless foam:  [α]D -81.6 (c 0.81, CHCl3); IR 
(neat) 3313, 3031, 2971, 1717, 1628, 1521, 1456, 1255 cm-1; 1H NMR δ 7.33-7.18 (m, 16 H), 
6.44 (d, J = 8.7 Hz, 1 H), 5.56 (bs, 1 H), 5.50 (d, J = 8.1 Hz, 1 H), 5.13-5.04 (m, 2 H), 4.86-4.77 
(m, 2 H), 4.16-3.94 (m, 1 H), 3.88-3.84 (m, 1 H), 1.98-1.88 (m, 2 H), 1.47 (dd, J = 8.9, 4.1 Hz, 1 
H), 1.37 (dd, J = 9.1, 4.0 Hz, 1 H), 1.23 (s, 3 H), 1.21 (s, 3 H), 1.14 (d, J = 6.5 Hz, 3 H), 1.11 (d, 
J = 6.5 Hz, 3 H), 0.77 (dd, J = 6.2, 4.5 Hz, 1 H), 0.62 (dd, J = 6.4, 4.1 Hz, 1 H); 13C NMR δ 
173.78, 173.14, 168.08, 156.37, 141.62, 141.41, 136.17, 128.68, 128.62, 128.59, 128.48, 128.14, 
128.02, 127.66, 127.44, 126.68, 67.03, 52.71, 52.47, 44.43, 41.71, 30.51, 30.18, 24.13, 22.76, 
20.31, 19.62, 14.63, 14.53; MS (EI) m/z (intensity) 624 (M+, 26), 516 (20), 389 (15), 327 (30), 
245 (43), 230 (47), 140 (91), 91 (100); HRMS (EI) m/z calculated for C37H44N4O5 624.3312, 










Cbz-D-αMe∆Phg-D-αMe∆Phg-L-Pro-OMe (425).  To a solution of (-)-393 (27 mg, 0.050 mmol) 
in MeOH (0.50 mL) was added NaOH (0.50 mL, 2.0 M in H2O) and THF (0.20 mL).  The 
reaction mixture was stirred for 2 h, acidified with 10% HCl and extracted with EtOAc (3x).  
The combined organic layers were washed with brine, dried (Na2SO4) and concentrated.  The 
residue was dissolved in dry DMF (1.0 mL), treated at 0 °C with L-Pro-OMe•HCl (12 mg, 0.075 
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mmol), BOP (26 mg, 0.060 mmol) and DIPEA (17 µL, 0.10 mmol), stirred for 30 min, warmed 
to r.t., stirred for 10 h, diluted with EtOAc and washed with H2O (5x) and brine, dried (MgSO4) 
and concentrated.  The residue was purified by chromatography on deactivated SiO2 (3:7, 
hexanes/EtOAc containing 1% v/v Et3N) to afford 425 (23 mg, 72%) as a colorless foam:      
[α]D -112.0 (c 0.69, CHCl3); IR (neat) 3319, 3030, 2952, 1743, 1714, 1628, 1522, 1453, 1426, 
1256, 1196, 1175 cm-1; 1H NMR δ 7.56 (d, J = 7.3 Hz, 2 H), 7.36-7.23 (m, 13 H), 6.10 (bd, J = 
8.2 Hz, 1 H), 5.38 (d, J = 8.2 Hz, 1 H), 5.12, 5.11 (AB, J = 12.2 Hz, 2 H), 4.80 (t, J = 9.9 Hz, 1 
H), 4.52 (bt, J = 9.7 Hz, 1 H), 4.21 (dd, J = 8.7, 4.5 Hz, 1 H), 3.71 (s, 3 H), 3.56-3.46 (m, 1 H), 
3.29-3.21 (m, 1 H), 2.19-2.09 (m, 1 H), 1.99-1.85 (m, 3 H), 1.83-1.67 (m, 2 H), 1.54 (dd, J = 9.0, 
4.2 Hz, 1 H), 1.32 (s, 3 H), 1.27 (s, 3 H), 1.32-1.21 (m, 1 H), 0.89-0.87 (m, 1 H), 0.74 (t, J = 5.3 
Hz, 1 H); 13C NMR δ 173.53, 172.78, 172.58, 155.98, 141.81, 141.74, 136.36, 128.69, 128.48, 
128.09, 128.03, 127.67, 127.47, 127.11, 126.60, 66.86, 59.08, 54.87, 52.86, 52.11, 46.92, 30.65, 
28.82, 27.34, 26.24, 24.95, 23.99, 20.31, 17.07, 15.10, 14.71; MS (EI) m/z (intensity) 637 (M+, 
2), 529 (2), 294 (19), 201 (57), 145 (58), 91 (100); HRMS (ESI) m/z calculated for C38H43N3O6 

























Saponification of 425:  To a solution of 425 (20 mg, 0.031 mmol) in MeOH (0.50 mL) was 
added NaOH (0.50 mL, 2.0 M in H2O) and THF (0.20 mL).  The reaction mixture was stirred for 
1.5 h, acidified with 10% HCl and extracted with EtOAc (3x).  The combined organic layers 
were washed with brine, dried (Na2SO4) and concentrated. 
N-Cbz Deprotection of 423:  To a mixture of 423 (24 mg, 0.038 mmol) and Pd/C (4.0 mg, 
0.0038 mmol) was added under N2 MeOH (1.0 mL).  The flask was evacuated and purged with 
H2, and the mixture was stirred under an atmosphere of H2 for 4 h, filtered through Celite and 
concentrated. 
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Fragment Coupling:  The amine and acid were concentrated into a 25 mL flask and the residue 
was dissolved in dry DMF (1.0 mL), cooled to 0 °C, treated with BOP (21 mg, 0.047 mmol) and 
DIPEA (8.0 µL, 0.047 mmol), stirred for 30 min, warmed to r.t. and stirred for 24 h.  The 
solution was diluted with EtOAc and washed with H2O (3x) and brine, dried (Na2SO4) and 
concentrated.  The residue was purified by chromatography on deactivated SiO2 (3:2, 
CH2Cl2/acetone containing 1% v/v Et3N) to afford 426 (24 mg, 70%) as a colorless solid:  [α]D - 
28.8 (c 0.25, CHCl3); IR (KBr) 3418, 3062, 3031, 2926, 2854, 1701, 1632, 1522, 1455, 1257, 
1197 cm-1; 1H NMR (600 MHz, DMSO-d6) δ 8.48 (t, J = 5.9 Hz, 1 H), 8.18 (d, J = 8.9 Hz, 1 H), 
8.15 (d, J = 8.9 Hz, 1 H), 8.11 (d, J = 9.0 Hz, 1 H), 7.93 (d, J = 8.9 Hz, 1 H), 7.50 (d, J = 7.4 Hz, 
2 H), 7.38-7.30 (m, 12 H), 7.27-7.23 (m, 5 H), 7.19-7.10 (m, 6 H), 5.04-5.00 (m, 2 H), 4.78 (t, J 
= 9.9 Hz, 1 H), 4.69 (t, J = 9.8 Hz, 1 H), 4.40 (t, J = 9.6 Hz, 1 H), 4.17-4.11 (m, 2 H), 3.91-3.85 
(m, 2 H), 3.61-3.55 (m, 2 H), 3.49-3.46 (m, 1 H), 2.06-2.03 (m, 1 H), 1.97-1.90 (m, 3 H), 1.79-
1.73 (m, 3 H), 1.66-1.61 (m, 1 H), 1.28 (s, 3 H), 1.18-1.14 (m, 3 H), 1.12 (s, 3 H), 1.04 (d, J = 
6.3 Hz, 3 H), 1.03 (d, J = 6.0 Hz, 3 H), 0.99 (s, 3 H), 0.93 (s, 3 H), 0.88-0.86 (m, 1 H), 0.56 (bs, 
1 H), 0.40-0.38 (bm, 2 H), -0.34--0.32 (bm, 1 H); 13C NMR (151 MHz, DMSO-d6) δ 172.96, 
172.74, 172.54, 172.44, 172.42, 168.10, 155.83, 142.94, 142.82, 142.63, 142.56, 137.09, 128.31, 
128.17, 128.03, 127.91, 127.76, 127.71, 127.07, 126.92, 126.90, 126.60, 126.49, 126.34, 126.16, 
65.34, 60.40, 54.01, 51.89, 51.28, 50.44, 47.24, 42.20, 40.72, 30.73, 29.84, 29.79, 28.73, 25.38, 
24.97, 24.74, 24.42, 24.22, 23.91, 22.24, 22.15, 19.47, 19.12, 17.81, 16.98, 14.83, 14.81, 14.73, 
14.33; MS (ESI) m/z (intensity) 1118 ([M+Na]+, 100); HRMS (ESI) m/z calculated for 









Table A1.  Crystal data and structure refinement for corey1. 
Identification code  corey1 
Empirical formula  C28H32NO2P 
Formula weight  445.52 
Temperature  150(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  Pna2(1) 
Unit cell dimensions a = 21.1797(19) Å α= 90°. 
 b = 7.0411(6) Å β= 90°. 
 c = 33.876(3) Å γ = 90°. 
Volume 5051.8(8) Å3 
Z 8 
Density (calculated) 1.172 Mg/m3 
Absorption coefficient 0.132 mm-1 
F(000) 1904 
Crystal size 0.38 x 0.11 x 0.02 mm3 
Theta range for data collection 1.92 to 25.00°. 
Index ranges -25<=h<=25, -8<=k<=8, -40<=l<=40 
Reflections collected 38165 
Independent reflections 8914 [R(int) = 0.1610] 
Completeness to theta = 25.00° 100.0 %  
Max. and min. transmission 0.9974 and 0.9514 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8914 / 1 / 593 
Goodness-of-fit on F2 0.959 
Final R indices [I>2sigma(I)] R1 = 0.0755, wR2 = 0.1415 
R indices (all data) R1 = 0.1426, wR2 = 0.1616 
Absolute structure parameter 0.51(16) 
Largest diff. peak and hole 0.369 and -0.331 e.Å-3 
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Table A2. Atomic coordinates  (x 104) and equivalent isotropic displacement parameters (Å2 x 103) for corey1. 
U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
 
 x y z U(eq)  x y z U(eq) 
P(1') 1976(1) 8471(2) 3238(1) 27(1) C(13') 3469(3) 6468(9) 4562(2) 32(2) 
P(1) -501(1) 3705(2) 5905(1) 27(1) C(13) 957(3) 2442(8) 4539(2) 30(2) 
N(1') 2459(2) 10266(6) 3278(2) 22(1) C(14') 3573(3) 4619(8) 4355(2) 37(2) 
O(1) -401(2) 2086(6) 5630(2) 44(1) C(14) 1070(3) 436(8) 4682(2) 36(2) 
N(1) -37(2) 5551(6) 5889(2) 21(1) C(15') 3768(3) 6601(9) 4970(2) 33(2) 
O(1') 2026(2) 6850(6) 3506(2) 42(1) C(15) 1251(3) 2933(8) 4144(2) 30(2) 
C(1') 3444(3) 11557(8) 2985(2) 23(2) C(16') 4485(3) 6609(8) 4961(2) 28(2) 
C(1) 936(3) 6802(8) 6204(2) 25(2) C(16) 1971(3) 2835(8) 4156(2) 33(2) 
O(2) 2248(2) 3364(6) 3792(1) 32(1) C(17') 1216(3) 9603(8) 3290(2) 28(1) 
O(2') 4748(2) 6437(6) 5346(1) 35(1) C(17) -1276(3) 4745(8) 5839(2) 31(2) 
C(2') 3286(3) 13416(9) 3025(2) 37(2) C(18') 769(3) 8744(9) 3524(2) 42(2) 
C(2) 772(3) 8715(9) 6179(2) 32(2) C(18) -1706(3) 3829(10) 5595(2) 55(2) 
C(3') 3590(3) 14789(9) 2794(2) 38(2) C(19) -2305(3) 4561(11) 5548(3) 61(2) 
C(3) 1062(3) 10022(9) 6412(2) 44(2) C(19') 177(3) 9649(11) 3571(2) 51(2) 
C(4') 4044(3) 14278(9) 2531(2) 40(2) C(20) -2469(4) 6194(12) 5729(3) 59(2) 
C(4) 1542(3) 9541(10) 6661(2) 39(2) C(20') 53(3) 11316(12) 3387(2) 55(2) 
C(5') 4211(4) 12382(10) 2490(3) 39(2) C(21') 497(4) 12178(9) 3142(3) 45(2) 
C(5) 1706(4) 7670(10) 6691(3) 42(2) C(21) -2056(4) 7115(11) 5963(3) 52(2) 
C(6) 1426(3) 6305(9) 6467(2) 39(2) C(22') 1074(3) 11307(9) 3099(2) 31(2) 
C(6') 3903(3) 11044(9) 2713(2) 36(2) C(22) -1445(3) 6402(10) 6027(2) 39(2) 
C(7') 3160(2) 10029(8) 3247(2) 25(1) C(23) -457(3) 2880(8) 6407(2) 26(2) 
C(7) 666(2) 5340(8) 5926(2) 25(1) C(23') 2039(3) 7693(8) 2748(3) 36(2) 
C(8') 3450(3) 10082(8) 3656(2) 26(1) C(24') 2206(3) 8900(10) 2430(2) 41(2) 
C(8) 977(3) 5471(8) 5530(2) 28(1) C(24) -637(3) 992(9) 6487(2) 41(2) 
C(9') 4097(3) 9178(8) 3697(2) 38(2) C(25) -636(4) 381(12) 6878(3) 62(3) 
C(9) 1597(3) 4433(9) 5464(2) 38(2) C(25') 2202(4) 8251(13) 2047(3) 54(2) 
C(10') 3526(3) 8268(8) 3886(2) 31(2) C(26) -475(4) 1487(13) 7181(3) 53(2) 
C(10) 996(3) 3759(9) 5267(2) 33(2) C(26') 2016(4) 6381(15) 1961(3) 73(4) 
C(11') 3445(3) 8265(8) 4325(2) 33(2) C(27) -295(3) 3333(12) 7106(2) 48(2) 
C(11) 929(3) 4063(8) 4843(2) 32(2) C(27') 1864(4) 5202(13) 2262(3) 60(2) 
C(12) 340(3) 3410(10) 4634(2) 43(2) C(28) -289(3) 4033(9) 6727(2) 38(2) 
C(12') 2854(3) 7474(8) 4507(2) 37(2) C(28') 1879(3) 5832(9) 2643(2) 47(2) 
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Table A3. Bond lengths [Å] and angles [°] for corey1. 
 
P(1')-O(1') 1.462(5) C(26')-C(27') 1.355(12) C(13)-C(12)-H(12B) 117.6 
P(1')-N(1') 1.633(5) C(26')-H(26B) 0.95 H(12A)-C(12)-H(12B) 114.7 
P(1')-C(23') 1.753(9) C(27)-C(28) 1.374(10) C(13')-C(12')-C(11') 60.1(4) 
P(1')-C(17') 1.804(6) C(27)-H(27A) 0.95 C(13')-C(12')-H(12C) 117.8 
P(1)-O(1) 1.488(5) C(27')-C(28') 1.364(11) C(11')-C(12')-H(12C) 117.8 
P(1)-N(1) 1.630(4) C(27')-H(27B) 0.95 C(13')-C(12')-H(12D) 117.8 
P(1)-C(23) 1.798(7) C(28)-H(28A) 0.95 C(11')-C(12')-H(12D) 117.8 
P(1)-C(17) 1.811(6) C(28')-H(28B) 0.95 H(12C)-C(12')-H(12D) 114.9 
N(1')-C(7') 1.497(6) O(1')-P(1')-N(1') 120.4(3) C(12')-C(13')-C(14') 118.8(6) 
N(1')-H(1N') 0.99(6) O(1')-P(1')-C(23') 109.8(3) C(12')-C(13')-C(11') 60.3(4) 
N(1)-C(7) 1.501(6) N(1')-P(1')-C(23') 105.8(3) C(14')-C(13')-C(11') 119.2(6) 
N(1)-H(1) 0.86(5) O(1')-P(1')-C(17') 110.5(3) C(12')-C(13')-C(15') 116.6(5) 
C(1')-C(2') 1.358(8) N(1')-P(1')-C(17') 102.1(2) C(14')-C(13')-C(15') 114.7(5) 
C(1')-C(6') 1.386(8) C(23')-P(1')-C(17') 107.4(3) C(11')-C(13')-C(15') 116.7(5) 
C(1')-C(7') 1.520(8) O(1)-P(1)-N(1) 120.2(3) C(12)-C(13)-C(15) 116.3(5) 
C(1)-C(2) 1.394(8) O(1)-P(1)-C(23) 109.7(3) C(12)-C(13)-C(14) 119.4(6) 
C(1)-C(6) 1.413(9) N(1)-P(1)-C(23) 105.0(3) C(15)-C(13)-C(14) 115.6(5) 
C(1)-C(7) 1.508(8) O(1)-P(1)-C(17) 111.1(3) C(12)-C(13)-C(11) 59.2(4) 
O(2)-C(16) 1.415(8) N(1)-P(1)-C(17) 102.7(3) C(15)-C(13)-C(11) 115.9(5) 
O(2)-H(2) 0.80(8) C(23)-P(1)-C(17) 107.1(3) C(14)-C(13)-C(11) 118.9(5) 
O(2')-C(16') 1.423(7) C(7')-N(1')-P(1') 122.0(4) C(13')-C(14')-H(14A) 109.5 
O(2')-H(2') 1.05(8) C(7')-N(1')-H(1N') 108(3) C(13')-C(14')-H(14B) 109.5 
C(2')-C(3') 1.400(9) P(1')-N(1')-H(1N') 114(3) H(14A)-C(14')-H(14B) 109.5 
C(2')-H(2'A) 0.95 C(7)-N(1)-P(1) 121.1(4) C(13')-C(14')-H(14C) 109.5 
C(2)-C(3) 1.359(9) C(7)-N(1)-H(1) 111(3) H(14A)-C(14')-H(14C) 109.5 
C(2)-H(2A) 0.95 P(1)-N(1)-H(1) 115(3) H(14B)-C(14')-H(14C) 109.5 
C(3')-C(4') 1.361(9) C(2')-C(1')-C(6') 119.4(6) C(13)-C(14)-H(14D) 109.5 
C(3')-H(3'A) 0.95 C(2')-C(1')-C(7') 121.7(5) C(13)-C(14)-H(14E) 109.5 
C(3)-C(4) 1.363(9) C(6')-C(1')-C(7') 118.8(5) H(14D)-C(14)-H(14E) 109.5 
C(3)-H(3A) 0.95 C(2)-C(1)-C(6) 117.4(6) C(13)-C(14)-H(14F) 109.5 
C(4')-C(5') 1.388(9) C(2)-C(1)-C(7) 121.9(5) H(14D)-C(14)-H(14F) 109.5 
C(4')-H(4'A) 0.95 C(6)-C(1)-C(7) 120.2(5) H(14E)-C(14)-H(14F) 109.5 
C(4)-C(5) 1.366(9) C(16)-O(2)-H(2) 132(6) C(16')-C(15')-C(13') 113.5(5) 
C(4)-H(4A) 0.95 C(16')-O(2')-H(2') 106(4) C(16')-C(15')-H(15A) 108.9 
C(5')-C(6') 1.372(10) C(1')-C(2')-C(3') 119.8(6) C(13')-C(15')-H(15A) 108.9 
C(5')-H(5'A) 0.95 C(1')-C(2')-H(2'A) 120.1 C(16')-C(15')-H(15B) 108.9 
C(5)-C(6) 1.361(10) C(3')-C(2')-H(2'A) 120.1 C(13')-C(15')-H(15B) 108.9 
C(5)-H(5A) 0.95 C(3)-C(2)-C(1) 120.4(6) H(15A)-C(15')-H(15B) 107.7 
C(6)-H(6A) 0.95 C(3)-C(2)-H(2A) 119.8 C(13)-C(15)-C(16) 112.2(5) 
C(6')-H(6'A) 0.95 C(1)-C(2)-H(2A) 119.8 C(13)-C(15)-H(15C) 109.2 
C(7')-C(8') 1.515(8) C(4')-C(3')-C(2') 120.5(6) C(16)-C(15)-H(15C) 109.2 
C(7')-H(7'A) 1 C(4')-C(3')-H(3'A) 119.7 C(13)-C(15)-H(15D) 109.2 
C(7)-C(8) 1.494(8) C(2')-C(3')-H(3'A) 119.7 C(16)-C(15)-H(15D) 109.2 
C(7)-H(7A) 1 C(2)-C(3)-C(4) 121.9(6) H(15C)-C(15)-H(15D) 107.9 
C(8')-C(10') 1.506(8) C(2)-C(3)-H(3A) 119.1 O(2')-C(16')-C(15') 111.9(5) 
C(8')-C(9') 1.517(7) C(4)-C(3)-H(3A) 119.1 O(2')-C(16')-H(16A) 109.2 
C(8')-H(8'A) 1 C(3')-C(4')-C(5') 119.9(7) C(15')-C(16')-H(16A) 109.2 
C(8)-C(10) 1.501(8) C(3')-C(4')-H(4'A) 120 O(2')-C(16')-H(16B) 109.2 
C(8)-C(9) 1.520(8) C(5')-C(4')-H(4'A) 120 C(15')-C(16')-H(16B) 109.2 
C(8)-H(8A) 1 C(3)-C(4)-C(5) 118.3(7) H(16A)-C(16')-H(16B) 107.9 
C(9')-C(10') 1.511(8) C(3)-C(4)-H(4A) 120.8 O(2)-C(16)-C(15) 112.4(6) 
C(9')-H(9'A) 0.99 C(5)-C(4)-H(4A) 120.8 O(2)-C(16)-H(16C) 109.1 
C(9')-H(9'B) 0.99 C(6')-C(5')-C(4') 119.0(7) C(15)-C(16)-H(16C) 109.1 
C(9)-C(10) 1.515(8) C(6')-C(5')-H(5'A) 120.5 O(2)-C(16)-H(16D) 109.1 
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Table A3. Cont’d 
 
C(9)-H(9A) 0.99 C(4')-C(5')-H(5'A) 120.5 C(15)-C(16)-H(16D) 109.1 
C(9)-H(9B) 0.99 C(6)-C(5)-C(4) 122.0(7) H(16C)-C(16)-H(16D) 107.9 
C(10')-C(11') 1.495(9) C(6)-C(5)-H(5A) 119 C(18')-C(17')-C(22') 119.8(6) 
C(10')-H(10A) 1 C(4)-C(5)-H(5A) 119 C(18')-C(17')-P(1') 118.4(5) 
C(10)-C(11) 1.460(8) C(5)-C(6)-C(1) 119.8(7) C(22')-C(17')-P(1') 121.7(5) 
C(10)-H(10B) 1 C(5)-C(6)-H(6A) 120.1 C(22)-C(17)-C(18) 119.8(6) 
C(11')-C(13') 1.500(9) C(1)-C(6)-H(6A) 120.1 C(22)-C(17)-P(1) 121.4(5) 
C(11')-C(12') 1.503(9) C(5')-C(6')-C(1') 121.3(6) C(18)-C(17)-P(1) 118.8(5) 
C(11')-H(11A) 1 C(5')-C(6')-H(6'A) 119.4 C(17')-C(18')-C(19') 118.5(6) 
C(11)-C(12) 1.505(9) C(1')-C(6')-H(6'A) 119.4 C(17')-C(18')-H(18A) 120.8 
C(11)-C(13) 1.538(8) N(1')-C(7')-C(8') 109.6(5) C(19')-C(18')-H(18A) 120.8 
C(11)-H(11B) 1 N(1')-C(7')-C(1') 110.8(5) C(19)-C(18)-C(17) 120.0(7) 
C(12)-C(13) 1.508(8) C(8')-C(7')-C(1') 110.8(4) C(19)-C(18)-H(18B) 120 
C(12)-H(12A) 0.99 N(1')-C(7')-H(7'A) 108.5 C(17)-C(18)-H(18B) 120 
C(12)-H(12B) 0.99 C(8')-C(7')-H(7'A) 108.5 C(20)-C(19)-C(18) 120.2(8) 
C(12')-C(13') 1.494(9) C(1')-C(7')-H(7'A) 108.5 C(20)-C(19)-H(19A) 119.9 
C(12')-H(12C) 0.99 C(8)-C(7)-N(1) 110.8(5) C(18)-C(19)-H(19A) 119.9 
C(12')-H(12D) 0.99 C(8)-C(7)-C(1) 110.6(5) C(20')-C(19')-C(18') 120.7(7) 
C(13')-C(14') 1.496(8) N(1)-C(7)-C(1) 111.1(4) C(20')-C(19')-H(19B) 119.6 
C(13')-C(15') 1.522(9) C(8)-C(7)-H(7A) 108.1 C(18')-C(19')-H(19B) 119.6 
C(13)-C(15) 1.515(9) N(1)-C(7)-H(7A) 108.1 C(19)-C(20)-C(21) 120.7(7) 
C(13)-C(14) 1.513(8) C(1)-C(7)-H(7A) 108.1 C(19)-C(20)-H(20A) 119.7 
C(14')-H(14A) 0.98 C(10')-C(8')-C(7') 119.8(5) C(21)-C(20)-H(20A) 119.7 
C(14')-H(14B) 0.98 C(10')-C(8')-C(9') 60.0(4) C(19')-C(20')-C(21') 121.3(7) 
C(14')-H(14C) 0.98 C(7')-C(8')-C(9') 116.2(5) C(19')-C(20')-H(20B) 119.3 
C(14)-H(14D) 0.98 C(10')-C(8')-H(8'A) 116.3 C(21')-C(20')-H(20B) 119.3 
C(14)-H(14E) 0.98 C(7')-C(8')-H(8'A) 116.3 C(22')-C(21')-C(20') 118.0(7) 
C(14)-H(14F) 0.98 C(9')-C(8')-H(8'A) 116.3 C(22')-C(21')-H(21A) 121 
C(15')-C(16') 1.519(8) C(7)-C(8)-C(10) 119.7(5) C(20')-C(21')-H(21A) 121 
C(15')-H(15A) 0.99 C(7)-C(8)-C(9) 118.9(5) C(20)-C(21)-C(22) 121.1(7) 
C(15')-H(15B) 0.99 C(10)-C(8)-C(9) 60.2(4) C(20)-C(21)-H(21B) 119.4 
C(15)-C(16) 1.527(9) C(7)-C(8)-H(8A) 115.6 C(22)-C(21)-H(21B) 119.4 
C(15)-H(15C) 0.99 C(10)-C(8)-H(8A) 115.6 C(21')-C(22')-C(17') 121.6(7) 
C(15)-H(15D) 0.99 C(9)-C(8)-H(8A) 115.6 C(21')-C(22')-H(22A) 119.2 
C(16')-H(16A) 0.99 C(10')-C(9')-C(8') 59.6(4) C(17')-C(22')-H(22A) 119.2 
C(16')-H(16B) 0.99 C(10')-C(9')-H(9'A) 117.8 C(17)-C(22)-C(21) 118.1(7) 
C(16)-H(16C) 0.99 C(8')-C(9')-H(9'A) 117.8 C(17)-C(22)-H(22B) 120.9 
C(16)-H(16D) 0.99 C(10')-C(9')-H(9'B) 117.8 C(21)-C(22)-H(22B) 120.9 
C(17')-C(18') 1.375(8) C(8')-C(9')-H(9'B) 117.8 C(28)-C(23)-C(24) 117.8(7) 
C(17')-C(22') 1.397(8) H(9'A)-C(9')-H(9'B) 114.9 C(28)-C(23)-P(1) 123.9(5) 
C(17)-C(22) 1.376(8) C(10)-C(9)-C(8) 59.3(4) C(24)-C(23)-P(1) 118.2(5) 
C(17)-C(18) 1.389(9) C(10)-C(9)-H(9A) 117.8 C(28')-C(23')-C(24') 115.3(8) 
C(18')-C(19') 1.414(9) C(8)-C(9)-H(9A) 117.8 C(28')-C(23')-P(1') 121.0(7) 
C(18')-H(18A) 0.95 C(10)-C(9)-H(9B) 117.8 C(24')-C(23')-P(1') 123.5(5) 
C(18)-C(19) 1.378(10) C(8)-C(9)-H(9B) 117.8 C(25')-C(24')-C(23') 121.1(7) 
C(18)-H(18B) 0.95 H(9A)-C(9)-H(9B) 115 C(25')-C(24')-H(24A) 119.5 
C(19)-C(20) 1.349(11) C(11')-C(10')-C(8') 120.3(5) C(23')-C(24')-H(24A) 119.5 
C(19)-H(19A) 0.95 C(11')-C(10')-C(9') 120.9(5) C(25)-C(24)-C(23) 118.3(8) 
C(19')-C(20') 1.355(10) C(8')-C(10')-C(9') 60.4(4) C(25)-C(24)-H(24B) 120.9 
C(19')-H(19B) 0.95 C(11')-C(10')-H(10A) 114.8 C(23)-C(24)-H(24B) 120.9 
C(20)-C(21) 1.349(11) C(8')-C(10')-H(10A) 114.8 C(26)-C(25)-C(24) 123.6(8) 
C(20)-H(20A) 0.95 C(9')-C(10')-H(10A) 114.8 C(26)-C(25)-H(25A) 118.2 
C(20')-C(21') 1.394(11) C(11)-C(10)-C(8) 117.7(6) C(24)-C(25)-H(25A) 118.2 
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Table A3. Cont’d 
 
C(20')-H(20B) 0.95 C(11)-C(10)-C(9) 118.0(5) C(24')-C(25')-C(26') 120.6(9) 
C(21')-C(22') 1.375(9) C(8)-C(10)-C(9) 60.5(4) C(24')-C(25')-H(25B) 119.7 
C(21')-H(21A) 0.95 C(11)-C(10)-H(10B) 116.3 C(26')-C(25')-H(25B) 119.7 
C(21)-C(22) 1.405(10) C(8)-C(10)-H(10B) 116.3 C(25)-C(26)-C(27) 118.6(8) 
C(21)-H(21B) 0.95 C(9)-C(10)-H(10B) 116.3 C(25)-C(26)-H(26A) 120.7 
C(22')-H(22A) 0.95 C(10')-C(11')-C(13') 122.0(5) C(27)-C(26)-H(26A) 120.7 
C(22)-H(22B) 0.95 C(10')-C(11')-C(12') 120.3(5) C(27')-C(26')-C(25') 118.9(8) 
C(23)-C(28) 1.402(10) C(13')-C(11')-C(12') 59.7(4) C(27')-C(26')-H(26B) 120.5 
C(23)-C(24) 1.410(8) C(10')-C(11')-H(11A) 114.6 C(25')-C(26')-H(26B) 120.5 
C(23')-C(28') 1.400(8) C(13')-C(11')-H(11A) 114.6 C(28)-C(27)-C(26) 120.9(8) 
C(23')-C(24') 1.417(11) C(12')-C(11')-H(11A) 114.6 C(28)-C(27)-H(27A) 119.5 
C(24')-C(25') 1.375(10) C(10)-C(11)-C(12) 119.8(6) C(26)-C(27)-H(27A) 119.5 
C(24')-H(24A) 0.95 C(10)-C(11)-C(13) 123.1(5) C(26')-C(27')-C(28') 120.5(8) 
C(24)-C(25) 1.393(11) C(12)-C(11)-C(13) 59.4(4) C(26')-C(27')-H(27B) 119.8 
C(24)-H(24B) 0.95 C(10)-C(11)-H(11B) 114.5 C(28')-C(27')-H(27B) 119.8 
C(25)-C(26) 1.333(12) C(12)-C(11)-H(11B) 114.5 C(27)-C(28)-C(23) 120.9(7) 
C(25)-H(25A) 0.95 C(13)-C(11)-H(11B) 114.5 C(27)-C(28)-H(28A) 119.6 
C(25')-C(26') 1.405(11) C(11)-C(12)-C(13) 61.4(4) C(23)-C(28)-H(28A) 119.6 
C(25')-H(25B) 0.95 C(11)-C(12)-H(12A) 117.6 C(27')-C(28')-C(23') 123.5(9) 
C(26)-C(27) 1.379(11) C(13)-C(12)-H(12A) 117.6 C(27')-C(28')-H(28B) 118.3 
C(26)-H(26A) 0.95 C(11)-C(12)-H(12B) 117.6 C(23')-C(28')-H(28B) 118.3 
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Table A4. Anisotropic displacement parameters (Å2 x 103) for corey1. The anisotropic displacement factor exponent 
takes the form:  -2π2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
 
 U11 U22 U33 U23 U13 U12 
P(1') 21(1) 20(1) 41(1) 3(1) -6(1) -2(1) 
P(1) 25(1) 17(1) 37(1) -3(1) -2(1) -3(1) 
N(1') 17(2) 14(2) 33(3) -5(2) 2(2) -2(2) 
O(1) 43(3) 27(2) 62(4) -11(2) 11(3) -3(2) 
N(1) 16(2) 15(2) 33(3) 4(2) 2(2) -5(2) 
O(1') 44(3) 24(2) 56(4) 12(2) -4(3) -2(2) 
C(1') 22(4) 28(3) 18(3) -3(3) -2(3) -2(3) 
C(1) 17(4) 27(4) 30(4) 1(3) 2(3) 5(3) 
O(2) 37(3) 25(2) 33(3) 1(2) 8(2) -3(2) 
O(2') 37(3) 28(3) 41(3) 9(2) -19(2) -2(2) 
C(2') 36(4) 29(4) 45(4) -1(3) 12(3) 10(3) 
C(2) 22(4) 27(4) 47(4) -7(3) -13(3) 2(3) 
C(3') 48(5) 23(3) 42(4) -1(3) 8(4) -6(3) 
C(3) 57(5) 23(3) 52(5) -7(3) -9(4) 4(3) 
C(4') 39(4) 39(4) 43(4) 1(3) 6(4) -11(3) 
C(4) 35(4) 42(4) 41(4) -5(3) -2(3) -14(3) 
C(5') 24(5) 50(5) 44(6) -1(4) 0(4) 4(3) 
C(5) 30(6) 58(5) 37(5) -1(4) -16(4) 0(3) 
C(6) 43(5) 33(4) 40(4) 3(3) -5(4) -9(3) 
C(6') 29(4) 34(4) 43(4) -5(3) 6(3) 9(3) 
C(7') 19(3) 24(3) 32(3) -4(3) 3(3) 3(2) 
C(7) 17(3) 29(3) 28(3) -4(3) 1(3) 9(2) 
C(8') 23(3) 17(3) 39(4) 0(3) -5(3) 5(2) 
C(8) 15(3) 28(3) 40(4) -9(3) -1(3) 3(3) 
C(9') 22(4) 42(4) 49(4) -1(3) -8(3) 12(3) 
C(9) 28(4) 48(4) 39(4) -5(3) 9(3) 3(3) 
C(10') 25(3) 29(4) 39(4) 7(3) -9(3) 3(3) 
C(10) 26(3) 34(4) 39(4) -5(3) 3(3) 2(3) 
C(11') 25(3) 27(3) 47(4) -1(3) -14(3) -4(3) 
C(11) 36(4) 29(4) 31(4) -6(3) 1(3) 0(3) 
C(12) 31(4) 47(4) 50(5) -3(4) 10(3) 3(4) 
C(12') 22(4) 41(4) 49(5) -7(3) -6(3) 3(3) 
C(13') 33(4) 30(4) 32(4) -2(3) -3(3) 1(3) 
C(13) 24(4) 35(4) 31(4) -2(3) 0(3) 0(3) 
C(14') 45(4) 27(4) 39(4) 1(3) -8(3) -3(3) 
C(14) 32(4) 30(4) 44(4) 2(3) 13(3) -11(3) 
C(15') 37(4) 27(4) 36(4) 2(3) 5(3) 4(3) 
C(15) 36(4) 24(3) 29(4) -6(3) 3(3) 2(3) 
C(16') 33(4) 22(3) 30(4) 3(3) -6(3) 5(3) 
C(16) 33(4) 23(3) 43(4) -3(3) -1(3) -5(3) 
C(17') 28(3) 21(3) 36(4) 1(3) -5(3) -1(3) 
C(17) 20(3) 26(3) 46(4) 1(3) -1(3) -3(3) 
C(18') 33(4) 30(4) 64(5) -3(4) 6(4) -7(3) 
C(18) 38(5) 41(4) 87(6) 10(4) -9(4) -8(4) 
C(19) 33(5) 56(5) 93(7) 27(5) -16(5) -24(4) 
C(19') 24(4) 43(4) 85(6) -20(4) 21(4) -14(3) 
C(20) 25(4) 59(5) 93(7) 32(5) 5(4) 2(4) 
C(20') 23(4) 69(6) 74(6) -41(5) -3(4) -3(4) 
C(21') 34(5) 39(4) 61(6) -14(4) -6(4) 14(3) 
C(21) 39(5) 59(5) 57(6) 5(4) 18(5) 16(4) 
C(22') 24(3) 32(4) 37(4) -3(3) -10(3) 5(3) 
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Table A4. Cont’d 
 
 U11 U22 U33 U23 U13 U12 
C(22) 35(4) 44(4) 39(4) 2(3) 3(3) 1(3) 
C(23) 26(4) 18(3) 33(5) 3(3) 2(3) 5(3) 
C(23') 7(4) 25(4) 75(7) -4(4) -11(4) 2(3) 
C(24') 23(4) 46(5) 53(5) -19(4) -13(3) 4(3) 
C(24) 22(4) 32(4) 69(6) 11(4) 4(4) 6(3) 
C(25) 39(5) 62(6) 85(7) 44(6) 17(5) 23(4) 
C(25') 32(5) 94(7) 35(5) -18(5) -5(4) 17(4) 
C(26) 31(5) 84(7) 44(6) 34(5) 10(4) 11(5) 
C(26') 23(5) 116(9) 79(8) -82(7) -9(5) 12(5) 
C(27) 14(4) 83(6) 49(6) 26(5) -7(4) -8(4) 
C(27') 31(5) 60(6) 88(7) -40(6) -7(5) 4(4) 
C(28) 21(4) 40(4) 52(5) 8(4) -2(3) -1(3) 
C(28') 25(4) 32(4) 83(6) -25(4) -18(4) 4(3) 
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Table A5. Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2 x 103) for corey1. 
 
 x y z U(eq)  x y z U(eq) 
H(1N') 2370(30) 11110(80) 3507(17) 35(17) H(14C) 4027 4406 4321 55 
H(1) -130(20) 6370(60) 5708(14) 0(13) H(14D) 875 271 4942 53 
H(2) 2130(40) 4040(110) 3620(20) 80(30) H(14E) 1525 205 4702 53 
H(2') 4690(30) 5010(120) 5430(20) 90(30) H(14F) 883 -466 4496 53 
H(2'A) 2971 13783 3209 44 H(15A) 3619 7778 5100 40 
H(2A) 455 9108 5998 39 H(15B) 3623 5512 5131 40 
H(3'A) 3477 16088 2821 45 H(15C) 1120 4231 4067 36 
H(3A) 927 11307 6401 53 H(15D) 1092 2041 3941 36 
H(4'A) 4247 15219 2375 48 H(16A) 4635 5543 4795 34 
H(4A) 1756 10484 6811 47 H(16B) 4634 7807 4839 34 
H(5'A) 4534 12016 2311 47 H(16C) 2129 3687 4366 40 
H(5A) 2025 7312 6873 50 H(16D) 2102 1523 4222 40 
H(6A) 1561 5021 6487 47 H(18A) 855 7569 3651 51 
H(6'A) 4005 9740 2680 43 H(18B) -1588 2698 5462 66 
H(7'A) 3250 8761 3126 30 H(19A) -2603 3913 5387 73 
H(7A) 756 4053 6037 30 H(19B) -136 9081 3733 61 
H(8'A) 3374 11260 3813 31 H(20A) -2881 6701 5690 71 
H(8A) 934 6721 5393 33 H(20B) -345 11910 3426 66 
H(9'A) 4281 8553 3462 45 H(21A) 404 13333 3009 54 
H(9'B) 4407 9808 3872 45 H(21B) -2180 8265 6088 62 
H(9A) 1920 5058 5297 46 H(22A) 1384 11878 2934 37 
H(9B) 1767 3663 5684 46 H(22B) -1156 7046 6195 47 
H(10A) 3368 7102 3749 37 H(24A) 2322 10179 2482 49 
H(10B) 803 2570 5375 40 H(24B) -757 158 6280 49 
H(11A) 3621 9407 4461 40 H(25A) -756 -893 6932 74 
H(11B) 1101 5301 4746 38 H(25B) 2326 9074 1839 65 
H(12A) 158 4263 4432 51 H(26A) -485 1013 7444 64 
H(12B) 26 2688 4790 51 H(26B) 1996 5951 1695 87 
H(12C) 2674 8152 4737 45 H(27A) -173 4132 7319 58 
H(12D) 2539 6887 4329 45 H(27B) 1746 3926 2208 72 
H(14A) 3367 4654 4096 55 H(28A) -169 5316 6682 45 

























Table B1.  Crystal data and structure refinement for corey6s. 
Identification code  corey6s 
Empirical formula  C22H26N2O3 
Formula weight  366.45 
Temperature  150(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/n 
Unit cell dimensions a = 12.8235(12) Å α= 90°. 
 b = 4.9657(5) Å β= 95.861(2)°. 
 c = 33.354(3) Å γ = 90°. 
Volume 2112.8(4) Å3 
Z 4 
Density (calculated) 1.152 Mg/m3 
Absorption coefficient 0.077 mm-1 
F(000) 784 
Crystal size 0.21 x 0.09 x 0.08 mm3 
Theta range for data collection 1.65 to 25.00°. 
Index ranges -15<=h<=15, -5<=k<=5, -39<=l<=39 
Reflections collected 15845 
Independent reflections 3716 [R(int) = 0.0777] 
Completeness to theta = 25.00° 100.0 %  
Absorption correction None 
Max. and min. transmission 0.9939 and 0.9840 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3716 / 0 / 253 
Goodness-of-fit on F2 1.371 
Final R indices [I>2sigma(I)] R1 = 0.0939, wR2 = 0.1838 
R indices (all data) R1 = 0.1289, wR2 = 0.1949 
Extinction coefficient 0.0007(11) 
Largest diff. peak and hole 0.250 and -0.251 e.Å-3 
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Table B2. Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2 x 103) for corey6s.  
U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
 
 x y z U(eq) 
O(1) 378(2) 479(5) 2126(1) 35(1) 
N(1) -404(2) -898(6) 1542(1) 22(1) 
C(1) 781(3) -766(9) 2965(1) 46(1) 
N(2) 2230(2) -276(6) 523(1) 25(1) 
O(2) -323(3) 3558(5) 1681(1) 60(1) 
C(2) 1277(4) -1846(10) 3314(1) 55(1) 
O(3) 1506(2) -4450(4) 541(1) 31(1) 
C(3) 2185(4) -733(10) 3487(1) 56(1) 
C(4) 2626(4) 1366(11) 3307(1) 63(2) 
C(5) 2139(4) 2428(10) 2955(1) 59(1) 
C(6) 1210(3) 1409(8) 2780(1) 38(1) 
C(7) 659(4) 2631(8) 2410(1) 57(1) 
C(8) -138(3) 1239(7) 1770(1) 27(1) 
C(9) -988(3) -716(7) 1143(1) 24(1) 
C(10) -386(3) -2162(7) 840(1) 23(1) 
C(11) -582(3) -1570(8) 406(1) 33(1) 
C(12) 426(3) -637(7) 639(1) 26(1) 
C(13) 1421(3) -1956(6) 564(1) 23(1) 
C(14) 3272(3) -1230(7) 447(1) 28(1) 
C(15) 3284(3) -2179(9) 15(1) 46(1) 
C(16) 4059(3) 976(8) 548(1) 46(1) 
C(17) -2114(3) -1639(7) 1160(1) 28(1) 
C(18) -2576(4) -3618(9) 922(2) 58(1) 
C(19) -3609(4) -4372(11) 942(2) 73(2) 
C(20) -4197(4) -3202(11) 1209(1) 58(1) 
C(21) -3738(4) -1307(14) 1459(2) 98(2) 
C(22) -2713(4) -517(12) 1430(2) 79(2) 
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Table B3. Bond lengths [Å] and angles [°] for  corey6s. 
 
O(1)-C(8) 1.351(4) C(20)-H(20A) 0.95 C(10)-C(11)-H(11A) 117.7 
O(1)-C(7) 1.449(4) C(21)-C(22) 1.384(7) C(12)-C(11)-H(11A) 117.7 
N(1)-C(8) 1.330(4) C(21)-H(21A) 0.95 C(10)-C(11)-H(11B) 117.7 
N(1)-C(9) 1.463(4) C(22)-H(22A) 0.95 C(12)-C(11)-H(11B) 117.7 
N(1)-H(1N) 0.93(4) C(8)-O(1)-C(7) 115.8(3) H(11A)-C(11)-H(11B) 114.9 
C(1)-C(2) 1.378(6) C(8)-N(1)-C(9) 123.3(3) C(13)-C(12)-C(10) 120.2(3) 
C(1)-C(6) 1.385(6) C(8)-N(1)-H(1N) 115(3) C(13)-C(12)-C(11) 119.0(3) 
C(1)-H(1A) 0.95 C(9)-N(1)-H(1N) 121(3) C(10)-C(12)-C(11) 58.6(2) 
N(2)-C(13) 1.349(4) C(2)-C(1)-C(6) 120.7(4) C(13)-C(12)-H(12A) 115.7 
N(2)-C(14) 1.463(4) C(2)-C(1)-H(1A) 119.6 C(10)-C(12)-H(12A) 115.7 
N(2)-H(2N) 0.82(4) C(6)-C(1)-H(1A) 119.6 C(11)-C(12)-H(12A) 115.7 
O(2)-C(8) 1.206(4) C(13)-N(2)-C(14) 122.8(3) O(3)-C(13)-N(2) 122.4(3) 
C(2)-C(3) 1.363(6) C(13)-N(2)-H(2N) 120(3) O(3)-C(13)-C(12) 122.2(3) 
C(2)-H(2A) 0.95 C(14)-N(2)-H(2N) 118(3) N(2)-C(13)-C(12) 115.4(3) 
O(3)-C(13) 1.246(4) C(3)-C(2)-C(1) 120.1(4) N(2)-C(14)-C(16) 109.3(3) 
C(3)-C(4) 1.355(6) C(3)-C(2)-H(2A) 120 N(2)-C(14)-C(15) 111.2(3) 
C(3)-H(3A) 0.95 C(1)-C(2)-H(2A) 120 C(16)-C(14)-C(15) 111.5(3) 
C(4)-C(5) 1.378(6) C(4)-C(3)-C(2) 120.1(4) N(2)-C(14)-H(14A) 108.3 
C(4)-H(4A) 0.95 C(4)-C(3)-H(3A) 120 C(16)-C(14)-H(14A) 108.3 
C(5)-C(6) 1.370(6) C(2)-C(3)-H(3A) 120 C(15)-C(14)-H(14A) 108.3 
C(5)-H(5A) 0.95 C(3)-C(4)-C(5) 120.0(4) C(14)-C(15)-H(15A) 109.5 
C(6)-C(7) 1.487(6) C(3)-C(4)-H(4A) 120 C(14)-C(15)-H(15B) 109.5 
C(7)-H(7A) 0.99 C(5)-C(4)-H(4A) 120 H(15A)-C(15)-H(15B) 109.5 
C(7)-H(7B) 0.99 C(6)-C(5)-C(4) 121.4(4) C(14)-C(15)-H(15C) 109.5 
C(9)-C(10) 1.513(5) C(6)-C(5)-H(5A) 119.3 H(15A)-C(15)-H(15C) 109.5 
C(9)-C(17) 1.522(5) C(4)-C(5)-H(5A) 119.3 H(15B)-C(15)-H(15C) 109.5 
C(9)-H(9A) 1 C(5)-C(6)-C(1) 117.7(4) C(14)-C(16)-H(16A) 109.5 
C(10)-C(11) 1.473(5) C(5)-C(6)-C(7) 121.4(4) C(14)-C(16)-H(16B) 109.5 
C(10)-C(12) 1.499(5) C(1)-C(6)-C(7) 120.8(4) H(16A)-C(16)-H(16B) 109.5 
C(10)-H(10A) 1 O(1)-C(7)-C(6) 107.9(3) C(14)-C(16)-H(16C) 109.5 
C(11)-C(12) 1.511(5) O(1)-C(7)-H(7A) 110.1 H(16A)-C(16)-H(16C) 109.5 
C(11)-H(11A) 0.99 C(6)-C(7)-H(7A) 110.1 H(16B)-C(16)-H(16C) 109.5 
C(11)-H(11B) 0.99 O(1)-C(7)-H(7B) 110.1 C(22)-C(17)-C(18) 116.1(4) 
C(12)-C(13) 1.478(5) C(6)-C(7)-H(7B) 110.1 C(22)-C(17)-C(9) 120.3(4) 
C(12)-H(12A) 1 H(7A)-C(7)-H(7B) 108.4 C(18)-C(17)-C(9) 123.5(3) 
C(14)-C(16) 1.505(5) O(2)-C(8)-N(1) 126.0(3) C(17)-C(18)-C(19) 121.8(4) 
C(14)-C(15) 1.519(5) O(2)-C(8)-O(1) 123.3(3) C(17)-C(18)-H(18A) 119.1 
C(14)-H(14A) 1 N(1)-C(8)-O(1) 110.7(3) C(19)-C(18)-H(18A) 119.1 
C(15)-H(15A) 0.98 N(1)-C(9)-C(10) 109.2(3) C(20)-C(19)-C(18) 121.0(5) 
C(15)-H(15B) 0.98 N(1)-C(9)-C(17) 110.2(3) C(20)-C(19)-H(19A) 119.5 
C(15)-H(15C) 0.98 C(10)-C(9)-C(17) 115.7(3) C(18)-C(19)-H(19A) 119.5 
C(16)-H(16A) 0.98 N(1)-C(9)-H(9A) 107.1 C(21)-C(20)-C(19) 117.9(4) 
C(16)-H(16B) 0.98 C(10)-C(9)-H(9A) 107.1 C(21)-C(20)-H(20A) 121.1 
C(16)-H(16C) 0.98 C(17)-C(9)-H(9A) 107.1 C(19)-C(20)-H(20A) 121.1 
C(17)-C(22) 1.361(6) C(11)-C(10)-C(12) 61.1(2) C(20)-C(21)-C(22) 120.7(5) 
C(17)-C(18) 1.362(5) C(11)-C(10)-C(9) 120.9(3) C(20)-C(21)-H(21A) 119.6 
C(18)-C(19) 1.385(6) C(12)-C(10)-C(9) 118.9(3) C(22)-C(21)-H(21A) 119.7 
C(18)-H(18A) 0.95 C(11)-C(10)-H(10A) 115.1 C(17)-C(22)-C(21) 122.3(5) 
C(19)-C(20) 1.355(7) C(12)-C(10)-H(10A) 115.1 C(17)-C(22)-H(22A) 118.8 
C(19)-H(19A) 0.95 C(9)-C(10)-H(10A) 115.1 C(21)-C(22)-H(22A) 118.8 
C(20)-C(21) 1.352(7) C(10)-C(11)-C(12) 60.3(2)   
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Table B4. Anisotropic displacement parameters (Å2 x 103) for corey6s. The anisotropic displacement factor 
exponent takes the form:  -2π2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
 
 U11 U22 U33 U23 U13 U12 
O(1) 51(2) 22(1) 30(2) -5(1) -10(1) 1(1) 
N(1) 27(2) 15(2) 24(2) 0(1) -1(1) -1(1) 
C(1) 37(3) 64(3) 37(3) -15(2) 0(2) -8(2) 
N(2) 25(2) 18(2) 32(2) -2(1) 6(1) 3(1) 
O(2) 93(3) 15(1) 61(2) -1(1) -37(2) 3(1) 
C(2) 58(3) 77(3) 30(2) -1(2) 3(2) -20(3) 
O(3) 31(2) 19(1) 44(2) 0(1) 10(1) -2(1) 
C(3) 52(3) 82(4) 33(3) -2(3) 4(2) 3(3) 
C(4) 43(3) 107(4) 36(3) 1(3) -11(2) -20(3) 
C(5) 59(3) 72(3) 44(3) 3(3) -10(2) -28(3) 
C(6) 41(3) 37(2) 34(2) -12(2) -3(2) 2(2) 
C(7) 84(4) 31(2) 48(3) -17(2) -27(3) 0(2) 
C(8) 30(2) 18(2) 31(2) -2(2) -2(2) -1(2) 
C(9) 27(2) 24(2) 22(2) 7(2) 2(2) 0(2) 
C(10) 22(2) 22(2) 24(2) 1(2) 2(2) -4(1) 
C(11) 24(2) 46(2) 29(2) 3(2) 1(2) 4(2) 
C(12) 30(2) 21(2) 27(2) 4(2) 5(2) 1(2) 
C(13) 33(2) 16(2) 19(2) -1(2) 4(2) -1(2) 
C(14) 21(2) 29(2) 35(2) -1(2) 4(2) 2(2) 
C(15) 41(3) 55(3) 45(3) -3(2) 17(2) 5(2) 
C(16) 32(2) 40(2) 66(3) -2(2) 10(2) -2(2) 
C(17) 28(2) 31(2) 24(2) 6(2) 4(2) 1(2) 
C(18) 43(3) 70(3) 64(3) -29(3) 17(2) -26(2) 
C(19) 47(3) 97(4) 74(4) -30(3) 11(3) -38(3) 
C(20) 31(3) 94(4) 51(3) 1(3) 7(2) -23(3) 
C(21) 43(3) 160(6) 96(5) -66(5) 29(3) -12(4) 
C(22) 32(3) 116(5) 93(4) -63(4) 19(3) -19(3) 
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Table B5. Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2 x 103) for corey6s. 
 
 x y z U(eq) 
H(1N) -260(30) -2550(90) 1664(12) 50(12) 
H(1A) 139 -1523 2849 56 
H(2N) 2140(30) 1350(70) 536(11) 27(11) 
H(2A) 985 -3366 3435 66 
H(3A) 2509 -1430 3735 67 
H(4A) 3270 2104 3424 75 
H(5A) 2455 3899 2831 71 
H(7A) 22 3589 2476 68 
H(7B) 1124 3940 2292 68 
H(9A) -1014 1231 1066 29 
H(10A) -204 -4078 908 27 
H(11A) -1115 -189 321 40 
H(11B) -541 -3084 215 40 
H(12A) 472 1334 700 31 
H(14A) 3460 -2790 630 34 
H(15A) 2777 -3644 -39 70 
H(15B) 3987 -2826 -26 70 
H(15C) 3095 -678 -169 70 
H(16A) 4039 1525 829 69 
H(16B) 3889 2523 371 69 
H(16C) 4763 318 509 69 
H(18A) -2178 -4506 736 70 
H(19A) -3910 -5730 766 87 
H(20A) -4909 -3698 1220 70 
H(21A) -4123 -508 1657 117 












Table C1.  Crystal data and structure refinement for cory602s. 
Identification code  cory602s 
Empirical formula  C23H28N2O3 
Formula weight  380.47 
Temperature  150.0 (2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  C 2/c 
Unit cell dimensions a = 16.161(2) Å α= 90°. 
 b = 9.6561(13) Å β= 94.793(3)°. 
 c = 27.197(4) Å γ = 90°. 
Volume 4229.4(10) Å3 
Z 8 
Density (calculated) 1.195 Mg/m3 
Absorption coefficient 0.079 mm-1 
F(000) 1632 
Crystal size 0.12 x 0.04 x 0.04 mm3 
Theta range for data collection 1.50 to 25.00°. 
Index ranges -19<=h<=19, -11<=k<=11, -32<=l<=32 
Reflections collected 16235 
Independent reflections 3732 [R(int) = 0.0691] 
Completeness to theta = 25.00° 99.9 %  
Absorption correction Sadabs 
Max. and min. transmission 0.9968 and 0.9906 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3732 / 0 / 365 
Goodness-of-fit on F2 1.295 
Final R indices [I>2sigma(I)] R1 = 0.0828, wR2 = 0.1786 
R indices (all data) R1 = 0.1116, wR2 = 0.1880 
Largest diff. peak and hole 0.318 and -0.238 e.Å-3 
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Table C2. Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2x 103) for cory602s.  
U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
 
 x y z U(eq) 
O(1) 4250(1) 5052(2) 1938(1) 31(1) 
C(1) 5563(2) 7398(4) 1243(2) 37(1) 
N(1) 3733(2) 2921(3) 1874(1) 28(1) 
O(2) 5129(1) 3252(2) 1862(1) 37(1) 
C(2) 5659(2) 7765(4) 764(2) 50(1) 
N(2) 3569(2) 1341(3) 3410(1) 31(1) 
O(3) 2847(1) -572(2) 3167(1) 33(1) 
C(3) 5221(2) 7117(5) 372(2) 50(1) 
C(4) 4671(2) 6086(4) 472(2) 44(1) 
C(5) 4571(2) 5702(4) 951(1) 38(1) 
C(6) 5008(2) 6343(3) 1344(1) 32(1) 
C(7) 4928(2) 5971(3) 1873(1) 29(1) 
C(8) 4428(2) 3689(3) 1887(1) 27(1) 
C(9) 3761(2) 1449(3) 1762(1) 27(1) 
C(10) 3297(2) 594(3) 2125(1) 24(1) 
C(11) 3689(2) -770(3) 2258(1) 32(1) 
C(12) 3786(2) 390(3) 2623(1) 28(1) 
C(13) 3354(2) 342(3) 3086(1) 28(1) 
C(14) 3202(2) 1530(4) 3878(1) 36(1) 
C(15) 3806(3) 2251(6) 4241(2) 61(1) 
C(16) 2376(3) 2281(5) 3800(2) 52(1) 
C(17) 2357(2) 743(4) 2097(2) 30(1) 
C(18) 2785(2) 1671(4) 977(1) 41(1) 
C(19) 2560(3) 1319(5) 497(2) 51(1) 
C(20) 3040(3) 423(4) 245(2) 48(1) 
C(21) 3755(2) -93(4) 481(2) 47(1) 
C(22) 3983(2) 253(4) 964(2) 39(1) 
C(23) 3505(2) 1133(3) 1226(1) 29(1) 
 
  233
Table C3. Bond lengths [Å] and angles [°] for cory602s. 
 
O(1)-C(8) 1.357(4) C(21)-C(22) 1.376(5) C(12)-C(11)-H(11C) 120(2) 
O(1)-C(7) 1.432(4) C(21)-H(21) 1.01(4) H(11B)-C(11)-H(11C) 110(3) 
C(1)-C(2) 1.370(6) C(22)-C(23) 1.386(5) C(13)-C(12)-C(11) 120.4(3) 
C(1)-C(6) 1.399(5) C(22)-H(22) 0.98(4) C(13)-C(12)-C(10) 120.7(2) 
C(1)-H(1) 1.06(4) C(8)-O(1)-C(7) 114.7(2) C(11)-C(12)-C(10) 59.3(2) 
N(1)-C(8) 1.344(4) C(2)-C(1)-C(6) 120.0(4) C(13)-C(12)-H(12) 112.9(19) 
N(1)-C(9) 1.456(4) C(2)-C(1)-H(1) 123(2) C(11)-C(12)-H(12) 122(2) 
N(1)-H(1N) 0.82(4) C(6)-C(1)-H(1) 117(2) C(10)-C(12)-H(12) 111(2) 
O(2)-C(8) 1.215(3) C(8)-N(1)-C(9) 120.2(3) O(3)-C(13)-N(2) 122.5(3) 
C(2)-C(3) 1.379(6) C(8)-N(1)-H(1N) 114(3) O(3)-C(13)-C(12) 122.5(3) 
C(2)-H(2) 0.98(4) C(9)-N(1)-H(1N) 124(3) N(2)-C(13)-C(12) 115.0(3) 
N(2)-C(13) 1.334(4) C(1)-C(2)-C(3) 121.7(4) N(2)-C(14)-C(15) 110.0(3) 
N(2)-C(14) 1.459(5) C(1)-C(2)-H(2) 125(2) N(2)-C(14)-C(16) 110.8(3) 
N(2)-H(2N) 0.78(4) C(3)-C(2)-H(2) 113(2) C(15)-C(14)-C(16) 112.7(4) 
O(3)-C(13) 1.237(4) C(13)-N(2)-C(14) 124.4(3) N(2)-C(14)-H(14) 106(2) 
C(3)-C(4) 1.377(6) C(13)-N(2)-H(2N) 115(3) C(15)-C(14)-H(14) 107(2) 
C(3)-H(3) 0.88(4) C(14)-N(2)-H(2N) 119(3) C(16)-C(14)-H(14) 109(2) 
C(4)-C(5) 1.375(6) C(4)-C(3)-C(2) 118.2(4) C(14)-C(15)-H(15B) 115(3) 
C(4)-H(4) 0.90(4) C(4)-C(3)-H(3) 119(2) C(14)-C(15)-H(15C) 105(2) 
C(5)-C(6) 1.378(5) C(2)-C(3)-H(3) 122(2) H(15B)-C(15)-H(15C) 104(3) 
C(5)-H(5) 0.93(4) C(5)-C(4)-C(3) 120.7(4) C(14)-C(15)-H(15A) 110(3) 
C(6)-C(7) 1.498(5) C(5)-C(4)-H(4) 120(2) H(15B)-C(15)-H(15A) 114(4) 
C(7)-H(7A) 0.95(3) C(3)-C(4)-H(4) 119(2) H(15C)-C(15)-H(15A) 108(4) 
C(7)-H(7B) 1.01(4) C(4)-C(5)-C(6) 121.4(4) C(14)-C(16)-H(16A) 102(2) 
C(9)-C(23) 1.511(5) C(4)-C(5)-H(5) 121(2) C(14)-C(16)-H(16B) 105(2) 
C(9)-C(10) 1.531(4) C(6)-C(5)-H(5) 117(2) H(16A)-C(16)-H(16B) 116(3) 
C(9)-H(9) 1.00(3) C(5)-C(6)-C(1) 118.0(3) C(14)-C(16)-H(16C) 109(3) 
C(10)-C(11) 1.493(4) C(5)-C(6)-C(7) 123.9(3) H(16A)-C(16)-H(16C) 110(4) 
C(10)-C(17) 1.521(4) C(1)-C(6)-C(7) 118.1(3) H(16B)-C(16)-H(16C) 114(4) 
C(10)-C(12) 1.522(4) O(1)-C(7)-C(6) 113.4(3) C(10)-C(17)-H(17A) 115.0(19) 
C(11)-C(12) 1.496(5) O(1)-C(7)-H(7A) 101.2(19) C(10)-C(17)-H(17B) 108.2(19) 
C(11)-H(11B) 0.98(3) C(6)-C(7)-H(7A) 114.4(18) H(17A)-C(17)-H(17B) 109(3) 
C(11)-H(11C) 0.97(4) O(1)-C(7)-H(7B) 111(2) C(10)-C(17)-H(17C) 112(2) 
C(12)-C(13) 1.490(5) C(6)-C(7)-H(7B) 112(2) H(17A)-C(17)-H(17C) 105(3) 
C(12)-H(12) 1.02(4) H(7A)-C(7)-H(7B) 104(3) H(17B)-C(17)-H(17C) 108(3) 
C(14)-C(15) 1.500(5) O(2)-C(8)-N(1) 126.0(3) C(19)-C(18)-C(23) 121.0(4) 
C(14)-C(16) 1.519(5) O(2)-C(8)-O(1) 123.3(3) C(19)-C(18)-H(18) 125(2) 
C(14)-H(14) 0.90(4) N(1)-C(8)-O(1) 110.7(3) C(23)-C(18)-H(18) 114(2) 
C(15)-H(15B) 0.97(5) N(1)-C(9)-C(23) 112.9(3) C(18)-C(19)-C(20) 120.9(4) 
C(15)-H(15C) 1.00(4) N(1)-C(9)-C(10) 111.4(3) C(18)-C(19)-H(19) 122(3) 
C(15)-H(15A) 1.07(6) C(23)-C(9)-C(10) 113.8(3) C(20)-C(19)-H(19) 117(3) 
C(16)-H(16A) 1.07(5) N(1)-C(9)-H(9) 105.6(18) C(21)-C(20)-C(19) 118.9(4) 
C(16)-H(16B) 1.04(5) C(23)-C(9)-H(9) 104.1(17) C(21)-C(20)-H(20) 122(2) 
C(16)-H(16C) 1.05(5) C(10)-C(9)-H(9) 108.4(18) C(19)-C(20)-H(20) 120(2) 
C(17)-H(17A) 0.99(4) C(11)-C(10)-C(17) 119.8(3) C(20)-C(21)-C(22) 120.5(4) 
C(17)-H(17B) 0.91(3) C(11)-C(10)-C(12) 59.5(2) C(20)-C(21)-H(21) 119(2) 
C(17)-H(17C) 0.93(4) C(17)-C(10)-C(12) 119.9(3) C(22)-C(21)-H(21) 120(2) 
C(18)-C(19) 1.368(5) C(11)-C(10)-C(9) 114.3(3) C(21)-C(22)-C(23) 121.6(4) 
C(18)-C(23) 1.397(5) C(17)-C(10)-C(9) 117.2(3) C(21)-C(22)-H(22) 122(2) 
C(18)-H(18) 0.90(3) C(12)-C(10)-C(9) 113.5(2) C(23)-C(22)-H(22) 116(2) 
C(19)-C(20) 1.382(6) C(10)-C(11)-C(12) 61.2(2) C(22)-C(23)-C(18) 117.1(3) 
C(19)-H(19) 0.95(4) C(10)-C(11)-H(11B) 123.7(19) C(22)-C(23)-C(9) 120.0(3) 
C(20)-C(21) 1.368(6) C(12)-C(11)-H(11B) 116.8(19) C(18)-C(23)-C(9) 122.9(3) 
C(20)-H(20) 0.94(4) C(10)-C(11)-H(11C) 118(2)   
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Table C4. Anisotropic displacement parameters (Å2 x 103) for cory602s. The anisotropic displacement factor 
exponent takes the form:  -2π2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
 
 U11 U22 U33 U23 U13 U12 
O(1) 22(1) 22(1) 51(2) 2(1) 9(1) 2(1) 
C(1) 20(2) 31(2) 59(3) 6(2) 2(2) 3(1) 
N(1) 14(1) 22(2) 48(2) 2(1) 5(1) 4(1) 
O(2) 13(1) 29(1) 70(2) -1(1) 8(1) 3(1) 
C(2) 27(2) 50(3) 75(3) 24(2) 13(2) 3(2) 
N(2) 24(2) 32(2) 37(2) 7(1) 2(1) -14(1) 
O(3) 21(1) 30(1) 48(2) 8(1) 1(1) -12(1) 
C(3) 39(2) 62(3) 50(3) 22(2) 14(2) 18(2) 
C(4) 36(2) 52(3) 44(2) -2(2) -1(2) 8(2) 
C(5) 28(2) 31(2) 56(3) 0(2) 3(2) 5(2) 
C(6) 21(2) 20(2) 53(2) -1(2) -1(2) 5(1) 
C(7) 23(2) 17(2) 48(2) -3(2) 0(2) -2(1) 
C(8) 25(2) 21(2) 35(2) 4(1) 6(1) 3(1) 
C(9) 14(2) 21(2) 46(2) 2(1) 6(1) 3(1) 
C(10) 13(2) 20(2) 38(2) 2(1) 1(1) 0(1) 
C(11) 26(2) 23(2) 48(2) 4(2) 7(2) 6(2) 
C(12) 14(2) 23(2) 46(2) 3(1) -1(1) -3(1) 
C(13) 17(2) 24(2) 41(2) 8(1) -4(1) 0(1) 
C(14) 34(2) 33(2) 39(2) 10(2) 0(2) -7(2) 
C(15) 48(3) 91(4) 44(3) -16(3) -1(2) -8(3) 
C(16) 34(2) 61(3) 61(3) 4(2) 6(2) 2(2) 
C(17) 14(2) 36(2) 38(2) 3(2) 2(2) -2(1) 
C(18) 40(2) 42(2) 41(2) 0(2) 10(2) 17(2) 
C(19) 42(2) 73(3) 37(2) 2(2) 5(2) 18(2) 
C(20) 49(2) 61(3) 35(2) -2(2) 8(2) 3(2) 
C(21) 47(2) 47(2) 48(2) -7(2) 14(2) 14(2) 
C(22) 33(2) 38(2) 47(2) 0(2) 11(2) 10(2) 
C(23) 20(2) 27(2) 41(2) 5(1) 9(1) 1(1) 
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Table C5. Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2 x 103) for cory602s. 
 
 x y z U(eq) 
H(1) 5910(20) 7850(40) 1548(15) 59(12) 
H(1N) 3310(20) 3370(40) 1856(12) 37(10) 
H(2) 5980(20) 8560(40) 665(14) 52(11) 
H(2N) 3840(20) 1930(40) 3313(12) 31(10) 
H(3) 5280(20) 7340(40) 64(14) 40(11) 
H(4) 4390(20) 5640(40) 219(14) 37(10) 
H(5) 4230(20) 4970(40) 1019(14) 55(12) 
H(7A) 4796(18) 6720(30) 2074(11) 24(8) 
H(7B) 5460(20) 5610(40) 2039(12) 41(10) 
H(9) 4360(20) 1190(30) 1803(11) 27(8) 
H(11B) 3380(20) -1580(40) 2354(11) 32(9) 
H(11C) 4160(20) -1070(40) 2081(13) 48(11) 
H(12) 4300(20) 1000(40) 2652(12) 44(10) 
H(14) 3120(20) 680(40) 3996(13) 38(10) 
H(15B) 3600(30) 2460(40) 4556(17) 65(13) 
H(15C) 3890(20) 3180(50) 4090(15) 57(13) 
H(15A) 4380(40) 1710(60) 4270(20) 108(19) 
H(16A) 2140(30) 2180(50) 4155(18) 75(14) 
H(16B) 2520(30) 3280(50) 3695(16) 73(14) 
H(16C) 1990(30) 1740(50) 3538(18) 87(16) 
H(17A) 2150(20) 1700(40) 2136(11) 33(9) 
H(17B) 2162(18) 200(30) 2335(11) 20(8) 
H(17C) 2110(20) 450(40) 1792(14) 41(10) 
H(18) 2540(20) 2330(30) 1145(11) 26(9) 
H(19) 2080(30) 1690(50) 320(16) 70(14) 
H(20) 2880(20) 210(40) -88(15) 47(11) 
H(21) 4110(20) -740(40) 298(13) 43(10) 












Table D1.  Crystal data and structure refinement for cs206m. 
Identification code  cs206m 
Empirical formula  C23 H28 N2 O3 – (C7 H8)0.5 
Formula weight  426.54 
Temperature  150(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/n 
Unit cell dimensions a = 11.6314(12) Å α= 90°. 
 b = 13.4650(14) Å β= 101.713(2)°. 
 c = 16.1777(17) Å γ = 90°. 
Volume 2480.9(4) Å3 
Z 4 
Density (calculated) 1.142 Mg/m3 
Absorption coefficient 0.074 mm-1 
F(000) 916 
Crystal size 0.35 x 0.21 x 0.21 mm3 
Theta range for data collection 1.98 to 32.58°. 
Index ranges -17<=h<=17, -19<=k<=20, -23<=l<=23 
Reflections collected 31166 
Independent reflections 8692 [R(int) = 0.0814] 
Completeness to theta = 32.58° 96.2 %  
Absorption correction Sadabs 
Max. and min. transmission 0.9845 and 0.9744 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8692 / 0 / 297 
Goodness-of-fit on F2 0.929 
Final R indices [I>2sigma(I)] R1 = 0.0618, wR2 = 0.1537 
R indices (all data) R1 = 0.1142, wR2 = 0.1715 
Largest diff. peak and hole 0.439 and -0.399 e.Å-3 
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Table D2. Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2x 103) for cs206m.  
U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
 
 x y z U(eq) 
O(1) 8724(1) 2652(1) 1498(1) 29(1) 
O(2) 7662(1) 1977(1) 304(1) 34(1) 
C(1) 8387(2) -245(1) -638(1) 43(1) 
N(1) 7000(1) 3327(1) 821(1) 27(1) 
C(2) 7856(2) -1133(2) -956(1) 64(1) 
O(3) 5181(1) 6746(1) 365(1) 35(1) 
C(3) 6879(2) -1471(2) -693(2) 67(1) 
C(4) 6408(2) -939(2) -123(1) 55(1) 
C(5) 6925(2) -63(1) 196(1) 40(1) 
C(6) 7926(1) 289(1) -50(1) 31(1) 
C(7) 8531(1) 1206(1) 343(1) 34(1) 
C(8) 7864(1) 2664(1) 931(1) 24(1) 
C(9) 6956(1) 4122(1) 1429(1) 26(1) 
C(10) 6176(1) 3840(1) 2041(1) 30(1) 
C(11) 4981(2) 3707(2) 1759(1) 58(1) 
C(12) 4279(2) 3429(2) 2314(1) 78(1) 
C(13) 4771(2) 3266(2) 3156(1) 59(1) 
C(14) 5942(2) 3422(1) 3447(1) 45(1) 
C(15) 6638(1) 3714(1) 2889(1) 35(1) 
C(16) 6549(1) 5062(1) 951(1) 28(1) 
C(17) 7396(2) 5765(1) 684(1) 37(1) 
C(18) 6763(1) 6071(1) 1376(1) 27(1) 
C(19) 5755(1) 6775(1) 1097(1) 26(1) 
N(2) 5514(1) 7421(1) 1665(1) 28(1) 
C(20) 4495(1) 8081(1) 1498(1) 30(1) 
C(21) 3497(2) 7640(2) 1839(2) 61(1) 
C(22) 4824(2) 9102(1) 1865(1) 40(1) 
C(23) 7461(1) 6142(1) 2268(1) 34(1) 
C(24) 9731(4) 5801(2) -524(3) 109(1) 
C(25) 10534(4) 5898(2) 197(3) 111(1) 
C(26) 10831(4) 5100(3) 731(3) 107(1) 
C(27) 11602(6) 5192(5) 1387(4) 98(2) 
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 Table D3.   Bond lengths [Å] and angles [°] for  cs206m. 
 
O(1)-C(8) 1.2114(16) C(25)-H(25A) 0.95 C(17)-C(16)-C(18) 60.43(10) 
O(2)-C(8) 1.3576(16) C(26)-C(27) 1.248(6) C(9)-C(16)-C(18) 120.77(12) 
O(2)-C(7) 1.4415(17) C(26)-C(24)#1 1.386(5) C(17)-C(16)-H(16A) 114.5 
C(1)-C(6) 1.384(2) C(27)-H(27A) 0.98 C(9)-C(16)-H(16A) 114.5 
C(1)-C(2) 1.394(3) C(27)-H(27B) 0.98 C(18)-C(16)-H(16A) 114.5 
C(1)-H(1A) 0.95 C(27)-H(27C) 0.98 C(16)-C(17)-C(18) 60.77(10) 
N(1)-C(8) 1.3295(18) C(8)-O(2)-C(7) 116.36(11) C(16)-C(17)-H(17A) 117.7 
N(1)-C(9) 1.4623(17) C(6)-C(1)-C(2) 119.56(18) C(18)-C(17)-H(17A) 117.7 
N(1)-H(1N) 0.826(18) C(6)-C(1)-H(1A) 120.2 C(16)-C(17)-H(17B) 117.7 
C(2)-C(3) 1.369(3) C(2)-C(1)-H(1A) 120.2 C(18)-C(17)-H(17B) 117.7 
C(2)-H(2A) 0.95 C(8)-N(1)-C(9) 121.99(12) H(17A)-C(17)-H(17B) 114.8 
O(3)-C(19) 1.2373(16) C(8)-N(1)-H(1N) 118.8(12) C(19)-C(18)-C(23) 118.91(12) 
C(3)-C(4) 1.367(3) C(9)-N(1)-H(1N) 118.8(12) C(19)-C(18)-C(17) 114.55(12) 
C(3)-H(3A) 0.95 C(3)-C(2)-C(1) 120.28(18) C(23)-C(18)-C(17) 118.36(13) 
C(4)-C(5) 1.376(3) C(3)-C(2)-H(2A) 119.9 C(19)-C(18)-C(16) 112.42(11) 
C(4)-H(4A) 0.95 C(1)-C(2)-H(2A) 119.9 C(23)-C(18)-C(16) 119.75(12) 
C(5)-C(6) 1.388(2) C(4)-C(3)-C(2) 120.47(19) C(17)-C(18)-C(16) 58.80(10) 
C(5)-H(5A) 0.95 C(4)-C(3)-H(3A) 119.8 O(3)-C(19)-N(2) 122.14(13) 
C(6)-C(7) 1.498(2) C(2)-C(3)-H(3A) 119.8 O(3)-C(19)-C(18) 120.26(13) 
C(7)-H(7A) 0.99 C(3)-C(4)-C(5) 119.80(19) N(2)-C(19)-C(18) 117.60(12) 
C(7)-H(7B) 0.99 C(3)-C(4)-H(4A) 120.1 C(19)-N(2)-C(20) 122.99(12) 
C(9)-C(16) 1.509(2) C(5)-C(4)-H(4A) 120.1 C(19)-N(2)-H(2N) 117.4(12) 
C(9)-C(10) 1.521(2) C(4)-C(5)-C(6) 120.87(17) C(20)-N(2)-H(2N) 118.7(12) 
C(9)-H(9A) 1 C(4)-C(5)-H(5A) 119.6 N(2)-C(20)-C(21) 110.39(14) 
C(10)-C(15) 1.378(2) C(6)-C(5)-H(5A) 119.6 N(2)-C(20)-C(22) 110.41(12) 
C(10)-C(11) 1.384(2) C(1)-C(6)-C(5) 119.01(16) C(21)-C(20)-C(22) 111.54(15) 
C(11)-C(12) 1.384(3) C(1)-C(6)-C(7) 120.38(15) N(2)-C(20)-H(20A) 108.1 
C(11)-H(11A) 0.95 C(5)-C(6)-C(7) 120.55(14) C(21)-C(20)-H(20A) 108.1 
C(12)-C(13) 1.383(3) O(2)-C(7)-C(6) 108.08(12) C(22)-C(20)-H(20A) 108.1 
C(12)-H(12A) 0.95 O(2)-C(7)-H(7A) 110.1 C(20)-C(21)-H(21A) 109.5 
C(13)-C(14) 1.364(3) C(6)-C(7)-H(7A) 110.1 C(20)-C(21)-H(21B) 109.5 
C(13)-H(13A) 0.95 O(2)-C(7)-H(7B) 110.1 H(21A)-C(21)-H(21B) 109.5 
C(14)-C(15) 1.387(2) C(6)-C(7)-H(7B) 110.1 C(20)-C(21)-H(21C) 109.5 
C(14)-H(14A) 0.95 H(7A)-C(7)-H(7B) 108.4 H(21A)-C(21)-H(21C) 109.5 
C(15)-H(15A) 0.95 O(1)-C(8)-N(1) 126.60(13) H(21B)-C(21)-H(21C) 109.5 
C(16)-C(17) 1.491(2) O(1)-C(8)-O(2) 123.21(12) C(20)-C(22)-H(22A) 109.5 
C(16)-C(18) 1.5215(19) N(1)-C(8)-O(2) 110.19(11) C(20)-C(22)-H(22B) 109.5 
C(16)-H(16A) 1 N(1)-C(9)-C(16) 108.59(11) H(22A)-C(22)-H(22B) 109.5 
C(17)-C(18) 1.516(2) N(1)-C(9)-C(10) 111.25(11) C(20)-C(22)-H(22C) 109.5 
C(17)-H(17A) 0.99 C(16)-C(9)-C(10) 112.13(12) H(22A)-C(22)-H(22C) 109.5 
C(17)-H(17B) 0.99 N(1)-C(9)-H(9A) 108.3 H(22B)-C(22)-H(22C) 109.5 
C(18)-C(19) 1.504(2) C(16)-C(9)-H(9A) 108.3 C(18)-C(23)-H(23A) 109.5 
C(18)-C(23) 1.5079(19) C(10)-C(9)-H(9A) 108.3 C(18)-C(23)-H(23B) 109.5 
C(19)-N(2) 1.3342(18) C(15)-C(10)-C(11) 118.39(15) H(23A)-C(23)-H(23B) 109.5 
N(2)-C(20) 1.4624(18) C(15)-C(10)-C(9) 121.00(13) C(18)-C(23)-H(23C) 109.5 
N(2)-H(2N) 0.814(16) C(11)-C(10)-C(9) 120.61(14) H(23A)-C(23)-H(23C) 109.5 
C(20)-C(21) 1.505(2) C(10)-C(11)-C(12) 120.43(18) H(23B)-C(23)-H(23C) 109.5 
C(20)-C(22) 1.514(2) C(10)-C(11)-H(11A) 119.8 C(25)-C(24)-C(26)#1 120.3(4) 
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Table D3. Cont’d 
 
C(20)-H(20A) 1 C(12)-C(11)-H(11A) 119.8 C(25)-C(24)-H(24A) 119.8 
C(21)-H(21A) 0.98 C(13)-C(12)-C(11) 120.1(2) C(26)#1-C(24)-H(24A) 119.8 
C(21)-H(21B) 0.98 C(13)-C(12)-H(12A) 119.9 C(24)-C(25)-C(26) 120.6(4) 
C(21)-H(21C) 0.98 C(11)-C(12)-H(12A) 119.9 C(24)-C(25)-H(25A) 119.7 
C(22)-H(22A) 0.98 C(14)-C(13)-C(12) 119.97(18) C(26)-C(25)-H(25A) 119.7 
C(22)-H(22B) 0.98 C(14)-C(13)-H(13A) 120 C(27)-C(26)-C(25) 120.0(5) 
C(22)-H(22C) 0.98 C(12)-C(13)-H(13A) 120 C(27)-C(26)-C(24)#1 121.0(5) 
C(23)-H(23A) 0.98 C(13)-C(14)-C(15) 119.59(17) C(25)-C(26)-C(24)#1 119.0(4) 
C(23)-H(23B) 0.98 C(13)-C(14)-H(14A) 120.2 C(26)-C(27)-H(27A) 109.5 
C(23)-H(23C) 0.98 C(15)-C(14)-H(14A) 120.2 C(26)-C(27)-H(27B) 109.5 
C(24)-C(25) 1.345(5) C(10)-C(15)-C(14) 121.43(16) H(27A)-C(27)-H(27B) 109.5 
C(24)-C(26)#1 1.386(5) C(10)-C(15)-H(15A) 119.3 C(26)-C(27)-H(27C) 109.5 
C(24)-H(24A) 0.95 C(14)-C(15)-H(15A) 119.3 H(27A)-C(27)-H(27C) 109.5 
C(25)-C(26) 1.378(5) C(17)-C(16)-C(9) 121.59(13) H(27B)-C(27)-H(27C) 109.5 
Symmetry transformations used to generate equivalent atoms: #1 -x+2,-y+1,-z 
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Table D4. Anisotropic displacement parameters (Å2x 103) for cs206m.  The anisotropic displacement factor 
exponent takes the form:  -2π2[ h2 a*2U11 + ...  + 2 h k a*b*U12] 
 
 U11 U22 U33 U23 U13 U12 
O(1) 32(1) 25(1) 26(1) -1(1) -1(1) 2(1) 
O(2) 40(1) 27(1) 31(1) -11(1) -5(1) 13(1) 
C(1) 58(1) 32(1) 43(1) -6(1) 19(1) 9(1) 
N(1) 29(1) 24(1) 25(1) -8(1) -3(1) 5(1) 
C(2) 99(2) 38(1) 59(1) -21(1) 26(1) 4(1) 
O(3) 40(1) 32(1) 28(1) -6(1) -5(1) 6(1) 
C(3) 96(2) 32(1) 69(1) -11(1) 7(1) -15(1) 
C(4) 65(1) 40(1) 59(1) 8(1) 10(1) -11(1) 
C(5) 48(1) 37(1) 36(1) 4(1) 11(1) 5(1) 
C(6) 39(1) 24(1) 28(1) 1(1) 6(1) 7(1) 
C(7) 36(1) 27(1) 38(1) -6(1) 4(1) 12(1) 
C(8) 31(1) 19(1) 22(1) 1(1) 6(1) 0(1) 
C(9) 30(1) 20(1) 26(1) -6(1) 2(1) 1(1) 
C(10) 34(1) 23(1) 31(1) -9(1) 6(1) -2(1) 
C(11) 41(1) 98(2) 36(1) -14(1) 7(1) -20(1) 
C(12) 52(1) 136(2) 48(1) -22(1) 17(1) -40(1) 
C(13) 63(1) 77(2) 45(1) -15(1) 26(1) -28(1) 
C(14) 56(1) 45(1) 34(1) -3(1) 13(1) -4(1) 
C(15) 37(1) 34(1) 33(1) 0(1) 4(1) 0(1) 
C(16) 33(1) 23(1) 26(1) -5(1) 1(1) 4(1) 
C(17) 43(1) 32(1) 39(1) 4(1) 15(1) 7(1) 
C(18) 29(1) 23(1) 29(1) -4(1) 2(1) 1(1) 
C(19) 28(1) 22(1) 27(1) -1(1) 1(1) -1(1) 
N(2) 29(1) 27(1) 23(1) -3(1) -4(1) 6(1) 
C(20) 27(1) 32(1) 29(1) -1(1) 1(1) 7(1) 
C(21) 40(1) 67(1) 79(2) 8(1) 20(1) 0(1) 
C(22) 46(1) 32(1) 37(1) -3(1) 1(1) 13(1) 
C(23) 36(1) 22(1) 37(1) -7(1) -7(1) 5(1) 
C(24) 150(3) 55(2) 159(3) 14(2) 120(3) -3(2) 
C(25) 160(4) 57(2) 156(3) 1(2) 124(3) -13(2) 
C(26) 129(3) 82(2) 144(3) -2(2) 105(3) -14(2) 
C(27) 96(4) 110(5) 92(5) 7(4) 28(4) -47(4) 
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Table D5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) for cs206m. 
 
 x y z U(eq) 
H(1A) 9061 -9 -824 52 
H(1N) 6435(16) 3252(13) 424(11) 36(5) 
H(2A) 8173 -1504 -1356 77 
H(3A) 6526 -2079 -909 80 
H(4A) 5725 -1174 53 66 
H(5A) 6593 307 590 48 
H(7A) 8912 1074 937 41 
H(7B) 9143 1415 34 41 
H(9A) 7770 4234 1761 31 
H(11A) 4641 3808 1179 70 
H(12A) 3457 3349 2117 94 
H(13A) 4293 3046 3532 71 
H(14A) 6278 3330 4028 54 
H(15A) 7451 3831 3095 42 
H(16A) 5782 5000 542 34 
H(17A) 7158 6090 127 44 
H(17B) 8242 5607 850 44 
H(2N) 5884(14) 7369(12) 2147(11) 27(4) 
H(20A) 4236 8151 872 36 
H(21A) 3305 6982 1589 91 
H(21B) 2808 8073 1697 91 
H(21C) 3728 7576 2454 91 
H(22A) 5471 9369 1627 59 
H(22B) 5071 9051 2479 59 
H(22C) 4144 9544 1724 59 
H(23A) 6944 6346 2645 51 
H(23B) 8090 6633 2292 51 
H(23C) 7805 5493 2446 51 
H(24A) 9548 6352 -894 131 
H(25A) 10900 6523 340 134 
H(27A) 11899 5875 1428 147 
H(27B) 12248 4732 1368 147 











Table E1.  Crystal data and structure refinement for corey70s. 
Identification code  corey70s 
Empirical formula  C19H18BrNO3 
Formula weight  388.25 
Temperature  571(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P2(1)2(1)2(1) 
Unit cell dimensions a = 5.3668(3) Å α= 90°. 
 b = 14.3480(7) Å β= 90°. 
 c = 23.0874(11) Å γ = 90°. 
Volume 1777.80(16) Å3 
Z 4 
Density (calculated) 1.451 Mg/m3 
Absorption coefficient 2.328 mm-1 
F(000) 792 
Crystal size 0.20 x 0.20 x 0.20 mm3 
Theta range for data collection 1.67 to 32.50°. 
Index ranges -8<=h<=8, -21<=k<=21, -34<=l<=34 
Reflections collected 23271 
Independent reflections 6280 [R(int) = 0.0503] 
Completeness to theta = 32.50° 99.2 %  
Absorption correction None 
Max. and min. transmission 0.6532 and 0.6532 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6280 / 0 / 222 
Goodness-of-fit on F2 0.955 
Final R indices [I>2sigma(I)] R1 = 0.0432, wR2 = 0.0849 
R indices (all data) R1 = 0.1031, wR2 = 0.1043 
Absolute structure parameter 0.000(9) 
Largest diff. peak and hole 0.418 and -0.209 e.Å-3 
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Table E2. Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2 x 103) for corey70s.  
U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
 
 x y z U(eq) 
Br 540(1) 8523(1) 101(1) 64(1) 
O(1) 5378(3) 8602(2) -2658(1) 53(1) 
O(2) -4945(3) 10722(2) -3538(1) 66(1) 
O(3) -2742(4) 10928(2) -2725(1) 63(1) 
N 1264(4) 8552(2) -2842(1) 44(1) 
C(1) 569(6) 8000(2) -1655(1) 51(1) 
C(2) -17(6) 7987(2) -1072(1) 56(1) 
C(3) 1458(5) 8464(2) -689(1) 48(1) 
C(4) 3570(6) 8914(2) -878(1) 57(1) 
C(5) 4148(5) 8926(2) -1458(1) 51(1) 
C(6) 2610(4) 8481(2) -1854(1) 40(1) 
C(7) 3222(4) 8550(2) -2488(1) 39(1) 
C(8) 1448(4) 8680(2) -3472(1) 39(1) 
C(9) -694(5) 9264(2) -3664(1) 42(1) 
C(10) -492(7) 9984(2) -4123(1) 64(1) 
C(11) -671(5) 10286(2) -3507(1) 51(1) 
C(12) -3018(5) 10672(2) -3279(1) 50(1) 
C(13) -4998(7) 11206(3) -2434(2) 79(1) 
C(14) 1533(5) 7757(2) -3787(1) 46(1) 
C(15) 3171(6) 7604(3) -4230(2) 74(1) 
C(16) 3168(9) 6768(3) -4534(2) 97(1) 
C(17) 1585(9) 6082(3) -4394(2) 92(1) 
C(18) -56(10) 6213(3) -3951(2) 104(2) 
C(19) -78(8) 7054(3) -3651(2) 81(1) 
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Table E3. Bond lengths [Å] and angles [°] for corey70s. 
 
Br-C(3) 1.890(2) C(14)-C(15) 1.367(4) N-C(8)-C(14) 111.7(2) 
O(1)-C(7) 1.224(3) C(15)-C(16) 1.389(5) C(9)-C(8)-C(14) 111.9(2) 
O(2)-C(12) 1.198(3) C(16)-C(17) 1.341(6) C(10)-C(9)-C(8) 123.2(3) 
O(3)-C(12) 1.339(4) C(17)-C(18) 1.363(6) C(10)-C(9)-C(11) 59.68(19) 
O(3)-C(13) 1.441(4) C(18)-C(19) 1.391(5) C(8)-C(9)-C(11) 117.9(2) 
N-C(7) 1.331(3) C(12)-O(3)-C(13) 115.4(3) C(9)-C(10)-C(11) 61.07(17) 
N-C(8) 1.470(3) C(7)-N-C(8) 123.7(2) C(12)-C(11)-C(10) 120.4(3) 
C(1)-C(6) 1.374(4) C(6)-C(1)-C(2) 120.9(3) C(12)-C(11)-C(9) 116.3(2) 
C(1)-C(2) 1.382(4) C(3)-C(2)-C(1) 119.4(3) C(10)-C(11)-C(9) 59.26(18) 
C(2)-C(3) 1.371(4) C(2)-C(3)-C(4) 120.3(2) O(2)-C(12)-O(3) 123.9(3) 
C(3)-C(4) 1.376(4) C(2)-C(3)-Br 119.7(2) O(2)-C(12)-C(11) 125.6(3) 
C(4)-C(5) 1.374(4) C(4)-C(3)-Br 120.0(2) O(3)-C(12)-C(11) 110.5(3) 
C(5)-C(6) 1.388(4) C(5)-C(4)-C(3) 120.0(3) C(19)-C(14)-C(15) 117.4(3) 
C(6)-C(7) 1.503(3) C(4)-C(5)-C(6) 120.2(3) C(19)-C(14)-C(8) 121.2(3) 
C(8)-C(9) 1.491(4) C(1)-C(6)-C(5) 119.0(2) C(15)-C(14)-C(8) 121.3(3) 
C(8)-C(14) 1.511(4) C(1)-C(6)-C(7) 122.2(2) C(14)-C(15)-C(16) 121.1(4) 
C(9)-C(10) 1.483(4) C(5)-C(6)-C(7) 118.8(2) C(17)-C(16)-C(15) 120.9(4) 
C(9)-C(11) 1.510(4) O(1)-C(7)-N 123.3(2) C(16)-C(17)-C(18) 119.2(4) 
C(10)-C(11) 1.490(4) O(1)-C(7)-C(6) 121.5(2) C(17)-C(18)-C(19) 120.0(4) 
C(11)-C(12) 1.474(4) N-C(7)-C(6) 115.2(2) C(14)-C(19)-C(18) 121.4(4) 
C(14)-C(19) 1.365(4) N-C(8)-C(9) 108.2(2)   
 
  245
Table E4. Anisotropic displacement parameters (Å2 x 103) for corey70s. The anisotropic displacement factor 
exponent takes the form:  -2π2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
 
 U11 U22 U33 U23 U13 U12 
Br 80(1) 80(1) 34(1) -2(1) 5(1) 11(1) 
O(1) 35(1) 79(1) 45(1) 7(1) 2(1) -4(1) 
O(2) 37(1) 93(2) 69(1) 2(1) -9(1) 1(1) 
O(3) 52(1) 66(1) 71(1) -16(1) -6(1) 1(1) 
N 34(1) 65(2) 32(1) 4(1) 5(1) 1(1) 
C(1) 53(2) 66(2) 35(1) 0(1) -3(1) -15(2) 
C(2) 55(2) 72(2) 40(1) 8(1) 4(1) -7(2) 
C(3) 54(2) 55(2) 34(1) 3(1) -2(1) 13(2) 
C(4) 58(2) 70(2) 41(2) -10(1) -11(1) -6(2) 
C(5) 45(2) 64(2) 44(1) -2(1) -2(1) -6(1) 
C(6) 37(1) 47(1) 35(1) 1(1) -1(1) 4(1) 
C(7) 36(1) 43(1) 38(1) 1(1) 0(1) 0(1) 
C(8) 32(1) 53(2) 33(1) 2(1) 3(1) -4(1) 
C(9) 33(1) 55(2) 37(1) 1(1) -2(1) -4(1) 
C(10) 57(2) 86(2) 49(2) 22(2) 11(2) 6(2) 
C(11) 33(1) 56(2) 65(2) 2(1) 0(2) -7(1) 
C(12) 42(2) 45(2) 64(2) 1(1) -4(1) -7(1) 
C(13) 76(2) 74(2) 88(3) -20(2) 6(2) 12(2) 
C(14) 40(1) 61(2) 37(1) 2(1) -1(1) 3(1) 
C(15) 60(2) 94(3) 67(2) -14(2) 20(2) -1(2) 
C(16) 87(3) 111(4) 92(3) -47(3) 26(3) 10(3) 
C(17) 99(3) 77(3) 100(3) -34(2) -12(3) 17(3) 
C(18) 132(4) 68(2) 112(3) -19(2) 14(3) -34(3) 
C(19) 91(3) 76(2) 77(2) -16(2) 29(2) -24(2) 
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Table E5. Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2 x 103) for corey70s. 
 
 x y z U(eq) 
H(1N) -140(60) 8630(20) -2732(12) 45(8) 
H(1A) -433 7679 -1916 61 
H(2A) -1400 7657 -942 67 
H(4A) 4607 9212 -613 68 
H(5A) 5574 9232 -1585 61 
H(8A) 2992 9018 -3556 47 
H(9A) -2327 8962 -3636 50 
H(10A) -1932 10086 -4369 77 
H(10B) 1103 10054 -4316 77 
H(11A) 867 10522 -3331 62 
H(13A) -4623 11370 -2040 119 
H(13B) -6166 10699 -2438 119 
H(13C) -5708 11734 -2628 119 
H(15A) 4306 8066 -4330 88 
H(16A) 4279 6684 -4839 116 
H(17A) 1605 5522 -4597 110 
H(18A) -1160 5741 -3849 125 










Table F1.  Crystal data and structure refinement for cory121s. 
Identification code  cory121s 
Empirical formula  C30H32N2O5 
Formula weight  500.58 
Temperature  295(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P2(1)2(1)2(1) 
Unit cell dimensions a = 10.4318(5) Å α= 90°. 
 b = 14.7988(6) Å β= 90°. 
 c = 35.7592(15) Å γ = 90°. 
Volume 5520.4(4) Å3 
Z 8 
Density (calculated) 1.205 Mg/m3 
Absorption coefficient 0.082 mm-1 
F(000) 2128 
Crystal size 0.12 x 0.12 x 0.23 mm3 
Theta range for data collection 1.49 to 25.00°. 
Index ranges -12<=h<=12, -17<=k<=17, -42<=l<=42 
Reflections collected 44716 
Independent reflections 9744 [R(int) = 0.1002] 
Completeness to theta = 25.00° 100.0 %  
Absorption correction Sadabs 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 9744 / 0 / 685 
Goodness-of-fit on F2 0.950 
Final R indices [I>2sigma(I)] R1 = 0.0673, wR2 = 0.1393 
R indices (all data) R1 = 0.1350, wR2 = 0.1639 
Absolute structure parameter -0.6(15) 
Largest diff. peak and hole 0.177 and -0.140 e.Å-3 
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Table F2. Atomic coordinates  (x 104) and equivalent  isotropic displacement parameters (Å2 x 103) for cory121s.  
U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
 
 x y z U(eq)  x y z U(eq) 
O(1) 8354(3) 3794(2) 1948(1) 71(1) C(24) 1871(6) 11232(3) 1537(1) 87(2) 
N(1) 6863(3) 5926(2) 2130(1) 41(1) C(25) 1211(5) 11527(3) 1194(1) 54(1) 
C(1) 9178(5) 7111(3) 2419(1) 69(1) C(26) 1851(6) 11867(4) 901(2) 83(2) 
O(2) 6347(3) 4110(2) 2102(1) 70(1) C(27) 1243(10) 12179(5) 588(2) 117(3) 
N(2) 3851(3) 9312(2) 1666(1) 45(1) C(28) -39(11) 12155(5) 570(2) 128(4) 
C(2) 9575(6) 7996(4) 2369(2) 97(2) C(29) -739(7) 11840(4) 856(3) 108(2) 
O(3) 6393(3) 6460(2) 1561(1) 66(1) C(30) -115(6) 11502(3) 1177(2) 78(2) 
C(3) 10357(6) 8210(4) 2082(2) 94(2) C(31) 5531(6) 11205(4) 1113(2) 85(2) 
N(3) 4652(4) 9254(3) 304(1) 66(1) C(32) 5429(6) 11811(5) 1398(2) 101(2) 
O(4) 2577(3) 10405(2) 1460(1) 56(1) C(33) 5272(7) 12708(5) 1317(2) 109(2) 
C(4) 10800(5) 7553(4) 1847(2) 81(2) C(34) 5230(7) 12972(4) 951(2) 114(2) 
N(4) 8065(4) 6324(3) 910(1) 63(1) C(35) 5314(7) 12361(4) 667(2) 97(2) 
O(5) 3085(3) 10352(2) 2070(1) 62(1) C(36) 5472(5) 11448(3) 746(2) 68(1) 
C(5) 10377(4) 6668(3) 1895(1) 64(1) C(37) 5580(5) 10742(3) 446(2) 83(2) 
C(6) 9583(4) 6435(3) 2182(1) 47(1) C(38) 4342(5) 10178(3) 396(1) 61(1) 
O(6) 2425(4) 10071(3) 59(1) 94(1) C(39) 3433(6) 10593(4) 120(1) 73(2) 
C(7) 9095(4) 5480(3) 2226(1) 51(1) C(40) 1506(8) 10445(5) -203(2) 153(3) 
O(7) 3599(5) 11318(3) -24(1) 114(2) C(41) 4914(5) 8655(3) 568(1) 65(1) 
C(8) 7852(4) 5317(3) 2006(1) 41(1) C(42) 5587(6) 7799(3) 455(1) 75(2) 
O(8) 4672(4) 8814(2) 898(1) 78(1) C(43) 5290(6) 6969(3) 685(2) 93(2) 
C(9) 7409(4) 4350(3) 2028(1) 46(1) C(44) 6488(5) 7459(3) 754(1) 61(1) 
O(9) 8959(3) 5040(2) 1080(1) 67(1) C(45) 5930(9) 7683(4) 43(1) 148(4) 
C(10) 8049(5) 2832(3) 1956(2) 90(2) C(46) 7810(5) 7104(3) 670(1) 64(1) 
O(10) 9479(3) 5651(2) 519(1) 75(1) C(47) 8822(6) 7840(3) 714(2) 75(2) 
C(11) 6234(4) 6489(3) 1905(1) 38(1) C(48) 9977(9) 7720(6) 880(2) 134(3) 
C(12) 5351(4) 7167(3) 2078(1) 41(1) C(49) 10892(10) 8430(8) 905(2) 169(5) 
C(13) 4008(4) 7166(3) 1919(1) 57(1) C(50) 10575(14) 9255(8) 755(3) 181(6) 
C(14) 4890(4) 7897(2) 1815(1) 41(1) C(51) 9500(13) 9356(8) 591(5) 254(9) 
C(15) 5520(5) 7367(3) 2489(1) 62(1) C(52) 8589(8) 8669(6) 575(3) 194(5) 
C(16) 4704(4) 8859(2) 1938(1) 41(1) C(53) 8880(5) 5677(3) 809(1) 56(1) 
C(17) 5950(4) 9368(2) 1986(1) 42(1) C(54) 9832(5) 4293(3) 1014(1) 75(2) 
C(18) 6181(5) 9872(3) 2299(1) 58(1) C(55) 11102(5) 4450(3) 1198(2) 69(1) 
C(19) 7305(5) 10344(3) 2342(1) 70(1) C(56) 11378(6) 4048(4) 1532(2) 85(2) 
C(20) 8225(5) 10319(3) 2067(2) 74(1) C(57) 12531(8) 4190(5) 1714(2) 104(2) 
C(21) 8014(5) 9808(3) 1755(2) 72(1) C(58) 13406(8) 4735(5) 1557(3) 115(2) 
C(22) 6890(5) 9334(3) 1716(1) 63(1) C(59) 13219(8) 5126(5) 1232(3) 117(2) 
C(23) 3194(4) 10050(3) 1757(1) 45(1) C(60) 12048(8) 5001(4) 1043(2) 107(2) 
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Table F3. Bond lengths [Å] and angles [°] for  cory121s. 
 
O(1)-C(9) 1.316(5) C(43)-C(44) 1.464(7) O(5)-C(23)-O(4) 122.7(4) 
O(1)-C(10) 1.459(5) C(44)-C(46) 1.506(7) N(2)-C(23)-O(4) 111.9(4) 
N(1)-C(11) 1.332(5) C(46)-C(47) 1.526(8) O(4)-C(24)-C(25) 109.1(4) 
N(1)-C(8) 1.439(5) C(47)-C(52) 1.345(9) C(26)-C(25)-C(30) 118.2(5) 
C(1)-C(6) 1.377(6) C(47)-C(48) 1.355(9) C(26)-C(25)-C(24) 122.0(5) 
C(1)-C(2) 1.386(7) C(48)-C(49) 1.423(10) C(30)-C(25)-C(24) 119.7(5) 
O(2)-C(9) 1.192(4) C(49)-C(50) 1.374(14) C(25)-C(26)-C(27) 122.4(6) 
N(2)-C(23) 1.330(5) C(50)-C(51) 1.274(18) C(28)-C(27)-C(26) 119.6(7) 
N(2)-C(16) 1.479(5) C(51)-C(52) 1.394(13) C(27)-C(28)-C(29) 121.1(7) 
C(2)-C(3) 1.349(8) C(54)-C(55) 1.497(7) C(28)-C(29)-C(30) 119.5(7) 
O(3)-C(11) 1.242(4) C(55)-C(56) 1.365(7) C(25)-C(30)-C(29) 119.2(6) 
C(3)-C(4) 1.365(8) C(55)-C(60) 1.395(8) C(32)-C(31)-C(36) 122.9(6) 
N(3)-C(41) 1.326(6) C(56)-C(57) 1.385(8) C(31)-C(32)-C(33) 119.3(6) 
N(3)-C(38) 1.443(5) C(57)-C(58) 1.341(9) C(34)-C(33)-C(32) 118.9(6) 
O(4)-C(23) 1.349(5) C(58)-C(59) 1.314(9) C(35)-C(34)-C(33) 121.5(6) 
O(4)-C(24) 1.455(5) C(59)-C(60) 1.409(9) C(34)-C(35)-C(36) 120.0(6) 
C(4)-C(5) 1.392(7) C(9)-O(1)-C(10) 116.2(4) C(31)-C(36)-C(35) 117.2(5) 
N(4)-C(53) 1.330(6) C(11)-N(1)-C(8) 124.0(3) C(31)-C(36)-C(37) 120.1(5) 
N(4)-C(46) 1.462(5) C(6)-C(1)-C(2) 121.0(5) C(35)-C(36)-C(37) 122.7(5) 
O(5)-C(23) 1.210(4) C(23)-N(2)-C(16) 121.5(4) C(36)-C(37)-C(38) 113.2(4) 
C(5)-C(6) 1.364(6) C(3)-C(2)-C(1) 120.0(6) N(3)-C(38)-C(39) 112.3(4) 
C(6)-C(7) 1.511(6) C(2)-C(3)-C(4) 120.3(6) N(3)-C(38)-C(37) 110.5(4) 
O(6)-C(39) 1.323(6) C(41)-N(3)-C(38) 121.1(4) C(39)-C(38)-C(37) 112.5(4) 
O(6)-C(40) 1.450(7) C(23)-O(4)-C(24) 114.7(3) O(7)-C(39)-O(6) 124.4(6) 
C(7)-C(8) 1.535(5) C(3)-C(4)-C(5) 119.3(5) O(7)-C(39)-C(38) 123.7(6) 
O(7)-C(39) 1.203(6) C(53)-N(4)-C(46) 121.7(4) O(6)-C(39)-C(38) 111.9(5) 
C(8)-C(9) 1.506(6) C(6)-C(5)-C(4) 121.4(5) O(8)-C(41)-N(3) 121.0(5) 
O(8)-C(41) 1.230(5) C(5)-C(6)-C(1) 117.8(4) O(8)-C(41)-C(42) 121.0(4) 
O(9)-C(53) 1.354(5) C(5)-C(6)-C(7) 121.3(4) N(3)-C(41)-C(42) 117.9(4) 
O(9)-C(54) 1.452(5) C(1)-C(6)-C(7) 120.8(4) C(41)-C(42)-C(44) 112.5(4) 
O(10)-C(53) 1.210(5) C(39)-O(6)-C(40) 114.2(5) C(41)-C(42)-C(43) 116.3(5) 
C(11)-C(12) 1.496(5) C(6)-C(7)-C(8) 112.2(3) C(44)-C(42)-C(43) 58.1(3) 
C(12)-C(15) 1.510(5) N(1)-C(8)-C(9) 111.0(3) C(41)-C(42)-C(45) 117.6(4) 
C(12)-C(14) 1.512(5) N(1)-C(8)-C(7) 110.5(3) C(44)-C(42)-C(45) 120.0(5) 
C(12)-C(13) 1.512(6) C(9)-C(8)-C(7) 112.4(3) C(43)-C(42)-C(45) 118.8(4) 
C(13)-C(14) 1.469(6) O(2)-C(9)-O(1) 124.0(4) C(44)-C(43)-C(42) 60.9(3) 
C(14)-C(16) 1.504(5) O(2)-C(9)-C(8) 125.4(4) C(43)-C(44)-C(46) 125.1(4) 
C(16)-C(17) 1.512(5) O(1)-C(9)-C(8) 110.7(4) C(43)-C(44)-C(42) 61.0(3) 
C(17)-C(18) 1.367(5) C(53)-O(9)-C(54) 116.9(4) C(46)-C(44)-C(42) 123.1(4) 
C(17)-C(22) 1.379(6) O(3)-C(11)-N(1) 120.8(4) N(4)-C(46)-C(44) 109.0(4) 
C(18)-C(19) 1.373(7) O(3)-C(11)-C(12) 121.0(3) N(4)-C(46)-C(47) 112.1(4) 
C(19)-C(20) 1.372(7) N(1)-C(11)-C(12) 118.2(3) C(44)-C(46)-C(47) 111.4(4) 
C(20)-C(21) 1.366(7) C(11)-C(12)-C(15) 117.6(3) C(52)-C(47)-C(48) 116.2(7) 
C(21)-C(22) 1.375(6) C(11)-C(12)-C(14) 114.6(3) C(52)-C(47)-C(46) 119.2(7) 
C(24)-C(25) 1.474(6) C(15)-C(12)-C(14) 120.2(3) C(48)-C(47)-C(46) 124.6(5) 
C(25)-C(26) 1.341(7) C(11)-C(12)-C(13) 114.5(3) C(47)-C(48)-C(49) 121.8(8) 
C(25)-C(30) 1.385(7) C(15)-C(12)-C(13) 118.2(4) C(50)-C(49)-C(48) 118.0(10) 
C(26)-C(27) 1.365(9) C(14)-C(12)-C(13) 58.1(3) C(51)-C(50)-C(49) 119.8(12) 
C(27)-C(28) 1.340(11) C(14)-C(13)-C(12) 60.9(3) C(50)-C(51)-C(52) 122.2(14) 
C(28)-C(29) 1.340(10) C(13)-C(14)-C(16) 122.8(3) C(47)-C(52)-C(51) 121.8(10) 
C(29)-C(30) 1.410(8) C(13)-C(14)-C(12) 60.9(3) O(10)-C(53)-N(4) 125.9(4) 
C(31)-C(32) 1.363(7) C(16)-C(14)-C(12) 122.4(3) O(10)-C(53)-O(9) 123.9(4) 
C(31)-C(36) 1.363(7) N(2)-C(16)-C(14) 108.3(3) N(4)-C(53)-O(9) 110.2(4) 
C(32)-C(33) 1.368(9) N(2)-C(16)-C(17) 111.5(3) O(9)-C(54)-C(55) 111.5(4) 
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Table F3. Cont’d 
 
C(33)-C(34) 1.366(8) C(14)-C(16)-C(17) 113.2(3) C(56)-C(55)-C(60) 117.0(6) 
C(34)-C(35) 1.364(8) C(18)-C(17)-C(22) 118.0(4) C(56)-C(55)-C(54) 120.2(5) 
C(35)-C(36) 1.390(7) C(18)-C(17)-C(16) 121.1(4) C(60)-C(55)-C(54) 122.8(6) 
C(36)-C(37) 1.502(7) C(22)-C(17)-C(16) 120.8(3) C(55)-C(56)-C(57) 122.0(6) 
C(37)-C(38) 1.548(7) C(17)-C(18)-C(19) 121.2(4) C(58)-C(57)-C(56) 118.9(7) 
C(38)-C(39) 1.500(7) C(20)-C(19)-C(18) 120.4(5) C(59)-C(58)-C(57) 122.4(8) 
C(41)-C(42) 1.504(7) C(21)-C(20)-C(19) 119.0(5) C(58)-C(59)-C(60) 119.7(7) 
C(42)-C(44) 1.508(6) C(20)-C(21)-C(22) 120.3(5) C(55)-C(60)-C(59) 119.9(7) 
C(42)-C(43) 1.509(7) C(21)-C(22)-C(17) 121.0(4)   
C(42)-C(45) 1.527(7) O(5)-C(23)-N(2) 125.3(4)   
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Table F4. Anisotropic displacement parameters (Å2 x 103) for cory121s. The anisotropic displacement factor 
exponent takes the form:  -2π2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
 
 U11 U22 U33 U23 U13 U12 
O(1) 59(2) 43(2) 110(3) -7(2) 9(2) 8(2) 
N(1) 47(2) 46(2) 31(2) 2(2) 3(2) 13(2) 
C(1) 64(3) 68(3) 75(3) -10(3) -4(3) -11(3) 
O(2) 58(2) 60(2) 91(2) -12(2) 11(2) -12(2) 
N(2) 59(2) 42(2) 34(2) -6(2) -3(2) 13(2) 
C(2) 97(5) 67(4) 127(6) -30(4) -11(4) -9(4) 
O(3) 84(2) 72(2) 40(2) 10(2) 6(2) 35(2) 
C(3) 88(5) 69(4) 125(6) 19(4) -28(4) -19(4) 
N(3) 112(3) 52(2) 35(2) -1(2) -4(2) 20(2) 
O(4) 69(2) 55(2) 43(2) -2(1) -13(2) 28(2) 
C(4) 59(4) 97(4) 88(4) 35(4) -10(3) -23(3) 
N(4) 95(3) 55(3) 38(2) 6(2) 8(2) 6(2) 
O(5) 77(2) 66(2) 43(2) -12(2) -7(2) 27(2) 
C(5) 52(3) 70(3) 69(3) 3(2) 3(3) -6(3) 
C(6) 34(2) 54(3) 52(3) 5(2) -13(2) 4(2) 
O(6) 91(3) 86(3) 105(3) 0(2) -19(2) 20(2) 
C(7) 47(3) 52(3) 56(3) 5(2) -1(2) 7(2) 
O(7) 173(4) 69(3) 99(3) 37(2) 3(3) 15(3) 
C(8) 41(2) 47(2) 36(2) 6(2) 5(2) 7(2) 
O(8) 124(3) 72(2) 39(2) 1(2) -1(2) 16(2) 
C(9) 40(3) 52(3) 45(2) -4(2) 3(2) -4(2) 
O(9) 88(2) 63(2) 50(2) 12(2) 3(2) 18(2) 
C(10) 80(4) 40(3) 152(5) -12(3) -7(4) -2(3) 
O(10) 104(3) 75(2) 46(2) -4(2) 11(2) 20(2) 
C(11) 41(2) 43(2) 31(2) 4(2) 3(2) -2(2) 
C(12) 38(2) 47(2) 39(2) 9(2) -3(2) 4(2) 
C(13) 46(3) 47(3) 77(3) -5(2) -2(2) 7(2) 
C(14) 41(2) 42(2) 40(2) 2(2) -1(2) 11(2) 
C(15) 80(4) 67(3) 39(2) 5(2) 7(2) 35(3) 
C(16) 52(3) 40(2) 31(2) 7(2) -5(2) 5(2) 
C(17) 48(3) 35(2) 43(2) 6(2) -4(2) 3(2) 
C(18) 61(3) 58(3) 54(3) -10(2) -8(2) 4(3) 
C(19) 85(4) 62(3) 62(3) -11(3) -19(3) -4(3) 
C(20) 66(4) 64(3) 92(4) 7(3) -7(3) -21(3) 
C(21) 67(4) 75(4) 75(4) 0(3) 9(3) -11(3) 
C(22) 64(3) 65(3) 59(3) -11(2) -1(3) -12(3) 
C(23) 47(3) 45(3) 42(3) -7(2) 0(2) 7(2) 
C(24) 115(5) 79(4) 65(3) -10(3) -22(3) 58(3) 
C(25) 59(3) 49(3) 55(3) -9(2) -2(3) 16(2) 
C(26) 86(4) 75(4) 89(4) 5(3) 21(4) 21(3) 
C(27) 181(9) 95(5) 76(5) 21(4) 23(5) 55(6) 
C(28) 207(11) 95(5) 81(5) -3(4) -39(6) 89(7) 
C(29) 81(5) 87(5) 156(7) -14(5) -56(5) 23(4) 
C(30) 86(5) 54(3) 95(4) 5(3) 7(3) 1(3) 
C(31) 93(4) 69(4) 94(4) -2(3) -20(3) -15(3) 
C(32) 115(5) 106(5) 82(4) -9(4) -22(4) -16(4) 
C(33) 121(6) 102(6) 105(6) -25(4) -6(4) -9(4) 
C(34) 153(7) 68(4) 120(6) -13(4) -3(5) -2(4) 
C(35) 138(6) 58(4) 94(4) 11(3) 9(4) -4(4) 
C(36) 62(3) 60(3) 81(4) 2(3) 8(3) -7(3) 
C(37) 76(4) 70(4) 102(4) -3(3) 15(3) -2(3) 
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Table F4. Cont’d 
 
 U11 U22 U33 U23 U13 U12 
C(38) 81(4) 50(3) 52(3) 0(2) 8(2) 10(3) 
C(39) 104(5) 61(4) 54(3) 1(3) 6(3) 8(3) 
C(40) 156(7) 154(7) 148(7) -34(5) -81(6) 64(6) 
C(41) 93(4) 56(3) 46(3) 2(2) -7(2) -4(3) 
C(42) 124(5) 52(3) 48(3) -7(2) -26(3) 23(3) 
C(43) 111(5) 46(3) 123(5) 8(3) -33(4) -6(3) 
C(44) 92(4) 52(3) 37(2) 6(2) -8(3) -3(3) 
C(45) 291(11) 110(5) 44(3) -33(3) -42(5) 110(6) 
C(46) 102(4) 53(3) 37(3) 1(2) 9(2) 5(3) 
C(47) 101(5) 52(3) 72(4) 1(3) 30(3) -1(3) 
C(48) 170(9) 156(7) 74(4) 15(4) -29(5) -81(6) 
C(49) 231(11) 201(10) 76(5) 5(6) -21(6) -138(9) 
C(50) 265(15) 133(9) 145(8) -67(7) 105(10) -95(11) 
C(51) 173(12) 84(7) 500(30) 7(10) 95(14) -32(9) 
C(52) 113(7) 82(6) 388(16) 47(7) 40(8) -5(5) 
C(53) 72(3) 59(3) 37(3) -7(2) 1(2) 4(3) 
C(54) 95(4) 55(3) 76(3) -5(3) 1(3) 12(3) 
C(55) 79(4) 46(3) 81(4) -2(3) 11(3) 18(3) 
C(56) 85(4) 83(4) 86(4) -3(3) 0(3) 15(3) 
C(57) 111(6) 106(5) 96(5) -11(4) -15(5) 24(5) 
C(58) 103(6) 82(5) 161(8) -26(5) -4(6) 9(5) 
C(59) 107(6) 78(5) 166(8) 14(5) 4(6) -18(4) 
C(60) 124(6) 71(4) 126(6) 13(4) 9(5) 1(4) 
  253
Table F5. Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2 x 103) for cory121s. 
 
 x y z U(eq)  x y z U(eq) 
H(1N) 6710(30) 6040(20) 2350(10) 31(11) H(28) -451 12361 356 153 
H(1) 8629 6971 2615 83 H(29) -1629 11845 843 129 
H(2N) 4000(30) 9170(20) 1444(10) 32(11) H(30) -588 11266 1374 94 
H(2) 9302 8443 2533 116 H(31A) 5645 10598 1171 102 
H(3) 10596 8808 2043 113 H(32A) 5466 11618 1645 121 
H(3N) 4780(40) 9090(30) 85(12) 52(13) H(33A) 5195 13132 1508 131 
H(4) 11377 7694 1658 97 H(34A) 5141 13582 895 136 
H(4N) 7680(40) 6290(30) 1125(13) 68(15) H(35A) 5266 12555 420 116 
H(5) 10643 6226 1727 76 H(37A) 6283 10339 506 99 
H(7A) 8941 5360 2489 62 H(37B) 5783 11035 210 99 
H(7B) 9746 5061 2139 62 H(38A) 3906 10168 639 73 
H(8) 8028 5452 1743 50 H(40A) 809 10028 -235 229 
H(10A) 7782 2665 2204 136 H(40B) 1917 10546 -440 229 
H(10B) 8795 2489 1888 136 H(40C) 1184 11007 -108 229 
H(10C) 7370 2709 1782 136 H(43A) 4619 7016 872 112 
H(13A) 3803 6717 1731 68 H(43B) 5346 6386 562 112 
H(13B) 3309 7314 2088 68 H(44A) 6459 7824 982 73 
H(14) 5231 7840 1560 49 H(45A) 6100 8264 -66 223 
H(15A) 5328 6835 2632 93 H(45B) 5227 7403 -86 223 
H(15B) 4950 7846 2561 93 H(45C) 6678 7309 21 223 
H(15C) 6390 7548 2535 93 H(46A) 7822 6898 409 77 
H(16) 4266 8850 2180 49 H(48A) 10176 7158 981 160 
H(18) 5566 9896 2487 69 H(49A) 11682 8339 1020 203 
H(19) 7444 10681 2557 83 H(50A) 11143 9737 772 217 
H(20) 8981 10646 2094 88 H(51A) 9317 9908 479 304 
H(21) 8635 9781 1569 87 H(52A) 7797 8786 466 233 
H(22) 6761 8984 1503 75 H(54A) 9957 4217 747 90 
H(24A) 2456 11699 1621 104 H(54B) 9457 3741 1111 90 
H(24B) 1249 11125 1734 104 H(56A) 10774 3666 1640 102 
H(26) 2741 11890 910 100 H(57A) 12697 3912 1943 125 






X-ray crystal data for 408 
 
 
Table G1.  Crystal data and structure refinement for CORY903. 
Identification code  cory903 
Empirical formula  C39H45N5O6 
Formula weight  679.80 
Temperature  200(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1) 
Unit cell dimensions a = 11.475(2) Å α= 90°. 
 b = 12.1310(10) Å β= 94.809(4)°. 
 c = 13.299(2) Å γ = 90°. 
Volume 1844.7(5) Å3 
Z 2 
Density (calculated) 1.224 Mg/m3 
Absorption coefficient 0.083 mm-1 
F(000) 724 
Crystal size 0.11 x 0.11 x 0.21 mm3 
Theta range for data collection 1.54 to 32.60°. 
Index ranges -17<=h<=16, -18<=k<=18, -19<=l<=19 
Reflections collected 22963 
Independent reflections 12339 [R(int) = 0.0769] 
Completeness to theta = 32.60° 95.9 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 12339 / 1 / 457 
Goodness-of-fit on F2 0.916 
Final R indices [I>2sigma(I)] R1 = 0.0729, wR2 = 0.1562 
R indices (all data) R1 = 0.1672, wR2 = 0.1986 
Absolute structure parameter -0.3(13) 
Largest diff. peak and hole 0.364 and -0.212 e.Å-3 
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Table G2. Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2x 103) for CORY903.  
U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
 
 x y z U(eq) 
N(1) 8874(3) 5637(2) 7403(2) 51(1) 
O(1) 7737(2) 4834(2) 6164(2) 61(1) 
C(1) 9351(4) 6608(3) 7949(3) 61(1) 
O(2) 8865(2) 9411(2) 6683(2) 46(1) 
N(2) 8774(2) 8493(2) 5208(2) 36(1) 
C(2) 9486(4) 4593(4) 7614(3) 77(1) 
O(3) 10975(2) 6975(2) 6228(2) 56(1) 
N(3) 11189(2) 8445(2) 5234(2) 37(1) 
C(3) 8031(3) 5668(3) 6654(3) 46(1) 
O(4) 9698(2) 6879(2) 3794(1) 40(1) 
N(4) 11641(2) 6906(2) 3657(2) 37(1) 
C(4) 7430(3) 6725(3) 6441(2) 50(1) 
N(5) 10853(2) 4668(3) 1170(2) 47(1) 
O(5) 11804(3) 4830(3) -243(2) 90(1) 
C(5) 6249(3) 6738(4) 5843(3) 65(1) 
C(6) 7294(2) 7117(3) 5357(2) 44(1) 
O(6) 12558(2) 3877(3) 1135(2) 80(1) 
C(7) 7520(2) 8306(3) 5159(2) 40(1) 
C(8) 9356(2) 9020(2) 5984(2) 34(1) 
C(9) 10654(2) 9163(3) 5943(2) 43(1) 
C(10) 11305(2) 7371(3) 5462(2) 38(1) 
C(11) 11899(2) 6651(2) 4733(2) 37(1) 
C(12) 13235(2) 6757(3) 4878(3) 50(1) 
C(13) 13612(3) 6338(3) 3870(3) 56(1) 
C(14) 12696(3) 6787(3) 3102(3) 53(1) 
C(15) 10528(2) 6902(2) 3256(2) 37(1) 
C(16) 10313(3) 6887(3) 2133(2) 46(1) 
C(17) 9137(3) 7185(3) 1633(3) 59(1) 
C(18) 9501(3) 6005(3) 1712(2) 43(1) 
C(19) 9852(3) 5332(3) 835(2) 45(1) 
C(20) 11728(3) 4494(4) 610(3) 60(1) 
C(21) 13693(3) 3706(5) 690(3) 122(2) 
C(22) 14644(3) 4354(5) 1378(3) 128(3) 
C(23) 15389(3) 3798(5) 2083(3) 187(5) 
C(24) 16222(12) 4100(30) 2587(14) 370(20) 
C(25) 16383(10) 5360(20) 2583(11) 288(14) 
C(26) 15648(9) 6105(10) 1807(9) 194(5) 
C(27) 14783(9) 5517(9) 1231(8) 164(3) 
C(28) 5711(3) 8838(3) 4058(3) 57(1) 
C(29) 5134(3) 9222(3) 3182(4) 70(1) 
C(30) 5782(4) 9542(5) 2396(4) 95(2) 
C(31) 6948(4) 9464(6) 2485(3) 111(2) 
C(32) 7522(3) 9079(5) 3381(3) 95(2) 
C(33) 6916(2) 8746(3) 4166(2) 45(1) 
C(34) 8794(4) 3551(4) 423(3) 77(1) 
C(35) 7800(5) 2989(5) -2(4) 98(2) 
C(36) 6927(4) 3512(6) -507(4) 98(2) 
C(37) 6967(4) 4626(6) -577(4) 106(2) 
C(38) 7909(4) 5214(4) -152(3) 78(1) 
C(39) 8834(3) 4663(3) 362(2) 47(1) 
  256
Table G3. Bond lengths [Å] and angles [°] for  CORY903. 
 
N(1)-C(3) 1.329(4) C(28)-C(33) 1.383(4) C(11)-C(12)-C(13) 102.5(3) 
N(1)-C(1) 1.466(5) C(29)-C(30) 1.389(7) C(14)-C(13)-C(12) 104.0(3) 
N(1)-C(2) 1.464(5) C(30)-C(31) 1.336(6) N(4)-C(14)-C(13) 104.6(3) 
O(1)-C(3) 1.235(4) C(31)-C(32) 1.393(6) O(4)-C(15)-N(4) 121.5(2) 
O(2)-C(8) 1.223(3) C(32)-C(33) 1.363(5) O(4)-C(15)-C(16) 120.4(3) 
N(2)-C(8) 1.342(4) C(34)-C(39) 1.353(6) N(4)-C(15)-C(16) 118.0(2) 
N(2)-C(7) 1.453(4) C(34)-C(35) 1.406(6) C(15)-C(16)-C(18) 115.4(3) 
O(3)-C(10) 1.215(3) C(35)-C(36) 1.321(8) C(15)-C(16)-C(17) 120.6(3) 
N(3)-C(10) 1.342(4) C(36)-C(37) 1.356(8) C(18)-C(16)-C(17) 59.8(2) 
N(3)-C(9) 1.457(4) C(37)-C(38) 1.376(6) C(18)-C(17)-C(16) 60.1(2) 
C(3)-C(4) 1.472(5) C(38)-C(39) 1.385(5) C(17)-C(18)-C(16) 60.2(2) 
O(4)-C(15) 1.239(3) C(3)-N(1)-C(1) 124.5(3) C(17)-C(18)-C(19) 123.9(3) 
N(4)-C(15) 1.341(4) C(3)-N(1)-C(2) 118.4(3) C(16)-C(18)-C(19) 118.6(3) 
N(4)-C(11) 1.470(4) C(1)-N(1)-C(2) 116.6(3) N(5)-C(19)-C(18) 108.7(2) 
N(4)-C(14) 1.477(4) C(8)-N(2)-C(7) 122.4(2) N(5)-C(19)-C(39) 113.3(3) 
C(4)-C(6) 1.513(5) C(10)-N(3)-C(9) 118.2(3) C(18)-C(19)-C(39) 111.4(3) 
C(4)-C(5) 1.512(5) O(1)-C(3)-N(1) 121.4(3) O(5)-C(20)-N(5) 126.3(4) 
N(5)-C(20) 1.317(4) O(1)-C(3)-C(4) 120.6(3) O(5)-C(20)-O(6) 124.3(4) 
N(5)-C(19) 1.442(4) N(1)-C(3)-C(4) 118.0(3) N(5)-C(20)-O(6) 109.4(3) 
O(5)-C(20) 1.215(4) C(15)-N(4)-C(11) 119.6(2) O(6)-C(21)-C(22) 106.6(2) 
C(5)-C(6) 1.482(5) C(15)-N(4)-C(14) 126.5(2) C(23)-C(22)-C(27) 120.0(5) 
C(6)-C(7) 1.493(5) C(11)-N(4)-C(14) 111.0(2) C(23)-C(22)-C(21) 120.4 
O(6)-C(20) 1.357(5) C(3)-C(4)-C(6) 117.8(3) C(27)-C(22)-C(21) 119.5(5) 
O(6)-C(21) 1.489(4) C(3)-C(4)-C(5) 119.7(3) C(24)-C(23)-C(22) 130.8(15) 
C(7)-C(33) 1.536(4) C(6)-C(4)-C(5) 58.6(2) C(23)-C(24)-C(25) 114(2) 
C(8)-C(9) 1.505(4) C(20)-N(5)-C(19) 122.6(3) C(26)-C(25)-C(24) 121.2(15) 
C(10)-C(11) 1.508(4) C(6)-C(5)-C(4) 60.7(2) C(27)-C(26)-C(25) 112.6(12) 
C(11)-C(12) 1.534(4) C(5)-C(6)-C(7) 122.4(3) C(26)-C(27)-C(22) 120.6(10) 
C(12)-C(13) 1.529(5) C(5)-C(6)-C(4) 60.7(2) C(29)-C(28)-C(33) 121.5(4) 
C(13)-C(14) 1.505(5) C(7)-C(6)-C(4) 117.8(3) C(30)-C(29)-C(28) 118.9(3) 
C(15)-C(16) 1.493(4) C(20)-O(6)-C(21) 118.1(3) C(31)-C(30)-C(29) 120.6(4) 
C(16)-C(18) 1.496(4) N(2)-C(7)-C(6) 109.3(2) C(30)-C(31)-C(32) 119.9(5) 
C(16)-C(17) 1.497(5) N(2)-C(7)-C(33) 111.0(2) C(33)-C(32)-C(31) 121.3(4) 
C(17)-C(18) 1.491(5) C(6)-C(7)-C(33) 114.5(3) C(32)-C(33)-C(28) 117.8(3) 
C(18)-C(19) 1.507(4) O(2)-C(8)-N(2) 122.5(2) C(32)-C(33)-C(7) 122.7(3) 
C(19)-C(39) 1.516(4) O(2)-C(8)-C(9) 120.2(3) C(28)-C(33)-C(7) 119.5(3) 
C(21)-C(22) 1.5741 N(2)-C(8)-C(9) 117.2(2) C(39)-C(34)-C(35) 119.3(5) 
C(22)-C(23) 1.39 N(3)-C(9)-C(8) 115.3(2) C(36)-C(35)-C(34) 121.8(5) 
C(22)-C(27) 1.435(11) O(3)-C(10)-N(3) 122.8(3) C(35)-C(36)-C(37) 119.0(5) 
C(23)-C(24) 1.181(16) O(3)-C(10)-C(11) 119.9(3) C(38)-C(37)-C(36) 121.3(5) 
C(24)-C(25) 1.53(3) N(3)-C(10)-C(11) 117.3(3) C(37)-C(38)-C(39) 119.7(5) 
C(25)-C(26) 1.57(2) N(4)-C(11)-C(10) 116.0(2) C(34)-C(39)-C(38) 118.9(4) 
C(26)-C(27) 1.396(13) N(4)-C(11)-C(12) 102.8(2) C(34)-C(39)-C(19) 122.5(3) 
C(28)-C(29) 1.372(6) C(10)-C(11)-C(12) 111.8(2) C(38)-C(39)-C(19) 118.6(3) 
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Table G4. Anisotropic displacement parameters (Å2 x 103) for CORY903. The anisotropic displacement factor 
exponent takes the form:  -2π2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
 
 U11 U22 U33 U23 U13 U12 
N(1) 63(2) 45(2) 46(2) -1(1) 8(1) 10(1) 
O(1) 57(1) 60(2) 68(2) -7(1) 5(1) 2(1) 
C(1) 88(3) 53(2) 42(2) 0(2) 0(2) 4(2) 
O(2) 51(1) 55(1) 32(1) -6(1) 5(1) 6(1) 
N(2) 30(1) 42(1) 36(1) -5(1) 0(1) 7(1) 
C(2) 99(3) 66(3) 64(2) 2(2) -11(2) 27(2) 
O(3) 67(1) 56(2) 48(1) 9(1) 14(1) 11(1) 
N(3) 36(1) 39(1) 37(1) -7(1) 1(1) -3(1) 
C(3) 46(2) 50(2) 46(2) -2(2) 17(2) -2(2) 
O(4) 33(1) 45(1) 41(1) -6(1) 0(1) -1(1) 
N(4) 33(1) 44(1) 33(1) -2(1) 5(1) -4(1) 
C(4) 53(2) 57(2) 42(2) -4(2) 13(1) 7(2) 
N(5) 46(2) 68(2) 29(1) -4(1) 5(1) -4(1) 
O(5) 105(2) 123(3) 46(2) 3(2) 35(2) 12(2) 
C(5) 41(2) 72(3) 81(3) 10(2) 6(2) 0(2) 
C(6) 33(1) 56(2) 42(2) -4(2) 3(1) -1(1) 
O(6) 63(2) 112(2) 67(2) -7(2) 14(1) 19(2) 
C(7) 28(1) 52(2) 40(2) -12(1) 6(1) 7(1) 
C(8) 33(1) 35(2) 32(1) 5(1) -3(1) 6(1) 
C(9) 38(2) 45(2) 44(2) -11(1) -3(1) 2(1) 
C(10) 28(1) 46(2) 39(2) 0(1) -1(1) 0(1) 
C(11) 33(1) 38(2) 38(2) 3(1) -5(1) 1(1) 
C(12) 33(1) 56(2) 59(2) -4(2) 1(1) 1(2) 
C(13) 40(2) 59(2) 72(3) -7(2) 17(2) -4(2) 
C(14) 45(2) 63(2) 52(2) -4(2) 14(2) -9(2) 
C(15) 43(2) 31(1) 35(1) -7(1) 0(1) -5(1) 
C(16) 55(2) 45(2) 39(2) 1(2) 5(1) -7(2) 
C(17) 75(2) 55(2) 44(2) 3(2) -14(2) 5(2) 
C(18) 43(2) 52(2) 34(2) 1(1) -4(1) -1(1) 
C(19) 49(2) 54(2) 30(2) 1(1) -2(1) -6(2) 
C(20) 61(2) 75(3) 44(2) -12(2) 5(2) -3(2) 
C(21) 108(4) 145(5) 121(5) -18(4) 65(4) 27(4) 
C(22) 44(2) 264(10) 81(4) 25(5) 23(2) 37(4) 
C(23) 101(5) 299(13) 169(8) 68(9) 54(5) 18(7) 
C(24) 85(7) 830(60) 193(14) 130(30) -28(7) -98(19) 
C(25) 68(6) 660(40) 135(10) -103(18) 9(6) 29(13) 
C(26) 138(8) 243(12) 211(11) -92(10) 84(8) -52(8) 
C(27) 156(8) 177(8) 165(8) 2(7) 44(7) 4(7) 
C(28) 41(2) 54(2) 73(2) 1(2) -9(2) 3(2) 
C(29) 39(2) 70(2) 96(3) -9(2) -30(2) 10(2) 
C(30) 73(3) 142(5) 65(3) -1(3) -25(2) 33(3) 
C(31) 72(3) 204(7) 57(3) 30(3) -4(2) 44(4) 
C(32) 49(2) 189(6) 47(2) 21(3) 7(2) 39(3) 
C(33) 34(1) 56(2) 46(2) -6(2) -4(1) 7(1) 
C(34) 71(3) 78(3) 78(3) -15(2) -11(2) -12(2) 
C(35) 92(4) 86(4) 116(4) -42(3) 8(3) -30(3) 
C(36) 61(3) 137(5) 94(4) -64(4) -3(3) -19(3) 
C(37) 74(3) 135(5) 101(4) -26(4) -38(3) -5(3) 
C(38) 66(3) 92(3) 71(3) -4(2) -22(2) 0(2) 
C(39) 48(2) 63(2) 30(1) -6(2) 1(1) -7(2) 
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Table G5. Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2 x 103) for CORY903. 
 
 x y z U(eq) 
H(1A) 8890 7260 7733 92 
H(1B) 10166 6717 7804 92 
H(1C) 9314 6497 8676 92 
H(2N) 9260(20) 8120(20) 4810(19) 16(6) 
H(2A) 9106 4009 7196 116 
H(2B) 9459 4406 8329 116 
H(2C) 10302 4666 7459 116 
H(3N) 11580(30) 8800(30) 4760(30) 44(9) 
H(4A) 7566 7310 6967 60 
H(5N) 10820(30) 4500(30) 1750(30) 67(12) 
H(5A) 5903 6020 5626 77 
H(5B) 5678 7302 6020 77 
H(6A) 7586 6593 4855 52 
H(7A) 7211 8737 5720 48 
H(9A) 10810 9938 5763 51 
H(9B) 11040 9030 6626 51 
H(11A) 11682 5866 4851 44 
H(12A) 13565 6297 5446 60 
H(12B) 13476 7533 4999 60 
H(13A) 14398 6619 3748 68 
H(13B) 13626 5522 3854 68 
H(14A) 12940 7508 2842 63 
H(14B) 12552 6270 2529 63 
H(16A) 11001 7051 1744 55 
H(17A) 8533 7441 2068 71 
H(17B) 9109 7537 960 71 
H(18A) 9115 5573 2232 52 
H(19A) 10100 5855 311 54 
H(21A) 13650 3992 -10 146 
H(21B) 13888 2912 678 146 
H(23A) 15195 3045 2175 225 
H(24A) 16744 3618 2959 447 
H(25A) 16940 5686 3060 346 
H(26A) 15775 6873 1736 232 
H(27A) 14284 5891 737 197 
H(28A) 5272 8631 4603 68 
H(29A) 4304 9269 3115 84 
H(30A) 5393 9817 1789 114 
H(31A) 7384 9672 1939 134 
H(32A) 8352 9048 3446 114 
H(34A) 9431 3153 750 92 
H(35A) 7755 2212 77 118 
H(36A) 6281 3113 -817 117 
H(37A) 6333 5008 -926 127 






































Figure H.1. Amide proton chemical shift dependence on temperature for a 5.0 mM solution of 










































Figure H.2. Amide proton chemical shift dependence on temperature for a 5.0 mM solution of 







































Figure H.3. Amide proton chemical shift dependence on temperature for a 5.0 mM solution of 





































Figure H.4. Amide proton chemical shift dependence on temperature for a 5.0 mM solution of 






























Figure H.5. Amide proton chemical shift dependence on temperature for a 5.0 mM solution of 









































Figure H.6. Amide proton chemical shift dependence on temperature for a 5.0 mM solution of 
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